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Abstract 
Genomic imprinting provides an exception to the Mendelian rule of inheritance, as 
imprinted genes are preferentially expressed in a parent-of-origin specific manner. They play 
important roles in the development of embryonic and extra-embryonic lineages and 
postnatally in the maintenance of correct metabolic homeostasis as well as regulation of adult 
behaviour. The parental conflict theory predicts that maternally expressed genes act as growth 
suppressors, limiting the usage of maternal resources, and that paternally expressed genes 
function in an opposite manner to promote growth at the expense of maternal resources. 
Growth factor bound protein 10 (Grb10) is an imprinted gene encoding an intracellular adaptor 
protein that can interact with several receptor tyrosine kinases and downstream signalling 
molecules. Recently, our lab has identified Grb10 as a unique imprinted gene capable of 
influencing fetal growth, postnatal energy metabolism and adult behaviour depending on 
functions of each of the parental alleles in distinct tissues. Grb10 predominantly expressed 
from the maternal allele during embryogenesis affects fetal and placental growth along with 
postnatal glucose homeostasis, whereas paternal Grb10 expression within the CNS influences 
social behaviour. Delta-like homologue 1 is (Dlk1) a paternally expressed imprinted gene 
coding for a protein belonging to the Notch/Delta family that acts as a membrane-associated 
or a soluble protein known to regulate differentiation of various cell types, notably adipocytes. 
In vivo Dlk1 has been associated with perinatal survival, regulation of normal growth and 
development and maintenance of the correct course of adipogenesis. Here a hypothesis is 
proposed that Grb10, as a predominantly maternally expressed growth inhibitor and Dlk1, 
a paternally expressed growth promoter, act antagonistically in a common genetic pathway. To 
test this hypothesis, we have generated Grb10m/+/Dlk1+/p double knockout mice and performed 
a phenotypic characterisation in comparison with wild type as well as the respective single 
knockout animals. Results obtained from allometric and metabolic analyses, together with 
histological studies, reveal strong similarities between the phenotypes of Grb10m/+and 
Grb10m/+/Dlk1+/p knockout mice. We found that overgrowth of Grb10m/+/Dlk1+/p embryos and 
placentae resemble the phenotype seen in Grb10m/+ mutants and that tissue overgrowth most 
likely results from higher proliferation rates of Grb10m/+and Grb10m/+/Dlk1+/p cells. 
Furthermore, Grb10m/+and Grb10m/+/Dlk1+/p knockout mice each exhibit improved glucose 
clearance and share an unusual characteristic accumulation of lipid in neonatal liver. These 
results are consistent with the proposed hypothesis and indicate that the Dlk1 and Grb10 
genes might be involved in the same genetic pathway. Moreover, the data suggest Dlk1 is an 
inhibitor of Grb10 which is in turn acting as a growth suppressor.  
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1.1 Genomic imprinting 
1.1.1 Introduction 
The vast majority of genes are inherited and expressed in agreement with Mendelian rule 
of inheritance, which assumes the equality of both of the parental genomes. In contrast to 
that, there is a small subset of so-called imprinted genes that do not follow this rule and 
exhibit expression predominantly from only one of the parental alleles, either maternal or 
paternal (Figure 1.1). Imprinted genes are usually thought to account for only a minor part of 
the total number of genes in the genome. However, a recent genome-wide screen suggests 
that more than 1,300 loci could show imprinted expression within the mouse brain (Gregg et 
al., 2010), which implies an important role of imprinting within the brain that was previously 
under-appreciated. These predictions, however, should be carefully tested and confirmed by 
detailed analysis of differential allelic expression along with investigation of functional roles of 
genes identified in the study by Gregg et al (2010). The presence of imprinted genes is limited 
to only a few taxa, including placental mammals, marsupials and seed plants. The comparison 
of imprinted genes between different species serves several purposes. First of all, it aims to 
identify genes that are prone to be imprinted. Secondly, it intends to recognise the DNA 
sequences responsible for monoallelic gene expression. Finally, this type of comparison should 
allow for identification of conserved functions of imprinted genes and help to understand the 
evolution of imprinting. So far 144 imprinted genes have been identified in mice (see 
http://www.har.mrc.ac.uk/research/genomic_imprinting/ or http://igc.otago.ac.nz/home.html) 
and approximately 100 in humans, and among them many were found to share the imprinting 
status between these two species.  
The first experiments indicating the existence of imprinted genes showed that 
gynogenetic (possessing two maternal genome copies) and androgenetic (possessing two 
paternal genome copies) mouse embryos were not viable and exhibited a variety of growth 
abnormalities of both fetus and placenta (Barton et al., 1984; Mann and Lovell-Badge, 1984; 
McGrath and Solter, 1984; Surani et al., 1984; Barton et al., 1985). Furthermore, it was noted 
that the development of tissues that made up the fetuses was somewhat different: 
parthenogenotes consisted mainly of embryonic material, with poorly developed placentae 
and extra-embryonic membranes, while androgenotes showed more advanced development 
of extra-embryonic tissues with disrupted fetal development. At around the same time, 
specific chromosomal domains with imprinted genes were identified in mouse genetic 
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experiments that revealed opposite developmental phenotypes arising from uniparental 
disomic (UPD) inheritance of specific chromosome regions from either the mother or father, 
further confirming the functional non-equivalence of the genomes (Cattanach and Kirk, 1985). 
These experiments supported the idea that two genomes are unequal and that disruptions in 
development during parthenogenesis are the result of allele-specific expression of imprinted 
genes.  
The term ‘imprinting of the genome’ that referred to the phenomenon of non-genetic 
difference distinguishing two parental genomes and leading to their functional non-
equivalence was originally used by Surani and colleagues (1984), who were the first to suggest 
that in order for normal development to occur the contributions from both male and female 
pronuclei are crucial.  
 
Figure 1.1 Mode of expression in biallelic and imprinted genes. 
Three hypothetical genes are depicted on chromosomes inherited either maternally (Mat) or 
paternally (Pat), with transcriptional activity indicated by arrows. The majority of genes when 
transcriptionally active are expressed equally from both of the parental alleles (green). A small 
subset of genes is imprinted, meaning that they are expressed predominantly from only one of 
the parental alleles: either maternal (red) or paternal (blue) and silenced (imprinted) on the 
other allele. In the case of uniparental disomies (UPDs), double expression results from 
duplication of one of the parental alleles, while gene silencing occurs following duplication of 
the opposite parental allele.  
In the past, the key to identification of imprinted genes was based on mapping candidates 
within chromosomal regions which displayed opposite phenotypes when inherited as 
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uniparental disomies or following uniparental transmission of a deletion. In this way, 
Insulin-like growth factor 2 receptor (Igf2r) leading to the maternal-effect mutation in Tme 
mice was discovered as one of the first imprinted genes (Barlow et al., 1991). The growth 
retarded Igf2r mutants were seen only upon transmission of the mutation through the 
paternal line. At about the same time, the Insulin-like growth factor 2 (Igf2) (DeChiara et al., 
1991) and H19 (Bartolomei et al., 1991) genes were identified as imprinted genes. Once this 
complex, unique mode of monoallelic expression was discovered, investigation of the 
underlying mechanisms regulating imprinted expression and functions of imprinted genes was 
initiated.  
1.1.2 Evolution of genomic imprinting 
The obvious advantage of diploids over haploids comes down to protection against 
detrimental results of genetic damage or mutation. Where expression of a gene from only one 
of the chromosomes is sufficient, the presence of two copies can offer a 'backup' in the event 
of malfunction or damage of the other. From an evolutionary point of view, having diploid 
chromosomes and potentially more genetic variety provides a better chance of survival in case 
one of the chromosomes is not well adapted to the environment. An organism can discard the 
advantage of diploidy by inactivation of a group of genes and becoming functionally haploid at 
these loci. This is the case for imprinted genes which are inherited in two copies, but only one 
of them is transcriptionally active. The obvious question then concerns the advantage of 
imprinting that is able to compensate for the loss of diploidy. Since the discovery of genomic 
imprinting in the mid-1980s (Surani et al., 1984), evolutionary biologists have been trying to 
establish the selective pressures and mechanisms that led to the evolution of imprinting 
(Moore and Haig, 1991; Spencer et al., 1999; Iwasa and Pomiankowski, 2001; Wolf and Hager, 
2006). There is an overabundance of theories trying to explain the role of imprinting in 
mammalian evolution. The majority of proposed hypotheses aim to explain most of the typical 
characteristics of imprinted genes, which include localisation within clusters, tissue specificity, 
effects of encoded gene products on growth, presence of imprinting in the germline of both 
sexes and phylogenetic distribution of imprinting. Nonetheless, so far a single model explaining 
the variety of roles of imprinted genes has not been discovered (Hurst and McVean, 1997; 
Morison et al., 2001; Wilkins and Haig, 2003).  
Haig and Westoby (1989) laid the foundation for the most widely discussed model 
explaining the evolution of imprinting called the parental conflict theory. They suggested that 
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genomic imprinting is a result of a conflict between males and females over the allocation of 
maternal resources. According to this theory, the father (and paternally expressed genes in the 
embryo or/and placenta) will favour the acquisition of maternal resources for his offspring at 
the expense of the mother and her potential future offspring. Males, whose energy investment 
in raising the litter is small in contrast to females, will try to promote the nutrient transfer to 
their offspring and, as any particular male might not father future offspring with the same 
female, he will try to give his offspring the best chance of survival regardless of damage to the 
fitness of the female. On the other hand, the mother will try to maximise her lifetime 
reproductive performance by limiting allocation of resources to particular offspring or litters 
and trying to allocate them equally between all of her offspring. Consequently, an equilibrium 
between differentially expressed maternal and paternal imprinted genes is achieved in order 
for normal growth and development to occur (Moore and Haig, 1991). 
Interestingly, in addition to eutherians, imprinting has also been identified in angiosperms 
(flowering plants) and the phenotypic differences in seed size resulting from imprinting 
manipulation in them greatly resemble those observed in mouse phenotypes caused by 
imprinting manipulation (reviewed in Feil and Berger, 2007). There is no definite explanation 
for the imprinted genes existence within the angiosperm plants, but it has been indicated that 
angiosperm plants are similar to mammals in a way that biparental seeds are also grown by 
one of the parents and demands of the embryo need to be in balance with the fitness of the 
mother, so both interests are controlled by inactivation of certain growth-related genes in one 
of the parents, which is in agreement with parental conflict theory (Moore and Haig, 1991).  
Surprisingly, the authors who first mentioned parental conflict hypothesis were able to 
correctly predict the sites and times of expression of imprinted genes. They suggested any 
genes associated with maternal resources acquisition could be affected, in particular those 
functioning in placental growth and efficiency, suckling and appetite, neonatal behaviour, 
postnatal growth and metabolism. With time and increasing number of identified imprinted 
genes it became clear that the majority of them are indeed expressed in relevant tissues and 
are involved in the processes described above. For example, both the Grb10 and Dlk1 genes 
were found to have major roles in regulation of embryonic and postnatal growth as well as 
metabolism (Moon et al., 2002; Charalambous et al., 2003; Lee et al., 2003; Smith et al., 2007).  
Many of the initially discovered imprinted genes seemed to act consistently with the 
conflict hypothesis, including the reciprocally imprinted Igf2 and Igf2r genes that exerted 
opposite effects on fetal growth (Barlow et al., 1991; DeChiara et al., 1991). As mammals tend 
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to require maternal resources not only during fetal development but also in early postnatal 
life, it has been suggested that imprinted genes acting in agreement with conflict hypothesis 
play roles in resource acquisition pre- and post-natally. For example, the reciprocal postnatal 
effects on metabolic rate and deposition of brown fat are the result of mutations in the Gsa 
and Gnasxl transcripts in the Gnas imprinted cluster (Plagge and Kelsey, 2006). Moreover, 
concordant with paternally expressed genes functioning to enhance acquisition of maternal 
resources, poor suckling and inability to thrive have been noted in mice with loss of functional 
copies of the paternally expressed Gnasxl gene (Plagge et al., 2004).  
The phenotypic characteristics of a number of mouse knockout models lacking imprinted 
genes undoubtedly provided support for the conflict hypothesis as a driving force for evolution 
of genomic imprinting. But even though it provides a justification for the function of multiple 
imprinted genes, it still fails to explain some other aspects of imprinting, for example the fact 
that paternally expressed genes are outnumbered by maternally expressed genes in the 
placenta. Therefore, it seems increasingly likely that this hypothesis will not be able to clarify 
and explain forces that led to maintenance of all the imprinted genes (Hurst and McVean, 
1997; Hurst and McVean, 1998), especially those not associated with any clusters (Smith et al., 
2003; Davies et al., 2004; Choi et al., 2005).  
Parthenogenesis is a process of asexual reproduction based on lack of male investment 
but giving each organism within a species that consists of only females the ability to 
independently produce offspring, which in theory enables each individual to unilaterally 
introduce this species into a new habitat. Parthenogenesis does not occur in mammals but has 
been found in over 80 species of other vertebrates, including reptiles, amphibians and fish 
(Alves et al., 2001; Lampert, 2008). It has therefore been suggested that the reason for the 
presence of imprinting only in mammals might be protection against parthenogenesis, 
especially in light of experiments that used manipulated imprinted gene dosage to infer that 
imprinting disruption prevents the successful parthenogenetic mouse development (Barton et 
al., 1991; Fundele et al., 1991). It is interesting to note that human parthenogenetic bimaternal 
ovarian teratomas and androgenetic bipaternal conceptuses (complete hydatidiform moles) 
show similar phenotypes to the ones observed in mice. 
Another hypothesis that attempts to explain the mechanism behind the evolution of 
parent-of-origin-specific gene expression is the ovarian time bomb hypothesis. It predicts that 
imprinting is a way of protection against ovarian trophoblastic disease in females (Varmuza 
and Mann, 1994), which is a result of a spontaneous development of an unfertilised egg in the 
8 
 
ovaries. The ovarian time bomb theory tries to explain the reason for some early embryonic 
growth enhancing genes (e.g. mouse Igf2) being maternally rather than paternally imprinted 
and also why the reciprocal imprinting status can be observed at some growth-restricting loci 
(e.g. mouse Igf2r). However, this hypothesis suggests that only a limited number of genes with 
critical role in embryonic development would be imprinted and fails to explain functions of 
imprinted genes in postnatal life (Plagge et al., 2004; Plagge et al., 2005). Hence, the existence 
of a relatively high number of imprinted genes argues against the ovarian time bomb 
hypothesis as, clearly, silencing of a single maternal allele should be enough to protect against 
parthenogenesis (Haig, 1994). Moreover, this model does not provide any explanation for 
imprinting of paternal loci. Also, the frequency of mammalian ovarian teratomas is very low, 
and the fact that the evolution of imprinting would act to protect specifically against such 
a rare disease is rather unlikely (Solter, 1994). Finally, it has also been argued that even if 
rarely occurring teratomas are able to preserve imprinting, higher pressure would be required 
for imprinting to develop in the first place (Weisstein et al., 2002). 
The recently suggested intralocus sexual conflict hypothesis implies that the driving force 
behind genomic imprinting is selection which at a particular locus favours different alleles in 
males versus females. This theory concentrates on the evolution of the locus that causes the 
imprinting instead of the locus that is imprinted (Day and Bonduriansky, 2004). It suggests that 
natural selection should act to silence expression from maternally inherited alleles in males 
and paternally inherited alleles in females. However, in disagreement with that, there are 
multiple maternal and offspring traits that both favour the increased fitness of the offspring, 
suggesting that they evolved as a result of mother and offspring traits positively 
complementing each other rather than as an outcome of conflict between two different 
interests. This adaptive connection between maternal and offspring traits has been proven by 
experiments in different species (Kolliker et al., 2000; Agrawal et al., 2001; Hager and 
Johnstone, 2003; Lock et al., 2004), and even in humans it has been found that offspring with 
intermediate birth weights are the fittest (Ulizzi et al., 1981), suggesting that increase in 
investment of maternal resources is not always preferable. This model might explain 
imprinting at loci under different selection in both sexes, but cannot justify the abundance of 
imprinted genes in the placenta. An explanation for this has been incorporated into the 
coadaptation theory (Wolf and Hager, 2006). 
Wolf and Hager (2006) demonstrated that natural selection favours expression of 
maternal gene copies because it leads to higher offspring fitness by increasing genetic 
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integration of the traits coadapted between maternal and offspring genomes. This 
coadaptation hypothesis is based on the prediction that loci associated with mother-offspring 
interaction have a greater chance of being maternally expressed, which could account for the 
high number of maternally expressed genes during placental (Wagschal and Feil, 2006) and 
seed development (Baroux et al., 2002). Therefore, unlike the conflict and intralocus 
hypotheses, this model tries to explain the overabundance of maternally expressed imprinted 
genes in placenta. The suggestion that imprinting evolved due to a variety of different selective 
pressures is particularly visible when it comes to maternal-offspring interactions, which are 
driven in some cases by genes that might be playing a role in conflict over investment of 
maternal resources, while other genes might be influenced as a result of maternal-offspring 
coadaptation.  
In order to thoroughly understand the function of imprinted genes in mammals, it is vital 
to further investigate the evolutionary basis and mechanisms driving this phenomenon, 
alongside with its influence on a range of developmental and physiological processes. Analyses 
of knockout mouse models together with genome-wide screens can provide important tools in 
this exciting investigation. It will be interesting to discover which of the hypotheses, if any, will 
be supported by the results obtained in the future. Moreover, it will be important to compare 
and study in detail differences between the imprinting status of genes in mice and humans, 
especially given that some crucial differences between both of the species have been 
discovered, especially in the placenta. 
Taken together, it still remains impossible to point at a single hypothesis as the only one 
explaining all the aspects of genomic imprinting. Instead, it seems increasingly likely that 
imprinted genes emerged as a result of variety of selective pressures at different loci in 
different taxa and as a result the imprinted genes counterparts between species might show 
differential special and/or temporal expression.  
1.1.3 Characteristics and mechanisms regulating imprinted genes 
There is an ongoing debate not only over the causes of genomic imprinting but also over 
the mechanisms that regulate this unique phenomenon. Up until now it is not clear if there is 
one universal mechanism governing parental allele-specific expression or there are different 
modes of regulation depending on the gene (reviewed in Edwards and Ferguson-Smith, 2007; 
Ideraabdullah et al., 2008; Bartolomei and Ferguson-Smith, 2011). So far, the examination of 
the subset of imprinted genes has revealed only a few common characteristics between them, 
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including location of the majority of imprinted genes within clusters, close vicinity to regions of 
parental allele-specific methylation and/or chromatin modifications, association with 
particular types of repeat sequences and the presence of antisense or overlapping transcripts. 
It is also known that imprinting occurs in a spatial and temporal manner rather than within all 
tissues in the body and throughout all developmental stages. Of particular interest is the 
regulation and role of imprinting in the earliest stages of development and its influence on cell 
cycle and associated growth, as many of imprinted genes identified so far have been 
demonstrated to be expressed during embryonic development (Weaver et al., 2009). It has 
been shown that in various cases parent-specific, monoallelic expression is generally 
conserved between mice and humans, with several exceptions including IGF2R that exhibits 
a monoallelic mode of expression in mice but is associated with polymorphic expression in 
humans, with only a small subset of individuals repressing the paternal copy of the gene to an 
appreciable extent (Kalscheuer et al., 1993; Pearsall et al., 1996).  
The vast majority of imprinted genes show differences in methylation between parental 
alleles. However, these so-called differentially methylated regions (DMRs) have different 
characteristics. In some DMRs the differential methylation is established in parental germ cells 
and persists throughout development in all tissues (Neumann et al., 1995; Olek and Walter, 
1997; Shemer et al., 1997), whereas in other DMRs changes in methylation are introduced at 
various stages of development and in different tissues (Feil et al., 1994). Moreover, 
methylation of the inactive allele is a typical feature of some DMRs while others are 
methylated on the active allele.  
During the course of the life cycle of an organism, genomic imprints are known to undergo 
some specific changes. Early on, imprints are established in germ cells, following fertilisation 
they are maintained during chromosome duplication and segregation, then finally in the germ 
cells of a new organism the imprints are erased, which leads to establishment of new imprints 
in germ cells and the cycle starts all over again. The maintenance and modifications of imprints 
in somatic cells occur during development and following that imprints are read, which results 
in allele-specific expression. 
In order for mature gametes to reflect the sex of the germline, the imprints in gametes 
need to be reset, which is thought to happen in two stages: first erasure of imprints and then 
establishment of new ones. In mouse, the erasure step is achieved by embryonic days 12 (E12) 
to 13 (E13) (Brandeis et al., 1993) and is based on a dramatic genome-wide DNA 
demethylation in germ cells. The evidence suggests that all the imprints are erased during this 
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stage (Tada et al., 1998; Davis et al., 2000). Following erasure, at late embryonic development 
stages, de novo DNA methylation occurs in germlines and continues after birth. Methylation in 
spermatocytes takes place before meiosis, whilst in oocytes, which are in meiotic arrest, it 
takes place during their growth (Obata et al., 1998; Ueda et al., 2000).  
1.1.3.1 Establishment of imprinted genes 
Methylation in vertebrates occurs on the cytosine residue of CpG dinucleotides by DNA 
methyltransferases. There are several candidate enzymes that could potentially govern de 
novo methylation in germ cells: Dnmt1 (DNA methyltransferase 1) but also Dnmt3a and 
Dnmt3b (Mertineit et al., 1998; Okano et al., 1999). The mode of their action is not perfectly 
clear, as DMRs in imprinted genes might be subject to de novo methylation in one of the 
germlines or de novo methylation could occur in both germlines but DMRs in only one of the 
germlines might be protected from it. There is a possibility that regulation of 
methyltransferases can be cell cycle-specific, as changes in replication timing might affect the 
availability of DNA for methylation. As it is possible for demethylation or de novo methylation 
to occur just after fertilisation, it is plausible to suspect that this is the time when some 
imprints might be established in only one of the parental alleles.  
It has been demonstrated that Dnmt3a and Dnmt3b have important roles in de novo 
methylation and are vital in the course of embryonic development (Okano et al., 1999). They 
play crucial roles in the establishment of germline imprints in both lineages. So far it still 
remains unclear if the imprints in Imprinting Control Regions (ICRs) arise due to active 
methylation or protection from active methylation. Maintenance of methylation marks and 
allele-specific expression in a number of imprinted genes is the primary role of Dnmt1, 
although in the absence of Dnmt1 some other mechanisms are also used, for example in 
a subset of genes imprinted in mouse placenta, such as Cd81, Phlda2, Kcnq, Osbpl1 and also 
Ascl2/Mash2 (Caspary et al., 1998; Lewis et al., 2004). In these genes, a placenta-specific 
mechanism based on chromatin modifications rather than DNA methylation has evolved in 
order to maintain imprinting status (Umlauf et al., 2004). It has been discovered that 
differential histone modifications are common features of many imprinted genes but the exact 
function of chromatin modifications either as a cause or a result of allele-specific expression 
remains to be elucidated.  
The important question for maintenance of imprinting is how DMRs manage to resist 
demethylation. Both active and passive mechanisms are believed to take part in demethylation 
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(Figure 1.2), with the paternal genome usually being subject to this process first, just after 
fertilisation. The maternal genome is affected later, by an inability to maintain methylation 
during DNA replication (Rougier et al., 1998; Oswald et al., 2000). Due to the fact that 
demethylation might be caused by chromatin remodelling of the sperm genome, it is believed 
that the maternal genome requires a protection mechanism against active demethylation 
during fertilisation. As each of the parental genomes seems to employ different methods of 
protection from demethylation, this might provide an explanation for the majority of 
methylation imprints being present on maternal genes.  
The imprints in both of the germlines need to be read, and that is converted into 
differential gene expression. Regulation of imprinting is very complex, and a variety of 
epigenetic mechanisms have been implicated to play a role in it, including modifications of 
promoter sequences, silencers, boundary elements and perhaps even of overlapping antisense 
transcripts (Ferguson-Smith, 2011). In this way, imprinted genes control transcription using 
typical mechanisms, but unlike most genes they are subject to further regulation by 
differential epigenetic modifications on parental chromosomes. 
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Figure 1.2 Establishment, maintenance, and erasure of genomic imprints during mammalian development.  
Imprinting in the germline is acquired in a sex-dependent manner, as maternal and paternal ICRs become hypermethylated in oocytes and sperm. Imprints 
persist after fertilisation despite reprogramming and changes in DNA methylation; active demethylation of the paternal genome in the zygote does not 
influence paternal imprints, nor does passive maternal demethylation in the preimplantation embryo change maternal imprints. At the end of the 
preimplantation stage of development de novo DNA methylation takes place and after that imprints persist in somatic cells throughout the entire lifetime. In 
preparation for transmission to the progeny, DNA methylation erasure occurs during migration of PGCs into the genital ridge and following that, imprinting 
status is re-established during gametogenesis. Figure adapted from (Bartolomei and Ferguson-Smith, 2011). 
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1.1.3.2 Clustering of imprinted genes 
There are a few imprinted genes that do not appear to be closely linked to other 
imprinted gene, such as Inpp5f, Nnat, Nap1l5 or Peg13 (Kagitani et al., 1997; Smith et al., 2003; 
Choi et al., 2005), however, the majority tend to be localised within clusters which usually 
consist of a group of protein-coding genes and at least one non-coding RNA (ncRNA). The 
majority of imprinted clusters are controlled by a maternally inherited methylation mark, 
including Igf2r/Air, IC2/Kcnq1, Gnas, and PWS/AS regions, while only three paternally 
methylated germline-derived DMRs have been found up to date: Igf2/H19 ICR, the Dlk1-Dio3 
imprinting control region, and the control region regulating the Rasgrf1 locus. The so-called 
imprinting control region is a major cis-acting element that governs the cluster, however other 
elements might modify its function. These ICRs are able to control the genes within the given 
cluster as they are subject to differential methylation between the two copies in germ cells. In 
the case of imprinted genes that do not lie within clusters, typically their differentially 
methylated promoters act as their ICRs.  
Two types of imprinted gene clusters have been identified: one with ICRs methylated 
during spermatogenesis following paternal inheritance and others with ICRs methylated during 
oogenesis after maternal inheritance. A number of common features, as well as some 
differences, can be drawn between the modes of regulation of parental allele-specific 
expression of imprinted genes situated within different clusters. The characteristic shared 
between all imprinted domains discovered so far is the ability of Dnmt3a to function in cis- in 
order to implement a germline-derived differentially methylated mark. Methylation on the 
maternal chromosome of the imprinted domain is usually located in a region responsible for 
repressing the protein-coding genes. Thus the expression of protein-coding genes is typically 
associated with a maternally methylated imprinting control element, with the exception of the 
PWS/AS domain, consisting of several paternally expressed protein coding genes. This region, 
however, has been demonstrated to have an intricate evolutionary origin and, in addition, two 
ancestral protein-coding genes situated within this region, Ube3a and Atp10a, exhibit maternal 
expression (Rapkins et al., 2006). Similarly, genes with a methylated paternally inherited 
control region show expression of the protein-coding genes from the paternally inherited 
chromosome that is controlled by a methylated paternally inherited imprinting control region. 
ncRNAs are expressed from the unmethylated chromosome and the ICR is usually a promoter 
for them. The reason for the epigenetic mechanisms of the two parental germlines that apply 
DNA methylation marks at different places at these particular loci is still unclear.  
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Allele-specific changes in DNA replication timing during S-phase are also common 
characteristics of imprinted genes, as asynchronous replication is established in the gametes 
and persists throughout development, which means that it may function as a primary 
epigenetic marker for distinguishing between the parental alleles (Simon et al., 1999). It has 
been shown that differential replication timing is linked to imprinted genes in a wide range of 
cell types, and occurs in the pre-implantation embryo following fertilisation. The erasure of 
this pattern takes place before meiosis in the germline, and afterwards parent-specific 
replication timing is reset in both sexes in late gametogenesis. The paternal copy of DNA in 
imprinted regions typically replicates earlier than the maternal one, however the underlying 
reason for this phenomenon is not understood. Furthermore, meiotic recombination occurring 
with different frequencies is commonly found in or next to imprinted clusters, along with 
increased recombination rate during male meiosis (Robinson and Lalande, 1995). The exact 
nature of association of these epigenetic changes with methylation and changes in chromatic 
structure remains to be elucidated. It is possible that all of the aforementioned epigenetic 
modifications could be linked to imprinting, however it is not known if chromatin modifications 
play roles in imprinting independent of DNA methylation, whereas the crucial role of 
methylation in maintenance of imprints has been established (Moore and Haig, 1991).  
The regulation of genomic imprinting is clearly very complex, and the employed 
mechanisms seem to differ in mode of action depending on parental allele and specific gene 
clusters. Evidently very tight control over the regulation of these complicated mechanisms is 
needed in order to avoid detrimental consequences, as imprinted genes play vital roles in 
growth and metabolism, and as a consequence their disruption can result in quite severe 
human syndromes (discussed below).  
1.1.4 Roles of imprinted genes in growth and metabolism 
In order to determine the size of an organism, growth needs to be precisely regulated at 
different levels, from cellular to systemic, by a variety of molecular mechanisms. The 
mechanisms controlling rates of cell growth, differentiation, proliferation and apoptosis need 
to be carefully coordinated for normal growth and development to commence, and during the 
course of development the provision of nutrients, hormones, growth factors and energy is also 
of great importance. Mouse knockout experiments have provided useful information about 
functions of individual imprinted genes. By these means it has been discovered that many 
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genes showing allele-specific expression are able to govern correct development, as in many 
cases lack of imprinted genes led to perturbed growth that affected the ultimate embryo size.  
Expression of the majority of imprinted genes has been identified in embryos at early 
stages of development and/or in placenta, an organ with a pivotal role in nutrient provision for 
developing embryos. This led to speculation that the effects of imprinted genes on growth 
might be consequence of either their perturbed expression in embryo or through 
discrepancies in correct nutrient supply due to abnormal expression in the placenta. In 
agreement with the conflict theory, conflict over nutrient acquisition would predict that 
embryo-expressed genes favour resource acquisition while genes expressed in the placenta try 
to limit resource supply. Further to that, regulation of metabolism is another known function 
of some imprinted genes. Various imprinted genes were found to be capable of influencing 
glucose tolerance, food intake, and adiposity. Interestingly, several imprinted genes have even 
been implicated in influencing postnatal behaviour (Plagge et al., 2005; Garfield et al., 2011). 
As many features identified in mice with altered imprinted gene expression can be compared 
with phenotypes seen in humans with perturbed function of the orthologous genes, some of 
them will be discussed here in more detail. A group of imprinted genes with their sites and 
modes of expression are shown in Table 1.1 whilst the most widely studied human disorders 
resulting from abnormal changes within imprinted genes are presented in Table 1.2. 
One of the most widely studied growth factors, the insulin like growth factor (Igf) forms 
a part of a major growth signalling system in mouse embryo that includes two ligands, Igf1 and 
Igf2, two membrane associated receptors, Igf1r and Igf2r and several Igf-binding proteins 
(Igfbps). A 40% growth reduction has been reported in neonatal mice with disrupted paternally 
expressed Igf2 or homozygous disruption of the non-imprinted Igf1 (DeChiara et al., 1991; Liu 
et al., 1993), whilst ablation of maternally expressed Igf2r resulted in significant overgrowth, 
elevated serum and tissue levels of IGF2 and frequent perinatal lethality (Lau et al., 1994; 
Leighton et al., 1995; Ludwig et al., 1996). The cause of the observed lethality has been 
associated with an excess of IGF2 overstimulating IGF1R, due to lack of IGF2R-mediated 
turnover, which has been proven by generation of fully viable Igf2/Igf2r double mutants (Lau 
et al., 1994; Ludwig et al., 1996). Additional information on the in vivo interactions between 
members of the Igf family was provided by characterisation of mice with targeted deletion of 
both Igf1 and Igf2 and also those lacking Igf1 and Igf1r (Liu et al., 1993). The survival of 
nullizygous Igf1 knockout mice exhibiting 40% growth reduction depends on the genetic 
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background but an even more dramatic phenotype (45% of normal growth and immediate 
death after birth due to respiratory failure) has been observed in Igf1r nullizygous animals. 
 
Maternally expressed Paternally expressed 
Embryo Cdkn1c, Gtl2, Grb10, Igf2r Dlk1, Igf2, Peg1, Peg3, Zac1 
Placenta Ascl2, Cdkn1c, Grb10, H19, 
Igf2r, Phlda2 
Igf2 P0, Peg1, Peg3,  
Peg10, Rtl1, Zac1 
Metabolism Atp10c, Gnasα , Grb10 Dlk1, Dio3, Gnasxl, Igf2, Zac1/Hyma1, Peg3, Rasgrf1 
Behaviour Ndn, Nesp55, Ube3a Gnasxl, Grb10, Peg1,  Peg3, Rasgrf1 
Table 1.1 Modes of expression and sites of action of several imprinted genes. 
Maternally and paternally expressed mouse imprinted genes affecting embryonic and 
placental growth, metabolic homeostasis and behaviour (Barlow et al., 1991; Bartolomei et al., 
1991; DeChiara et al., 1991; Da Costa et al., 1994; Kagitani et al., 1997; Lefebvre et al., 1998; Li 
et al., 1999; Grandjean et al., 2000; Constancia et al., 2002; Charalambous et al., 2003; Font de 
Mora et al., 2003; Ma et al., 2004; Plagge et al., 2004; Salas et al., 2004; Curley et al., 2005; 
Plagge et al., 2005; Takahashi et al., 2005; Ono et al., 2006; Yevtodiyenko and Schmidt, 2006; 
da Rocha et al., 2007; Lin et al., 2007; Lui et al., 2008; Sekita et al., 2008; Garfield et al., 2011). 
Igf2/Igf1r and Igf1/Igf2 double mutants exhibited identical phenotypes, suggesting that 
IGF1R is responsible for mediating growth effects of both IGF ligands (Liu et al., 1993). 
Igf1/Igf1r double mutants were indistinguishable from Igf1r knockout mice, unequivocally 
demonstrating that IGF1 interacts exclusively with IGF1R. A 70% reduction in normal body 
weight of Igf2/Igf1r double mutants, significantly more pronounced than in either of single 
knockout animals (Liu et al., 1993), implied interaction between these two genes and a role for 
an additional receptor with an effect on growth, identified later as insulin receptor (IR) (Louvi 
et al., 1997). The mitogenic effects of Igf2 are in part regulated by insulin-like growth factor 2 
receptor (IGF2R), also called the mannose-6-phosphate receptor (M-6-Pr), which has been 
identified as a negative regulator of Igf2. Following maternal transmission of the disrupted 
Igf2r locus significant embryonic overgrowth has been noted (Lau et al., 1994; Ludwig et al., 
1996). Deletion of an element vital for repression of the paternal allele resulted in biallelic 
expression of Igf2r as did paternal inheritance of the non-imprinted allele, causing 20% fetal 
weight reduction maintained until adulthood (Wutz et al., 2001). The lethal phenotype of Igf2r 
maternal knockouts was overcome following loss of Igf2, as Igf2/Igf2r mutants were viable. 
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Human syndrome Epigenetic causes Clinical features 
Beckwith–
Wiedemann 
syndrome (BWS) 
Epimutation of IGF2/H19 DMR1, 
epimutation of KCNQ1/CDKN1C 
DMR2 both on 11p15, 
hypomethylation of DMR2 
(50%), hypermethylation DMR1 
(2%–7%), PatUPD11, CDKN1C 
mutation 
Pre/postnatal overgrowth, 
neonatal hypoglycemia, 
exompholos, macroglossia, 
hemihypertrophy, increased 
embryonal tumours 
Prader–Willi 
syndrome (PWS) 
De novo paternal deletion in 
15q11-q13 (70%), MatUPD15 
(29%), imprinting defects (1%) 
Neonatal hypotonia, 
childhood obesity, cognitive 
impairment, 
behavioural characteristics, 
hypogonadism 
Angelman syndrome 
(AS) 
15q11.2-q13 deletion (70%) 
PatUPD15 (7%), UBE3A mutation 
(11%), methylation defects (3%), 
epimutation 
Mental retardation, speech 
impairment, ataxia, seizure, 
microcephaly 
Silver–Russell 
syndrome (SRS) 
Paternal DMR1 hypomethylation 
at 11p15 (>50%), MatUPD7 (5%) 
Matdup11p15, unknown (30%) 
Intrauterine/postnatal 
growth retardation, variable 
features (including 5th finger 
clinodactyl, learning 
disabilities) 
Pseudohypo-
parathyroidism type 
b (PHP1b) 
Microdeletion upstream of 
GNAS at 20q, maternal 
hypomethylation, PatUPD20 
Resistance to parathyroid 
hormone, hypocalcaemia, 
hyperphophatemia 
Transient neonatal 
diabetes mellitus 
type (TNDM) 
Paternal UPD6, paternal 
duplication 6q22-q23, 
maternal hypomethylation at 
ZAC1/PLAGL1 DMR 
Growth retardation, 
hyperglycemia with 
low/undetectable insulin 
resolved by 6 months old, 
40% Type-2 diabetes later in 
life 
Maternal UPD14  
(and UPD14 mat-
like) syndrome 
MatUPD14, paternal 
microdeletions at 14q32.2, 
hypomethylated DMRs at 
DLK1/GTL2 
Low birth weight, short 
stature, characteristic faces, 
premature 
puberty, hypotonia 
Paternal UPD14  
(and UPD14 pat-like) 
syndrome 
PatUPD 14, maternal 
microdeletions at 14q32.2, 
hypermethylation at DMRs at 
DLK1/GTL2 
Bell-shaped thoracic cage, 
mental retardation, 
placentomegaly, 
polyhydramnios 
Table 1.2 Several widely-studied human imprinting disorders with their epigenetic causes 
and observed clinical features. Table adapted from (Bartolomei and Ferguson-Smith, 2011). 
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Moreover, although individual Igf1r and Igf2r knockout mice were not viable, loss of both of 
these receptors did not result in lethality, which has been associated with Igf2 functioning 
through IR, as Igf2/Igf1r/Igf2r triple mutants were nonviable (Ludwig et al., 1996).  
Even though the knockout experiments helped to delineate in vivo roles for a number of 
imprinted genes, because many of them are expressed simultaneously in embryo and placenta 
it proved difficult to pinpoint their functions in each of these lineages. In particular, altered 
imprinted gene expression in the placenta might directly change growth or function of the 
placenta, with an indirect effect on overall growth of the embryo. Both embryo and placenta 
are affected in Igf2 and Igf2r mutants, but deletion of Igf2P0 transcripts provided a useful tool 
for identifying the role of Igf2 specifically in the placenta. Even though only 10%  of the 
placental Igf2 transcripts arise from the tissue specific promoter Igf2P0, loss of Igf2P0 
transcripts leads to restriction of placental size during early- and mid-gestation comparable to 
that observed for complete Igf2 knockout embryos (DeChiara et al., 1991; Constancia et al., 
2002). Interestingly, growth retardation of the placenta in Igf2P0 mice had a relatively small 
influence (embryos weighed 96% and 78% of wild type at E16 and E19, respectively) on overall 
embryonic growth retardation compared with Igf2 knockout embryos (approximately 60%).  
One of the best characterised human imprinted disorders is Beckwith-Wiedemann 
syndrome (BWS), localised to human chromosome 11p15.5 containing a cluster of 15 genes, 
9 of which are imprinted (Walter and Paulsen, 2003). Up until now three imprinted genes 
within this cluster have been most commonly associated with BWS, that is IGF2, H19 and 
CDKN1C/p57KIP2 (Maher and Reik, 2000). Individuals affected by BWS suffer from intrauterine 
overgrowth of both embryonic and extra-embryonic tissues, with overgrowth persisting into 
adulthood. Furthermore, they display macroglossia (hypertrophy of the tongue), exomphalos 
(anterior abdominal wall defects) and a predisposition to childhood cancers (Maher and Reik, 
2000). Around 20% of sporadic BWS cases are associated with IGF2 elevated expression (and 
decrease in H19 expression) resulting from pUPD of the locus, with two paternally-derived 
copies of chromosome 11p15 and no maternal contribution for that region (Henry et al., 
1991). In many cases an increase in Igf2 expression seems to play a crucial role in causing 
overgrowth, including the vast majority of BWS patients who lack cytogenetic abnormalities 
(Weksberg et al., 1993). IGF2 imprinting is typically disturbed by changes in the methylation 
status of ICRs that result in both parental alleles adopting the epigenotype of the expressed 
paternal allele (Maher and Reik, 2000). H19, a maternally expressed, untranslated gene 
located in the vicinity of IGF2 on chromosome 11 can also be silenced as a result of alterations 
in methylation status of the parental alleles (Maher and Reik, 2000). Another imprinted gene, 
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the maternally-expressed p57KIP2 gene also lies within the BWS locus. Mutations in this gene 
have been reported in 5-10 % of sporadic and 40 % of familial BWS cases (Weksberg et al., 
2005). Interestingly, the symptoms in these patients resemble ones noted for cases with 
disrupted IGF2/H19, although the expression or methylation of both of these genes is not 
altered (Maher and Reik, 2000), which might indicate that patients with CDKN1C mutations 
might lack protein involved in the IGF2 signalling pathway. Indeed, one of the suggested roles 
for Igf2 has been negative regulation of Cdkn1c (Grandjean et al., 2000). Another mouse model 
with loss of Igf2 imprinting as well as inactivation of p57KIP2 has been generated in order to 
understand the possible relationship of p57KIP2 and Igf2 genes in the aetiology of BWS (Caspary 
et al., 1999). The mutant mice exhibited a number of BWS characteristics, such as 
placentomegaly, kidney dysplasia, macroglossia, cleft palate and polydactyly and some of the 
observed phenotypes were found to depend on Igf2. Additionally, it has been found that both 
of these genes are acting in an antagonistic manner in two of the affected tissues (Caspary et 
al., 1999), adding to the concept that BWS results from a mutation in either p57KIP2 or Igf2 
gene. BWS can also be a consequence of loss of methylation on the maternal allele at the ICR 
located within KCNQ1, which was originally identified in BWS cases with inversion breakpoints 
in this region. This has been linked to biallelic IGF2 expression without disruption of imprinted 
H19 expression and normal methylation patterns at the IGF2/H19 locus, which could indicate 
IGF2 expression being controlled independently of H19 in a manner yet to be elucidated. 
A schematic representation of the BWS locus and mechanisms regulating imprinted genes 
within this region is presented in Figure 1.3. 
Imprinted genes have also been implicated in other human disorders, such as Prader-Willi 
and Angelman syndromes (PWS/AS) which have been mapped to an imprinted locus on human 
chromosome 15 (Ohta et al., 1999). Patients suffering from AS exhibit ataxia and severe 
mental retardation, whilst those with PWS have obesity, mild mental retardation and short 
stature (Walter and Paulsen, 2003). Both of these disorders are believed to affect neurological 
development and are results of deletions and UPDs at the PWS/AS locus (Mann and 
Bartolomei, 1999). PWS is caused by a deficiency of paternal gene expression and AS is the 
switch between the maternal and paternal epigenotypes resulting from a deficiency of 
maternal gene expression. The AS/PWS imprinting control centre deletions have been found in 
some of AS patients. On the other hand, thorough analysis of both human patients and mouse 
models suggests the contribution of other genes to the AS phenotype (reviewed in Buiting, 
2010). 
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Figure 1.3 Schematic representation of the BWS locus on 11p15.5 (not drawn to scale).  
H19 and IGF2 imprinting is regulated by IC1 acting as an insulator or chromatin boundary 
element. IC1 on the maternal allele is unmethylated, which allows for binding of the CTCF 
insulator protein and prevents the access of the IGF2 promoter to downstream enhancers so 
that H19 maternal copy utilises these enhancers and is transcribed. Methylation of IC1 on the 
paternal chromosome blocks binding of CTCF to IC1, thus IGF2 can access downstream 
enhancers and is expressed whereas H19 is silenced. A) Normal parent-of-origin-specific 
imprinted allelic expression within BWS locus, B) and C) only show the region that is altered as 
a result of loss (IC2) and gain (IC1) of methylation, respectively, D) IC1 and IC2 defects during 
pUPD, E) CDKN1C mutations. IC: imprinting centre, Cen- centromere, Tel- telomere, mat- 
maternal, pat- paternal, DMR- differentially methylated region, OT1- KCNQ1 antisense 
transcript KCNQ1OT1, arrows- expression of a gene, filled lollipops- hypermethylation, bars at 
the telomeric region- enhancer. Figure adapted from (Choufani et al., 2010).  
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Another complex human disorder associated with an imprinted locus is Silver-Russell 
syndrome (SRS), characterised by both intrauterine and postnatal growth retardation as well 
as other distinct characteristics, including triangular facial features, hemihypertrophy of trunk 
and limbs, brachydactyly of the fifth finger and cranial sparing (Preece, 2002). Around 10% of 
SRS cases are associated with mUPD of chromosome 7 which consists of at least three 
imprinted genes: MEST and COPG2 at 7q32 and GRB10 at 7p12 (Hannula et al., 2001). Mest 
has been identified as a paternally expressed growth enhancer as its ablation in mice resulted 
in growth retardation of both embryos and placentae (Lefebvre et al., 1998). The case of one 
patient with SRS that has been identified with mUPD of the 7q32 region has been confirmed 
(Hannula et al., 2001), however, the majority of cases are associated with mUPD of 7p11.2-p12 
at which GRB10 is situated (Preece, 2002). Two other genes within this region, biallelically-
expressed IGFBP1 and EGFR seem to be less likely than GRB10 to be a cause of SRS. Targeted 
deletion of Grb10 in mice resulted in overgrowth (Charalambous et al., 2003) and its 
overexpression caused the reciprocal phenotype (Shiura et al., 2005; Shiura et al., 2009). This 
was similar to the opposite growth phenotypes associated with paternal and maternal 
duplication, respectively, of mouse proximal chromosome 11, the region that includes Grb10 
(Cattanach et al., 1996). Arnaud et al (2003) demonstrated that there was no change in 
methylation status of GRB10 ICRs in 24 SRS patients, suggesting another control mechanism 
for the expression of GRB10, if indeed it is the cause of SRS. It is yet to be established if GRB10, 
MEST or both of these genes really play a role in causing SRS, and recently the IGF2 gene, 
known for its crucial role in control of growth, has been implicated as the cause of some SRS 
cases. In 2005 the hypomethylation of the differentially methylated ICR of IGF2-H19 at 
chromosome 11p15 was reported in a few SRS patients for the first time (Gicquel et al., 2005), 
and further studies have confirmed this finding in more SRS patients in whom reduction or loss 
of methylation at telomeric ICR1 on chromosome 11 was found to be a likely primary cause of 
SRS (Bliek et al., 2006; Eggermann et al., 2006; Netchine et al., 2007; Yamazawa et al., 2008). It 
has also been found that reciprocal methylation changes within the IGF2-H19 locus were 
observed in a small group of patients (5%-10) suffering from BWS. Recent study of 201 
patients with SRS or SRS-like phenotypes have provided more evidence for changes within 
IGF2-H19 locus as a cause of SRS, as these kinds of epimutations were recognised in 
approximately 40% of SRS patients (Bartholdi et al., 2009). This study was also the first one to 
report familial cases of hypomethylation at the IGF2-H19 locus (Bartholdi et al., 2009).  
Reciprocal methylation changes at the ICR controlling IGF2-H19 lead to opposite 
alterations within IGF2-H19 expression and subsequently, can result in BWS and SRS as two 
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contrasting disorders. It has been shown that reciprocal IGF2-H19 imprinting is controlled by 
DNA methylation of the ICR that blocks binding of the insulator protein CTCF. A recent study 
has demonstrated that altered histone modifications, changes within CTCF-cohesin binding 
and DNA methylation at the ICR of BWS and SRS can be associated with the higher chromatin 
structure at the IGF2-H19 locus (Nativio et al., 2011). Specific changes within the ICR chromatin 
structure were shown to have contrasting effects on the parent-of-origin-specific looping 
conformation and also IGF2- H19 expression potential, demonstrating an interesting and novel 
case of modified transcriptional genomic neighbourhood being able to participate in causing 
human disease.  
In contrast to the abovementioned genes, the Gnas locus, located on mouse chromosome 
2, is typically involved in the regulation of metabolism, rather than growth (for more details 
see Section 1.1.4 and Chapter 5). The Gnas locus consists of a maternally-expressed Nesp gene 
as well as paternally expressed genes, Nespas, Gnasxl and Exon1a, and also Gnas (Plagge and 
Kelsey, 2006), which is biallelically expressed in the majority of tissues but maternally 
expressed in the proximal renal tubules, anterior pituitary gland, thyroid gland, ovary 
(Hayward et al., 2001; Germain-Lee et al., 2002; Mantovani et al., 2002) and white and brown 
adipose tissue (Yu et al., 1998). Exon 2 is a transcript shared between all members of the Gnas 
family except for Nespas (which generates a non-coding RNA). Knockout experiments 
demonstrated that Gnas has different maternal and paternal gene products, and mice lacking 
exon 2 on the maternal and paternal alleles exhibited reciprocal metabolic phenotypes (Yu et 
al., 1998; Yu et al., 2000; Yu et al., 2001). Disruption of Gnas through the maternal line resulted 
in a hypometabolic phenotype while disruption through the paternal line resulted in mice that 
were lean and hypermetabolic. The metabolic phenotype of mice lacking Gnasxl was similar to 
that observed for animals with paternal transmission of the Gnas exon 2 deletion (Plagge et al., 
2004), whereas paternal deletion of Gnas exon 1 resulted in a phenotype that resembled that 
of maternal exon 2 ablation (Chen et al., 2005). As a result, Gnas and Gnasxl exhibit reciprocal 
effects on glucose and lipid metabolism and these opposing effects of maternally and 
paternally expressed products of the Gnas locus can be considered to support the parental-
conflict hypothesis of imprinting.  
The imprinting of GNAS locus in humans has clinical significance, as heterozygous 
inactivating mutations within Gsα-encoding GNAS exons have been identified in individuals 
with pseudohypoparathyroidism type 1a (PHP-Ia), who also exhibit physical features called 
Albright's hereditary osteodystrophy (AHO). AHO features include subcutaneous ectopic 
24 
 
ossifications, obesity, cognitive defects and brachydactyly. Patients with typical AHO features 
but not displaying hormone resistance, who are said to suffer from so-called 
pseudopseudohypoparathyroidism (PPHP), also carry heterozygous inactivating Gsα 
mutations. Maternal inheritance of this mutation results in PHP-Ia (AHO plus hormone 
resistance), while paternal inheritance leads to PPHP (AHO only) (Bastepe, 2008). 
Predominantly maternal expression of Gsα in specific tissues is thought to be a cause for this 
imprinted mode of inheritance of hormone resistance.  
In addition, some individuals suffer from PHP-Ib caused by loss of imprinting at the exon 
A/B DMR that determines tissue-specific monoallelic expression of GNAS. It is believed that 
a marked reduction of Gsα levels in this epigenetic disorder is a result of cis- silencing of Gsα 
expression in maternally expressed tissues. PHP1b is, interestingly, a unique imprinted gene 
syndrome with cis-acting mutations altering methylation of germline-derived imprint marks 
(Kelsey, 2010). Despite some overlapping features of both PHP1a and PHP1b, and the fact that 
they both involve decreased Gsα expression in tissues with allele-specific GNAS expression, the 
underlying basis for both of these disorders and all the differences between them are yet to be 
elucidated.  
Transient neonatal diabetes mellitus type (TNDM) is a rare type of diabetes which 
presents in the neonatal period, resolves in the first months after birth, but often recurs in 
later life (Temple and Shield, 2002). The symptoms usually include growth retardation and 
hypoglycaemia. TNDM is associated with imprinted region situated on human chromosome 
6q24 that encompasses two imprinted, paternally expressed genes: ZAC (which encodes 
a proapoptotic zinc finger protein) and HYMA1 located approximately 50kb upstream of ZAC 
(which encodes an untranslated mRNA) (Gardner et al., 2000; Arima et al., 2001). Rather than 
being a result of mutation in these genes, TNDM is a consequence of their overexpression due 
to pUPD6 in 40% of cases, duplication of 6q24 on the paternal allele in another 40% or 
hypomethylation at the DMR on the maternal allele in 20% of cases (Temple and Shield, 2010). 
Mice with overexpression of the human TNDM locus were shown to have hyperglycemia and 
impaired glucose tolerance. The expression of human ZAC and HYMA1 in these animals 
recapitulated the distinct characteristics of TNDM and indicated a role of abnormal 
development of the endocrine pancreas and defective β-cell function in this disorder (Ma et 
al., 2004).  
Analysis of TNDM patients provided interesting insights into the causes of imprinting 
disorders. Many patients with maternal hypomethylation at the TNDM locus also show 
25 
 
hypomethylation of other maternally methylated imprinted genes throughout the genome 
(GRB10, MEST, PEG3 and KvDMR) (Mackay et al., 2006), which could point at the existence of 
a novel imprinting syndrome resulting from maternal hypomethylation at multiple loci, as has 
also been described in several publications (Rossignol et al., 2006; Boonen et al., 2008). Up 
until now, the exact causes of TNDM and hypomethylation syndrome have not been identified 
and future studies of these disorders are necessary to gain further insights not only into the 
biological mechanisms of imprinting, but also the role of epigenetics in diabetes.  
Other imprinted genes have also been implicated in the regulation of both growth and 
metabolism. This includes the Delta like-homologue 1 gene (Dlk1), whose ablation in mice 
resulted in significant growth retardation and later on in life in increased adiposity associated 
with adipocyte hypertrophy and altered differentiation (Moon et al., 2002). Conversely, 
overexpression of this gene led to a reciprocal, overgrowth phenotype with reduced adiposity, 
hyperglycemia and insulin resistance (Lee et al., 2003). As a result, Dlk1 is believed to play 
a role in controlling adipocyte differentiation and act as a paternally expressed growth 
enhancer, in agreement with the parental conflict hypothesis. Overexpression of Dlk1 in 
skeletal muscle, along with Peg11, is thought to be a source of the callipyge phenotype in 
sheep (Cockett et al., 2005), however its disruption and definite implication in any human 
disorders are yet to be reported. 
Overall, even though the group of imprinted genes within mammalian genomes is 
relatively small, their roles in development and postnatal metabolic homeostasis seem to be of 
great importance, as confirmed by severe phenotypes of knockout mice lacking some of these 
genes alongside many related human disorders. Knockout mice and UPD mouse models have 
been a powerful tool to study genomic imprinting and have helped with characterisation of 
recessive diseases and genomic imprinting disorders in humans. Recent progress in genomic 
technologies as well as conventional microsatellite marker methods that played a role in 
a functional and mechanistic investigation of UPD, have helped gather clinically valuable data 
providing further insight into diverse genetic processes and disease pathogenesis. Such 
investigations might benefit affected children and families as with more detailed knowledge 
clinicians will be able to define recurrence risk, predict phenotype, and suggest medical 
treatment. 
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1.2 Growth factor receptor bound protein 10 
1.2.1 The Grb7/10/14 protein family 
1.2.1.1 Protein structure 
Growth factor receptor binding protein 10 (Grb10) is a member of an adapter protein 
family identified in both humans and mice that also includes Grb7 and Grb14. They share 
a distinct, highly conserved structure with almost 60% similarity between Grb7 protein family 
members that is also present in the Caenorhabditis elegans Mig-10 protein and thus referred 
to as the GM region, for Grb and Mig (Manser et al., 1997). This conserved region is 
represented by N-terminal proline rich sequences, a Ras-association-like domain (with 
homology to the C.elegans Mig-10 protein), a central pleckstrin homology (PH) domain, a C-
terminal Src homology 2 (SH2) domain and a conserved, unique receptor binding domain 
situated between the PH and the SH2 domains named BPS. Mig-10 seems to have a function 
similar to Grb10 as it is responsible for transducing signals required for cell migration (Manser 
et al., 1997). A recent study of tandem RA-PH domains of Grb10 and Grb14 has provided 
valuable details of mechanism by which Grb10 and Grb14 proteins are involved in IR signalling 
downregulation (Depetris et al., 2009, see Figure 1.4 and below). The tandem RA-PH domains 
of Grb7/10/14 are conserved in MRL proteins (Holt and Daly, 2005), another family of adapter 
proteins that also includes the C.elegans protein MIG-10 (Manser et al., 1997), the mammalian 
proteins RIAM (Lafuente et al., 2004; Jenzora et al., 2006) and lamellipodin (Lpd) (Krause et al., 
2004) and the Drosophila melanogaster protein pico (Lyulcheva et al., 2008). 
A recent report has for the first time provided information on the Drosophila pico gene 
being required for growth at the tissue and organismal level. Lower levels of pico expression 
caused a decrease in cell division rates along with growth retardation, an increase in 
monomeric (G) : filamentous (F) actin ratios and lethality (Lyulcheva et al., 2008), whereas pico 
overexpression caused reciprocal effects and resulted in increased growth and cell 
proliferation. These effects were confirmed in the mammalian orthologue of pico, Lpd, as both 
pico and Lpd were found to exert changes in actin dynamics and serum response factor (SRF) 
activation, consequently linking extracellular signalling to tissue growth (Lyulcheva et al., 
2008).  
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The most highly conserved region between members of the Grb10 protein family is the 
SH2 domain, which shares 72% nucleotide identity between Grb10 and Grb14 and 67% 
between Grb10 and Grb7. This region plays a pivotal role in binding to receptor tyrosine 
kinases and other intracellular signalling molecules, such as Nedd4 (Huang and Szebenyi, 
2010). Most probably, the SH2 domain is responsible the ability of Grb10 to efficiently bind to 
both insulin receptor and insulin-like growth factor receptor, however it is also able to interact 
with specific cytosolic proteins in a manner independent of tyrosine phosphorylation (Nantel 
et al., 1998). In contrast to the majority of SH2 motifs that are usually monomeric, this domain 
of Grb10 crystallises into a dimer which favours binding to IR and IGFR (Stein et al., 2003). The 
phosphorylated activation loops of the IR and IGFR are thought to show affinity to the Grb10 
SH2 domain, as it preferentially interacts with turn-containing phosphotyrosine sequences 
instead of an extended conformation, which is the case for other SH2 domains. The unique BPS 
domain, initially identified in Grb10 (He et al., 1998), shares 56% and 63% amino acid sequence 
identity with Grb7 and Grb14, respectively. It belongs to a subset of intrinsically unstructured 
proteins (IUPs) (Moncoq et al., 2003). The isolated BPS maintains its activity and ability to 
interact with the activated IR and IGFR (He et al., 1998) and can inhibit catalytic activity of IR 
(Stein et al., 2001). Both SH2 and BPS domains of Grb10 are thought to have comparable 
ability to bind to the phosphorylated IR. The PH domain of Grb7/10/14 family members shares 
60% sequence identity among them. PH domains are very common in the human proteome, 
usually responsible for facilitating localisation of proteins to membranes by binding to 
phosphoinositides. This mode of action, however, is debatable in the case of the human 
Grb10β isoform as it is still able to translocate to the cell membrane even though it lacks the 
PH domain (Dong et al., 1997). A Ras-association-like (RA) domain, located within the centre of 
the GM (Grb-Mig) region of Grb7/10/14, has been suggested to have a potential role in 
mediating interactions with members of the Ras protein superfamily, as has been previously 
described in the case of RasGTP effectors (Ponting and Benjamin, 1996). Presence of the highly 
conserved domains, discussed above, within Grb7/10/14 family highlights their capacity to 
bind and modify the activity of variety of proteins and, subsequently, regulate intracellular 
signalling.  
Depetris et al (2009), as mentioned above, proposed a model for a multicomponent 
assembly by which domains of Grb10 and Grb14 proteins are able to negatively control insulin 
signalling. According to this model, Grb10 or Grb14 complex interacting with IR consists of: PH 
domain-mediated binding to phosphoinositides (their role is to target Grb proteins to 
membrane surfaces), the RA domain directing Grb10 proteins to activated GTPases and SH2 
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and BPS domains that interact with IR kinase domain at two different sites (Depetris et al., 
2009). Consistent with this model, Grb10/14 capacity to regulate insulin receptor signalling is 
dependent upon all four interactions within their PH, RA, SH2 and BPS domains which have an 
ability to block further kinase-mediated phosphorylation events and, also to physically 
interrupt binding of IRS proteins with the insulin receptor. It is suggested that this 
multicomponent assembly might be necessary to permit for a sufficient amount of insulin 
receptor kinase signalling before the Grb10- or Grb14-mediated inhibition is established 
(Ceccarelli and Sicheri, 2009). Recent study showed Grb10 interaction with mammalian target 
of rapamycin (mTOR) in vitro and in cells, which was mapped to the sites situated within or in 
proximity of BPS or proline-rich domains of Grb10 (Hsu et al., 2011), providing further details 
of Grb10 mode of action within the pathway involved in insulin signalling regulation. 
 
Figure 1.4 Schematic representation of Grb10 and Grb14-mediated negative regulation of IR 
signalling.  
PH domain interactions with membrane-tethered Phosphoinositides (PI) target Grb proteins to 
membrane surfaces while the Grb RA domain interacts with activated GTPases accumulating 
upon insulin signalling. The SH2 and BPS domains bind the IR kinase domain at two 
phosphotyrosine sites (P) in the substrate binding cleft and the phosphorylated activation 
loop. No dimer or multimer arrangement of subunits is represented in this model. N, N lobe of 
insulin receptor kinase domain; C, C lobe of insulin receptor kinase domain. Figure adapted 
from (Ceccarelli and Sicheri, 2009). 
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Even though definitive roles for each of the Grb domains have not been fully elucidated 
yet, numerous studies have suggested that they are able to interact with a number of receptor 
and non-receptor signalling proteins (reviewed in Holt and Siddle, 2005). The conserved nature 
of the aforementioned protein family indicates important functions of its members, thus 
deciphering further details of potential functional redundancies between Grb proteins should 
provide invaluable insight into insulin signalling, diabetes and other disorders that result from 
abnormalities within Receptor Tyrosine Kinase (RTK) signalling. 
1.2.2 Grb10 gene and expression 
Mouse Grb10 is situated on the proximal region of chromosome 11, spans around 110 kb 
and consists of 18 exons (Figure 1.5). It is flanked telomerically by the dopa-decarboxylase 
(Ddc) and centromerically by cordon-bleu (Cobl) and Egfr genes. Its translational start sites are 
found in exon 3 and the termination site is located in exon 18. Most of the Grb10 gene 
transcripts arise from the maternal chromosome, with mGrb10α and mGrb10Δ being two 
major species. Both transcripts are initiated in exon 1A, but mGrb10Δ lacks exon 5. It has 
proven difficult to pinpoint the differences in functions and tissue-specific expression between 
these two transcripts. Additionally, Sanz et al (2008) have identified an embryo-specific 
transcript initiating from exon 1A and splicing into exon 1C (Sanz et al., 2008). Paternal 
transcripts initiating from exons 1B1, 1B2 and 1C, splicing into exon 2, and with exons 5 and 
6 either present or absent, have also been described (Arnaud et al., 2003).  
The human GRB10 gene, situated on chromosome 7 between the DDC and COBL genes, 
spans around 190kb and consists of 17 exons (22 if subdivided exons are considered). The 
hGrb10γ shares the most similarity with Grb7 and Grb14 and other Grb10 isoforms are formed 
by extensions at their N-terminal ends generated by alternative splicing with the use of 
different exons. The N-terminal region of Grb7/10/14 harbours the proline-rich region that 
contains a conserved P(S/A)IPNPFPEL sequence as well as other PXXP motifs (Holt and Siddle, 
2005). Typically, sequences rich in proline interact with Src-homology 3 (SH3) and 
tryptophan-rich (WW) domains of other proteins. Two novel Grb10 interacting proteins, 
named GYGYF1 and GYGYF2, identified by yeast-two-hybrid screening, were found to bind to 
tandem proline-rich regions in the N-terminus of Grb10 via GYF motifs rather than SH3 
domains (Giovannone et al., 2003). Both of the GYF proteins are thought to play a role in IGF1 
signalling after experiments showed that stimulation of IGF1 receptor-expressing fibroblasts 
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with IGF1 increased binding of GIGYF1 to Grb10, and induced transient association of both of 
these proteins with the IGF1 receptors (Giovannone et al., 2003). 
In 1998 Grb10 imprinting status was first discovered in mouse (Miyoshi et al., 1998) and 
confirmed in humans two years later (Yoshihashi et al., 2000). This finding raised much interest 
because of a possible role for Grb10 as a growth regulator, not least as a potential cause of 
Silver-Russell syndrome, due to the presence of GRB10 on human chromosome 7 (see Section 
1.1.5 for more details), and due to the location of Grb10 on proximal chromosome 11 in 
mouse, a region previously linked to an imprinted growth phenotype (Cattanach et al., 1996).  
The expression of mouse Grb10 has been first reported in embryonic tissues of the heart, 
kidney, lung and liver as well as in the adult brain (Miyoshi et al., 1998), while paternal 
expression has been initially limited to adult tissues (Hikichi et al., 2003). Recent study by our 
lab has argued that within the brain Grb10 is paternally expressed during fetal life into 
adulthood and that ablation of this expression causes changes within some aspects of social 
behaviour, especially social dominance (Garfield et al., 2011). In the same study maternal 
Grb10 expression during fetal development has been noted in mesodermal and endodermal 
tissues but absent in the central nervous system (CNS) proper. The ventricular ependymal 
layers, the epithelium of the choroid plexus and the meninges were identified as sites of 
maternal Grb10 expression in E14.5 brain. In consistence with the expression pattern during 
embryogenesis, predominantly paternal and almost completely absent maternal Grb10 
expression has also been observed in the adult brain (Garfield et al., 2011). Previous 
expression analysis in E14.5 embryos revealed Grb10 maternal expression in the 
subependymal layers, the meninges and in the choroid plexus of the brain, in a variety of 
muscle tissue, liver, bronchioles, and cartilage of the atlas, ribs, and long bones (Charalambous 
et al., 2003). Additionally, maternal Grb10 expression was clearly detectable in the developing 
tubules and the mesenchyme of the kidneys, the adrenal gland and the pancreatic bud. Adult 
expression of Grb10 from the maternal allele was absent in the liver but highly pronounced in 
skeletal muscle, WAT, the intrinsic muscle of the tongue, and cells of pancreatic islets (Smith et 
al., 2007). Furthermore, in females maternal Grb10 expression was present in the uterine 
horns and oviducts, whereas in male mice was noted in the Leydig cells of the testes.  
The expression of human GRB10 has also proven to be quite complex, with expression 
from the paternal allele in the human fetal brain, from the maternal allele in skeletal muscle 
and biallelic expression in peripheral tissues (Blagitko et al., 2000). The interesting pattern of 
paternal expression in the brain has been found to be conserved in humans and mice (Blagitko 
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et al., 2000; Arnaud et al., 2003; Hikichi et al., 2003) and more thorough investigation of Grb10 
allelic methylation patterns between these two species uncovered some similarities, such as 
maternal hypermethylation of a second CpG identified as a DMR (Arnaud et al., 2003). The 
authors have therefore suggested that any discrepancies in expression between humans and 
mice are due to differences in reading genetic marks rather than an acquisition of an imprint 
mark. Hikichi et al (2003) have also examined the mechanisms responsible for the regulation of 
mouse Grb10 and human GRB10 and found novel, brain-specific promoters that lead to 
paternal expression in the brain, in contrast to expression elsewhere that is either exclusively 
or predominantly maternal. As mentioned above, Garfield et al (2011) recently reported 
predominantly paternal Grb10 expression in the adult brain which was studied by analysing 
LacZ expression in mice with a disrupted Grb10 allele (Garfield et al., 2011). Paternal Grb10 
expression has been confirmed in thalamic, hypothalamic, midbrain and hindbrain nuclei, in 
septal nuclei and the cholinergic inter-neurons of the caudate putamen within the forebrain 
along with absence of cortical expression (Garfield et al., 2011). Median preoptic nucleus, 
medial habenular, medial amygdaloid nuclei and ventromedial hypothalamus were recognised 
as sites of biallelic Grb10 expression in the brain. 
In order to further explore the biological relevance of Grb10 tissue-specific reciprocal 
pattern of imprinting, another study aimed to examine its conservation in humans (Monk et 
al., 2009). GRB10 paternal expression was confirmed in human brain whereas maternal allele-
specific expression was present in the placental villous trophoblasts (placental site necessary 
for nutrient transfer). The remaining fetal tissues showed biallelic Grb10 expression. These 
findings highlight the potential evolutionally important role of GRB10 placental expression in 
fetal growth control. Similarly to the situation in mouse, the maternal transcripts arise from 
a promoter region with no allelic chromatin differences located upstream of the ICR of the 
domain. Some features of the paternal brain-specific expression from the ICR are also 
reminiscent of situation in the mouse, as it is DNA-methylated on the maternal allele and is 
marked on the paternal allele by developmentally regulated bivalent chromatin, with the 
presence of both H3 lysine-4 and H3 lysine-27 methylation (Monk et al., 2009). This 
comparative analysis between mice and humans revealed significant similarities in GRB10 
imprinting mechanisms between these two species and suggested that conserved reciprocal 
allelic expression between placenta and brain indicated that imprinting of GRB10 evolved to 
regulate different roles in mammalian growth and behaviour. 
The mechanisms that govern the complex imprinting of mouse Grb10 have been studied 
in detail (Arnaud et al., 2003; Hikichi et al., 2003; Sanz et al., 2008). Three CpG islands have 
32 
 
been localised in the promoter region of this gene. The first of the CpG islands (CpGl1) was 
hypomethylated on both alleles in all tissues and stages investigated, so it is does not form 
a DMR. On the other hand, a germline DMR (CpGI2) located 3’ to exon 1A was 
hypermethylated on the maternal chromosome (Arnaud et al., 2003; Hikichi et al., 2003). The 
fact that methylation of CpGI2 permits for Grb10 expression has been established by analysis 
of Grb10 expression in primordial germ cell-derived mouse cloned embryos which showed 
imprint erasure and biallelic Grb10 silencing (Lee et al., 2002). In addition, another study 
showed that ablation of Grb10 maternal methylation in embryos lacking Dnmt3l results in 
silencing of Grb10 gene (Arnaud et al., 2006).  
A somatic, tissue-specific DMR that lies within CpGl3 appears to control the brain-specific 
transcripts that initiate from exons 1B1, 1B2 and 1C. CpGl3 is hypomethylated on the paternal 
allele but biallelically hypermethylated in peripheral tissues (Arnaud et al., 2003). The use of 
different promoters is linked to histone tail modifications. Histone tail modifications, in 
particular methylation of lysine 27 on histone H3 (H3K27me3) is usually present in the case of 
transcriptionally inactive chromatin. This repressive mark has been found by Sanz et al (2008) 
to be a very likely mechanism causing the promoter switch in Grb10 as it was enriched on the 
unmethylated paternal allele at the germline DMR (CpGI2), whereas this was not the case in 
brain. Recent studies have found that the mouse Grb10 DMR is vital for the imprinting within 
this locus (Shiura et al., 2009) and it is marked by mono-allelic bivalent chromatin, with 
enrichment of both H3K4me2 and H3K27me3 on the paternal allele (Sanz et al., 2008). Recent 
publication by Shiura et al (2009) demonstrated that the Grb10 DMR controls in a tissue-
specific manner a Grb10 imprinting region that encompasses at least five imprinted transcripts 
of three genes: Cobl, Grb10 Types I and II and Ddc-exon1 and –exon1a. Biased, maternally 
imprinted expression of Ddc in neonatal heart (consistent with previous finding by Menheniott 
et al., 2008), liver and yolk sac along with reciprocal imprinted expression of Cobl in yolk sac 
were reported. In addition, Shiura et al (2009) have established that genomic imprinting 
regulation is comparable between deletion of the Grb10 DMR and fully methylated status of 
the maternal allele Grb10 DMR.  
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Figure 1.5 Schematic representation of Grb10 gene localisation on mouse chromosome 11, Grb10 gene organisation and Grb10 protein structure (not 
drawn to scale).  
A) The localisation of Grb10 gene, predominantly expressed from maternal allele but also showing brain-specific paternal expression, on proximal 
chromosome 11. Grb10 is flanked by the biallelically expressed genes Dopa decarboxylase (Ddc) and Cordon blue (Cobl) which have been shown to exhibit 
biased expression in yolk sac, neonatal liver and heart (Ddc) and in yolk sac (Cobl), hence longer arrows representing slightly biased expression on the 
paternal and maternal alleles of these two genes, respectively. Tel, telomeric region; Cen, centromeric region. B) Grb10 gene organisation (UCSC 
annotation). LacZ integration sites within Grb10 are shown for the Grb10KO and Grb10Δ2-4 mouse lines. Initiation of maternal transcripts starts from exon 
1A within CpG island (CpGI) 1, hypomethylated on both parental alleles whereas paternal, brain-specific transcripts initiate from exons 1B1, 1B2 and 1C. 
Both 1B1 and 1B2 are situated within CpGI2, which is a germline differentially methylated region (gDMR), hypermethylated on the maternal allele and 
hypomethylated on the paternal allele in all tissues, with a crucial role of regulating imprinted expression of Grb10 locus. CpGI3, displaying differential 
methylation on the parental alleles distinctly in brain, overlies exon 1C. White boxes, untranslated exonic sequence; black boxes, coding exons; empty and 
filled lollipops, hypo- and hyper-methylation, respectively. C) Different Grb10 splice variants share a similar structure with five distinct molecular 
interactions domains: P, a small proline-rich region (11 aa; aa- amino acids), the structural domain closest to the amino-terminus (N), is encoded by exon 4 
and can interact with SH3 and WW domains; RA, Ras-associated-like domain (84 aa) is homologue to a region of the MIG-10 protein, it allows for 
interactions with Ras-like GTP-binding proteins; PH, pleckstrin homology domain (124 aa or 85 aa in isoform α of Grb10), encoded by exons 10-13, ensures 
association with phospholipid molecules and may play a part in targeting Grb10 to both the plasma and mitochondrial membranes; BPS, between PH and 
SH2 domain (48 aa), encoded by exons 13-16, necessary for binding to activated IR and, to a lesser extent, Igf1r; SH2, Src-homology 2 domain (104 aa) is 
encoded by exons 16-17 and is the structural domain closest to carboxyl- terminus (C). This domain allows for interactions with phosphotyrosine-containing 
domains of several proteins and is required for RTK binding. RA and PH domains form a region termed GM (Grb-Mig). Grb10 has an ability to 
dimerise/oligomerise due to interaction between the N-terminal domain of one molecule and the GM region of another.  
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The first Grb10 knockout mice, termed Grb10Δ2‐4, were generated by using a gene-trap 
construct that contained a LacZ reporter which was inserted within the Grb10 locus such that 
it was controlled by endogenous Grb10 promoters and enhancers. The LacZ reporter provided 
a method for detection of parental allele-specific expression, while mRNA in situ hybridisation 
and immunohistochemistry were used to assess tissue-specific expression of endogenous 
Grb10. Both experimental methods demonstrated primarily maternal Grb10 expression in 
a range of tissues (described above). The adult hypothalamus showed Grb10 paternal 
expression (Smith et al., 2007), which is consistent with previous predictions (Arnaud et al., 
2003), while reporter expression failed to be demonstrated in fetal brain, with the exception of 
maternal expression within subependymal layers, the meninges and choroid plexus 
(Charalambous et al., 2003). On the other hand, anti-Grb10 antibody allowed for detection of 
additional expression in the brain (Charalambous et al., 2003). To overcome these potential 
discrepancies in detected expression, another transgenic mouse line (termed Grb10KO) with 
a LacZ reporter cassette inserted within exon 8 was created (Garfield et al., 2011). The 
maternal expression of Grb10 detected in this mouse line resembled previously reported sites 
in Grb10Δ2‐4 animals, however, more pronounced Grb10 paternal expression has been 
observed in the developing CNS of mice with paternally transmitted gene trap. Garfield et al 
(2011) have demonstrated paternal Grb10 expression in fetal and adult brain as well as the 
consequences of lack of this expression resulting in abnormalities within social behaviour. The 
uniqueness of Grb10 gene is pronounced by its ability to show tissue-specific, imprinted 
expression from each of the parental alleles which results in entirely distinct phenotypic 
outcomes, as ablation of maternally expressed Grb10 leads to fetal and placental overgrowth 
and metabolic abnormalities (Charalambous et al., 2003; Smith et al., 2007). Hence, up until 
now, Grb10 is the only example of an imprinted gene able to influence growth, metabolism 
and behaviour, depending on parent-of-origin-specific expression in different tissues. 
Generation of two Grb10 knockout models, discussed above, allowed for detailed investigation 
of parent-of-origin -specific expression of Grb10 and encouraged characterisation of the 
phenotypic effects resulting from disruption of this differential expression in vivo.  
1.2.3 Grb10 signalling 
Grb 7/10/14 protein family has been subject to number of biochemical studies which 
suggested potential binding partners for members of this family, however the outcomes of 
these studies do not always accurately reflect the real interactions in vivo. Mouse Grb10 was 
initially identified during a yeast-two-hybrid experiment as one of the potential interacting 
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partners of EGFR (Ooi et al., 1995). However, the preference of Grb10 for interaction with 
a number of other receptor proteins and lack of evidence for EGFR interaction in vivo would 
suggest that binding to EGFR might not be physiologically relevant. Grb10, as an adaptor 
protein, is known to be able to bind to a wide spectrum of molecules, both RTKs and non-RTKs. 
Several experiments have demonstrated the ability of Grb10 to bind to various receptor 
tyrosine kinases, however a preference for binding with the IR has been acknowledged (Frantz 
et al., 1997; Laviola et al., 1997).  
1.2.3.1 Grb10 and insulin signalling 
Although the overall consensus from in vivo studies is that Grb10 is a potent negative 
regulator of insulin signalling (Shiura et al., 2005; Smith et al., 2007; Yamamoto et al., 2008), 
the results from in vitro studies are not always consistent with this. Both negative and positive 
effects of Grb10 binding to IR have been reported in cell culture experiments. For example 
Deng et al (2003) showed that overexpression of Grb10 in differentiated 3T3-L1 adipocyte 
cells, as well as mouse L6 cells, resulted in an increased metabolic response, including glycogen 
synthesis, glucose and amino acid transport and lipogenesis. In contrast, expression of 
a dominant-negative Grb10 SH2 domain in the same cells eliminated these responses. 
However, the majority of in vitro experiments have shown that, in parallel to its apparent role 
in vivo, Grb10 acts as an inhibitor of insulin signalling. Catalytic activity of the IR in vitro was 
shown to be inhibited by binding of Grb10 via its SH2 and BPS domains (Stein et al., 2001). It 
was also demonstrated that overexpression of Grb10 in primary rat hepatocytes specifically 
inhibits insulin-stimulated glycogen synthase (GS) activity, and thereby glycogen synthesis, in 
a manner independent of IRS-1/2 and PI3-kinase (Mounier et al., 2001). Another group has 
revealed that inhibition of the IR by Grb10 could be due to blocking the binding between IRS 
proteins and IR (Wick et al., 2003). Overexpression of Grb10 in Chinese hamster ovary cells 
expressing the insulin receptor or in 3T3-L1 adipocytes reduced insulin-stimulated 
phosphorylation of MAPK, and in rat primary adipocytes inhibited insulin-stimulated 
phosphorylation of the MAPK downstream substrate Elk1 (Langlais et al., 2004). From these 
findings the authors concluded that a direct block of insulin-stimulated Shc tyrosine 
phosphorylation is the most plausible explanation for the inhibitory effect of Grb10 on the 
MAPK pathway.  
It is difficult to interpret the data suggesting that Grb10 is able to act both positively and 
negatively on insulin signalling, as reciprocal effects of its overexpression have been reported 
in the same 3T3-L1 cell line which excludes the dependence on the cellular context as the 
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source of variation, at least in this instance. Other possible alternative explanations for 
observed discrepancies between experiments could include effects of different levels of 
expression or the use of different Grb10 isoforms, but the most important thing is to consider 
if these types of study provide information on the role of Grb10 that is relevant in 
a physiological context. The majority of the overexpression studies have been conducted in cell 
lines that do not form typical insulin target tissues. Some of the more recent studies have 
overcome the problems associated with overexpression, potentially at super-physiological 
levels, by using techniques to investigate the effects of knocking down expression of 
endogenous Grb10. The importance of IGF1 in embryonic and postnatal growth is clearly 
established and the role of Grb10 in these processes is clearly evident, however there is 
conflicting information regarding the physiological interaction between the two factors. 
Several studies have demonstrated Grb10 interactions with the IGF1R and its role in IGF1 
mediated mitogenesis (O'Neill et al., 1996; Morrione et al., 1997; Wang et al., 1999; Morrione, 
2003) but they did not provide information on the role of endogenous levels of Grb10 in IGF1 
signalling. A few studies used overexpressed full length Grb10 or Grb10 constructs to show 
that Grb10 has a positive role in insulin signalling, metabolic responses (Deng et al., 2003) and 
IGF1 induced mitogenesis (O'Neill et al., 1996; Wang et al., 1999). On the other hand, some 
other experiments demonstrated negative effects of the overexpression of Grb10 on insulin 
signalling (Liu and Roth, 1995; Wick et al., 2003; Langlais et al., 2004) and IGF1 mediated 
growth (Morrione et al., 1997; Morrione, 2003). The limitations of these studies are due to 
varied experimental approaches and the fact that Grb10 overexpression levels might influence 
its interactions with receptors and downstream signalling molecules and therefore might not 
properly represent the real physiological interactions between them. As the IGF1 pathway is 
vital in early and postnatal development, it is of interest to identify the effects of endogenous 
Grb10 on IGF1 signalling in order to gain more insight into normal physiological functions of 
Grb10.  
Langlais et al (2004) have used small interfering (si)mRNA knockdown of Grb10 in HeLa 
cells overexpressing insulin receptors to determine Grb10 negative regulation of insulin 
signalling. In another study aiming to identify endogenous Grb10 function in the IGF signalling 
response, small interfering RNA has been used to show that Grb10 knockdown leads to 
increased phosphorylation of IGF1-mediated IRS proteins, Akt/protein kinase B and ERK1/2, 
and to enhanced DNA synthesis (Dufresne and Smith, 2005). The authors suggested that Grb10 
acts as an endogenous inhibitor of IGF1-stimulated cell signalling and DNA synthesis, which is 
in agreement with findings reported by Langlais et al (2004) concerning the effects of Grb10 on 
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insulin signalling. The mode of endogenous Grb10 action presented in this study depended on 
maintaining phosphorylation of IGF1 receptor tyrosine through inhibition of protein tyrosine 
phosphatases on activated receptors (Dufresne and Smith, 2005).  
In summary, the majority of studies confirm Grb10 as a negative regulator of insulin 
signalling, however some evidence has proven otherwise, which might be due to context-
specific function of Grb10. The overall conclusion from experiments performed so far is that 
Grb10 is involved in the regulation of insulin, and perhaps IGF signalling.  
IGF1R tyrosine kinase signalling controls the normal course of growth and development 
through regulation of numerous physiological processes (reviewed in Annunziata et al., 2011). 
IGF1 or IGF2 activates IGF1R and leads to antiapoptotic and mitogenic responses. In some 
cases IGF1 also functions in differentiation, cell size regulation as well as transformation and 
motility. Changes within IGF1R signalling frequently result in growth abnormalities, such as 
acromegaly, gigantism or dwarfism (Abuzzahab et al., 2003; Manjila et al., 2010), depending on 
either an increase or decrease in IGF1R signalling. It is known that enhanced IGFR signalling 
plays a role in several cancers (Pollak et al., 2004; Pollak, 2008), including prostate and breast 
cancers. Receptor autophosphorylation on tyrosine residues and recruitment of signalling 
mediators, including IRS and Shc, to the activated receptor are stimulated by ligand binding to 
IGF1R. Phosphorylation of these compounds, mediated by the IGF1R, results in activation of 
MAPK and PI3-K signalling pathways, which leads to the downstream biological effects of IGF1 
and IGF2. The activated IGF1R, following ligand binding, does interact with other molecules, 
among them Grb10 protein.  
1.2.3.2 Grb10 and other interacting partners 
As mentioned above, Grb10 has been shown to interact with insulin receptor and insulin-
like growth factor 1 receptor, but also Raf1 kinase, MEK1 kinase and neural precursor cell 
expressed developmentally down-regulated protein 4 (Nedd4) (Giorgetti-Peraldi et al., 2001; 
Morrione, 2003; Murdaca et al., 2004; Dufresne and Smith, 2005; Ramos et al., 2006; Huang 
and Szebenyi, 2010). The SH2 domain of Grb10 has been identified as a target during yeast-
two-hybrid screens using the Eph receptor family member ELK (Eph-related receptor tyrosine 
kinase) (Stein et al., 1996) as well as Ret tyrosine kinase receptor (Pandey et al., 1995). The Eph 
receptor belongs to a family of proteins with roles in a variety of physiological processes, such 
as cell migration, while ELK has a known function in endocrine organ development. Another 
yeast-two-hybrid experiment showed that Grb10 is able to interact with Tec, a non-receptor 
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tyrosine kinase and by overexpression inhibits downstream effector activation (Mano et al., 
1998). MEK1 kinase was also used as bait in a yeast-two-hybrid screen and yielded the Grb10 
SH2 domain as a region interacting with both Raf1 and MEK1 kinase in a phosphotyrosine-
independent manner (Nantel et al., 1998). Grb10 also possesses the ability to interact with  
c-Abl (Frantz et al., 1997) which encodes the Bcr-Abl oncoprotein (Bai et al., 1998) that usually 
activates the PI 3-kinase, MAP kinase and STAT signalling cascades, and has been implicated in 
both chronic myelogenous leukaemia (CML) and acute lymphoblastic leukaemia (ALL). 
Moutoussamy et al (1998) implicated Grb10 in negative regulation of growth hormone (GH) 
signalling as they showed that interaction with GH receptor through the Grb10 SH2 domain is 
possible in vitro (Moutoussamy et al., 1998). Evidence has also been provided for Grb10 being 
a part of the c-kit signalling pathway and the fact that the expression level of Grb10 has a great 
influence on Akt activity (Jahn et al., 2002). 
The mammalian target of rapamycin (mTOR) protein kinase is a master growth promoter 
that nucleates two complexes, mTORC1 and mTORC2 and controls cell growth and metabolism 
in normal physiological and pathogenic states (Dobashi et al., 2011). Its substrates, however, 
are still under investigation. Recently two different studies have identified Grb10 as an 
mTORC1 substrate (Hsu et al., 2011; Yu et al., 2011). It was argued that Nedd4 knockout mice, 
which have increased Grb10 protein levels and are insulin and IGF resistant (Cao et al., 2008) 
show a signalling phenotype reminiscent of cells with ablation of TSC1 or TSC2 (the tuberous 
sclerosis complex 1 or 2) described in this report (Hsu et al., 2011). Both studies showed Grb10 
being directly phosphorylated by mTORC1 which resulted in increased Grb10 stability (Hsu et 
al., 2011; Yu et al., 2011). Moreover, in agreement with genetic experiments in mice, Grb10 
ablation from cells caused enhanced insulin sensitivity whilst its overexpression had an 
inhibitory effect on insulin signalling (Hsu et al., 2011; Yu et al., 2011). These publications have 
suggested that Grb10 forms part of a negative feedback loop in which, when activated 
downstream of insulin or IGFs, mTORC1 phosphorylates Grb10 and through that it raises the 
capacity of Grb10 to inhibit signals from insulin and IGF receptors (Hsu et al., 2011; Yu et al., 
2011). This complements the already established feedback pathway with S6K1 
phosphorylating IRS and targeting it for degradation. It has also been pointed out that 
downregulation of Grb10 expression often accompanies various cancers and that Grb10 
ablation and loss of the well-established tumour suppressor phosphatase PTEN are mutually 
exclusive events, which indicated Grb10 function might as a potential tumour suppressor 
controlled by mTORC1 (Yu et al., 2011), raising the possibility of Grb10 role as a target in 
cancer therapy. 
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A recent study using a pro-apoptotic member of the Bcl-2 family, Bim L, as bait in yeast-
two-hybrid experiment has identified Gr10 as an interacting partner of Bim L (Hu et al., 2010) 
and suggested that the anti-apoptotic activity of Grb10 depends on the phosphorylation of 
dynein binding domain (DBD) of Bim protein.  
It has also been shown that even though Grb10 does not possess ubiquitin ligase activity, 
it can still bind the C2 domain of the of the E3 ubiquitin ligase Nedd4 through its SH2 domain, 
and through the formation of Grb10-Nedd4 complex it induces IGF1-stimulated 
multiubiquitination, internalization and IGF1R degradation (Morrione et al., 1999; Vecchione 
et al., 2003; Monami et al., 2008). It was unclear in what manner Grb10 SH2 domain was able 
to bind the C2 domain of Nedd4 and the kinase domain of IGF1R simultaneously until a recent 
report identified the Nedd4 C2/Grb10 SH2 complex structure. It was demonstrated that in the 
Nedd4/Grb10/IGF1R complex Grb10 acts as a connector, forming a bridge between Nedd4 and 
IGF1R, and Grb10 SH2 co-localises an ubiquitin ligase (Nedd4) and its substrate (IGF1R) (Huang 
and Szebenyi, 2010). 
As discussed above, Grb10, as an adaptor protein, has an ability to bind to numerous 
receptors and ligands, however its mode of action is sometimes debatable. The explanations 
for the discrepancies in the true nature of its mechanism of action might be dependent on the 
variety of Grb10 isoforms and differences in the manner that various experiments have been 
performed. Relevant experimental variables include forced overexpression to different levels, 
the variety of tested cell types and the different endpoints used. Thus, in vitro binding 
experiments, yeast-two-hybrid screens and co-immunoprecipitation experiments used in the 
discussed studies might not always represent the true role of Grb10 in vivo. 
1.2.4 Role of Grb10 in development and metabolism 
The Grb10 imprinted expression pattern, specifically its predominant expression from the 
maternal allele, is in agreement with its role as a growth suppressor as predicted by the 
conflict hypothesis. Use of knockout mice provided a valuable tool to investigate the influence 
of Grb10 on both fetal and postnatal development as well as adult metabolic status. As 
mentioned previously, Charalambous et al (2003) were the first to describe the phenotype of 
mice lacking functional Grb10 gene. The Grb10Δ2-4 animals were generated by insertion into 
the Grb10 locus of a gene trap construct containing a splice acceptor, β-geo cassette and 
a polyadenylation sequence which caused the deletion of 36 kb between exons 2 to 4 that 
includes the translation initiation codon in exon 3. In situ analysis has shown that expression 
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from the LacZ reporter gene closely follows the endogenous pattern of Grb10 expression. The 
characterisation of mice without functional Grb10 following maternal transmission of the 
mutant allele (Grb10Δ2-4m/+ animals) revealed significant overgrowth of the placenta (from 
E14.5) and embryos (from E12.5 onwards). This overgrowth phenotype resulted in a mean 
birth weight of Grb10Δ2-4m/+ animals that was approximately 30% greater than their wild type 
littermates. In addition, neonatal Grb10Δ2-4m/+ animals exhibited relative brain sparing and 
disproportionate overgrowth of the liver (Charalambous et al., 2003), an unusual effect as very 
few genes are known to have an effect on overall body size during embryogenesis and also 
cause the disproportional growth of different organs.  
Smith et al (2007) followed up the phenotypic analysis of Grb10Δ2-4m/+ mice by 
characterising their postnatal growth and metabolism. A 13% increase in body weight was 
noted in mutant animals, even at the age of 6 months. DXA analysis of these mice revealed 
significantly reduced fat tissue and enhanced lean tissue content but with no obvious 
alterations in fat and muscle cell histology. The food intake in Grb10Δ2-4m/+ mice was not 
altered. Furthermore, glucose tolerance tests revealed that lack of functional Grb10 led to 
improved whole-body glucose tolerance and insulin sensitivity in adult mice. It has been 
suggested that the increased muscle mass is the reason for increased glucose tolerance, 
caused by enhanced glucose clearance into the muscle. The Grb10 knockout mice exhibited 
tissue-specific changes in insulin-induced IR and IRS-1 tyrosine phosphorylation as well as in 
level of IGF1R and IRS-1 tyrosine phosphorylation in response to IGF1R (Smith et al., 2007). 
Thus, enhanced signalling through IR and/or Igf1r could also directly contribute to the 
observed improvement in glucose handling. The increase in skeletal muscle tissue mass alone 
might not be enough to lead to significant abnormalities in the regulation of blood glucose as, 
in the case of Mstn knockout mice, lean tissue content was dramatically elevated without 
changes in glucose or insulin levels, or in the ability to clear a glucose load (McPherron and 
Lee, 2002). As expected, the phenotype of transgenic mice ectopically overexpressing Grb10 
was to some extent opposite to that of Grb10Δ2-4m/+ mice (Shiura et al., 2005). The first 
described transgenic mice with ectopic expression of Grb10 did not show any alterations in 
body size during embryonic development or at birth but at the age of 4 months they were 10 
to 15% lighter than their wild type counterparts. The limitations of this model came down to 
the possibility that transgenic Grb10 animals did not precisely mimic Grb10 expression profile 
during development, as the transgene lacked the original promoter and was coupled with an 
external enhancer and it was likely that the contribution of the transgene expression 
increasing with time in some organs caused the postnatal growth retardation (Shiura et al., 
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2005). Because Grb10 expression is high during the late embryonic stages but diminishes after 
birth, it is possible that postnatal growth effects in Grb10 transgenic animals were resulting 
from ectopic overexpression of the transgene. Metabolic characterisation of Grb10 transgenic 
mice revealed insulin resistance which in some cases led to development of diabetes as 
a result of hyper-negative regulation of the insulin and IGF1 receptors (Shiura et al., 2005). 
Additionally, increased adipocyte content in the pancreas of has also been observed, though 
the overall fat tissue content was not reported. The altered body size and tissue composition 
in the Grb10 transgenic mice mirrors that seen in Grb10Δ2-4m/+ mice and might be the reason 
for disrupted glucose metabolism or at least contribute to it. A recent study of the same model 
suggested that Grb10 transgenic mice resemble some characteristics of human type-2 diabetes 
(Yamamoto et al., 2008), as they showed decreased ability to clear glucose, significantly 
reduced levels of blood urea nitrogen and abnormally high levels of plasma triglyceride, 
insulin, adiponectin and resistin. These abnormal phenotypic changes have been accompanied 
by significantly decreased body, visceral fat and liver weights in Grb10 transgenic mice and 
60% higher incidence of type-2 diabetes in these mice when fed on a high fat diet (Yamamoto 
et al., 2008). A careful interpretation of these results is necessary as the ectopic transgene 
expression might have resulted in false phenotypic effects.  
Recently another mouse model has been generated to overcome these limitations, as 
Shiura et al (2009) by deletion of the imprinting control region Grb10-DMR have created 
transgenic Grb10 mice with double Grb10 Type I transcript expression in organs and tissues 
that normally express Grb10. Type I transcripts from upstream promoters are maternally or 
biallelically expressed in the majority of tissues in mice and humans, respectively, whilst Type II 
transcripts from downstream promoters are paternally expressed in the brain of both species 
(Arnaud et al., 2003; Hikichi et al., 2003; Yamasaki-Ishizaki et al., 2007). Transgenic mice 
exhibited similar phenotype to the one observed for animals with maternal disomy 
Chromosome 11 (MatDi(11)) and maternally duplicated proximal Chromosome 11 
(MatDp(prox11)), and an increased Grb10 expression was suggested as a cause for the 
observed growth retarded phenotype in embryos and neonatal mice (Shiura et al., 2009). 
A plausible explanation for the Grb10 overexpression and knockout mice growth 
phenotypes was that Grb10 forms an inhibitory interaction with Igf1r, as Grb10 has 
a demonstrated capacity for binding directly with both IR and Igf1r. Furthermore, the 
overgrowth observed in Grb10Δ2-4m/+ mice is comparable in magnitude to the growth 
retardation seen in mice lacking genes in the IGF signalling pathway (Efstratiadis, 1998). 
Additionally, the expression pattern of Grb10 and its time of action appeared similar to that of 
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IGF2. IGF2 is a known embryonic and placental growth factor with almost exclusive expression 
from the paternal allele which acts primarily through the IGF1 receptor in the embryonic 
growth and through insulin receptor in the placenta. By creating a cross between Grb10Δ2-4m/+ 
female and Igf2+/p male mice (which gave rise to mice of four different genotype: wild type, 
Grb10Δ2-4m/+, Igf2+/p and Grb10Δ2-4m/+/Igf2+/p) it was possible to analyse if Grb10 was exerting 
its growth effects through any of these receptors (Charalambous et al., 2003). Grb10 
interaction with Igf2 receptor would be associated with double mutants exhibiting similar 
phenotype to Igf2+/p animals. However, analyses of total body weights and organ weights from 
double mutants showed an additive effect of both parental genotypes and significantly 
differed from Igf2+/p neonates. In addition, E16.5 embryos and placentae of double mutants 
displayed an additive effect of the two gene deletions. These results suggested that Grb10 
exerts its growth effects through a pathway that is possibly independent of IGF1 receptor and 
IR. However, it could still be argued that ablation of Igf1r (a component shared between Igf2 
and Igf1 pathways) would provide more compelling evidence for Grb10 role in Igf-growth 
effects. As a result, genetic crosses between female Grb10Δ2-4m/+and male Igf1r-/- animals 
were generated (Garfield, 2007), and similarly to the Grb10Δ2-4m/+/Igf2+/p data, double 
knockout neonates displayed additive body weights between the two single mutants. Organ 
weight analysis showed the intermediate phenotypes in hearts, lungs and kidneys, but not 
brains and livers, suggesting that maternal Grb10 does not have significant role in brain 
development whilst Igf1r does not exert its effects in the liver. This provides evidence 
independent of the Grb10Δ2-4m/+/Igf2+/p cross indicating that the Igf-pathway is not that 
primarily responsible for the overgrowth phenotype in Grb10 mutants. Overall, genetic 
experiments described above indicate that Grb10 is controlling growth in an as yet 
unidentified way by interacting with signalling molecules that are to be elucidated. Further 
investigation of Grb10 possible interactions with other genes, particularly imprinted ones with 
reciprocal expression pattern and phenotypic effects, seems to be a plausible way of looking 
more closely into Grb10 signalling pathways.  
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1.3 Delta-like homologue 1 
1.3.1 The Dlk1 protein and signalling 
The gene encoding Delta-like homologue 1 (Dlk1) is also known as Preadipocyte factor 1 
(Pref-1) and Fetal antigen 1 (FA1). Dlk1 is situated on mouse distal chromosome 12 (Gubina et 
al., 2000) and human chromosome 14q32 (Gubina et al., 1999). Together with Dio3 and Rtl1 it 
forms a part of an imprinted gene cluster, Dlk1-Dio3 (Figure 1.6). Dlk1 encodes 
a transmembrane epidermal growth factor (EGF)-like protein which possesses six EGF-like 
repeats in the extracellular domain, a juxtamembrane region, a transmembrane domain and 
a short, intracellular tail (Smas et al., 1994). A soluble form of Dlk1 called fetal antigen 1 (FA1) 
acting as a growth factor during development can be generated from cleavage at the 
extracellular domain of Dlk1 (Jensen et al., 1994) . In addition, a constitutively membrane-
bound Dlk1-C2 is yet another splice variant of Dlk1 lacking the proteolytic cleavage site 
(Floridon et al., 2000). EGF-like motifs present in Dlk1 are similar to those observed in 
members of the Delta/Notch/Serrate protein family (Laborda et al., 1993; Laborda, 2000). 
However, when compared with these signalling molecules, it has been noted that Dlk1 lacks 
a Delta:Serrate:Lag-2 (DSL) domain, which is generally thought to be crucial for activation of 
Notch signalling (Smas and Sul, 1993). Thus it was surprising that Dlk1 dimers, lacking the DSL 
motif, were able to increase thymocyte cellularity in an HES-1 dependent manner (Kaneta et 
al., 2000). Instead of DSL, Dlk1 N-terminal EGF-like repeats encompass a DOS (Delta and OSM-
11) motif, which has been found in typical Notch ligands and other proteins able to act in the 
Notch pathway in the presence of DSL containing Notch ligands (Komatsu et al., 2008; Kopan 
and Ilagan, 2009) 
Despite lack of the DSL domain, experiments both in vivo (Bray et al., 2008) and in vitro 
(Baladron et al., 2005; Nueda et al., 2007) have shown that Dlk1 is still able to bind to Notch 
receptor, without activating it, and that it can act as Notch antagonist (Baladron et al., 2005; 
Kopan and Ilagan, 2009). Dlk1 acts as Notch antagonist by interacting with Notch receptors 
through its EGF repeats as it has been demonstrated to bind to Notch in Drosophila and 
Notch1 in mammalian cell cultures (Baladron et al., 2005; Nueda et al., 2007; Bray et al., 2008). 
However a role for Dlk1 in enhancing Notch signalling has also been suggested in a study that 
implied the DSL and DOS motifs function together in order to activate Notch signalling 
(Komatsu et al., 2008).  
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Figure 1.6 Schematic representation of Dlk1 gene localisation on chromosome 14, Dlk1 organisation and Dlk1 protein structure (not drawn to scale).  
A) Localisation of the maternally imprinted Dlk1 gene on the distal part of chromosome 12. Dlk1 is situated within the Dlk1-Dio3 cluster, which also 
comprises two other imprinted, protein coding genes, paternally expressed retrotransposon-like 1 (Rtl1) and type III iodothyronine deiodinase (Dio3), as 
well as maternally expressed non coding RNA genes, gene trap locus 2 (Gtl2), RNA imprinted and accumulated in nucleus (Rian) and miRNA containing gene 
(Mirg) and antisense Rtl1 (Anti-Rtl1). Tel, telomeric region; Cen, centromeric region. B) Dlk1 gene organisation. Neo-cassette integration sites within the 
Dlk1 gene are shown for the knockout mouse lines generated in two different studies, Dlk1Δ1-3 (Raghunandan et al., 2008) and Dlk1Δ2-3 (Moon et al., 
2002). Initiation of transcripts starts from exon 1 within a CpG island hypomethylated on both parental alleles. black boxes, coding exons; empty and filled 
lollipops, hypo- and hyper-methylation, respectively. C) Structure of Dlk1 protein which contains six EGF-like repeat domains and juxtamembrane domain 
(JM) in the extracellular region as well as a transmembrane (TM) domain and cytoplasmic (CY) region. Dlk1 protein, comprising 385 aa (amino acids) 
contains a signal sequence at the amino acid terminus (N) and a single transmembrane domain (amino acids 300-322). EGF-like repeats in Dlk1 protein are 
similar to those observed in proteins of the Notch/Delta/Serrate protein family, however Dlk1 lacks the DSL (Delta/Serrate/Lag-2) domain conserved in all 
classic Notch ligands in order to provide Notch-receptor : ligand interaction. In its place, the N-terminal EGF tandem repeats of Dlk1 comprise DOS (Delta 
and OSM-11), a motif found to act in the Notch pathway in the presence of DSL-containing Notch ligands. There are four major alternative splicing products 
of Dlk1, the largest full-length form as well as three shorter ones containing deletions in the JM region or part of the sixth EGF-like repeat domain. 
Proteolytic cleavage of Dlk1 at two sites of the extracellular domain leads to generation of soluble forms of Dlk1.  
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Komatsu et al (2008) also demonstrated that Dlk1 could substitute for OSM-11 in 
C.elegans development, which suggested conservation of DOS motif function across species. 
A recent study has shown that DLK1 can interact with another EGF-like protein, DLK2, and that 
through interacting with themselves and with each other they can modulate NOTCH signalling 
by acting as inhibitory non-canonical protein ligands for the NOTCH receptor (Sanchez-Solana 
et al., 2011). The suggestion was that DLK1-DLK2 interaction results in reciprocal inhibition of 
activities of each of the proteins which leads to induction of NOTCH signalling.  
The membrane-bound form of Dlk1, but not the soluble form which lacks the 
transmembrane domain, has an ability to antagonise Notch in Drosophila wing development 
(Bray et al., 2008), while in contrast an experiment in C.elegans showed that Dlk1 activated 
Notch by binding to Notch ligand (Kopan and Ilagan, 2009). Up until now, the interaction of full 
length Notch with Dlk1 has not been reported and contradictory data on the influence of 
Notch on adipocyte differentiation has been published. On one hand, Notch has been 
suggested to be necessary for adipocyte differentiation (Garces et al., 1997) and also inhibition 
of adipocyte differentiation has been reported in the presence of the Notch ligand, Jagged1. 
On the other hand, it has been demonstrated that knockdown of Hes-1, the protein 
downstream of Notch, caused inhibition of adipocyte differentiation (Ross et al., 2004). 
Moreover, another group established that the role of Notch in adipocyte differentiation is not 
essential, as Notch1 knockout cells were able to undergo differentiation into adipocytes 
(Nichols et al., 2004). Other studies also suggested that Notch is not required for adipocyte 
differentiation and that it inhibits this process rather than activates it (Wang et al., 2010). 
These findings are yet to be confirmed by analyses of Dlk1 molecular and biochemical 
interactions so that a concrete insight into the basis and mechanisms of interactions between 
Dlk1 and Notch can be established. In order to inhibit adipocyte differentiation one of the Dlk1 
mechanisms of action is to antagonise insulin/IGF1 signalling which leads to reduced activation 
of Erk1/2 and Akt pathways (Zhang et al., 2003). Dlk1 was also found to modulate ERK/MAPK 
signalling triggered by Insulin/IGF1 in response to specific differentiation factors (Ruiz-Hidalgo 
et al., 2002). In addition, Dlk1 binding to IGFBP1/IGF1 complexes appears to lead to release of 
IGF1R and increases the adipogenic potential of 3T3-L1 cells (Nueda et al., 2008), suggesting 
the role of membrane-bound Dlk1 variants in initiating adipogenesis in response to IGF1. 
Recent study has shown Dlk1 expression can be supressed directly by BMP7, which allows for 
adipogenesis to commence (Zhang et al., 2010).  
46 
 
Dlk1 can also interact with itself through its EGF-like repeat domains and can undergo 
(TACE)-mediated cleavage by ADAM17/tumour necrosis factor alpha converting enzyme to 
produce a soluble form of Dlk1 (Wang et al., 2006). Expression of Dlk1 has been the most 
widely studied in preadipocytes, where it is highly expressed until the differentiation into 
adipocytes. The details of Dlk1 mechanism of action in the inhibition of adipogenesis have 
been investigated recently (Kim et al., 2007; Wang and Sul, 2009; Wang et al., 2010). Using 
a yeast-two hybrid system Wang et al (2010) found that the Dlk1 juxtamembrane region binds 
to the C-terminal region of fibronectin. Following that, Dlk1 activates integrin downstream 
signalling to activate the MEK/ERK pathway, which in turn upregulates Sox9. Sox9 is 
a transcription factor important for chondrogenesis and osteogenesis. Wang et al (2009) also 
discovered that Sox9 subsequently suppresses transcription of C/EBPβ and C/EBPδ by binding 
to their promoters and that it leads to the inhibition of adipocyte differentiation (Figure 1.7).  
 
Figure 1.7 Schematic diagram of Dlk1 inhibition of adipogenesis.  
Membrane-bound splice variants of Dlk1 undergo TACE-mediated cleavage at the 
juxtamembrane region in order to generate a soluble form of Dlk1. Soluble Dlk1 is then able to 
interact with a putative Dlk1 receptor at the preadipocytes membrane which activates 
MEK/ERK. MEK/ERK increases expression of Sox9 which in turn binds to C/EBPδ and C/EBPβ 
promoter regions to supress their transcription which leads to inhibition of adipocyte 
differentiation. Figure adapted from (Sul, 2009). 
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1.3.2 Dlk1 gene and Dlk1-Dio3 imprinted cluster regulation 
Phenotypic analyses of mice with uniparental duplications of distal region of chromosome 
12 (mUPD12 and pUPD12: maternal and paternal disomy for chromosome 12, respectively) 
(Georgiades et al., 2000; Tevendale et al., 2006) and observations of patients suffering from 
uniparental duplications of the orthologous region on human chromosome 14q (Georgiades et 
al., 1998; Kotzot, 2004; Kagami et al., 2005) suggested the presence of imprinted genes in this 
region. Dlk1, Dio3 and Rtl1 are protein coding, imprinted genes situated within 1Mb cluster on 
distal region of mouse chromosome 12 (Figure 1.6). These three genes are repressed on the 
maternally inherited chromosome, whereas in the same region exclusive maternal allele 
expression occurs from multiple non-coding RNA (ncRNA) genes, namely Gtl2, AntiRtl1, Rian 
and Mirg. The Dlk1-Dio3 imprinting cluster contains the intergenic germline-derived DMR (IG-
DMR) and Gtl2-DMR with methylation marks established in the germline or upon fertilisation, 
respectively (Takada et al., 2000; Takada et al., 2002). Gtl2, which lies at the proximal end of 
the cluster together with Dlk1, is a paternally imprinted gene whose ablation resulted in 
abnormal embryo size when paternally transmitted (Schuster-Gossler et al., 1996; Takahashi et 
al., 2009).  
The intergenic germline derived differentially methylated region (IG-DMR) that is placed 
between Dlk1 and Gtl2 is thought to be responsible for the imprinting regulation of the 1Mb 
domain (Lin et al., 2003; Lin et al., 2007). Targeted disruption of the mouse IG-DMR has 
demonstrated that unmethylated maternally inherited IG-DMR is crucial in the maintenance of 
the unmethylated status of the Gtl2-DMR, expression of the ncRNAs and the repression of the 
protein-coding genes in the maternal allele in the embryo (Lin et al., 2003). It has been found 
that the phenotype of mice with pUPD12 (Lin et al., 2007) is similar to that of mice with 
a deletion of the IG-DMR on the maternal chromosome (Takada et al., 2002), a phenomenon 
referred to as an epigenetic switch. Da Rocha et al (2007) investigated the co-localisation of 
the expression of Dlk1 and Gtl2 genes throughout development and concluded that the 
mechanism of imprinting regulation of this 1Mb domain is different to insulator or co-ordinate 
non-coding RNA mechanisms previously noted for other domains, such as the Igf2/H19 region, 
and that Dlk1 and Gtl2 are functioning in distinct tissues in an independent manner (da Rocha 
et al., 2007). 
The Gtl2-DMR has an interesting characteristic as it has been shown to act as crucial long-
range imprinting regulator. A maternally-inherited heterozygous microdeletion encompassing 
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the MEG3-DMR (the human orthologue of the mouse Gtl2-DMR) but not the IG-DMR, has been 
found in a neonatal patient with a paternal uniparental disomy 14-like phenotype in the body 
but not in the placenta (Kagami et al., 2010). This patient also had DLK1 reactivation on the 
maternal allele.  
Several recent studies using mouse knockout models with targeted deletions of the Gtl2 
locus spanning the Gtl2-DMR have pointed out the possibility that Gtl2 and/or the Gtl2-DMR 
might be able to control maternally expressed gene expression (Takahashi et al., 2009; Zhou et 
al., 2010). These findings point at the methylation of the Gtl2-DMR as a vital part of  
Dlk1-Dio3 imprinted domain. Moreover, a recent study showed that mouse induced 
pluripotent stem cells (iPSC) with repressed expression of maternally expressed ncRNAs within 
the Dlk1-Dio3 domain contributed poorly to chimeras and were unable to generate all-iPSC 
mice (Stadtfeld et al., 2010). The repressed expression in ncRNAs has been linked to 
hypermethylation of both IG-DMR and Gtl2-DMR which is thought to be a result of iPSC 
reprogramming (Stadtfeld et al., 2010). This study has implicated a role for the Dlk1-Dio3 
cluster in cell proliferation and/or differentiation at early gestational stages, while another 
exciting study revealed that the conserved imprinted Dlk1-Dio3 region was activated in fully 
pluripotent mouse stem cells but repressed in partially pluripotent stem cells and that the 
activation level of Dlk1-Dio3 positively correlated with pluripotency levels (Liu et al., 2010). 
This implies that activity of Dlk1-Dio3 could potentially act as a biomarker to identify fully 
pluripotent iPS cells, adding to the notion that Dlk1 might be an important regulator of not 
only proliferation and differentiation of embryonic and adult stem cells (Li et al., 2005; 
Abdallah et al., 2007; Wang and Sul, 2009), but also function to maintain the pluripotency of 
embryonic stem cells. 
Taking into account the essential functions of Gtl2 and Gtl2-DMR in imprinting control of 
this region, another recent study aimed to elucidate their mechanisms of action, revealing that 
methylation of Gtl2-DMR is not required for Gtl2 imprinted expression and that Gtl2 is possibly 
playing a role in regulation of cell proliferation and differentiation at early gestation stages 
(Sato et al., 2011). This study also reported that one of the regions of IG-DMR shows variations 
in allelic methylation patterns that are tissue-dependent, providing more insight into 
mechanisms by which allele-specific IG-DMR methylation results in Dlk1-Dio3 imprinted 
expression.  
Dlk1 does not only have an established role in affecting adipogenesis (Smas and Sul, 1993), 
but it is also involved in the differentiation of other cell types, including chondrocytes (Chen et 
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al., 2011), osteoblasts (Sul, 2009; Wang and Sul, 2009), thymocytes (Kaneta et al., 2000) and 
adrenal gland cells (Okamoto et al., 1997). Recent study has also shown that expression of 
membrane– bound and secreted DLK1 distinguishes neural stem cells (NSCs) and niche 
astrocytes and that differential processing of DLK1 gene acting simultaneously in both cell 
types results in their distinct functional characteristics (Ferron et al., 2011). The same study 
also demonstrated that biallelic Dlk1 expression is important for normal neurogenesis, as it 
showed specific and selective lack of Dlk1 imprinting in the NSC and niche astrocyte 
populations starting at postnatal stages and continuing into adulthood. Several in vitro and 
transgenic mouse studies have indicated a role for Dlk1 role in inhibition of bone development 
(Abdallah et al., 2004; Abdallah et al., 2007; Abdallah et al., 2011b). Increased Dlk1 expression 
has been linked to many types of tumours including myeloid leukemia (Laborda et al., 1993; 
Astuti et al., 2005; Kawakami et al., 2006; Espina et al., 2009; Khoury et al., 2010; Yanai et al., 
2010). Furthermore, various reports have indicated on Dlk1 as a regulator of proliferation, 
differentiation but also pluripotency of embryonic stem cells (Smas and Sul, 1993; Li et al., 
2005; Abdallah et al., 2007; White et al., 2008; Wang and Sul, 2009; Liu et al., 2010; Stadtfeld 
et al., 2010). Dlk1 is widely expressed in the range of embryonic tissues and in placenta during 
development (Yevtodiyenko and Schmidt, 2006; da Rocha et al., 2007). Schmidt et al (2000) 
have shown that Dlk1 expression starts as early as E11 in mouse embryo and its levels increase 
until late gestation. A dramatically elevated Dlk1 expression has been noted during 
myogenesis, from E13 to E16 (da Rocha et al., 2007). Dlk1 expression in adult tissues is limited 
primarily to preadipocytes and some endocrine tissues, including the somatotroph cells of the 
pituitary gland (Larsen et al., 1996), insulin-producing β-cells of the pancreas (Tornehave et al., 
1993), Leydig cells of the testes and cells in the ovaries (Jensen et al., 1999). 
1.3.3 Role of Dlk1 in development and metabolism 
Dlk1, encoding a constitutively membrane-bound or a cleaved circulating protein form, 
like many other imprinted genes plays an important role in normal growth and in development 
of several tissues in mammals. In agreement with the conflict hypothesis, the imprinted status 
of Dlk1, which is predominantly expressed from the paternal allele, predicts that Dlk1 
functions as an enhancer of growth. Similar to other imprinted genes, the role of Dlk1 in vivo 
has been established using a knockout mouse model lacking a functional Dlk1 gene. Moon et al 
(2002) generated mice lacking paternal, maternal or both parental copies of the Dlk1 gene and 
performed a phenotypic characterisation. The Dlk1 disruption was achieved by targeted 
insertion of a neomycin-resistance cassette that replaced exons 2 and 3 of Dlk1 (Dlk1Δ2-3 in 
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Figure 1.4). A survival rate of about 50% beyond 2 days after birth indicated a role for Dlk1 in 
perinatal growth and lethality (Moon et al., 2002). Absence of Dlk1 expression in paternal 
heterozygotes and significant pre- and post-natal growth retardation in these mice comparable 
to that of Dlk1 null mice confirmed that Dlk1 is an imprinted gene, predominantly expressed 
from the paternal allele.  
Besides an abnormal growth, other phenotypic malformations were also reported in Dlk1 
knockout mice. These included skeletal abnormalities, such as rib fusions and asymmetrical 
junction of ribs to sternum, and also eyelid malformations similar to blepharophimosis as 
reported in patients with mUPD14 or with a deletion of the 14q32 region that contains the 
Dlk1 locus. Moon et al (2002) suggested that these skeletal and pulmonary defects, together 
with an impaired suckling ability arising from these defects, might have contributed to the high 
perinatal death rate in Dlk1 knockout mice. At 15 weeks of age Dlk1 null mice exhibited 
a slightly elevated fat mass, therefore, the authors decided to investigate whether a high fat 
diet would have a more pronounced effect on adiposity in Dlk1 knockout animals. Indeed, the 
accelerated weight gain in Dlk1 knockout mice was found to be due to excessive adiposity, 
manifested by significantly greater fat pad mass, which has been associated with adipocyte cell 
hypertrophy. Substantially enlarged, fatty livers with increased fatty acid synthetase (FAS) and 
stearoyl-Coenzyme A desaturase 1 (SCD-1) (markers of adipocyte differentiation) expression 
were also found in Dlk1 knockout mice. Moreover, levels of lipid metabolites, including 
triglycerides, cholesterol and free fatty acids in serum of Dlk1 knockout animals were 
considerably elevated, which further indicated that disrupted lipid metabolism is a major 
consequence of the lack of a functional Dlk1 gene. Thus, Moon et al (2002) were the first to 
report that Dlk1 is a gene involved in normal embryonic development, postnatal growth and 
adiposity.  
Another Dlk1 mouse knockout model has been generated more recently by deletion of 
exons 1-3 of Dlk1 (Dlk1Δ1-3; Figure 1.6; Raghunandan et al., 2008). The study aimed to 
determine the role of Dlk1 in B cell development in vivo and reported increased numbers of 
the earliest B-lineage cells and reduced numbers of re-circulated B-lineage cells in the bone 
marrow, along with alterations within B cells in peripheral lymphoid organs. In addition, they 
have found that Dlk1 knockout mice showed aberrant levels of pre-immune serum 
immunoglobulin and reported an exaggerated antigen-specific humoral immune response. 
Taken together, these results suggested Dlk1 as a potent regulator of a B cell development 
(Raghunandan et al., 2008).  
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Lee et al (2003) generated transgenic mice expressing the full ectodomain corresponding 
to the large soluble form of Dlk1 fused to human immunoglobulin-γ constant (hFc) region. The 
specific expression of this fusion protein in adipose tissue resulted in abnormalities in 
adipogenesis that included a decrease in fat pad weight, adipocyte cell hypotrophy and 
reduced expression of adipocyte marker genes (Lee et al., 2003). Moreover, expression of the 
soluble Dlk1 fusion protein in the liver also resulted in lower adipose tissue weight. Transgenic 
Dlk1 animals also exhibited several other impairments, including hypertriglyceridemia, slower 
glucose clearance and decreased insulin sensitivity. The authors concluded that the large 
soluble form of Dlk1 is able to inhibit adipocyte differentiation, similar to an effect previously 
reported in the differentiation of 3T3-L1 cells in vitro (Mei et al., 2002).  
Dlk1 and the neighbouring Gtl2 gene are expressed in the majority of tissues after E12.5 
and the peak of their expression is reached after E15.5 in some tissues (Takada et al., 2000). 
The crucial role of IG-DMR and Gtl2-DMR in regulation of genes comprising the Dlk1-Dio3 
cluster has been provided by studies of mice with maternally transmitted deletions of these 
DMR regions (Lin et al., 2003; Takahashi et al., 2009; Kagami et al., 2010; Zhou et al., 2010). 
Prenatal and perinatal lethality along with abnormalities within tissues such as liver, lung, bone 
and skeletal muscle have been found in these animals (Takahashi et al., 2009; Kagami et al., 
2010; Zhou et al., 2010). Several recent studies have pointed at Dlk1 function in development 
of skeletal muscle. The levels of Dlk1 protein and transcripts were found to be the highest in 
developing fetal muscle and to decrease after birth (Floridon et al., 2000; Andersen et al., 
2009). One study has reported that in some myopathies (for example in Becker and Duchenne 
muscular dystrophy, associated with muscle degeneration and regeneration) there were 
increased numbers of Dlk1+ mononuclear cells (Andersen et al., 2009). In addition, the ability 
of Dlk1 to increase neonatal skeletal muscle mass has been described in transgenic mice with 
Dlk1 overexpression (Davis et al., 2004; da Rocha et al., 2009) and in sheep with callipyge 
(clpg) mutations, causing a rise in the levels of Dlk1 expression (Davis et al., 2004; Perkins et 
al., 2006; Vuocolo et al., 2007). Callipyge sheep that overexpress Dlk1 and at least one other 
imprinted gene, Peg11 (also called Rtl1 in mice), have a lean phenotype with muscle 
hypertrophy that is most pronounced in the pelvic limb (Koohmaraie et al., 1995; Jackson et 
al., 1997; Freking et al., 1998). This phenotype is characterised by an unusual mode of 
inheritance, called ‘polar overdominance’, meaning that the phenotype is expressed only in 
heterozygous animals paternally inheriting the clpg mutation (Cockett et al., 1996). 
Interestingly, a recent study of Dlk1 allelic transmission pattern in obese children has provided 
evidence for the first time that polar dominance exists in humans (Wermter et al., 2008). The 
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clpg mutation is a single nucleotide substitution (A to G) that lies within the Dlk1-Gtl2 domain 
(Freking et al., 2002). It has been demonstrated that the callipyge phenotype correlates with 
ectopic expression of Dlk1 in hypertrophic muscle of clpg sheep and mice (Davis et al., 2004; 
Murphy et al., 2005; Perkins et al., 2006; Vuocolo et al., 2007). The definitive interpretation of 
the callipyge sheep phenotype is difficult as the clpg mutation also changes the expression of 
other imprinted genes in the proximity of the Dlk1 allele (Bidwell et al., 2001; Charlier et al., 
2001; Murphy et al., 2005; Perkins et al., 2006; Takeda et al., 2006; Fleming-Waddell et al., 
2007; Vuocolo et al., 2007). However, given the antiadipogenic role of Dlk1, overexpression of 
this gene in callipyge sheep is likely to be the cause of the observed phenotype. Others have 
also indicated that Dlk1 functions in the commitment and/or proliferation of fetal myoblasts as 
well as in the maintenance of hypertrophy in fully differentiated myofibers (White et al., 2008).  
The exact mode of function and signalling mechanisms of the predominantly membrane-
bound form of Dlk1 in skeletal muscle is not clear. To add to our understanding of it, another 
study of Dlk1 role in mouse muscle development has been provided by generation of 
conditional knockout using a Dlk1-floxed allele with a Myf5-Cre driver (Myf5 is a crucial muscle 
regulatory factor in early development), so that the function of local non-circulating Dlk1 in 
skeletal muscle development and regeneration could be examined (Waddell et al., 2010). 
Muscle-specific ablation of Dlk1 in mice led to reduction in body weight (more prominent in 
older than younger mice) and skeletal muscle mass, associated with reduced numbers of 
myofibers as well as decreased myosin heavy chain IIB gene expression. Moreover, postnatal 
growth retardation and delayed muscle regeneration were also described as a result of altered 
myogenic inhibitory signalling in these animals (Waddell et al., 2010). Impaired regeneration of 
Dlk1 conditional knockout fibers in adult mice was associated with lower expression levels of 
myogenin and the activated form of phosphorylated Akt. This might be a result of disturbed 
Akt/mTOR signalling pathway, which stimulates protein synthesis and myotube hypertrophy 
(Rommel et al., 2001), a result consistent with recent finding of improved Akt signalling in DLK1 
overexpressing callipyge sheep (Fleming-Waddell et al., 2009). Fleming-Waddell et al (2010) 
have also shown that Dlk1, at a progenitor cell level, non-cell autonomously promotes 
myogenic differentiation but inhibits myoblast proliferation. This provides evidence of a role 
for Dlk1 in controlling proliferation and differentiation of satellite cells and suggests a way in 
which elevated Dlk1 expression is able to cause muscle hypertrophy in callipyge sheep and 
transgenic mice (Charlier et al., 2001; Davis et al., 2004; da Rocha et al., 2009). Paternal and 
maternal uniparental disomies for chromosome 14 (pUPD14 and mUPD14) result in very 
distinct phenotypes.  
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Human pUPD14 is a cause of facial abnormality, small bell-shaped thorax, abdominal wall 
defects and polyhydramnios whereas mUPD14 leads to numerous abnormal features including 
pre- and postnatal growth failure, hypotonia, mild facial abnormalities, small hands and early 
onset of puberty. The phenotypes resulting from mUPD14 vary in severity and can range from 
a near normal phenotype to a very severe one, similar to that observed in Prader-Willi 
syndrome. Moreover, in pUPD14 placentomegaly has been reported, whereas the size of the 
placenta has not been studied in mUPD14.  
Expression of the imprinted genes on the distal part of mouse chromosome 12 is 
monoallelic in both normal embryo and placenta. As a result, pUPD12 results in a variety of 
abnormal phenotypic features including prenatal lethality, cartilage defects, abdominal 
swelling and placentomegaly, whereas mUPD12 causes perinatal lethality, growth retardation 
(of around 60%), and placental hypoplasia. Despite more pronounced lethality in mice and 
more obvious rib anomalies in human pUPD14 disomies, the phenotypes of disomic (UPD12) 
mice show enough analogy to the features observed in individuals with human UPD14 to 
indicate similar regulatory mechanisms might operate within the conserved region of the two 
species.  
The importance of the Dlk1 gene in adipogenesis and differentiation of several other cell 
types, supported by numerous in vitro studies, has been confirmed in vivo by mouse knockout 
experiments and through them we have learned about its crucial role in normal growth and 
development. Some of the features found in mice with ablation of Dlk1 share similarities 
between symptoms found in patients with UPD14, which could implicate a role for Dlk1 in 
these human disorders. However, many aspects of Dlk1 function, together with its interacting 
partners and pathways it is part of, remain to be established.  
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1.4 Concluding remarks and aims 
The crucial role of imprinted genes in the course of normal development and in the 
maintenance of metabolic homeostasis postnatally should not be underestimated. Our 
knowledge, however, is not yet sufficient to understand all the underlying mechanisms, modes 
of regulation and the forces that have led to evolution of genomic imprinting, even though the 
parental conflict hypothesis is widely accepted to explain the evolution of imprinting. The 
ability to generate knockout mice with ablation of specific imprinted genes provides 
a powerful means of investigating their roles in vivo. Generation of double or triple knockouts 
has been used effectively to study the potential interaction of those genes with opposite 
phenotypic effects, such as the reciprocally expressed Igf2/Igf2r of Grb10/Igf2 gene pairs. 
Altered imprinting status of various genes leads to similar phenotypic features usually 
involving pre- and postnatal growth changes which indicated the possibility of imprinted genes 
acting in common genetic pathways. For example mice with a disrupted Zac1 imprinted gene 
simultaneously show an abnormal transcription of many other imprinted genes. It has been 
suggested that Zac1 might be involved in control of an imprinted gene network (including 
genes such as Igf2, H19, Cdkn1c and Dlk1) that is crucial in regulation of prenatal growth 
control (Varrault et al., 2006), however more detailed investigation is needed to establish if 
this prediction is true.  
Grb10 and Dlk1 are imprinted genes that seem to act in agreement with the parental 
conflict hypothesis. Grb10 is a maternally expressed growth inhibitor and Dlk1 is a paternally 
expressed growth enhancer. Both of these genes are expressed in the placenta (Yevtodiyenko 
and Schmidt, 2006; Charalambous et al., 2010) and there is evidence for co-expression of both 
of these genes in embryonic tissues, such as developing muscle and cartilage tissues, 
pancreatic bud, liver, lung bronchioles and developing kidneys and adult tissues, for example 
monoaminergic neurons in the CNS, cells within ovaries and testes as well as β- cells of 
pancreatic islets (Charalambous et al., 2003; Yevtodiyenko and Schmidt, 2006; da Rocha et al., 
2007; Lui et al., 2008). Their overlapping expression sites during pre- and post-natal periods 
are summarised in Table 1.3. Germline ablation of Grb10 results in adult mice with a lean 
phenotype (reduced adiposity) and an enhanced ability to clear a glucose load, whereas the 
lack of Dlk1 leads to increased adiposity (mild obesity when fed on high fat diet) in adulthood 
(Table 1.4). As a result of the opposite imprinting status and phenotypic features seen in 
knockout mice, our hypothesis predicts that the reciprocally imprinted Grb10 and Dlk1 genes 
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are acting through a common genetic pathway. Figure 1.8 illustrates two possible pathways: 
one predicts that the paternally expressed Dlk1 acts as inhibitor upstream of Grb10, while 
Grb10 functions to inhibit growth and the other predicts Grb10 inhibiting Dlk1 which is in turn 
acting to promote growth. 
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Table 1.3 Sites of mouse Grb10 and Dlk1 expression pre- and postnatally (Tornehave et al., 1993; Jensen et al., 2001; Charalambous et al., 2003; 
Yevtodiyenko and Schmidt, 2006; da Rocha et al., 2007; Smith et al., 2007; Wang et al., 2007; Ferron et al., 2011; Garfield et al., 2011). 
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The aim of this project was to test the abovementioned hypothesis and gain further 
insight into the possible mechanisms of action of Grb10 and Dlk1 and their potential for 
interaction. This was to be achieved through characterisation of Grb10m/+/Dlk1+/p double 
knockout mice and their comparison with wild type, Grb10m/+ and Dlk1+/p single knockout 
animals.  
Grb10 Dlk1 
•  Maternally expressed 
•  Growth suppressor 
•  Grb10 knockout mice: 
-  Overgrowth 
-  Increased lean mass 
-  Decreased adiposity 
•  Paternally expressed 
•  Growth enhancer 
•  Dlk1 knockout mice: 
-  Growth retardation 
-  Slight obesity 
-  Increased adiposity 
Table 1.4. Comparison of Grb10 and Dlk1 genes and the phenotypes resulting from their 
ablation in mice.  
Reciprocal effects of oppositely expressed Grb10 and Dlk1 genes on growth and lean and 
adipose tissue content.  
 
 
Figure 1.8 Possible modes of interactions between the Grb10 and Dlk1 genes in the same 
genetic pathway.  
First of the proposed models predicts Grb10 (acting as a growth suppressor) inhibition by Dlk1, 
whereas the alternative model proposes that Grb10 is inhibiting Dlk1 (potent growth 
enhancer). Note that the indicated genetic interactions do not necessarily imply direct physical 
interaction between Grb10 and Dlk1 proteins. 
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This study aimed to: 
1. Analyse the roles of Grb10 and Dlk1 during embryonic development by studying cell 
growth, proliferation and prenatal growth differences in Grb10m/+/Dlk1+/p double 
knockout mice. 
2. Characterise the effects of Grb10 and Dlk1 ablation on postnatal growth and 
characterise the phenotype of Grb10m/+/Dlk1+/p double knockout mice. 
3. Investigate the influence of ablation of Grb10 and Dlk1 genes on energy homeostasis 
by characterising the glucose-regulated metabolic phenotype of Grb10m/+/Dlk1+/p 
double knockout mice. 
If the hypothesis is correct, Grb10m/+/Dlk1+/p knockout mice should, in at least some 
respects, resemble phenotypically either Grb10m/+ or Dlk1+/p single knockout animals.  
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2.1  Animals 
2.1.1 Animal husbandry 
Mice were maintained in accordance with UK Home Office Regulations on an artificial 
light/dark cycle which provided 13 hours of light/11 hours of darkness (including 30 min of 
artificial dawn and dusk lighting). The temperature was maintained at 21°C ± 2°C with 
a relative humidity of 55 ± 10%. Animals were provided unrestricted access to food (CRM 
formula, Special Diets Services, UK) and water (unless otherwise stated). Mice were housed in 
individually ventilated cages at a density of one to six animals per cage. 
2.1.2 Schedule 1 methods 
Mice were culled by a Home Office Personal Licence holder according to recognised 
Schedule 1 methods. Embryos were culled by immersion in ice cold 0.1% (v/v) PBS (phosphate 
buffered saline, Oxoid, UK) for 10 min after removal from the uterus. Neonatal animals were 
sacrificed by decapitation and adult animals by cervical dislocation or by administration of 
a lethal dose of Euthatal (Merial Animal Health Ltd, UK). 
2.1.3 Derivation of knockout mice 
The Grb10Δ2-4m/+ knockout mouse strain (from this point named Grb10m/+) was created by 
Dr. William Bennett using the KST268 ES cell gene trap line (Baygenomics) in an ES cell co-
culture method (Charalambous et al 2003) and maintained on a mixed C57BL/6/CBA genetic 
background. The mutant Grb10m/+ allele includes the replacement of 3 exons, including the 
first 2 protein coding exons, with a LacZ reporter gene. Dlk1Δ1-3+/p knockout mice (from this 
point named Dlk1+/p) were generated in the laboratory of Dr. Steven Bauer (Raghunandan et 
al., 2008). In the Dlk1+/p knockout mice a neomycin resistance cassette replaced 3.8 kbp of the 
endogenous allele, including the promoter and first three exons of Dlk1. Dlk1Δ1-3+/p animals 
were maintained on a C57BL/6 genetic background. 
Both knockout strains described above (Figure 2.1) were interbred to derive 
Grb10m/+/Dlk1+/p double knockout mice.  
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Figure 2.1 Grb10 and Dlk1 knockout alleles used to generate Grb10m/+ and Dlk1+/p mice.  
A) Grb10 allele with the insertion of a LacZ cassette replacing exons 2 - 4, which also included 
splice acceptor (SA) and poly-adenylation (pA) sites. B) Dlk1 allele and Neomycin cassette 
replacing exons 1, 2 and 3. 
Grb10m/+ female mice (30% neonatal and 13% adult overgrowth, decreased fat tissue and 
increased lean tissue content, improved glucose tolerance) were generated by crossing of 
Grb10m/+ female mice with wild type male mice. Dlk1+/p male mice were obtained by crossing 
Dlk1+/p male mice with wild type female mice. Grb10m/+ and Dlk1+/p mice were crossed in order 
to generate wild type, Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p double knockout mice (Figure 
2.2). Due to parent-of-origin-specific expression of both Grb10 and Dlk1, generation of mice 
always involved crossing Grb10m/+ female with Dlk1+/p male animals. Mice at of at least 6 weeks 
of age were bred in cages containing one male and either 1 or 2 females. Detection of 
a cervical plug (defined as day 0.5 post coitum) allowed for the recovery of embryos at the 
relevant gestational stage. 
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Figure 2.2 Cross of Grb10m/+ and Dlk1+/p mice and resulting genotypes of animals used in this 
study.  
In order to generate Grb10m/+/Dlk1+/p double knockout mice, female mice with maternal 
transmission of Grb10 deletion (Grb10m/+) were crossed with male mice with paternal 
transmission of Dlk1 ablation (Dlk1+/p). The resulting genotypes of animals used in this study 
included wild type, Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p.  
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2.2 Molecular methods 
The majority of reagents used in the study were obtained from Sigma Aldrich, UK or Fisher 
Scientific, UK unless stated otherwise. 
2.2.1 Genotyping of transgenic mice 
Polymerase chain reaction (PCR) was used as a genotyping method for all transgenic mice. 
Crude DNA extracts were prepared from whole yolk sacs (from embryos), tail clips 
(approximately 2 mm of tail tip from neonates) or ear clips (1-3 ear-punch discs of 
approximately 2 mm diameter from adult mice). Tissues were boiled in 600 μl of 0.1 M sodium 
hydroxide for 10 min and subsequently vortexed for approximately 10 seconds. 50 μl of 1M 
Tris-HCL pH 8 solution was then added to each sample before vortexing again. 1 μl of DNA 
solution was used as the template in each PCR reaction. PCR reactions were then carried out in 
a total volume of 20 μl of GoTaq Green Master Mix (Promega, UK) with appropriate primers 
used at final concentration of 0.25 μM (Invitrogen, UK; Table 2.1). PCR was carried out using 
a G-Storm Mark 1 thermal cycler (Gene Technologies Ltd., UK). The primers used for Grb10 and 
Dlk1 genotyping are listed in Table 2.1 and reaction conditions given in Table 2.2. Upon 
amplification, 15 μl of each sample was loaded on a 1% (w/v) (Grb10 genotyping) or 1.5% (w/v) 
(Dlk1 genotyping) agarose (Invitrogen, UK) gel with an addition of 0.5 μg/ml ethidium bromide 
in 1x TAE buffer (2 M Tris 50 mM EDTA, 5.7% (v/v) acetic acid). A 1kb DNA ladder (Promega, 
UK) was run alongside the reactions for band size estimation. DNA samples were visualised 
under ultraviolet light (Alphaimager 3400) and data was recorded digitally.  
Genotyping 
primers Primer Sequence Band size 
 
Grb10 
 
β-geo-F 
β-geo-R 
ttc aac atc agc cgc tac ag 
ctc gtc ctg cag ttc att ca 
571 bp 
 
Dlk1 
Dlk1 F 
Dlk1 R 
neo F 
cat ctg cac gag act agt g 
ctg tat gaa gag gac caa gg 
cca aat gtc tat agt ctc ctc 
423 bp + 339 bp 
Table 2.1. Grb10 and Dlk1 primers used for PCR genotyping. 
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Experimental parameters Grb10 genotyping Dlk1 genotyping 
Initial denaturation 3 min at 94°C 3 min at 94°C 
Annealing 
36 cycles of: 
 
1 min at 94 °C 
1 min at 60 °C 
1 min at 72°C 
18 cycles of: 
 
30 sec at 94 °C 
30 sec at 64 °C 
30 sec at 55.5 °C 
30 sec at 72 °C 
 
25 cycles of: 
 
30 sec at 94 °C 
30 sec at 55 °C 
30 sec at 72 °C 
Elongation 5 min at 72 °C 10 min at 72°C 
Table 2.2. Experimental parameters for PCR used to genotype Grb10m/+, Dlk1+/p and 
Grb10m/+/Dlk1+/p transgenic mice. 
2.2.2 Urine protein analysis using SDS- PAGE gels 
Urine samples were collected from 3 months old male mice and placed on dry ice before 
transferring to -20°C. When needed, 15 µl of MQ water was added to 1.5 ml tubes before 
adding 5 µl of 5x reducing buffer (3.1 ml 2M Tris – HCl pH 6.8, 2.4 ml 20% SDS, 2.5 ml glycerol, 
2.5 ml β– mercaptoethanol, 500µl 1% bromophenolblue). Urine samples were thawed on ice 
and then 5 µl of urine was added to reducing buffer mixed with water in the corresponding 
tube. Samples were boiled for 10 minutes and chilled on ice. After centrifuging for 20 seconds 
samples were run at 150 V for about 1 hour on a Criterion ® Precast Gel (10% Tris– HCl,  
1.0 mm, 18 combs, 30 µl, BIO–RAD) containing 1x Running Buffer (made from 5x Running 
Buffer: 9 g Tris, 43.2 g of glycine, 3 SDS, made up to 600 ml with MQ water). The gel was then 
placed in Coomasie Blue Solution (40% methanol, 10% acetic acid in MQ water,  
2.5 g Coomassie Brilliant Bluer – 50% dye content; filtered with filter paper, Whatman, UK) on 
a plastic tray on a rocking platform. After 1 hour the gel was washed in Coomasie Destain (40% 
methanol, 10% acetic acid), this step was repeated another 2 times for 20 minutes each, then 
for 1 hour. Protein was visualized with white light using an Alphaimager® 3400 machine. 
Results were compared to a dual colour Precision Plus Protein® Standards ladder (BIO-RAD). 
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2.3 Allometric analyses 
2.3.1 Tissue dissection 
Total body weights were recorded immediately following sacrificing of mice according to 
Schedule 1 methods. Organs collected from 1 day old mice included: livers, hearts, brains, 
kidneys and lungs. From adult mice gonads, pancreata, livers, kidneys, gonadal and renal fat 
pads, masseter and gastrocnemius muscles, tongues and brains were dissected. All tissues 
were dabbed on aluminium foil to get rid of excess liquid and weights were subsequently 
recorded. Organs were immediately frozen in liquid nitrogen and kept at -80°C until needed or 
processed further if necessary.  
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2.4 Histological analyses 
Histological methods were based on Bancroft and Gamble (2002).  
2.4.1 Tissue fixation and processing for wax embedding and sectioning 
Whole organs destined for wax embedding were fixed in 4% (w/v) paraformaldehyde 
(PFA) in 0.1% PBS at 4oC overnight. The following day organs were washed in 0.1% PBS, 
transferred into 70% ethanol solution and stored at 4oC until needed. Organs were processed 
using a Leica TP 1020 machine. Firstly, they were washed for 3 hours in 70 % ethanol, then for 
2 hours each in: 90% ethanol, twice in 100% ethanol, twice in histoclear and twice in wax. 
After processing, organs were embedded in wax blocks using a Leica EG 1160 work 
station. Embedded tissues were then cut into 6 μm sections using a microtome (Leica RM 
2155). Tissue sections were then transferred onto Polysine microscope slides (VWR 
International, UK) and left to dry overnight.  
2.4.2 Tissue fixation and processing for cryosectioning 
Organs destined for cryosectioning were fixed for 30 min in 2% PFA, 0.2% glutaraldehyde 
in 0.1% PBS and then were transferred into ice cold 30% (w/v) sucrose and incubated at 4°C 
overnight. Tissues were dried by dragging them across aluminium foil, embedded by placing in 
a cassette filled with Optimal Cutting Temperature (OCT) compound (VWR International, UK) 
and allowed to freeze on dry ice. Cryo-blocks were stored at -80°C before being sectioned at 
10 μm using a cryostat (CM1850; Leica). Sections were transferred onto SuperFrost Plus 
microscope slides (VWR International, UK), air dried and stored at -80°C. 
2.4.3 Haematoxylin and Eosin (H&E) staining 
The wax embedded tissue sections were dewaxed in histoclear twice for 2 min and then 
hydrated through an alcohol series: 100%, 100%, 95%, 90%, 70% and 50% ethanol for 1 min in 
each. Sections were placed in MQ water for 1 min and then transferred to filtered 
haematoxylin for 15 min. Afterwards, sections were washed gently in running tap water for 
3 min and then transferred into 1% concentrated HCl in 70% ethanol for 30 sec, 1% NH3 in 70% 
ethanol for 1 min and then washed in 70% ethanol for 30 sec. Slides were transferred to 
filtered eosin for 5 min and then washed in 70% ethanol for 3 sec, 90% ethanol for 3 sec and 
then washed twice in 100% ethanol for 5 sec which was followed by two washes in histoclear 
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for 2 minutes. Samples were mounted under coverslips in DPX mounting medium (VWR 
International, UK). 
2.4.4 Periodic Acid - Schiff (PAS) Staining 
Sections were dewaxed in histoclear twice for 2 min, hydrated through an ethanol series 
(as for H&E staining) and washed in MQ water for 1 min. Slides were then placed in freshly 
prepared 1% periodic acid in MQ water for 6 min and washed under running tap water for 
3 minutes. After incubation in MQ water for 1 min sections were placed for 15 min in Schiff 
reagent. Slides were washed under running tap water for 5 min, counterstained with 
haematoxylin for 2 min, dehydrated and mounted as described in section 2.4.3. 
2.4.5 Oil Red O staining 
0.5 g of Oil Red O (Lamb, UK) was dissolved in 100 ml of 100% isopropanol. MQ water was 
added to stock Oil Red O to make a working solution of Oil Red O in 60% isopropanol. The 
solution was heated and stirred at 100°C for 5 min and then filtered using 25 µm filter paper 
(Whatman, UK), first when hot and then again when cool. This solution was kept and filtered 
before every use. Cryosections were air-dried and rinsed with 60% isopropanol prior to 
incubating in Oil Red O solution for 15 min. Sections were then rinsed with 60% isopropanol 
and gently washed under running tap water until clear. Slides were counterstained with 
Meyer’s haematoxylin or Light Green for 30 sec, washed under running tap water for 
approximately 3 min and mounted in gel mounting medium (VectaShield, Vector Laboratories, 
UK).  
2.4.6  LacZ staining 
Cryosections were fixed for 30 min in 4% PFA and then incubated in 1mg/ml 5-bromo-4-
chloro-3-indolyl-beta-D-galactopyranoside (X-gal) in stain base (30 mM K4Fe(CN)6, 30 mM 
K3Fe(CN)6.3H2O, 2 mM MgCl2, 0.01 % (w/v) sodium deoxycholate, 0.02 % (v/v) Igepal CA-630 in 
0.1% PBS) overnight at 37°C. Following incubation, sections were rinsed in 0.1% PBS and 
stained with Nuclear Fast Red (Vector Laboratories, UK) for 2 min, dehydrated through 
ascending ethanol series, placed in histoclear for 5 min and mounted in DPX. 
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2.4.7 Microscopy 
Stained sections were viewed under a Nikon Eclipse E800 compound microscope under 
the magnification stated in each figure legend. Pictures were taken using a colour Nikon digital 
Sight DS-U1 camera operated with NIS Elements D 2.30 software. 
2.4.8 Morphometric analysis 
Pictures of tissue sections (including lungs, kidneys and adipocyte tissue) were taken 
under 200x magnification and were visualised on the computer screen. Using an 8 x 4 grid, the 
whole section was divided into 32 areas and five areas were randomly chosen from each slide. 
These same areas were used in each slide section for cell counting. 
2.4.9 Alcian Blue/ Alizarin Red staining 
Upon sacrifice, skin and dense organs were removed from mice. Skeletons were fixed in 
100% ethanol for 3 days and then in acetone for 1 day. Skeletons were washed in MQ water 
for several minutes before staining in colour solution (1 part 0.3% Alcian Blue in 70% ethanol: 
1 part 0.1% Alizarin Red in 95% ethanol: 1 part Glacial Acetic Acid: 17 parts 70% ethanol) for 
3 days at room temperature. Skeletons were then washed in MQ water for several minutes 
and soft tissues cleared in 1% KOH until the skeleton was visible. They were then transferred 
into 50% glycerine, and on the following day into 80% glycerine. Afterwards skeletons were 
kept in 100% glycerine.  
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2.5 Metabolic analyses 
2.5.1 Dual energy X-ray absorptiometry 
Adult mouse carcasses were analysed by Dual energy X-ray absorptiometry (DXA) using 
a PIXImis scanner (Lunar, Madison, WI) with small-animal software. Bone mineral density and 
content, total area, lean and fat tissue weight were recorded. Lean and fat tissue weights were 
expressed as percentages of total body weight before performing statistical analysis.  
2.5.2 Monitoring of food consumption 
Mice were separated into single cages and left to acclimatize for 10 days. A recorded 
amount of food was then placed in each cage and the weight of both mice and food was 
recorded every other day for a period of two weeks at the same time of the day in order to 
calculate the amount of food consumed per gram of body weight per day which was calculated 
using a metabolic scaling exponent of M2/3. The relationship between mammalian basal 
metabolic rate (BMR, ml of O2 per h) and body mass (M, g) has been the subject of thorough 
investigation. Data encompassing five orders of magnitude variation in M and featuring 619 
species from 19 mammalian orders in a study of the allometry of mammalian BMR that 
accounts for variation associated with body temperature, digestive state, and phylogeny 
supported use of a metabolic scaling exponent of M2/3 (White and Seymour, 2003).    
2.5.3 Measurement of serum triglyceride levels 
Triglyceride assay was used to assess the blood serum levels of triglycerides. Mice were 
fasted for 16 hours prior to the start of the experiment. Between 50 µl and 100 µl of blood was 
obtained from the tail tip and the tail was sealed with tissue adhesive (Abbott Laboratories, 
UK). Triglyceride levels were measured using a Triglyceride Assay Kit (Cayman Chemical 
Company, UK) according to manufacturer’s instructions.  
2.5.4 Glucose tolerance tests 
Glucose tolerance tests (GTT) were performed to assess whole body glucose clearance. 
Mice were fasted for 16 hours prior to the start of the experiment. Between 50 and 100 µl of 
blood was taken from the tail tip at time point ‘0’ and the tail was sealed with tissue adhesive 
(Abbott Laboratories, UK). 30% D-glucose at 1 g per kg of body weight was administered by 
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intraperitoneal injection and timing began from the point of injection. Measurements of 
glucose level were performed on blood drawn from the tail tip at 15 min, 30 min, 60 min and 
120 min post injection using a glucometer (One-Touch ULTRA, LifeScan, UK). 
2.5.5 Measurements of glucose levels in fed and fasted mice 
Mice with ad libitum access to food (fed) and mice fasted for 16 hours (fasted) prior to the 
start of the experiment were subject to measurements of glucose levels. Between 50 and 100 
µl of blood was taken from the tail tip at time point ‘0’ and the tail was sealed with tissue 
adhesive (Abbott Laboratories, UK). Measurements of glucose level were performed on blood 
drawn from the tail tip using a glucometer (One-Touch ULTRA, LifeScan, UK). 
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2.6 Cell culture-based techniques  
2.6.1 Derivation of primary mouse embryonic fibroblast (pMEF) cell 
cultures 
Derivation of primary embryonic fibroblast cells was carried out according to methods 
described in Mouse Cell Culture: Methods and Protocols (Ward and Tosh, 2008). 14.5 day old 
embryos were dissected out of the uterus and placed in ice cold 0.1% PBS. Weight of both 
embryos and placentae were recorded, placentae were frozen in liquid nitrogen and yolk sacs 
were stored in -20°C for genotyping. Embryos were then decapitated and heads were placed in 
X-Gal in stain base solution for β-galactosidase expression analysis. Decapitated embryos were 
transferred into 2 ml of complete pre-warmed Dulbecco's Modified Eagle's medium  
(DMEM) (Gibco, Invitrogen, UK) (DMEM media, 10% Fetal bovine serum (FBS), 1% penicillin/ 
streptomycin) and livers were removed and frozen in liquid nitrogen. Embryos were then 
dissociated in 1 ml of pre-warmed media without serum by pushing them through a 1 ml 
syringe and then P1000 pipette and transferred into 15 ml Falcon tube. 250 µl of 0.5% Trypsin-
EDTA solution (Gibco, Invitrogen, UK) was added and the tubes were incubated at 37°C for 30 
min, gently inverted every 5 min. The cell suspension was then transferred into a 25 cm2 
culture flask (Gibco, Invitrogen, UK) with 8ml of warm DMEM complete media. Flasks were 
incubated at 37°C in 5% CO2 environment. 
2.6.2 Maintenance of pMEFs cultures 
DMEM media was changed every 1-2 days: old media was removed and cells washed 
twice with pre-warmed 0.1% PBS, 8 ml of fresh media was then added to the flask. Flasks with 
confluent cells were subject to passaging or freezing down. When passaged, media was 
removed and cells washed with 0.1% PBS. 1 ml of 0.5 % Trypsin-EDTA (Gibco, Invitrogen, UK) 
solution per 25 cm2 was then added and flasks incubated for 5 min at 37°C. 3 ml of warm 
DMEM complete media per 25 cm2 was added, the cell suspension was transferred into a 15 
ml Falcon tube which was then centrifuged for 4 min at 180g. To freeze the cells the pellet was 
resuspended in 90% FBS and 10% Dimethyl sulfoxide (DMSO), frozen at -20°C overnight and 
then at -80°C before being stored in liquid nitrogen. To passage the cells, the pellet was 
resuspended in 1 ml of DMEM complete media and equal aliquots of the suspension were 
used to seed fresh flasks. 
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2.6.3 pMEFs growth curve analysis 
Following the protocol for passaging cells (see Section 2.6.2), the pellet was resuspended 
in 1 ml of media and an aliquot of 15 µl was transferred to each side of a haemocytometer. 
Cells were counted in order to determine the number of cells present in 1 ml, using the 
following equation: 
Average cell number from 5 squares within a haemocytometer grid x Dilution factor x 104 
1x104 cells were then seeded into each well of a 24 well plate and incubated at 37°C. An 
initial count of the attached cell number was taken 24 hours later, after which point cells were 
counted every 48 hours over a 12 day period. Every second day cells from four wells were 
removed after 5 min incubation in 250 μl of 0.5 % Trypsin-EDTA (Gibco, Invitrogen, UK) 
solution and centrifuged for 4 min at 180g after adding 200 μl of media. Cells were 
resuspended in an appropriate volume of DMEM complete media/0.1% PBS and the number of 
cells per ml of medium in each well was determined twice per well by use of 
a haemocytometer filled with diluted cell suspension. Cells in the remaining wells were 
washed in 0.1% PBS and provided with fresh medium, as described before. Counting was 
carried out over 12 days for pMEFs derived from embryos of all 4 genotypes in 3 separate 
experiments and the results used to calculate mean values. Cell growth was calculated as 
a percentage of the initial seeding density.  
2.6.4 Propidium iodide staining of embryos and pMEF cell cultures for 
fluorescence activated cell sorting (FACS) analysis 
E11.5 embryos were dissected from the uterus and washed several times in 0.5 ml of 
filtered, ice cold 0.1% PBS. Embryos were disaggregated using a pestle inside the 1.5 ml tube, 
gently resuspended through a P1000 pipette tip and centrifuged for 10 min at 500g. Cell 
resuspension in ice cold 0.1% PBS and centrifugation were repeated twice. Cells were then 
gently dissociated by filtering through a 40 µm nylon cell strainer (BD Falcon, BD Biosciences, 
USA). In the case of pMEFs, in approximately 70% confluent 75 cm2 flasks media was removed 
and cells were washed with 0.1% PBS. 1 ml of 0.5 % Trypsin-EDTA (Gibco, Invitrogen, UK) 
solution per 25 cm2 was then added and flasks incubated for 5 min at 37°C. Cells were then 
washed twice in ice cold 0.1% PBS. Embryonic and pMEFs cell suspensions were inspected by 
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spreading droplets of suspensions onto glass slides and air dried at room temperature. Spreads 
were stained with DAPI (1 µg/ml) and viewed under a fluorescent microscope (Leica DMIRB).  
Embryonic cell suspensions and pMEFs cultures were then stained for 30 min at 37°C in 
propidium iodide buffer (50 µg/ml propidium iodide, 100 µg RNAse A, 0.1% Igepal CA-630 and 
50 µg/ml trisodium citrate in 0.1% PBS). Stained cells were then washed in 0.1% PBS and 
100000 events were collected by FACS Canto (BD Biosciences, USA) at the excitation 
wavelength of 488 nm and an emission wavelength of 600 nm. Cells were analysed for cell size 
(forward scatter FSC vs side scatter SSC) (Figure 2.3) and cell cycle position (propidium iodide 
concentration) (Figure 2.4). Data was analysed using FlowJo software (v7.6, FlowJo Software. 
USA). 
 
Figure 2.3 Scatter plot with 100,000 analysed cells and gates used for FACS analysis. 
Side scatter (SSC) determines the granularity of the cell and forward scatter (FSC) the size. A) 
100 000 analysed cells, displayed using side and forward scatter, were gated to get rid of any 
debris and dead cells B) Only gated cells were subject to further analysis C) Four equally-sized 
gates were created along the FSC-axis (0-25k, 25k-50k, 50k to 75k and 75k-100k) and the 
percentages of cells in each one of them were calculated. 
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Figure 2.4 Scatter plots and representing 100,000 analysed cells and histogram with G1, S 
and G2 cell cycles phases indicated. 
A) 100 000 analysed cells, displayed using side and forward scatter, were gated to get rid 
of any debris and dead cells B) Gated cells were then displayed using PI-A and PI-W and 
showed a characteristic shape and cells above 200K were excluded from further analysis C) 
Cells in the left hand side of obtained shape represented single cells whereas cells on right 
hand side represented doublet cells. D) Only single cells were subject to cell cycle analysis E) 
Analysed single cells presented on histogram with indicated G1, S and G2 phases of cell cycle.  
75 
 
2.7 Statistical analysis 
GraphPad Prism (v5, GraphPad Software, CA, USA) was used for statistical analysis. Results 
were statistically analysed by tests stated in the corresponding figure legends. The majority of 
data was subject to one-way analysis of variance (One-way ANOVA), which is a way to test the 
equality of three or more means at one time by using variances. The assumptions for One-way 
ANOVA are:  the populations from which the samples were obtained must be normally or 
approximately normally distributed, the samples must be independent and the variances of 
the populations must be equal. The null hypothesis will be that all population means are equal, 
the alternative hypothesis is that at least one mean is different. This test was used as a way to 
compare means for four different genotypes.  
A post-hoc Tukey test was applied in order to find which means are significantly different 
from one another. It is a single-step multiple comparison procedure and statistical test 
generally used in conjunction with an ANOVA to find which means are significantly different 
from one another. It compares all possible pairs of means, and is based on a studentized range 
distribution. It is based on assumptions that the observations being tested are independent  
and that there is equal variation across observations. Graphs represent arithmetic means 
± standard error mean (SEM). For the purpose of clarity, no stars representing significant 
differences are depicted in any of the graphs but all possible statistical comparisons and any 
significant differences are shown in tables that accompany each graph.  
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CHAPTER 3 
3 Prenatal characterisation of Grb10m/+/Dlk1+/p double 
knockout mice 
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3.1 Introduction 
Cell growth (the increase in cell size and protein mass) and cell proliferation are highly 
coordinated processes that underlie correct growth of an organism. The preservation of 
precise control over the cell cycle is an essential condition for an organism to undergo normal 
development. Highly specific and accurately timed mitotic events are based upon progression 
through a range of molecular phases in a highly regulated order (Cooper, 2000). As a result, 
any disruptions of this well-organised process may lead to suppression of the process of 
proliferation and can result in tumourigenesis (reviewed in Malumbres and Barbacid, 2009). 
Similarly, misregulated signalling by factors that control cell cycle progression might have 
detrimental consequences on normal growth and development, which can be observed in 
a range of human growth disorders and corresponding mouse phenotypes resulting from an 
aberrant regulation of growth controlling genes.  
A complex set of interactions that function on systemic, cellular and molecular levels is 
necessary for the control of growth, and all of them must operate correctly to achieve cell, 
tissue, organ and organism size within the normal range for a given species (Malumbres and 
Barbacid, 2001). Site- and time-specific coordination between cell growth (mass), as well as 
cell proliferation and cell death (number), are crucial requirements for normal growth and 
development of the organism (Weinkove et al., 1999; Crickmore and Mann, 2008). In 
mammals, cell number in the whole organism is largely determined by hormones, nutrient 
supply and growth factors (Burns and Hassan, 2001). 
Identification of the IGF (Insulin Growth Factor) pathway as crucial during development 
was based on observations of in utero growth retardation following ablation of genes encoding 
proteins that were part of IGF-pathway (DeChiara et al., 1990; Liu et al., 1993), suggesting that 
this pathway functions to control the rate of normal cell proliferation. This was further 
supported by a study showing that embryonic growth retardation is a result of slower 
progression through the cell cycle which leads to the generation of lower numbers of cells 
during embryonic development (Baker et al., 1993), and was confirmed by analysis of Ifg1r 
deficient embryos-derived primary mouse embryonic fibroblasts (pMEFs) that displayed highly 
extended cell cycle phases and hypoproliferation (Sell et al., 1994).  
Imprinted genes are regarded as key players in the regulation of the normal course of 
development (see Chapter 1). The essential contribution of both of the parental genomes 
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during embryogenesis was proven by mid-gestational lethality of uniparental embryos (Barton 
et al., 1984; Surani et al., 1984). A valuable model for studying the role of parental alleles in 
the cell cycle and tumourigenesis has been provided by generation of primary embryonic 
fibroblasts from uniparental embryos (Hernandez et al., 2003). Consistent with previously 
described parthenogenetic and androgenetic phenotypes in mice, the role of each genome in 
in vitro proliferation and survival was different: androgenesis (lack of maternal genome) 
caused faster cell cycle progression and, as a consequence, induced hyperproliferation, whilst 
parthenogenesis (loss of paternal genome) led to premature cell death and slight growth 
reduction (Hernandez et al., 2003). Both of these phenotypes were in consistence with 
parental conflict theory, which predicts that in the absence of the growth retarding influence 
of the maternal genome, cell growth is enhanced whereas absence of growth enhancing 
paternal genome leads to cell growth arrest (Moore and Haig, 1991). The rescue of 
hypoproliferative parthenogenetic pMEFs was possible by specific deletion of either the 
Cdkn1C or Igf2r genes, both maternally expressed imprinted genes acting to suppress 
proliferation through inhibition of transition from S- to G1-phase and enhancing the 
elimination of growth factors (Hernandez et al., 2003).  
Several studies have suggested that Grb10 interacts with a number of different growth-
related pathways. Evidence for a Grb10 growth inhibitory role has been directly demonstrated 
by the generation and characterisation of Grb10m/+ knockout mice (Charalambous et al., 2003; 
Smith et al., 2007; Garfield et al., 2011) with a LacZ reporter gene incorporated within the 
Grb10 gene, which allowed for ready visualisation of the sites of Grb10 expression from early 
development and into adulthood (Charalambous et al., 2003). Maternal expression of Grb10 in 
E14.5 conceptuses is widespread, including skeletal and cardiac muscle, liver and bronchioles, 
as well as pancreatic buds and developing tubules in the kidney (see Table 1.3 in Section 1.4; 
Charalambous et al., 2003). Expression of Grb10 from the paternal allele proved to be much 
more limited, and has been found in some cells of the heart, gut, umbilicus, lungs, tongue and 
cartilage. Some of these tissues are therefore thought to be sites of biallelic Grb10 expression, 
although with slight predominance from the maternal allele. One of the most interesting sites 
of Grb10 expression is CNS, with limited contribution of the maternal allele, as confirmed by 
cranial sparing in Grb10m/+ mice (Charalambous et al., 2003), but some evidence has been 
provided for paternal Grb10 expression in the neonatal brain (Arnaud et al., 2003). Consistent 
with that, our group has recently detected similar pattern of predominantly paternal Grb10 
expression in the adult brain (Garfield et al., 2011). Detailed histological study of LacZ 
expression in mice with a knockout of the paternal Grb10 allele revealed a specific pattern of 
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Grb10 expression present within thalamic, hypothalamic, midbrain and hindbrain nuclei and 
lack of cortical expression identified at any point in the brain. In addition, the septal nuclei as 
well as the cholinergic inter-neurons of the caudate putamen were the sites of expression 
within the forebrain (Garfield et al., 2011). Previously detected Grb10 maternal expression in 
ependymal and choroid plexus in the embryo (Charalambous et al., 2003) did not persist until 
adulthood, however a few regions, such as the median preoptic nucleus, medial habenular, 
medial amygdaloid nuclei and ventromedial hypothalamus were recognised as sites of biallelic 
Grb10 expression in the brain (Garfield et al., 2011). This unique, reciprocally imprinted 
pattern of Grb10 expression seems to be of great importance in the regulation of distinct 
processes: early developmental growth and postnatal metabolism (maternal expression) and 
adult behaviour (paternal expression).  
Transmission of a non-functional Grb10 allele through the maternal line results in fetal 
and placental growth effects that are in agreement with the parental conflict hypothesis. 
Overgrowth of Grb10m/+ placentae has been reported from E14.5 onwards, whereas embryos 
displayed overgrowth from E12.5 (Charalambous et al., 2003). In addition, an increase in 
placental efficiency has been noted in E17.5 Grb10m/+ placentae and embryo/placenta weight 
ratio was around 10% higher in Grb10m/+ embryos when compared to wild type controls 
(Charalambous et al., 2010). These results indicated a function for Grb10 in limiting placental 
efficiency, and the increased volume of labyrinth in Grb10m/+ placentae suggested an increased 
surface area for nutrient exchange as a possible explanation for the observed phenomenon.  
The Grb10m/+ placenta is a unique example of an overgrown placenta that also displays 
increased placental efficiency. There are examples of other maternally expressed, imprinted 
genes causing placental hyperplasia but not resulting in higher placental efficiency. For 
example, Ipl gene ablation results in placental overgrowth without associated embryonic 
weight increase (Frank et al., 2002), which is suggestive of a role for Ipl as a suppressor of 
nutrient supply but not demand. In the case of the Grb10 gene, increased growth of both 
Grb10m/+ embryos and placentae implies its functions as a suppressor of both supply and 
demand. It may seem that inhibition of embryonic demand for nutrients is not advantageous 
for the fetus, however, studies in humans have shown that the most optimal birth weight is 
not substantially higher than the mean, and severe overgrowth is in fact associated with 
increased lethality. The optimal birth weight was instead found to be slightly above the mean 
birth weight for the population (Sansing and Chinnici, 1976), suggesting that it is not in the 
interest of the embryo to reach a specific ‘threshold’ of nutrient demand. Presumably in 
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normal situations placental maternally-expressed genes, acting in the interest of the mother, 
suppress nutrient transfer, and as a result, the threshold of nutrient demand is not reached. 
Conversely, in the case of overabundance of nutrients due to a highly efficient placenta, 
activation of demand suppressors prevents potentially dangerous embryonic overgrowth.  
Dlk1 is another gene expressed in a parent-of-origin-specific manner in the embryo and 
placenta, and its paternal expression was first identified at E11 in the mouse, with levels 
increasing until late gestation (Schmidt et al., 2000). The precise analysis of Dlk1 expression 
revealed that in E12.5 mouse embryos high levels of Dlk1 expression were present in the 
developing pituitary, pancreas, lung, adrenal and other mesodermally derived tissues and by 
E16.5 its expression diminished in most tissues, with exceptions of the pituitary, adrenal gland 
and skeletal muscle (Yevtodiyenko and Schmidt, 2006; da Rocha et al., 2007). Interestingly, 
Dlk1 expression was also found in the growing branches of organs developing through the 
process of branching morphogenesis, including lungs, pancreas and submandibular gland 
(Yevtodiyenko and Schmidt, 2006). In addition, analysis of Dlk1 expression in extra-embryonic 
tissues allowed for its detection in endothelial cells lining the fetal blood vessels of the 
labyrinth, and in the junctional zone on the membrane of some glycogen cells (Yevtodiyenko 
and Schmidt, 2006; da Rocha et al., 2007), which implied a potential role for Dlk1 in regulation 
of the interactions between mother and fetus.  
Growth and neurodevelopmental defects observed in human imprinting disorders are 
consistent with the placental and brain expression of numerous imprinted genes (Wilkinson et 
al., 2007; Fowden et al., 2011). Majority of the known imprinted genes show prominent 
expression in the placenta (Bressan et al., 2009) and an abnormal physiology and development 
of placenta is particularly characteristic of disrupted imprinting status, exemplified by lack of 
the Igf2 placental specific isoform that results in an aberrant transport of nutrients between 
maternal and fetal tissues (Sibley et al., 2004). It has also been demonstrated that for example 
maternally expressed Ascl2 (achaete-scute homolog complex 2) is necessary for the correct 
spongiotrophoblast cells differentiation during early development of murine placenta 
(Guillemot et al., 1995) and also paternally expressed 10 (Peg10) and retrotransposon-like 
1 (Rtl1) are imprinted genes vital for normal function of the placenta (Ono et al., 2006; Sekita 
et al., 2008). In addition to placental imprinting being crucial in regulation of nutrient transfer 
between mother and fetus, disrupted imprinting within the embryo is also able to influence its 
growth in a manner not dependent on the imprinting status of the placenta.  
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Recently, da Rocha et al (2009) generated a unique model that allowed for studying the 
consequences in the growing embryo of single, double, and triple dosage of Dlk1. The authors 
were able to assess the developmental and physiological functions of Dlk1, and found that 
triple dosage of Dlk1 leads to substantial organ malformations and, subsequently, to lethality. 
Conceptuses with a double dose of Dlk1 displayed overgrowth, but they failed to thrive, 
showing that the advantage of higher fetal weight is overcome by increased postnatal 
mortality. In most cases, except for the brain, levels of Dlk1 overexpression were in correlation 
with tissue specific overgrowth, indicating a role for Dlk1 in organ growth (da Rocha et al., 
2009). The authors suggested that imprinted levels of Dlk1 are providing exactly the correct 
dose of this gene for maintaining balance between growth and lethality. One of the 
hypotheses they proposed was based on the prediction that Dlk1 influences the differentiation 
versus proliferation equilibrium and the result is a trade-off between prenatal size and 
developmental maturity. Consistent with that, malformations found in a range of organs, 
including lung and liver, might be consequences of developmental immaturity at these sites. 
More detailed analysis of this interesting phenomenon of embryonic overgrowth and 
subsequent growth suppression is necessary. Another important outcome from study carried 
out by da Rocha et al (2009) was that, unlike many other studies that cannot discern between 
real embryonic growth changes and embryonic growth effects as secondary consequences of 
altered imprinting in the placenta, this model provided information on the influence of Dlk1 on 
embryonic phenotype in the presence of a normal placenta with unaltered Dlk1 expression. 
Obtained results demonstrated that Dlk1 is able to influence embryonic growth in a placenta-
independent manner.  
Moon et al (2002), who generated the first Dlk1 knockout mice, reported that lack of 
a functional Dlk1 gene resulted in prenatal retardation, which is in agreement with predictions 
of the parental conflict hypothesis. Examination of E18.5 embryos revealed approximately 20% 
growth reduction in comparison with wild type controls, along with a range of abnormalities 
accumulated during gestation (including skeletal and pulmonary defects) that led to 
approximately 50% lethality within two days after birth (Moon et al., 2002). These results 
highlighted a crucial role for Dlk1 in normal perinatal growth, development and survival.  
The importance of the dosage of imprinted genes situated on mouse chromosome 12, 
including Dlk1 and Dio3, has been highlighted by the dramatic phenotype of embryos with 
maternal and paternal uniparental disomy for chromosome 12 (Georgiades et al., 2000; 
Tevendale et al., 2006). Detailed analysis of phenotypes of these embryos and placentae 
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provided evidence of an essential role for the Dlk1-Dio3 imprinted domain in fetal viability, 
prenatal growth control, and the normal development of extraembryonic tissues as well as 
some mesodermal and neural crest-derived lineages.  
Several studies have indicated that different imprinting regulation mechanisms are 
employed in embryo and placenta (Chapman et al., 1984; Wagschal and Feil, 2006; Lin et al., 
2007). Other studies showed a group of genes exhibiting imprinted expression only in the 
placenta (Coan et al., 2005). Together, these findings highlight the difference in the epigenetic 
profiles of embryonic versus extraembryonic tissues and suggest that regulation of the 
imprinting in these tissues is complex and requires further investigation.  
It is striking that Grb10 and Dlk1 are two oppositely imprinted genes with many sites of 
co-expression and that they result in reciprocal growth and adiposity phenotypes in mice. 
Consistent with the parental conflict hypothesis, lack of the maternally expressed growth 
suppressor Grb10 leads to significant fetal and placental overgrowth which is persistent after 
birth until the difference in weight starts to diminish due to decreased adiposity in these mice. 
In contrast, loss of the Dlk1 gene in mice leads to pre- and post-natal growth retardation and 
predisposition to diet-induced obesity in adulthood. Assessment of the relationship between 
Grb10 and Dlk1 and their importance during fetal growth and development will be discussed in 
this chapter and hopefully will shed light on the early developmental consequences of 
knockouts of both of these genes. This will help to test the hypothesis that these two genes 
are acting in a common genetic pathway.  
In order to investigate the mechanisms of Grb10/Dlk1 growth control in vivo, we 
improved on previous studies that employed weight and morphometry alone as measures of 
growth. Therefore, in this chapter, in addition to allometric analysis of embryos and placentae 
from three different gestational stages we generated cell suspensions from whole E11.5 
embryos. This allowed us to employ fluorescence activated cell sorting (FACS) analysis to 
delineate any potential changes within cell cycle progression, analyse the cell size distribution 
and compare cells of the mutant genotypes to wild type controls. Moreover, we also examined 
the effects of Dlk1 and Grb10 ablation on in vitro growth by using primary fibroblasts from 
E14.5 embryos. Proliferation rates, cell cycle progression and cell size distribution were studied 
in fibroblasts from knockout embryos and compared to wild type controls. As a result, work in 
this chapter aims to assess the effects of ablation of Dlk1+/p and Grb10m/+ genes on embryonic 
growth in vivo and, by using an in vitro approach, attempts to identify cellular mechanisms 
affected by the lack of these genes.  
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3.2 Results 
3.2.1 Analysis of embryonic and placental growth and placental 
efficiency in Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E12.5, E14.5 
and E17.5 embryos. 
Numerous maternally and paternally expressed imprinted genes have been implicated in 
causing serious growth malfunctions during fetal development (DeChiara et al., 1991; Liu et al., 
1993; Ludwig et al., 1996; Curley et al., 2005). In accordance with that, our lab has previously 
demonstrated significant overgrowth of Grb10m/+ embryos starting from E12.5 and of 
placentae starting from E14.5 (Charalambous et al., 2003), while another group has reported 
significant growth reduction as a consequence of Dlk1 ablation in mice (Moon et al., 2002). To 
permit for an investigation of the growth phenotype resulting from lack of both Grb10 and 
Dlk1 genes, embryonic and placental wet weights together with placental efficiencies have 
been analysed at different gestational stages. 
3.2.1.1 E12.5 
First, placentae and fetuses were isolated 12 days after the observation of a cervical plug 
(E12.5). As previously demonstrated by our lab (Charalambous et al., 2003), in the present 
study we found that E12.5 Grb10m/+ embryos were significantly larger than wild type controls 
and also Dlk1+/p littermates (Figure 3.1 A). The assessment of embryonic wet weight changes in 
E12.5 Grb10m/+/Dlk1+/p also revealed similar significant increase in embryonic weights, while no 
changes were found in Dlk1+/p embryonic weights. Consistent with previous studies, no 
statistically significant alterations in placental mass of E12.5 Grb10m/+ were noted, and also 
placental weights of other mutant genotypes did not show any significant deviations from wild 
type controls (Figure 3.1 B). Analysis of placental efficiency also failed to show a difference for 
any of the analysed genotypes in consistence with previous studies on Grb10m/+ placentae 
(Figure 3.1 C), in which increased efficiency was not reported until later on in gestation 
(Charalambous et al., 2010).  
3.2.1.2 E14.5 
In agreement with previous findings from our group (Charalambous et al., 2003), Grb10m/+ 
embryos and placentae were significantly enlarged at the stage of E14.5 (Figure 3.2 A and B). 
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Following on from the results obtained for E12.5 embryos, statistically significant overgrowth 
of both Grb10m/+/Dlk1+/p embryos and placentae confirmed that Grb10m/+/Dlk1+/p embryos 
shared the growth phenotype with Grb10m/+ at the E14.5 stage. Similar to E12.5, all genotypes 
failed to show significant changes in placental efficiency at E14.5 (Figure 3.2 C). This is again 
consistent with a previous study showing that a statistically significant improvement in 
Grb10m/+ placental efficiency was not detected until E17.5 (Charalambous et al., 2010). No 
statistically significant differences in placental or embryonic wet weights were found in Dlk1+/p 
embryos, although the trend of slightly decreased embryonic mass of Dlk1+/p embryos was 
noted.  
3.2.1.3 E17.5 
Comparative analysis of Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E17.5 embryonic and 
placental wet weights showed persistent embryonic and placental overgrowth in Grb10m/+ and 
Grb10m/+/Dlk1+/p animals, but in the case of placental overgrowth only in comparison to Dlk1+/p 
(Figure 3.3 A and B). Although slightly lighter, the weights of Dlk1+/p embryos and placentae 
were not significantly smaller. An earlier report (Charalambous et al., 2010) indicated 
embryonic stage E17.5 as the time when placental efficiency in Grb10m/+ became significantly 
increased, and the present study has confirmed this result (Figure 3.3 C), as improved Grb10m/+ 
placental efficiency was again apparent. Grb10m/+/Dlk1+/p placentae also showed significantly 
increased efficiency. Consistent with findings for earlier gestation stages, E17.5 Dlk1+/p 
placentae did not exhibit any changes in efficiency. We also identified significant overgrowth in 
wet weights and relative weights of Grb10m/+ and Grb10m/+/Dlk1+/p E17.5 livers (Figure 3.3 D 
and E). This results, however, should be further confirmed by analyses of larger animal cohort 
as analysed number do not provide enough evidence to draw firm conclusions.  
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Figure 3.1. Analysis of wet weights of wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E12.5 
embryos and placentae, together with placental efficiency.  
A) Comparative analysis of wet weights of E12.5 embryos revealed that at this stage of 
development both Grb10m/+ (*p<0.05) and Grb10m/+/Dlk1+/p (**p<0.01) embryos were 
significantly heavier than their wild type and Dlk1+/p littermates. B) Trends for increased 
placental mass in Grb10m/+ and Grb10m/+/Dlk1+/p have also been observed, however no 
significant changes have been noted. C) No changes have been detected in placental efficiency 
between the analysed genotypes. D) Table summarising results of statistical analysis. All values 
represent means ± SEM, one way ANOVA with Tukey’s post-hoc analysis. WT n=23, Dlk1+/p 
n=13, Grb10m/+ n=13, Grb10 m/+ /Dlk1 +/p n=16. 
 
 
 
86 
 
 
Figure 3.2 Analysis of wet weights of wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E14.5 
embryos and placentae, together with placental efficiency.  
A) E14.5 Grb10m/+ embryos were significantly overgrown when compared to wild type 
(***p<0.001) and Dlk1+/p (***p<0.001) embryos and it was a similar case for Grb10m/+/Dlk1+/p 
embryos compared to wild type (**p<0.01) and Dlk1+/p (***p<0.001). B) Similarly, a higher 
placental wet weight mass was noted in Grb10m/+ when compared to wild type (**p<0.01) and 
Dlk1+/p (***p<0.001) and in Grb10m/+/Dlk1+/p placentae compared to wild type (*p<0.05) and 
Dlk1+/p (**p<0.01) for this stage in gestation. C) No statistically significant deviations in 
placental efficiency were found. D) Table summarising results of statistical analysis. All values 
represent means ± SEM, one way ANOVA with Tukey’s post-hoc analysis. WT n=19, Dlk1+/p 
n=22, Grb10m/+ n=22, Grb10 m/+ /Dlk1 +/p n=25. 
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Figure 3.3 Analysis of wet weights of wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E17.5 
embryos, livers and placentae, together with placental efficiency and relative liver weights.  
A) Significant overgrowth was noted in E17.5 Grb10m/+ compared to wild type and Dlk1+/p 
(***p<0.001) embryos and in Grb10m/+/Dlk1+/p compared to wild type (**p<0.01) and Dlk1+/p 
(***p<0.001) embryos. B) Grb10m/+ (**p<0.01) and Grb10m/+/Dlk1+/p (*p<0.05) placentae were 
overgrown compared to Dlk1+/p. C) Significantly higher placental efficiency was noted in 
Grb10m/+ (*p<0.05) compared to wild type and Dlk1+/p and Grb10m/+/Dlk1+/p compared to wild 
type (*p<0.05) and Dlk1+/p (**p<0.01) animals. D) Grb10m/+ and Grb10m/+/Dlk1+/p livers were 
overgrown compared to wild type (*p<0.05) and Dlk1+/p (***p<0.001). E) Relative liver weights 
were increased in Grb10m/+ and Grb10m/+/Dlk1+/p compared to Dlk1+/p (*p<0.05) liver weights. F) 
Table summarising results of statistical analysis. All values represent means ± SEM, one way 
ANOVA with Tukey’s post-hoc analysis. WT n=4, Dlk1+/p n=8, Grb10m/+ n=6, Grb10 m/+ /Dlk1 +/p 
n=8.  
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3.2.2 Analysis of cell proliferation in Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p E14.5 pMEFs 
Specific and highly regulated rates of cell proliferation, cell death and cell size during 
embryogenesis are the basis of controlled growth during the normal course of development. 
Ablation of the Grb10 gene has been previously reported to lead to overgrowth (Charalambous 
et al., 2003), whereas lack of the Dlk1 gene resulted in growth retardation in mice (Moon et al., 
2002). Moreover, Grb10 has already been shown as an interacting partner of several proteins 
involved in regulation of cell proliferation and apoptosis, such as Igf1r, growth hormone 
receptor or Raf1 and Akt (Moutoussamy et al., 1998; Nantel et al., 1998; Dufresne and Smith, 
2005; Urschel et al., 2005), implying its possible role in controlling the kinetics of this 
processes. Also, a recent in vitro study in neuroblastoma cells demonstrated that 
overexpression of DLK1 leads to protection from apoptosis by nutrient depletion (Kim, 2010) 
which was consistent with previous finding that exogenous DLK1 prevented an increase of 
apoptosis caused by AS2O3 in K562 leukaemia cells (Qi et al., 2008). 
Primary embryonic fibroblasts derived from E14.5 embryos with the absence of functional 
Grb10 have previously been subject to analysis of the rate of cell proliferation and 
susceptibility to apoptosis (Garfield, 2007). Hyperproliferation was observed in Grb10m/+ cells, 
while lack of a functional Grb10 gene did not appear to alter susceptibility to at least some 
pro-apoptotic signals.  
The differences in the growth phenotypes at the analysed embryonic developmental 
stages, in particular the overgrowth that was prominent in Grb10m/+ and Grb10m/+/Dlk1+/p 
embryos from E12.5 and then throughout the remaining gestation period, might be associated 
with either an increase in cell size or in cell number. To analyse the latter, an investigation of 
proliferation rates of primary embryonic fibroblasts derived from E14.5 embryos was carried 
out in a manner described in detail in Section 2.6.3. Cells were seeded at an initial density of 
1x104 per well and counted every 48 hours over a two week period. The results revealed that 
Grb10m/+ and Grb10m/+/Dlk1+/p cells exhibited hyperproliferation in vitro (Figure 3.4). Starting 
from 72 hours post-seeding, Grb10m/+/Dlk1+/p cells displayed an increase in density, which was 
not apparent until 120 hours post-seeding for wild type, Dlk1+/p and Grb10m/+ cells. From 168 
hours post-seeding onwards a substantial increase in proliferation was noted for Grb10m/+ 
cells, alongside an even more prominent increase (reaching up to three times those observed 
for wild type cells) for Grb10m/+/Dlk1+/p cells and these trends continued until the end of the 
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investigation at the time of 264 hours post-seeding. Statistical analysis of areas under the 
growth curves revealed that over the course of the study both Grb10m/+ and Grb10m/+/Dlk1+/p 
cells showed a significant increase in total growth (Figure 3.4). No significant deviation from 
wild type growth was shown by Dlk1+/p cells, although they did exhibit a consistent trend to 
proliferate at a slightly lower rate than wild type cells. 
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Figure 3.4 Analysis of growth rates in wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/pE14.5 
pMEFs.  
Proliferation of wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/pE14.5 pMEFs has been studied 
under standard growth conditions, starting from an initial seeding density of 1x104 cells. 
Changes in cell numbers for each genotype have been calculated every 48 hours. Growth 
curves (A) and areas under curves (B) are presented for wild type, Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p E14.5 pMEFs over the time of 264 hours post-seeding. Statistical analysis of 
total areas under growth curves showed significantly faster growth for Grb10m/+ pMEFs 
compared to wild type (*p<0.05) and Dlk1+/p (**p<0.01) cells as well as for Grb10m/+/Dlk1+/p 
compared to wild type (***p<0.001) and Dlk1+/p (***p<0.001) E14.5 pMEFs. Each data point 
represents the mean of 5 independent experiments, 4 replicates for each time point, counted 
twice. C) Table summarising results of statistical analysis. All values represent means ± SEM, 
tested using one way ANOVA with Tukey’s post-hoc analysis. WT n=5, Dlk1+/p n=5, Grb10m/+ 
n=5, Grb10m/+/Dlk1+/p n=5. 
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3.2.3 FACS analysis of Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E11.5 
embryos and E14.5 pMEFs 
Fluorescently activated cell sorting (FACS) was employed to examine the basis for the 
hyperproliferative phenotype of Grb10m/+ and Grb10m/+/Dlk1+/p E14.5 pMEFs and to investigate 
the possibility of cellular hypertrophy. E14.5 pMEFs from all four genotypes, cultured under 
standard conditions and allowed to grow to approximately 80% confluence, were stained with 
propidium iodide and 100,000 individual cells were then used for an assessment of cell size 
and cell cycle progression.  
To allow for more direct investigation of potential cell size modifications in transgenic 
embryos, we have used the same type of FACS analysis directly on cells freshly isolated from 
E11.5 embryos. Following isolation, embryos were disaggregated and rendered into single-cell-
suspensions, which were then stained with propidium iodide. Similarly to pMEFs analysis, 
100,000 individual cells were used for investigations of cell size and cytokinetic profile.  
The reasons for choosing E11.5 whole embryos for FACS analysis were based upon the 
practical issues associated with disaggregation of embryos older than E11.5. Cells tend to 
aggregate significantly after the E11.5 stage of development and use of collagenase or 
proteases would be required for obtaining single cell suspension. This additional step might 
have resulted in loss of cells and interfering with real results. In addition, significant 
overgrowth has been identified in Grb10m/+ E12.5 embryos by our group, so it is hypothesised 
that at E11.5 Grb10m/+ cells will exhibit changes to the normal course of the cell cycle that lead 
to the alteration in embryonic growth evident at E12.5, and that similar changes might be 
occurring in Grb10m/+/Dlk1+/p embryos. For these reasons we decided that the gestational stage 
of E11.5 would be suitable for the FACS analysis we wanted to perform.  
3.2.3.1 Analysis of cell size in wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E11.5 
embryos and E14.5 pMEFs 
Cell size and granulation can be analysed using diffraction and scattering of laser beams 
upon contact with individual cells. Side scatter (SSC) defines the granularity of the cell and 
forward scatter (FSC) the size. No deviations from wild type were found in the ranges of cell 
sizes upon FACS analysis of Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p cells from either E11.5 
embryos (Figure 3.5) or E14.5 pMEFs (Figure 3.6), suggesting that the observed overgrowth 
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phenotypes in Grb10m/+ and Grb10m/+/Dlk1+/p embryos are not due to altered growth of 
individual cells (cell hypertrophy). However, the used method of gating out any debris from the 
actual cells did not separate the singlet and dublet cells as it did for cell cycle progression 
analysis, therefore it should be taken into account that obtained results might not reflect true 
cell sizes and the results from this experiment should be re-analysed using gating method 
described in Figure 2.4.  
3.2.3.2 Analysis of cell cycle progression in wild type Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p E11.5 embryos and E14.5 pMEFs 
Analysis of specific cell cycle stages can be achieved by staining cells with propidium 
iodide, which allows for an assessment of DNA content that is related directly to cell cycle 
progression. By studying the histogram representing cell cycle progression, percentages of 
cells in each of the cell cycle phases can be determined.  
Comparative FACS analysis of cell cycle stages in freshly derived single cell suspensions 
from Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E11.5 embryos revealed several differences in the 
distribution of cells within cell cycle phases between genotypes (Figure 3.7). We found that 
significantly lower percentages of Grb10m/+ and Grb10m/+/Dlk1+/p cells were in the S-phase of 
the cell cycle at the time of analysis when compared to Dlk1+/p cells (Figure 3.7 B). Conversely, 
there was an increased number of Grb10m/+ and Grb10m/+/Dlk1+/p cells in G2-phase of the cell 
cycle, this time in comparison to wild type cells (Figure 3.7 C). Similar observations were made 
with E14.5 pMEFs (Figure 3.8), as FACS analysis revealed a statistically significant decrease in 
the proportion of Grb10m/+ and Grb10m/+/Dlk1+/p cells in S-phase compared to Dlk1+/p and wild 
type cells (Figure 3.8 B) along with an increased number of Grb10m/+ and Grb10m/+/Dlk1+/p cells 
in G2-phase compared to wild type (Figure 3.8 C). Dlk1+/p cells from E11.5 embryos and E14.5 
pMEFs did not exhibit any significant differences in their distribution within cell cycle phases 
when compared to wild type controls.  
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Figure 3.5 FACS analysis of cell size in wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E11.5 
embryos. 
Cells derived from wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E11.5 embryos were 
stained with propidium iodide and analysed using FACS in order to reveal any potential 
changes in cell size. 100,000 cells were FACS analysed for each sample and calculations were 
carried out to identify cell size deviations between wild type, Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p E11.5 cells. Cell sizes were analysed and compared according to which one of 
four gates they fell into: A) 0-25k; B) 25k-50k; C) 50k-75k; D) 75k-100k. Statistical analysis did 
not reveal any differences in cell sizes between the studied genotypes. E) Table summarising 
results of statistical analysis. All values represent means ± SEM, one way ANOVA with Tukey’s 
post-hoc analysis. WT n=10, Dlk1+/p n=8, Grb10m/+ n=10, Grb10 m/+ /Dlk1 +/p n=8. 
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Figure 3.6 FACS analysis of cell size in wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E14.5 
pMEFs. 
Wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E14.5 derived pMEFs, cultured under 
standard growth conditions, were stained with propidium iodide and analysed with FACS to 
determine any potential differences in cell size. 100,000 cells were FACS analysed for each 
sample and calculations were carried out to identify cell size deviations. Cell sizes were 
analysed and compared according to one of four gates they fell into: A) 0-25k; B) 25k-50k;  
C) 50k-75k; D) 75k-100k. Statistical analysis revealed no deviations in cell size ranges between 
examined genotypes. E) Table summarising results of statistical analysis. All values represent 
means ± SEM, one way ANOVA with Tukey’s post-hoc analysis. WT n=9, Dlk1+/p n=7, Grb10m/+ 
n=9, Grb10 m/+ /Dlk1+/p n=7. 
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Figure 3.7 FACS analysis of cell cycle progression in wild type, Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p E11.5 embryos.  
Cells derived from wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E11.5 embryos were 
stained with propidium iodide and analysed with FACS in order to reveal any potential changes 
in cell cycle progression. 100,000 cells were FACS analysed for each sample and calculations 
were carried out to determine percentages of cells in each phase of cell cycle. A) No significant 
differences were found in cell distribution in the G1-phase of the cell cycle for any of the 
analysed genotypes. B) Statistical analysis revealed a significant decrease in percentages of 
cells in S-phase exhibited by Grb10m/+ (*p<0.05) and Grb10m/+/Dlk1+/p (*p<0.05) cells when 
compared to Dlk1+/p cells. C) Significantly increased numbers of Grb10m/+ (*p<0.05) and 
Grb10m/+/Dlk1+/p (*p<0.05) cells were noted in G2-phase by when compared to wild type 
controls. D) Table summarising results of statistical analysis. All values represent means ± SEM, 
one way ANOVA with Tukey’s post-hoc analysis. WT n=16, Dlk1+/p n=16, Grb10m/+ n=9,  
Grb10m/+ /Dlk1 +/p n=10. 
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Figure 3.8 FACS analysis of cell cycle progression in wild type, Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p E14.5 pMEFs.  
Wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p E14.5 derived pMEFs, cultured under 
standard growth conditions, were stained with propidium iodide and analysed with FACS to 
determine any differences in cell cycle progression. 100,000 cells were FACS analysed for each 
sample and calculations were carried out to determine percentages of cells in each phase of 
the cell cycle. A) No significant differences were found in cell distribution in the G1-phase of 
the cell cycle for any of the analysed genotypes. B) Statistical analysis revealed significantly 
lower percentages of Grb10m/+ (*p<0.05) and Grb10m/+/Dlk1+/p (*p<0.05) cells in S-phase of the 
cell cycle in comparison to wild type controls and to Dlk1+/p cells. C) Significantly higher 
percentages of Grb10m/+ (*p<0.05) and Grb10m/+/Dlk1+/p (*p<0.05) cells were observed in G2-
phase of the cell cycle when compared to wild type control cells. D) Table summarising results 
of statistical analysis. All values represent means ± SEM, one way ANOVA with Tukey’s post-
hoc analysis. WT n=5, Dlk1+/p n=10, Grb10m/+ n=8, Grb10 m/+/Dlk1 +/p n=10. 
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3.3 Discussion 
Genomic imprinting is a process based on epigenetic marking that results in parent-of-
origin regulation of a subset of genes (see Chapter 1; Ferguson-Smith, 2011). This leads to 
functional non-equivalence of at least thirteen murine subchromosomal regions, for which 
both of the parental copies are required if development is to proceed normally (see 
MouseBook http://www.mousebook.org/imprinting/gen-map.html). Experiments that allowed 
for the generation of parthenogenetic and androgenetic embryos or chimaeras indicated 
crucial roles for imprinted genes in the development of the placenta as well as several 
mesodermal and ectodermal derivatives within the embryo (Barton et al., 1984; McGrath and 
Solter, 1984; Barton et al., 1991; Fundele et al., 1991). In agreement with these studies, the 
identification of imprinted genes, along with their roles and expression patterns, has 
highlighted the important function of imprinted genes in controlling the allocation of pre- and 
post-natal resources (Constancia et al., 2004) and influencing correct embryonic growth and 
development (Georgiades et al., 2000; Moon et al., 2002; Charalambous et al., 2003). 
Consistent with this, most of the imprinted genes identified up until now show expression in 
the extraembryonic tissues (reviewed in Coan et al., 2005; Fowden et al., 2011) and imprinted 
gene knockouts in mice have provided evidence that they contribute to many aspects of 
placental growth, organisation and morphology as well as nutrient transfer between mother 
and the developing embryo (Constancia et al., 2002; Reik et al., 2003; Sibley et al., 2004). 
Differential interest of parental genomes with regard to resource allocation is often considered 
as one of the selective pressures that led to evolution of imprinting. During pregnancy, 
maternally imprinted genes (e.g. Igf2) tend to increase the level of nutrient supply or demand 
necessary for the growth of the fetus, whilst maternally expressed imprinted genes (e.g. 
Cdkn1c or Igf2r) exert a reciprocal function.  
Maintenance of proper control between proliferation, differentiation, apoptosis and 
correct cell size is a pivotal condition for a normal course of development to take place. Any 
disruptions within this set of cell characteristics may result in abnormal development that can 
lead to incorrect physiological and metabolic status later in life. The growth pathways and 
cellular basis through which Grb10 and Dlk1 mediate their effects need further investigation, 
therefore we decided to examine and describe the growth effects in Grb10m/+/Dlk1+/p embryos 
and perform an in vitro investigation of proliferation, cell size and cell cycle kinetics in 
Grb10m/+/Dlk1+/p primary embryonic fibroblast cultures.  
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Previously generated crosses between Grb10m/+ and Igf2+/p mutant mice demonstrated an 
intermediate growth phenotype and pointed at a non-epistatic relationship between Grb10 
and the Igf2 signalling pathway, suggesting that a non-IGF pathway regulates the overgrowth 
phenotype observed in Grb10m/+ mice (Charalambous et al., 2003). Another examination of the 
possible interaction between Igf signalling and Grb10 in growth regulation was performed by 
generating Grb10m/+/Igf1r-/- double knockout mice (Gafield, 2007). This experiment once again 
showed an additive phenotype in double mutants, providing further evidence that the 
pathway predominantly involved in causing Grb10 overgrowth phenotype is not the IGF 
pathway.  
Investigation of fetal growth in Grb10 and Dlk1 knockout mice in the present study 
revealed that Grb10m/+ embryos were significantly overgrown from gestational day 12 onwards 
(17% bigger than wild type), whereas Dlk1+/p embryos exhibited reciprocal fetal growth 
phenotype  from E14.5, which, however, did not become statistically significant. These growth 
phenotypes are consistent with the ones observed in the original Grb10 (Charalambous et al., 
2003) and Dlk1 (Moon et al., 2002) knockout lines, where Grb10 embryos were found to be 
overgrown from E12.5 onwards (Charalambous et al., 2003), and Dlk1 E18.5 embryos were 
significantly growth retarded (Moon et al., 2002). Both growth effects are in agreement with 
the parental conflict theory (Moore and Haig, 1991), and Grb10 and Dlk1 are therefore 
established as maternally expressed growth suppressor and paternally expressed growth 
enhancer, respectively.  
Reciprocal phenotypes of Grb10 and Dlk1 knockout mice suggest that the Grb10 and Dlk1 
imprinted genes might form part of a common genetic pathway, crucial for growth and 
development. In addition, there is some evidence for co-expression of both of these genes in 
embryonic tissues, such as developing muscle and cartilage tissues, pancreatic bud, liver, lung 
bronchioles and developing kidneys (Charalambous et al., 2003; Yevtodiyenko and Schmidt, 
2006; da Rocha et al., 2007; Lui et al., 2008). Our main interest, therefore, was to investigate 
the growth phenotype of Grb10m/+/Dlk1+/p double knockout embryos, in light of previous 
failure to identify a possible Grb10 interacting pathway by generation of Grb10m/+/Igf2+/p and 
Grb10m/+/Igf1r-/- double knockout mutants (Charalambous et al., 2003, Garfield, 2007). In 
contrast, study of growth effects in Grb10m/+/Dlk1+/p embryos revealed a growth phenotype 
similar to Grb10m/+ embryos. Significant overgrowth of Grb10m/+/Dlk1+/p conceptuses started 
from the day E12.5, when a 19% enlargement in comparison to wild types has been observed, 
and lasted throughout the rest of the gestational period (24% at E14.5 and 27% at E17.5). 
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Importantly, the overgrowth in Grb10m/+/Dlk1+/p embryos was comparable to overgrowth of 
Grb10m/+ fetuses (17% at E12.5, 35% E14.5 and 36% at E17.5). These results imply on similarity 
between Grb10m/+/Dlk1+/p embryos and their Grb10m/+ littermates, which raises the possibility 
of both genes interacting with each other in fetal growth control. More specifically, the data 
obtained through analysis of embryonic growth suggests that Grb10, a potent growth 
suppressor, might be epistatic, and antagonistic, to the paternally-expressed gene Dlk1 during 
fetal development. 
Birth size largely depends upon the nutrient supply, which is determined by the 
morphology, size and efficiency of the placenta (reviewed in Fowden et al., 2011). The 
observations made for growth of Grb10m/+/Dlk1+/p embryos suggested an epistatic growth 
pathway involving both of these genes, therefore it was of interest to examine if it was the 
same case for extraembryonic tissues. Dlk1 and Grb10 are co-expressed in the fetal 
endothelium of the placenta (Yevtodiyenko and Schmidt, 2006; Charalambous et al., 2010) and 
Grb10 is also present in the trophoblast of the placenta. Experiments presented in this chapter 
revealed no differences in the placental weights in E12.5 embryos. Grb10m/+ and 
Grb10m/+/Dlk1+/p placentae were overgrown from E14.5, so again Grb10m/+/Dlk1+/p double 
mutant mice displayed a growth phenotype similar to Grb10m/+ single mutants. The placental 
overgrowth at E17.5 was also significant, however, only when Grb10m/+ and Grb10m/+/Dlk1+/p 
placental weights were compared to Dlk1+/p, whereas E17.5 Grb10m/+ and Grb10m/+/Dlk1+/p 
embryos were significantly overgrown when compared to Dlk1+/p and wild type. This could 
suggest that although changes within placental imprinting and subsequently in placental 
growth might influence embryonic growth, even without overgrown placentae Grb10m/+ and 
Grb10m/+/Dlk1+/p embryos maintained increased body weight, however it has to be taken into 
account that numbers of analysed E17.5 animals were small and need to be increased in order 
to draw any certain conclusions. The shortage of E17.5 embryos and lack of significant 
differences when comparing Grb10m/+ and Grb10m/+/Dlk1+/p placentae to those of wild type 
mice indicate that the obtained results need to be interpreted carefully and that more detailed 
investigation is needed in order to provide firm evidence for the role of placentae and their 
efficiency in observed Grb10m/+ and Grb10m/+/Dlk1+/p fetal overgrowth, as there exists 
a possibility that for example highly efficient Grb10m/+/Dlk1+/p placenta could be the major 
contributor to the observed Grb10m/+/Dlk1+/p embryonic overgrowth.  The influence of 
placentomegaly on embryonic development seems to be less severe than that resulting from 
placental growth retardation, and despite placental overgrowth the associated embryos 
sometimes display normal growth (Fowden et al., 2011). It should, however, be noted that in 
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spite of a relatively frequent cases of overgrown placentae resulting from imprinted gene 
disruption, it seems that they are not associated with improved well-being of the fetus 
(Georgiades et al., 2001; Salas et al., 2004). The roles of Grb10 and Dlk1 in embryonic and 
placental growth regulation might be independent, as exemplified by different functions of 
Igf2 P0 and embryonic transcripts (DeChiara et al., 1991; Constancia et al., 2002). It would 
therefore be interesting to analyse the outcomes of Grb10 and Grb10/Dlk1 overexpression and 
knockout solely within placentae and only in the embryo in order to uncover the real effects of 
Grb10 and combination of Grb10/Dlk1 imprinting in embryonic and extraembryonic tissues on 
normal growth and development of the embryo, as it has been done elsewhere for Dlk1 (da 
Rocha et al., 2009). 
Grb10 does not only possess an ability to affect embryonic and placental size, but also to 
control placental efficiency (Charalambous et al., 2010). Grb10m/+ placentae were shown to 
have an increased volume of labyrinth and subsequently exhibited higher efficiency in 
enhancing the growth of the fetus, implying that the normal Grb10 role is to reduce 
labyrinthine exchange of nutrients and thereby limit fetal growth. This type of mechanism 
might be employed to overcome the reciprocal forces of growth enhancement as well as to 
protect the mother from the disadvantageous consequences of fetal overgrowth (McLaren, 
1965; Henriksen, 2008). As a result, Grb10 seems to act as a regulator of the allocation of 
maternal resources, thereby mediating choice between different reproductive strategies (large 
pups within small litter versus small pups in a large litter), presumably in line with prevailing 
conditions (Charalambous et al., 2010).  
Yevtodiyenko and Schmidt (2006) suggested the involvement of Dlk1 in endothelial 
development and, at the same time, in control of branching morphogenesis in the placenta. 
They also pointed out that Dlk1 expression patterns in the murine placental labyrinth is distinct 
from the pattern noted in human placenta, in which DLK1 expression is detected in the stromal 
cells of the chorionic villi. Both of these structurally different tissues are situated in close 
proximity to maternal-fetal exchange sites, and Dlk1 is expressed within cells separating fetal 
and maternal blood supplies, implying potential roles for Dlk1/DLK1 in the regulation of 
maternal-fetal communication. A role for Dlk1 in placenta has also been confirmed by 
observation of phenotypes resulting from uniparental disomies of chromosome 12 (Tevendale 
et al., 2006). Prenatal lethality was observed in both mUPD as well as pUPD animals, along 
with growth abnormalities and developmental defects in muscle, cartilage/bone and either 
a decrease or increase in placental growth, respectively (Georgiades et al., 2000; Georgiades et 
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al., 2001). Moreover, the observation of a disrupted fetal vasculature in pUPD12 placentae 
suggests the requirement for Dlk1 in normal development of the labyrinth tissue, again 
supporting the idea that Dlk1 functions within maternal and fetal exchange in placenta.  
In the present study, significant growth retardation has been noted in Dlk1+/p placenta 
only at E12.5 and was not maintained until later stages of gestation although there was a trend 
for the Dlk1+/p placenta to remain smaller than wild type controls. Previously mentioned 
elegant study performed by da Rocha et al (2009) described a model in which embryonic Dlk1 
over-expression was engineered in the presence of a normal placenta with a normal Dlk1 dose. 
The results showed that Dlk1 is able to control embryonic growth independently of the 
placenta. That could explain the observation that despite significant growth retardation of 
Dlk1+/p fetuses, their placentae do not exhibit a dramatically altered growth phenotype.  
So far there is a relatively poor understanding of the mechanisms of fetal growth control, 
and yet it is vital that at birth whole body and all the organs have reached correct sizes and 
proportions. A mammalian embryo during the onset of its growth and development relies on 
the accurate function of the placenta for most of the gestational period. Previously mentioned 
wide expression of imprinted genes in the placenta and identification of a number of genes 
with expression restricted only to this organ suggest a crucial role of imprinted genes in 
placental development and, subsequently, coordination of embryonic growth. As discussed 
above, Grb10 and Dlk1 exert effects on both embryonic and placental development, therefore 
it will be interesting to conduct more detailed analysis of Grb10m/+/Dlk1+/p placentae, especially 
of their capacity for nutrient transfer in vivo, in order to uncover the influence of Grb10 and 
Dlk1 on placental morphology and physiology. Stereological analysis of specific tissues forming 
Grb10m/+/Dlk1+/p placentae is under way, and hopefully it will shed more light on the outcomes 
of Grb10 and Dlk1 ablation on placental characteristics.  
Various publications have demonstrated independent signalling pathways involved in 
regulation of cell growth and proliferation (Coelho and Leevers, 2000; Conlon et al., 2001; 
Echave et al., 2007). Generation and study of Pdk1 knockout mice revealed a strong correlation 
between expression levels of Pdk1 in various organs and both total animal size and organ 
volumes (Lawlor et al., 2002). Lawlor et al (2002) found that the size of primary MEFs derived 
from Pdk1 knockout embryos was 35% reduced in comparison to wild type controls. In support 
of the fact that size and cell proliferation are processes usually regulated by different 
pathways, despite the reduction in Pdk1-/- MEFs cell size, no change was observed in their 
proliferation rate (Lawlor et al., 2002). On the other hand, in Drosophila the insulin 
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receptor/PI3- kinase pathway has been found to be equally important for controlling both cell 
size and cell number (Kozma and Thomas, 2002).  
In study presented in this chapter we examined both cell size and cell proliferation, along 
with cell cycle progression, in order to determine the reason for the observed overgrowth 
phenotype in Grb10m/+ and Grb10m/+/Dlk1+/p animals. Fluorescent activated cell sorting (FACS) 
allowed us to determine any potential differences in cell sizes between mutant and wild type 
cells. We have decided not only to analyse primary MEFs from E14.5 embryos, as it has been 
done before for Grb10m/+ cultures, but also to perform FACS analysis on freshly dissected E11.5 
embryos. The method used for the generation of single cell suspensions was based on that 
described for analysis of cell proliferation and apoptosis in Igf2 deficient mouse embryos 
between days 9 and 10 of gestation (Burns and Hassan, 2001). Burns and Hassan (2001) 
reported that genetic disruption of Igf2 was associated with enhanced apoptosis and 
a decreased rate of cell proliferation in E9–E10 embryos, resulting in reduced cell numbers 
with no alterations in cell size. Their novel method has proven to be particularly useful for 
detecting the causes of a growth phenotype which would be otherwise difficult to identify 
using commonly used cell culture techniques. In the case of Igf2 knockout mice, a size 
difference was first detectable from embryonic stage E11, with a growth reduction of 40% 
apparent at birth that was maintained throughout life, but despite this size difference these 
animals were fertile and exhibited normal proportions (DeChiara et al., 1990; DeChiara et al., 
1991). A similar phenotype was seen in insulin receptor substrate 1 (Irs1) knockout mice, 
which were born 40-60% smaller than their wild type counterparts and their proportional size 
differences persisted throughout life, but despite that they underwent normal bone 
development and did not show any changes in fertility (Araki et al., 1994).  
Increased cell proliferation, lower rate of apoptosis or enhanced cell size could be 
potential factors that influence the embryonic overgrowth phenotype in Grb10m/+ animals. 
Previous analysis of Grb10m/+proliferation rates revealed that the Grb10m/+cells proliferated 
significantly faster in comparison to wild type controls (Garfield, 2007). On the other hand, 
study of the apoptotic basal rate and its potential contribution to the observed 
hyperproliferative phenotype showed that Grb10m/+ fibroblasts did not exhibit a reduced 
frequency of apoptosis in response to at least some pro-apoptotic signals, excluding a primary 
role for disrupted apoptosis in the generation of increased cell numbers (Garfield, 2007).  
This finding is in line with reports that the total loss of maternal genome in primary 
embryonic fibroblasts results in more rapid cell cycle and hyperproliferation along with 
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formation of tumours at low passage number, as androgenetic MEFs displayed anchorage-
independent growth and produced fibrosarcomas when injected into adult nude mice 
(Hernandez et al., 2003). It is also in agreement with the parental conflict theory, as cell 
proliferation is enhanced due to loss of the maternal genome’s growth suppressing function. 
Another study suggested that significant Igf1r-mediated growth inhibition was the 
consequence of an overexpression of functional Grb10 gene that caused a delay in the S- and 
G2-phases of the cell cycle (Morrione et al., 1997), implying a Grb10 negative function in cell 
proliferation, which has also been shown elsewhere (Liu and Roth, 1995). On the other hand, 
our group has previously demonstrated that Grb10m/+ animals do not owe their overgrowth 
phenotype to altered Igf signalling (Charalambous et al., 2003; Garfield, 2007). Additionally, 
a variety of studies have shown that Grb10 overexpression causes phosphorylation changes of 
several downstream signalling proteins, such as Akt and PI3K (Holt and Siddle, 2005), 
suggesting that Grb10 inhibits cell proliferation through yet unknown pathway. Furthermore, 
two recent studies identified Grb10 as a substrate of mTOR, a cellular enzyme called 
mechanistic (or mammalian) target of rapamycin responsible for regulation of cell growth and 
division, and implicated as an important drug target in cancer (Hsu et al., 2011; Yu et al., 2011). 
Both reports provided evidence for Grb10 as a participant in a negative feedback loop in which 
mTORC1, activated downstream of insulin or IGFs, phosphorylates Grb10 and enhances its 
ability to inhibit signals from IGF and insulin receptors (Hsu et al., 2011; Yu et al., 2011), 
a mechanism which complements an already established feedback pathway, with S6K1 
phosphorylating IRS and targeting it for degradation.  
In the present study we have used FACS to analyse cell size by looking at forward scatter, 
with cells separated into four different size gates. We found that the apparent overgrowth 
phenotype in Grb10m/+ and Grb10m/+/Dlk1+/p embryos could not be obviously associated with 
an increased cell size at the embryonic stage of E11.5, as the cells acquired from knockout 
embryos did not differ from wild type controls. The same negative result was obtained during 
FACS analysis of cell size in Grb10m/+ and Grb10m/+/Dlk1+/p E14.5 pMEFs, which is consistent 
with previous results provided for Grb10m/+ cultures (Garfield, 2007). These results need to be 
interpreted with care and their analysis repeated using similar gating method as the one used 
for analyses of cell cycle phases, as gating of the cells for the cell size analysis allowed for 
excluding the debris from the experiment but did not distinguish between singlet and dublet 
cells, which could have had a great impact on the obtained results.  
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Our finding of significantly increased proliferation rates in E14.5 Grb10m/+/Dlk1+/p pMEFs is 
also in line with earlier studies of Grb10m/+. Moreover, as the Grb10m/+/Dlk1+/p E14.5 pMEFs 
hyperproliferative phenotype is similar, or even more pronounced than the one previously 
observed for Grb10m/+ fibroblasts, we can conclude that Grb10 and Dlk1 genes might be indeed 
acting in the same genetic pathway to regulate proliferation rates in embryonic cells, 
consistent with the hypothesis we have proposed. Certainly, Grb10m/+/Dlk1+/p E14.5 pMEFs 
growth rates are not exhibiting an additive phenotype between Grb10m/+ and Dlk1+/p knockout 
cells, which provides evidence against the possibility of these two genes acting independently 
in two distinct genetic pathways to control proliferation. 
A hyperproliferative phenotype can be associated with alterations to the normal cell cycle, 
specifically with more rapid cell cycle progression. For that reason we have employed FACS to 
analyse cell cycle kinetics in Grb10m/+/Dlk1+/p E14.5 pMEFs and compare them to single 
knockout cells and wild type controls. No alterations were detected in the G1-phase of the cell 
cycle for any of the analysed genotypes, indicating that the observed hyperproliferative 
phenotype in Grb10m/+ and Grb10m/+/Dlk1+/p cultures was not due to a role for Grb10 in the 
transition from G1- to S-phase, a result also consistent with a previous study (Morrione et al., 
1997). We found that the most likely reason for increased proliferation rates in Grb10m/+ and 
Grb10m/+/Dlk1+/p cells lies within changes in the S- and G2-phases of cell cycle. Significantly 
lower Grb10m/+ and Grb10m/+/Dlk1+/p cell numbers were observed in S-phase, with 
a concomitant significantly increased accumulation of cells in G2-phase.  
The progression of cells through the division cycle is controlled by a variety of extracellular 
signals from the environment, such as growth factors, as well as by a number of internal 
signals that act to regulate the processes that take place within particular cell cycle phases 
(Malumbres and Barbacid, 2009). In addition, the complex cellular processes that take place 
within different phases of cell cycle, such as cell growth, DNA replication and mitosis, must be 
coordinated during cell cycle progression. This is accomplished by a series of control points 
that regulate progression through various phases of the cell cycle (Kastan and Bartek, 2004). 
During S-phase of the cell cycle the precise replication of the entire DNA content of the 
nucleus must take place, usually within a period of several hours. The length of S-phase differs 
not only between species, but also between different developmental stages within a species, 
however within the same type of cell the duration of S-phase is usually consistent (Cooper, 
2000). Following completion of DNA synthesis the G2-phase takes place, during which cell 
growth and protein synthesis continues before mitosis (Norbury and Nurse, 1992). FACS 
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analysis allowed us to distinguish cells within different stages of the cell cycle by analysing 
changes in their DNA content, however it did not specify if the elongated G2- phase indicates 
that more Grb10m/+ and Grb10m/+/Dlk1+/p cells are undergoing mitosis. In order to clarify this 
issue, for example MPM-2 or phospho-Histone H3 antibodies could be used as markers for 
mitosis during FACS analysis in the future.  
Morrione et al (1997) conducted in vitro experiments to investigate the effects of Grb10 
overexpression on cell proliferation. They have found that excess Grb10 resulted in a delay in 
the S- and G2-phases of the cell cycle upon Igf1 stimulation. It would appear that, as found in 
the present study, decreased numbers of Grb10m/+ and Grb10m/+/Dlk1+/p cells within S-phase 
are indicative of more rapid progression through the S-phase of the cell cycle, and as 
a consequence of a reduced likelihood of detection of the cell in this phase of the cell cycle 
during FACS analysis. It seems that Grb10 is able to affect only the S- and G2-phases, in 
contrast to Igf1r which has been found not to be specific to these phases of the cell cycle (Sell 
et al., 1994), which falls in line with previous findings of Grb10 growth regulation being 
independent of IGF pathway (Charalambous et al., 2003; Garfield, 2007). 
Usually shorter G1- and/or G2-phases of cell cycle or shorter cell cycle in general are 
thought to initiate an increase in cell proliferation, so it is rather difficult to explain the 
observed hyperproliferative phenotype without more detailed analysis of each of the cell cycle 
phases, together with total cell cycle length. The fact that the same effects on S-phase of cell 
cycle phase has been reported previously in Grb10m/+ cells is, however reassuring that the 
hyperproliferation and shorter S-phase of cell cycle are real consequences of a lack of Grb10 
activity. Thus, it would be of interest to examine the basis of increased pMEFs growth by 
studying the length of each of the cell cycle phases together with overall cell cycle duration by 
using FACS analysis. Variations of cell labelling experiments could be used to determine the 
length of different stages of the cell cycle, for example cells in S-phase could be identified 
because they incorporate radioactive thymidine, which is used exclusively for DNA synthesis.  
Our analysis of the embryonic phenotype of Grb10m/+/Dlk1+/p animals and in vitro study of 
Grb10m/+/Dlk1+/p pMEFs cultures provides evidence supporting the hypothesis of an epistatic 
and antagonistic relationship between the Grb10 and Dlk1 genes in regulation of embryonic 
growth. The resemblance of the growth phenotype between Grb10m/+ and Grb10m/+/Dlk1+/p 
animals during early development indicates that Grb10 influences growth by acting as 
an inhibitor downstream of Dlk1 at this developmental stage. These results, however, are 
complicated by 4 different genotypes obtained in each cross and the use of the Grb10m/+ 
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mothers in all the crosses, which are known to have altered body composition and glucose 
metabolism (more lean tissue mass and improved glucose tolerance), which could have an 
effect on the developing progeny during gestation and interfere with identifying the real 
effects of the Dlk1 and Grb10 ablation on embryos and their placentae. However, female mice 
with paternal transmission of Grb10 deletion (exhibiting normal body composition and glucose 
homeostasis but different social behaviour) could not be used in generation of our crosses as 
we aimed for maternal Grb10 and paternal Dlk1 ablation in our double knockout mice. On the 
other hand, homozygous mothers could be used if we wanted to reduce the number of 
obtained offspring genotypes from 4 to 3 which could be beneficial during statistical analyses 
and because we were mostly interested in comparing our double knockout mice to Dlk1+/p and 
Grb10m/+, and this type of cross generation should be considered during future investigation. It 
also needs to be taken into account that overgrowth of Grb10m/+/Dlk1+/p embryos might be 
consequence of double mutant placentae being much more efficient in supplying nutrients and 
subsequently leading to overgrown double mutant embryos similar to Grb10m/+. Therefore, 
there is a need to analyse the morphology and efficiency of the transport systems within the 
Grb10m/+/Dlk1+/p placentae that will aid to clarify the nature of the observed Grb10m/+/Dlk1+/p 
embryonic overgrowth.  
Further experiments, including Western Blot analysis of whole embryos from various 
developmental stages and double Grb10 and Dlk1 antibody staining will be useful in identifying 
the details of possible Grb10 and Dlk1 interaction and will provide more information on their 
mode of action during embryonic growth and development. Western Blots would help to 
delineate specific changes in the expression of Grb10 in Dlk1+/p animals and Dlk1 in 
Grb10m/+mice and clarify the relevance of our hypothesis of them interacting in the same 
genetic pathway, however so far attempts of Western Blot analysis on whole embryos and 
embryonic livers proved unsuccessful due to unspecific binding of the used antibodies, and this 
solving this issue in the future would be necessary in supporting the hypothesis of Grb10 and 
Dlk1 interaction. Also the antibody staining experiments (especially in whole embryos and in 
organs with known, well-pronounced expression of both Grb10 and Dlk1, e.g. liver) could be 
informative of altered expression associated with forming a part of the same genetic pathway 
in specific tissues and stages of development. Results from this chapter imply that Dlk1 might 
indeed be acting upstream of Grb10 which in turns is inhibiting embryonic growth, as the data 
from the allometric study of the embryos and placentae of three developmental stages show 
that the growth phenotype of Grb10m/+/Dlk1+/p mice is similar to that observed in Grb10m/+. In 
addition, the increased growth rates of E14.5 pMEFs have been confirmed in Grb10m/+/Dlk1+/p 
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and Grb10m/+ cells along with shortened S-phase and elongated G2-phase in E11.5 embryonic 
cells and E14.5 pMEFs from these two genotypes, findings that could also point at Dlk1-Grb10 
interactions in regulation of cell proliferation during embryonic development. Analysis of 
Grb10m/+/Dlk1+/p placental morphology and any potential physiological changes within this 
crucial site of nutrient exchange between mother and offspring is under way. We hope it will 
give us an insight into, primarily, the effects of combined lack of Grb10 and Dlk1 genes on 
normal placental function and additionally will be informative of the role of Dlk1 in the 
placenta on its own, as there is a shortage of studies on Dlk1 knockout placentae until now. In 
addition, more precise experiments, particularly study of total cell number in embryos at E11.5 
and earlier using the FACS analysis method described by Burns and Hassan (2001) will be 
employed in order to shed more light on the basis of the Grb10m/+ and Grb10m/+/Dlk1+/p 
overgrowth phenotype.  
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CHAPTER 4 
4 Postnatal characterisation of Grb10m/+/Dlk1+/p double 
knockout mice 
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4.1 Introduction 
Adult diseases, for example metabolic complications such as diabetes or obesity, can be 
consequences of disproportionate growth of tissues during embryonic and postnatal 
development (Eriksson et al., 2003). A range of maternal characteristics, including type of diet, 
body composition, stress levels and fitness contribute to reaching appropriate body size and 
proportions (Victora et al., 2008; George et al., 2010), although mouse genetic studies have 
unequivocally implicated several genes that play crucial roles in controlling this process. There 
is rather poor understanding of the function of mother-offspring genetic interactions affecting 
correct growth and adult health status. The on-going arguments over the explanation for the 
existence of genomic imprinting do not undermine the vital role of this phenomenon in both 
pre- and post-natal development, as in mammals imprinted genes involved in nutrient 
acquisition through the placenta have been shown to play a part in fetal programming.  
Opposing interests of parental genomes over allocation of maternal resources are 
frequently considered to be among selective pressures that resulted in evolution of imprinting. 
Throughout gestation, paternally expressed are genes usually thought to increase the level of 
nutrient supply or demand required for embryonic development, in contrast to maternally 
expressed imprinted genes with an opposite function. Consequently, reciprocal interests of 
parental genomes could also explain the ability of imprinted genes to disrupt the interaction 
between mother and pre-weaning offspring due to persisting dependence of mammalian 
offspring on maternal resources up to this stage of development. Postnatal regulation of 
resource acquisition by imprinted genes might be based on control of milk release in the 
mother or regulation of sucking behaviour in the offspring. After weaning, imprinted genes 
might also function to allocate the resources acquired by the offspring into growth, deposition 
of adipose tissue and other processes involved in the maintenance of homeostasis, like 
regulation of glucose metabolism and body temperature, as fetal and postnatal growth and 
metabolism are linked and frequently regulated by the same genetic pathways. It has been 
shown that a number of adult disorders result from impairment in normal embryonic 
development and epigenetic regulation of the metabolic gene network has been linked to in 
utero availability of nutrients (reviewed in Waterland and Jirtle, 2004).  
Various mouse genetic studies suggested a role for imprinted genes in regulation of 
postnatal relationship between mother and offspring (Isles et al., 2002; Hager and Johnstone, 
2003), but their physiological roles in maternal behaviour and offspring growth have been first 
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exemplified by knockout experiments of two paternally expressed genes: Peg1 and Peg3 
(Lefebvre et al., 1998; Li et al., 1999). Both acting as potent growth enhancers, they were 
found to control maternal care, including placentophagia, nest-building, and pup gathering. 
Disruption of Peg3 resulted in mice with reduced growth and difficulties with suckling and 
thermoregulation which led to delayed weaning and puberty (Curley et al., 2004), while 
mothers with Peg3 paternal knockout were deficient in milk secretion caused by reduced 
numbers of oxytocin-producing neurons in hypothalamus (Li et al., 1999). Due to Peg3 having 
previously been implicated in controlling maternal behaviour in adult females, it seems that 
proper maternal care and ability to extract resources by offspring are an example of 
coadaptation at this locus.  
An imprinted Gnas cluster, able to produce various proteins by using alternative 
promoters and initial exons splicing onto a group of downstream exons (Holmes et al., 2003), 
generates the G-protein α subunit (Gsα) and paternally expressed, neuroendocrine-specific 
Gsα isoform XLα. They both have been found to exert reciprocal effects on metabolism, as 
Gnasxlα paternal knockout mice displayed an insulin-sensitive, lean phenotype (Plagge et al., 
2004) and mice with paternal deletion of Gsα exon 1 showed insulin resistance and obesity 
(Chen et al., 2005). Mice with Gnasxlα paternal knockout were growth retarded upon birth, 
which led to an increased rate of lethality (Plagge et al., 2004). Moreover, these animals 
showed a disrupted suckling ability confirmed by identification of Gnasxlα in sites of the brain 
that are responsible for motor innervation of the orofacial, jaw and tongue muscles (Plagge et 
al., 2004). 
Interestingly, our lab has recently discovered that Grb10, with already recognised roles in 
regulating mother-offspring interaction during gestation (Charalambous et al., 2010), might 
also be acting to promote mother-offspring coadaptation postnatally. Our investigation 
focused on Grb10 imprinting in mammary gland, an organ crucial in postnatal nutrient 
acquisition and a site of conflict over maternal resources. We have found that imprinted Grb10 
in mammary gland throughout pregnancy and lactation is able to control nutrient supply and 
postnatally nutrient demand, regulating the size of the offspring (Cowley et al., submitted). 
Interestingly, maternal Grb10 has been found to exert effects on adiposity whereas Grb10 in 
the offspring controlled lean tissue content. These findings support a role for Grb10 in 
influencing mother-offspring coadaptation to optimise fitness of the progeny, as achieving 
correct body proportions and fat/lean ratio requires functional Grb10 in both mother and pup 
(Cowley et al, submitted). The capacity for Grb10 to control postnatal nutrient supply and 
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demand and subsequently to influence body composition and proportions highlights its role in 
connecting early development and postnatal health status through fetal programming.  
Generation of Grb10m/+ knockout animals by our lab allowed for an investigation of the 
in vivo role of the Grb10 gene in not only early stage development but also in postnatal life. 
Neonatal Grb10m/+ animals were 36% heavier than their wild type counterparts and their 
organs (including hearts, lungs and kidneys) were also proportionally enlarged with the 
exception of the liver and brain in which disproportionate overgrowth and sparing have been 
noted, respectively (Charalambous et al., 2003). The total body overgrowth effect decreased 
during postnatal life and by 6 months of age, Grb10m/+ knockout animals were only 13% 
heavier than wild types (Smith et al., 2007). Weights of a cohort of animals were monitored 
from birth for 80 days, which revealed that the weight difference between Grb10m/+ knockout 
and wild type mice diminished mainly during the post-weaning period. It was also noted that 
that relative weights of abdominal and renal fat pads in Grb10m/+ knockout mice of both sexes 
were significantly reduced in size when compared to wild type littermates (Smith et al., 2007). 
These results indicate a crucial role for Grb10 in the regulation of postnatal growth and 
development. In support of that, a model studying the effects of overproduction of Grb10 has 
been provided by Shiura et al (2005). Although the described study has not proven useful in 
delineating the effects of Grb10 in embryonic growth control due to poor Grb10 transgene 
expression during fetal development, mice overexpressing Grb10 postnatally displayed growth 
retardation commencing from the age of 4 weeks, with a 10-15% decrease in weight when 
compared to wild type controls at the age of 4 months (Shiura et al., 2005). However, these 
results should be interpreted with care, as the ectopic postnatal overexpression of Grb10 in 
several organs such as liver, skeletal muscle and adipose tissue might have contributed to the 
observed phenotypes, producing artifactual effects. 
In addition to the mouse phenotypes resulting from modifications of the expression of 
the Grb10 gene situated on chromosome 11, mutations encompassing human chromosome 
7 (which includes GRB10) have been implicated in the aetiology of Silver-Russell Syndrome 
(SRS) and several other conditions associated with growth restriction phenotypes (Kotzot et 
al., 1995). A number of observations have highlighted the potential role for GRB10 as a cause 
of this disorder, especially that a group of SRS patients has been found to exhibit maternal 
duplication of the region including the GRB10 locus (Joyce et al., 1999; Yoshihashi et al., 2000) 
and, in support of that, a recent publication described a family carrying a maternally inherited 
duplication of chromosome 7 not including GRB10 and without SRS (Leach et al., 2007). 
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Nevertheless, several studies have argued against a role for GRB10 in this syndrome and up 
until now various screening studies failed to provide evidence for either point mutations in the 
coding region or aberrant methylation of GRB10 in Silver-Russell syndrome patients 
(Mergenthaler et al., 2001; Arnaud et al., 2003; Monk et al., 2003). Currently the most 
common epimutations and mutations found in SRS patients are associated with chromosomal 
region 11p15, with hypomethylation at the telomeric H19 imprinting control region believed to 
result in IGF2 downregulation, which has been found in 38-63% of SRS cases (reviewed in 
Eggermann et al., 2010). The underlying causes of hypomethylation are unknown in the 
majority of cases, however in some instances they have been found to be based on mosaic 
maternal uniparental disomy of chromosome 11 (Bullman et al., 2008), maternal duplication of 
11p15 (Eggermann et al., 2011) and potentially gene mutations of H19-ICR (Demars et al., 
2011). 
Moon et al (2002) were the first to report that mice lacking the paternal allele of the 
Dlk1 gene showed pre- and post-natal growth retardation. Growth restriction of around 20% 
was shown to persist until weaning in both male and female mice. The authors also fed 
knockout mice on a high fat diet in order to investigate the effect that a lack of Dlk1 might 
have on overall weight and adipose tissue content. At 65 days in males and 95 days in females 
differences in total body weight between wild type and Dlk1 knockout mice were no longer 
evident. The catch-up in body weights of Dlk1 knockout mice has been linked to increased 
adipose tissue mass in these animals. At the age of 8 weeks, weights of white fat pads 
(including inguinal, retroperitoneal and gonadal fat pads) in Dlk1 knockout mice were not 
different to wild types. However, at 16 weeks of age, and after feeding on a high fat diet for 13 
weeks, a significant increase in relative fat pad weights have been noted for both male and 
female Dlk1 knockout mice. Weights of other organs, including kidneys, pancreata, lungs and 
thymus stayed persistently smaller than wild type, whereas livers were reported to be 
significantly enlarged with increased total lipid content in both sexes (Moon et al., 2002).  
The importance of Dlk1 in perinatal survival has been highlighted by an increased 
incidence of lethality in Dlk1 knockout mice (Moon et al., 2002), as approximately 50% of them 
died within 2 days from birth. Several skeletal malformations were also reported in Dlk1 
knockout mice, including asymmetrical junction of ribs to sternum and fusion of ribs in 
embryos and mice that died within 2 days from birth. The authors suggested that these 
problems, leading to defects including poor suckling ability, as well as pulmonary 
abnormalities, might be the reasons for the low survival rate in Dlk1 knockout mice. They also 
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described numerous cases of eyelid abnormalities that resembled the malformations detected 
in individuals with blepharophimosis. Blepharophimosis has been reported in people with 
deletions of 14q32 that encompass the DLK1 locus, as well as in patients with mUPD14 
(Yamamoto et al., 1986; Sutton and Shaffer, 2000). Human mUPD14 results in clinical features 
that also include pre- and post-natal growth retardation, hypotonia, mild facial abnormalities 
and early onset of puberty. The phenotypic characteristics of patients with pUPD14 range from 
an almost normal phenotype to a rather severe condition that involves facial anomalies, 
a small, bell-shaped thorax with rib deformities and associated respiratory insufficiency, and 
mental retardation that varies in severity (Georgiades et al., 1998; Sutton and Shaffer, 2000; 
Kagami et al., 2005; Kagami et al., 2008). Interestingly, some of these feature including skeletal 
abnormalities and pulmonary defects, are similar to the phenotypic characteristics observed in 
Dlk1 knockout mice (Moon et al., 2002).  
Dlk1 shares a structural similarity with members of the Delta/Notch family of 
membrane-associated receptors and ligands involved in cell signalling and cell fate 
determination, however, it lacks the DSL domain conserved between most of the Notch 
ligands to allow for receptor-ligand interaction for Notch. So far there is no evidence of direct 
interaction between biologically active Dlk1 and Notch (Baladron et al., 2005; D'Souza et al., 
2008). Moreover, there are also contradictory reports regarding Dlk1 effects on expression of 
Hes-1, a downstream target of Notch (Kaneta et al., 2000; Ross et al., 2004). The most likely 
prediction for Dlk1 action is that it functions by binding to one or more as yet unknown 
interacting proteins/receptors that probably contain EGF-repeats to facilitate protein-protein 
interactions (see Section 1.3.1). Identification of the Dlk1 interacting partner(s) and clear 
establishment of its biochemical and functional interaction with Dlk1 are necessary in 
elucidating Dlk1 action. Lack of any obvious correlation of Dlk1 with the IGF-pathway, distinct 
growth phenotype of Dlk1 knockout mice and the onset of clinical features present in UPD14 
patients all indicate a signalling role for Dlk1 in an IGF-independent mitogenic axis.  
The expression sites of Grb10 in adult mice encompass primarily insulin-responsive 
tissues, such as skeletal muscle, adipose tissue and endocrine cells of the pancreas, which is in 
agreement with a role for Grb10 in mediating insulin signalling (discussed in more detail in 
Chapter 5). Other sites of Grb10 expression include the Leydig cells of the testes, the oviduct 
and uterine horns of the female reproductive system, and some cell populations of the CNS 
(Smith et al., 2007; Garfield et al., 2011). Expression of Dlk1 in adulthood is also restricted, 
being most prominent in preadipocytes, β-cells of islets of Langerhans, testes, pituitary and 
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adrenal glands as well as in monoaminergic neurons in the CNS (Tornehave et al., 1993; Jensen 
et al., 2001; Yevtodiyenko and Schmidt, 2006).  
Given the substantial roles of both of the imprinted Grb10 and Dlk1 genes in fetal 
growth and development and their evident importance in adult metabolic homeostasis, 
together with the fact that they both appear to act in an IGF-independent manner, the idea of 
a potential interaction between these two genes seems plausible. To investigate this further 
and gain more knowledge about the postnatal effects that result from a lack of both the Grb10 
and Dlk1 genes, we have analysed postnatal growth of Grb10m/+/Dlk1+/p double knockout mice 
and compared them to wild type and single knockout littermates. Should an interaction 
between Grb10 and Dlk1 be a part of the same genetic pathway, it would be predicted that 
Grb10m/+/Dlk1+/p double mutants would be phenotypically similar to one of the single 
knockouts.  
In this chapter, analyses of various aspects of the postnatal phenotypes of 
Grb10m/+/Dlk1+/p double knockout mice are presented and compared to wild type, Grb10m/+ 
and Dlk1+/p animals. Following on from investigations of prenatal growth discussed in the 
previous chapter, allometric analyses of neonatal and adult mice have been performed. 
Several organs have also been investigated in detail, either histologically or morphometrically, 
these included kidneys, bones and lungs. Through these analyses we hoped to gain more 
knowledge about the role of Grb10, Dlk1 and their potential to interact during postnatal life in 
mice. 
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4.2 Results 
4.2.1 Characterisation of neonatal Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p mice. 
It has been previously reported that loss of the Grb10 gene resulted in significant 
overgrowth of neonatal mice (Charalambous et al., 2003), whereas lack of the Dlk1 gene 
caused a reciprocal effect, as Dlk1 knockout mice displayed significant growth retardation on 
the day of birth (Moon et al., 2002). By characterising the growth of neonatal Grb10m/+/Dlk1+/p 
double knockout animals, along with histologically and morphometrically examining several 
tissues, we aimed to study the effects of loss of both of these genes and test the hypothesis 
that the two genes work in the same genetic pathway.  
4.2.1.1 Body and organ weight analysis 
Neonatal mice of all four genotypes were sacrificed by decapitation and their total body 
weights were recorded. Additionally, the wet weights of organs including livers, brains, 
kidneys, lungs and hearts were noted (Figure 4.1). The weights of all analysed organs were also 
expressed as percentages of total body weights (Figure 4.2).  
As expected, Dlk1+/p knockout mice were significantly smaller than wild type mice  
whilst Grb10m/+ knockout mice were significantly overgrown on the day of birth (Figure 4.1 A). 
Grb10m/+/Dlk1+/p double knockout mice were similar in weight to Grb10m/+ single knockouts, 
also displaying a significantly overgrown phenotype. Analysis of organ wet weights showed 
that livers, brains, lungs and hearts were also significantly enlarged in Grb10m/+and 
Grb10m/+/Dlk1+/p double knockout mice, with kidney weights remaining comparable between 
all the genotypes.  
When all the organ weights were expressed as percentages of total body weights (Figure 
4.2), sparing of the brain and of kidneys was seen in Grb10m/+ and Grb10m/+/Dlk1+/p double 
knockout neonates, whereas livers in mice of these genotypes were disproportionately 
overgrown. In contrast, the weights of hearts and lungs changed in proportion to total body 
weights in animals of all analysed genotypes, as no differences were noted in the relative 
weights of these organs. 
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4.2.1.2 Histological and morphometric analyses 
Following the previous reports of neonatal death in some Grb10m/+mice that was 
associated with blood filled lung alveoli (Charalambous et al., 2003) and pulmonary defects 
noted in Dlk1 knockout mice (Moon et al., 2002), we performed histological analysis on H&E 
stained neonatal lungs (Figure 4.3). Histological examination indicated slightly increased 
thickness of lung epithelial walls in both Grb10m/+and Grb10m/+/Dlk1+/p knockout mice. To 
confirm this observation, morphometric analysis of neonatal lungs was carried out (as 
described in Section 2.4.8; Figure 4.4), revealing that indeed, Grb10m/+ and Grb10m/+/Dlk1+/p 
neonatal mice had significantly thicker epithelial walls than both Dlk1+/p and wild type mice. 
Due to the clear weight differences between mice of all analysed genotypes, one 
obvious issue was to consider the growth effects on the skeletons of neonatal animals. Skeletal 
malformations were previously reported in Dlk1 knockout mice (Moon et al., 2002) and its 
soluble form Fetal Antigen-1 (FA1) has been identified as a novel endocrine factor regulating 
bone and fat mass in vivo along with chondrocyte differentiation (Abdallah et al., 2007; Chen 
et al., 2011). A recent study of gene expression in growth plate in rats revealed that the 
expression of imprinted gene network, including Grb10 and Dlk1, unsurprisingly changes from 
the date of birth and towards adulthood(Andrade et al., 2009), which might imply the 
contribution of a number of imprinted genes in postnatal growth deceleration. As the 
expression of Grb10 in bone has not been investigated previously, we decided to employ LacZ 
staining in order to track the expression Grb10 in neonatal bones of Grb10 knockout mice that 
incorporate a β-galactosidase reporter gene within the endogenous Grb10 locus (Figure 4.5). 
Grb10 expression was detected in growth plates of developing neonatal Grb10m/+and 
Grb10m/+/Dlk1+/p bones, indicating a possible role for Grb10 in growth of long bones during 
skeletogenesis.  
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Figure 4.1 Whole body and organ wet weight analysis of wild type, Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p neonates.  
A) Dlk1+/p mice were significantly growth retarded (***p<0.001) whereas Grb10m/+ and 
Grb10m/+/Dlk1+/p animals demonstrated whole body overgrowth (***p<0.001) when compared 
to wild type and Dlk1+/p mice. B) Grb10m/+ and Grb10m/+/Dlk1+/p mice had overgrown brains 
when compared to wild type (*p<0.05) and Dlk1+/p (***p<0.001) animals. C) Significant 
enlargement of the livers was noted in Grb10m/+ and Grb10m/+/Dlk1+/p mice compared to wild 
type (***p<0.001) and Dlk1+/p (***p<0.001) animals. D) Significant overgrowth of kidneys has 
been noted in Grb10m/+/Dlk1+/p mice compared to Dlk1+/p (*p<0.05). E) Significant enlargement 
of the lungs was observed in Grb10m/+ and Grb10m/+/Dlk1+/p mice compared to wild type 
(***p<0.001) and Dlk1+/p (***p<0.001) animals. F) Grb10m/+ and Grb10m/+/Dlk1+/p mice 
exhibited significantly enlarged hearts compared to wild type (***p<0.001) and Dlk1+/p 
(***p<0.001) animals. G) Table summarising results of statistical analysis. All values represent 
means ± SEM, analysed using one way ANOVA with Tukey’s post-hoc analysis. WT n=19, Dlk1+/p 
n=36, Grb10m/+ n=23, Grb10m/+/Dlk1+/p n=22. 
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Figure 4.2 Whole body and relative organ weight analysis of wild type, Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p neonates.  
A) Dlk1+/p mice were significantly growth retarded (***p<0.001) whereas Grb10m/+ and 
Grb10m/+/Dlk1+/p animals demonstrated whole body overgrowth (***p<0.001) when compared 
to wild type and Dlk1+/p mice. B) Cranial sparing was seen in Dlk1+/p mice in Grb10m/+ compared 
to wild type (***p<0.001) and Dlk1+/p (***p<0.001) mice and similar results were seen in 
Grb10m/+/Dlk1+/p animals compared to Dlk1+/p mice (***p<0.001); Dlk1+/p had enlarged brains in 
comparison to wild type mice (***p<0.001) C) Grb10m/+ and Grb10m/+/Dlk1+/p mice had 
disproportionally overgrown livers when compared to wild type (***p<0.001) and Dlk1+/p 
(***p<0.001) animals. D) Kidney sparing was seen in Grb10m/+ compared to wild type 
(***p<0.001) and Dlk1+/p (***p<0.001) mice and opposite growth effect was seen in Dlk1+/p 
(***p<0.001) animals. E) Proportionate growth of hearts was seen in all the analysed 
genotypes. F) Overgrowth of lungs was noted in Dlk1+/p mice compared to wild type (*p<0.05) 
mice. G) Table summarising results of statistical analysis. All values represent means ± SEM, 
analysed using one way ANOVA with Tukey’s post-hoc analysis. WT n=19, Dlk1+/p n=36, 
Grb10m/+ n=23, Grb10m/+/Dlk1+/p n=22. 
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Figure 4.3 H&E stained neonatal lungs of wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p 
mice under 100x magnification with 400x magnification insets in bottom right corners . 
Thickened epithelial walls were noticed in Grb10m/+ and Grb10m/+/Dlk1+/p lungs while Dlk1+/p 
lungs appeared to display normal histology. The presented images are representative sections 
for each of the analysed genotypes. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 and Grb10m/+/Dlk1+/p n=5. 
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Figure 4.4 Comparison of epithelial wall thickness in neonatal wild type, Dlk1+/p, Grb10m/+ 
and Grb10m/+/Dlk1+/p mice. 
A) Morphometric analysis of the epithelial walls thickness revealed a significant increase in 
thickness in neonatal Grb10m/+ (*p<0.05) compared to wild type mice and Grb10m/+/Dlk1+/p 
(***p<0.001) compared to wild type and Dlk1+/p mice, with no differences in Dlk1+/p lungs 
compared to wild type. B) Table summarising results of statistical analysis. All values represent 
means ± SEM, analysed using one way ANOVA with Tukey’s post-hoc analysis. WT n=5, 
Dlk1+/p=5, Grb10m/+ n=5 and Grb10m/+/Dlk1+/p n=5. 
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Figure 4.5 LacZ stained neonatal wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p femur 
bones under 40x magnification. 
LacZ (blue) staining was detected in Grb10m/+ and Grb10m/+/Dlk1+/p neonatal bones, specifically 
in growth plates and muscle tissue adjacent to the long bones. The images show the distal 
growth plate (GP) of the femur, with associated muscle (M) and in some cases the knee joint 
and adjacent growth plate of the tibia. Presented images show representative sections for 
each of the analysed genotypes. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 and Grb10m/+/Dlk1+/p n=5. 
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4.2.2  Characterisation of 1-2 week old Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p mice. 
4.2.2.1 Body and organ weight analysis 
To investigate if the identified body weight differences detected at birth would persist 
into postnatal life we next analysed wild type, Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p mice at 
1 week after birth. We compared their body weights and also performed an analysis of liver 
weights (Figure 4.6), as it was the organ exhibiting the most pronounced overgrowth 
immediately after birth. At 1 week of age, persistent overgrowth was seen in Grb10m/+ and 
Grb10m/+/Dlk1+/p knockout mice. Wet weights of the Grb10m/+ and Grb10m/+/Dlk1+/p livers also 
stayed significantly elevated until this stage. However, when liver weights were expressed as 
percentages of the total body weights, no significant differences between the genotypes were 
found, indicating a shift from the disproportional overgrowth seen at birth to a proportional 
increase in liver weight in Grb10m/+ and Grb10m/+/Dlk1+/p mice.  
4.2.2.2 Investigation of possible skeletal anomalies 
Prompted by the previous report of skeletal abnormalities in Dlk1 knockout mice (Moon 
et al., 2002), we observed that one particular litter of mice at 2 weeks of age consisted of 
individual animals notably different from normal in length and appearance (Figure 4.7). Upon 
sacrifice, Alcian Blue/Alizarin Red bone and cartilage staining was carried out on animals from 
this litter to identify any potential skeletal malformations. Defects previously described for 
Dlk1 knockout mice included asymmetrical attachment of ribs to the sternum, fusion of ribs 
and also fusion of the vertebrae. In Figure 4.8 the carcasses of Alcian Blue/Alizarin Red stained 
2 week old mice are presented. Except for the previously noted significant overgrowth (in the 
case of Grb10m/+ and Grb10m/+/Dlk1+/p animals) and growth retardation (in the case of Dlk1+/p) 
no other differences were evident in the bone and cartilage of analysed skeletons.  
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Figure 4.6 Whole body, liver wet weight and relative liver weight analysis of wild type, 
Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p 1 week old mice. 
A) Significantly increased body weights were noted in Grb10m/+ compared to wild type 
(*p<0.05) and Dlk1+/p (*** p<0.001) and in Grb10m/+/Dlk1+/p compared to Dlk1+/p (* p<0.05) 
mice whereas weights of Dlk1+/p animals did not differ from wild types. B) Analysis of wet 
weights of the livers revealed significant enlargement in Grb10m/+ compared to wild type 
(*p<0.05) and Dlk1+/p (***p<0.001) mice and in Grb10m/+/Dlk1+/p compared to Dlk1+/p (*p<0.05) 
animals. C) No differences were found in relative liver weights. D) Table summarising results of 
statistical analysis. All values represent means ± SEM, analysed using one way ANOVA with 
Tukey’s post-hoc analysis. WT n=10, Dlk1+/p n=9, Grb10m/+ n=15, Grb10m/+/Dlk1+/p n=8. 
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Figure 4.7  2 week old mice exhibiting potential skeletal anomalies, including wild type, 
Dlk1+/p. Grb10m/+ and Grb10m/+/Dlk1+/p animals.  
Genotypes of mice presented in top picture, from left to right: Dlk1+/p, Grb10m/+, Dlk1+/p, wild 
type, Dlk1+/p and Grb10m/+/Dlk1+/p. Bottom pictures show comparison in appearance of 
Grb10m/+and Dlk1+/p mice. There were evident size differences between the two genotypes, 
along with associated differences in posture. 
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Figure 4.8 Alcian Blue/ Alizarin Red stained 2 weeks old carcasses of wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p mice. 
Analysis of carcasses of 2 weeks old wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p mice with previously noted abnormal growth/posture (as presented in 
Figure 4.7) revealed no obvious differences in skeletal components, including the ribs and sternum previously reported to be affected in Dlk1 knockout mice 
(Moon et al., 2002). 
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4.2.3 Characterisation of adult Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p 
mice. 
4.2.3.1 Body and organ weight analysis 
Given the previously described effects of ablation of the Dlk1 and Grb10 genes on growth 
at the early stages of postnatal development, further investigation of growth in 3-6 month old 
as well as 7-9 month old mice of both genders was performed. Total body weights along with 
wet weights of several organs were analysed. Relative organ weights (expressed as 
percentages of total body weights) were also studied.  
Results obtained for 3-6 month male animals are presented in Figures 4.9 and 4.10. There 
were no appreciable differences in whole body weights but a significant increase in wet 
weights of pancreas was noted in Grb10m/+ and Grb10m/+/Dlk1+/p when compared to Dlk1+/p 
(Figure 4.9). Significantly smaller testes were a feature found in Dlk1+/p mice when compared 
to wild types and Grb10m/+ animals. Additionally, significant reduction in in kidney weights was 
found in Grb10m/+ as well as Grb10m/+/Dlk1+/p mice. Analysis of relative weights (Figure 4.10) 
revealed significantly smaller Grb10m/+and Grb10m/+/Dlk1+/p livers compared to Dlk1+/p along 
with significantly enlarged pancreas weights in Grb10m/+/Dlk1+/p mice and also a similar, but 
non-significant, trend observed in Grb10m/+ mice.  
Whole body weights of 7-9 month male mice did not differ significantly between all 
analysed genotypes (Figure 4.11), but significantly larger testes were observed in Grb10m/+ 
mice when compared to wild type and Dlk1+/p. Significantly smaller kidney weights were noted 
in Grb10m/+ and Grb10m/+/Dlk1+/p animals when compared to wild type controls. Analysis of 
relative organ weights (Figure 4.12) showed significantly smaller kidneys in Grb10m/+and 
Grb10m/+/Dlk1+/p animals, whereas the rest of the analysed organs stayed proportional to total 
body weights.  
Examination of total body and wet organ weights in 3-6 month female mice (Figure 4.13) 
showed significant overgrowth of Grb10m/+ mice when compared to wild type and Dlk1+/p along 
with increased pancreas weights. Significantly smaller gonadal fat pads were observed in 
Grb10m/+/Dlk1+/p mice compared to Dlk1+/p and Dlk1+/p animals had enlarged renal fat pads in 
comparison to all other genotypes. Grb10m/+ also showed significant overgrowth of 
gastrocnemius muscle when compared to wild type and Dlk1+/p. 
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Analysis of relative weights (Figure 4.14) revealed significant overgrowth of pancreas in 
Grb10m/+ and Grb10m/+/Dlk1+/p mice when compared to Dlk1+/p and significantly smaller gonadal 
fat pad mass in Grb10m/+/Dlk1+/p animals which was statistically different to Dlk1+/p. On the 
other hand, the size of renal fat pads of Dlk1+/p was increased and statistically different to wild 
type whilst the size of renal fat pads of Grb10m/+ and Grb10m/+/Dlk1+/p was significantly smaller 
when compared to Dlk1+/p.  
Body weights, and in most cases organ weights, of 7-9 month old female mice did not vary 
significantly between genotypes (Figure 4.15), however pancreas weights of Grb10m/+/Dlk1+/p 
females were significantly higher than those of Dlk1+/p. Grb10m/+ mice displayed significantly 
reduced weights of gonadal fat pads in comparison to wild type animals. Relative pancreas 
weights of Grb10m/+/Dlk1+/p mice were significantly higher than those of Dlk1+/p mice (Figure 
16), but no other significant differences in relative weight were found. 
In summary, we found that several of the analysed organs consistently showed profound 
differences in weights between genotypes, these included pancreata, kidneys, livers, testes 
and fat pads. Among them, largely similar growth trends between Grb10m/+ and 
Grb10m/+/Dlk1+/p mice have been noted in pancreata, kidneys, livers, and fat pads. 
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Figure 4.9 Weight analysis of 3-6 month old male wild type, Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p mice. 
No significant differences were found in A) total body weights and weights of B) livers, D) 
brains, E) gonadal fat pads, F) renal fat pads, I) gastrocnemius muscles, J) masseter muscles 
and K) tongues. C) A significant increase in pancreas weight was noted in Grb10m/+ (*p<0.05) 
and Grb10m/+/Dlk1+/p (**p<0.01) when compared to Dlk1+/p mice. G) Significant testes growth 
reduction was observed in Dlk1+/p when compared to WT mice (***p<0.001) and the 
contrasting result of significant testes overgrowth was noted in Grb10m/+ animals when 
compared to Dlk1+/p (***p<0.001). H) Significant decreases in kidney weights were found in 
Grb10m/+ (*p<0.05) and Grb10m/+/Dlk1+/p (**p<0.01) mice. L) Tables summarising results of 
statistical analysis. All values represent means ± SEM, analysed by one way ANOVA with post 
hoc Tukey’s analysis. WT n=7, Dlk1+/p=6, Grb10m/+ n=6 and Grb10m/+/Dlk1+/p n=6.  
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Figure 4.10 Proportionate weight analysis of 3-6 month old male wild type, Dlk1+/p, Grb10m/+ 
and Grb10m/+/Dlk1+/p mice. 
Weights of whole animals and selected organs were recorded and organ weights expressed as 
a percentage of total body weights. No significant differences were found in weights of C) 
brains, D) gonadal fat pads, E) renal fat pads, F) testes, G) kidneys, H) gastrocnemius muscles, 
I) masseter muscles and J) tongues. A) Both Grb10m/+ and Grb10m/+/Dlk1+/p mice exhibited 
a significant decrease in relative liver weights (*p<0.05) when compared to Dlk1+/p mice. B) 
Significantly elevated relative pancreas mass was noted in Grb10m/+/Dlk1+/p animals which was 
statistically different to Dlk1+/p (**p<0.01). K) Tables summarising results of statistical analysis. 
All values represent means ± SEM, analysed by one way ANOVA with post hoc Tukey’s analysis. 
WT n=7, Dlk1+/p=6, Grb10m/+ n=6 and Grb10m/+/Dlk1+/p n=6.  
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Figure 4.11 Weight analysis of 7-9 month old male wild type, Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p mice. 
Weights of whole animals and selected organs were recorded. No significant differences were 
found in A) total body weights and weights of B) livers, C) pancreata, D) brains, E) gonadal fat 
pads, F) renal fat pads, I) gastrocnemius muscles, J) masseter muscles and K) tongues. G) 
Significantly enlarged testes were observed in Grb10m/+ mice when compared to wild type 
(*p<0.05) and Dlk1+/p (***p<0.001) animals. H) Kidney weights were significantly reduced in 
Grb10m/+ and Grb10m/+/Dlk1+/p mice in comparison to wild type controls (*p<0.05). L) Tables 
summarising results of statistical analysis. All values represent means ± SEM, analysed by one 
way ANOVA with post hoc Tukey’s analysis. WT n=7, Dlk1+/p=6, Grb10m/+ n=6 and 
Grb10m/+/Dlk1+/p n=6. 
134 
 
 
135 
 
  
Figure 4.12 Proportionate weight analysis of 7-9 month old male wild type, Dlk1+/p, Grb10m/+ 
and Grb10m/+/Dlk1+/p mice. 
Weights of whole animals and selected organs were recorded and organ weights expressed as 
percentage of total body weights. No significant differences were found in weights of A) livers, 
B) pancreata, C) brains, D) gonadal fat pads, E) renal fat pads, F) testes, H) gastrocnemius 
muscles I) masseter muscles and J) tongues. G) Grb10m/+ and Grb10m/+/Dlk1+/p mice exhibited 
a significant decrease in kidney weights compared to wild type animals (**p<0.01 and 
***p<0.001, respectively). K) Tables summarising results of statistical analysis. All values 
represent means ± SEM, analysed by one way ANOVA with post hoc Tukey’s analysis. WT n=7, 
Dlk1+/p=6, Grb10m/+ n=6 and Grb10m/+/Dlk1+/p n=6. 
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Figure 4.13 Weight analysis of 3-6 month old female wild type, Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p mice. 
Weights of whole animals and selected organs were recorded. A) Analysis of total body 
weights revealed that Grb10m/+ animals were significantly larger than wild type (*p<0.05) and 
Dlk1+/p (**p<0.01) mice. No significant differences were found in weights of: B) livers, D) 
brains, G) kidneys, I) masseter muscles and J) tongues. C) Grb10m/+ animals exhibited increased 
pancreas weights when compared to wild type (***p<0.001) and Dlk1+/p (***p<0.001) animals; 
significantly overgrown pancreata were also found in Grb10m/+/Dlk1+/p mice when compared to 
wild type (**p<0.01) and Dlk1+/p (***p<0.001) animals. E) Significantly smaller gonadal fat pads 
were noted in Grb10m/+/Dlk1+/p mice compared to Dlk1+/p (*p<0.05). F) Dlk1+/p animals had 
elevated renal fat pad mass when compared to all other genotypes (***p<0.001). H) Grb10m/+ 
displayed significant increase in gastrocnemius muscle mass when compared to wild type 
(*p<0.05) and Dlk1+/p (**p<0.01) mice. K) Tables summarising results of statistical analysis. All 
values represent means ± SEM, analysed by one way ANOVA with post hoc Tukey’s analysis. 
WT n=7, Dlk1+/p=6, Grb10m/+ n=6 and Grb10m/+/Dlk1+/p n=7.  
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Figure 4.14 Proportionate weight analysis of 3-6 month old female wild type, Dlk1+/p, 
Grb10m/+ and Grb10m/+/Dlk1+/p mice. 
Weights of whole animals and selected organs were recorded and organ weights expressed as 
percentage of total body weights. No significant differences were found in weights of A) livers, 
C) brains, F) kidneys, G) gastrocnemius muscles, H) masseter muscles and I) tongues; B) 
Grb10m/+ and Grb10m/+/Dlk1+/p mice displayed significantly elevated pancreas mass (**p<0.01 
for Grb10m/+ and *p<0.05 for Grb10m/+/Dlk1+/p) when compared to Dlk1+/p mice. D) Significant 
decrease in gonadal fat pad mass was noted in Grb10m/+/Dlk1+/p animals compared to Dlk1+/p 
(*p<0.05). E) Renal fat pads of Dlk1+/p animals were enlarged and statistically different to wild 
type (**p<0.01) whereas renal fat pads of Grb10m/+ (*p<0.05) and Grb10m/+/Dlk1+/p 
(***p<0.001) mice were significantly smaller when compared to those of Dlk1+/p. J) Tables 
summarising results of statistical analysis. All values represent means ± SEM, analysed by one 
way ANOVA with post hoc Tukey’s analysis. WT n=7, Dlk1+/p=6, Grb10m/+ n=6 and 
Grb10m/+/Dlk1+/p n=7.  
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Figure 4.15 Weight analysis of 7-9 month old female wild type, Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p mice. 
Weights of whole animals and selected organs were recorded. No significant differences were 
found in A) total body weights and weights of B) livers, D) brains, F) renal fat pads, G) kidneys, 
H) gastrocnemius muscles, I) masseter muscles and J) tongues. C) Grb10m/+/Dlk1+/p pancreata 
were significantly larger when compared to Dlk1+/p (*p<0.05). E) Grb10m/+ mice had 
significantly smaller gonadal fat pads in comparison to wild type animals (**p<0.01). K) Tables 
summarising results of statistical analysis. All values represent means ± SEM, analysed by one 
way ANOVA with post hoc Tukey’s analysis. WT n=6, Dlk1+/p=6, Grb10m/+ n=6 and 
Grb10m/+/Dlk1+/p n=5.  
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Figure 4.16 Proportionate weight analysis of 7-9 month old female wild type, Dlk1+/p, 
Grb10m/+ and Grb10m/+/Dlk1+/p mice. 
Weights of whole animals and internal organs were recorded and organ weights expressed as 
a percentage of total body weights. No significant differences were found in weights of A) 
livers, C) brains, D) gonadal fat pads, E) renal fat pads, F) kidneys, G) gastrocnemius muscles, 
H) masseter muscles and I) tongues. B) Grb10m/+/Dlk1+/p mice had significantly increased 
pancreas mass (*p<0.05) when compared to Dlk1+/p. J) Tables summarising results of statistical 
analysis. All values represent means ± SEM, analysed by one way ANOVA with post hoc Tukey’s 
analysis. WT n=6, Dlk1+/p=6, Grb10m/+ n=6 and Grb10m/+/Dlk1+/p n=5.  
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4.2.4 Histological and morphometric analyses of Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p mice. 
Earlier we made an observation that Grb10m/+and Grb10m/+/Dlk1+/p neonatal lungs had 
thicker epithelial walls than wild type and Dlk1+/p mice (Section 4.2.1.2), therefore we decided 
to carry out an investigation whether this effect persisted until adulthood. H&E stained 
sections of adult lungs revealed no obvious abnormalities between genotypes (Figure 4.17) 
and morphometric study of the adult lungs from all the genotypes (Figure 4.18) confirmed that 
there were essentially no differences in epithelial wall thickness, in contrast to the results seen 
in neonatal Grb10m/+and Grb10m/+/Dlk1+/p mice.  
The wet weights of neonatal kidneys (presented in Section 4.2.1.1) seemed to be 
comparable between the genotypes regardless of changes in total body weights. As a result, 
when presented as relative weights, the weights of kidneys in Grb10m/+and Grb10m/+/Dlk1+/p 
mice were significantly decreased. Similarly, we have found several significant weight 
differences in adult kidneys, especially in Grb10m/+and Grb10m/+/Dlk1+/p knockout mice (Figures 
4.9 to 4.16). Previous reports demonstrated Grb10 kidney expression during early 
development (Charalambous et al., 2003; Lui et al., 2008), prompting an investigation of the 
Grb10 expression in the adult kidneys. Since it has been confirmed that expression of the LacZ 
reporter in Grb10m/+ mice generally recapitulates the endogenous expression of the Grb10 
gene we performed LacZ staining on cryosections from adult kidneys (Figure 4.19). By looking 
at Grb10m/+and Grb10m/+/Dlk1+/p kidneys, we found that Grb10 expression was present in the 
brush borders of proximal tubules. The evident expression of Grb10 in kidneys, together with 
the proportional changes of kidney weights according to body weights encouraged us to 
perform further histological analysis of adult kidneys stained with PAS (Figure 4.20). No 
obvious histological differences were noted between kidneys from mice of the four different 
genotypes and, additionally, morphometric analysis of glomerulus numbers showed no 
statistically significant differences (Figure 4.21). To gain insight into correct kidney function we 
analysed the protein content of urine samples from 3 month old male mice and ran them on 
the SDS-PAGE gel. This analysis did not reveal any unexpected proteins in any of the analysed 
samples, indicating normal kidney function in mice of all the analysed genotypes, however for 
this experiment to be more convincing it should be repeated whilst using a positive control and 
quantification analysis.  
145 
 
 
Figure 4.17 H&E stained adult wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p lungs under 
100x magnification.  
Histological analysis of lungs from 3 month old male mice revealed no abnormalities in any of 
the studied genotypes. Presented images show representative sections for each of the 
analysed genotypes. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 and Grb10m/+/Dlk1+/p n=5. 
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Figure 4.18 Comparison of epithelial wall thickness in adult wild type, Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p mice. 
A) Morphometric analysis of adult lung epithelial wall thickness revealed no significant 
differences for any of the analysed genotypes. B) Table summarising results of statistical 
analysis. All values represent means ± SEM, analysed by one way ANOVA with post hoc Tukey’s 
analysis. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 and Grb10m/+/Dlk1+/p n=5. 
147 
 
 
Figure 4.19 LacZ stained adult wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p kidneys, 
counterstained with eosin under 200x magnification.  
Distinctive blue LacZ staining was observed in Grb10m/+ and Grb10m/+/Dlk1+/p kidneys in brush 
borders of the adult proximal tubules. Presented images show representative sections for each 
of the analysed genotypes. BB: brush border. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 and 
Grb10m/+/Dlk1+/p n=5. 
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Figure 4.20 H&E stained adult wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p kidneys 
under 200x magnification with 400x magnification insets in bottom right corners.  
No obvious abnormalities were identified through the histological analysis of kidneys from 
3 month old male mice. To account for possible changes within intra-cellular spaces and 
glomerulus numbers morphometric analysis has been performed (Figure 4.21). Presented 
images show representative sections for each of the analysed genotypes. WT n=5, Dlk1+/p=5, 
Grb10m/+ n=5 and Grb10m/+/Dlk1+/p n=5.  
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Figure 4.21 Glomerulus numbers in adult wild type, Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p 
kidneys. 
A) Morphometric analysis of 3 month old male kidneys revealed no significant differences 
between glomerulus numbers among all the analysed genotypes. B) Table summarising results 
of statistical analysis. All values represent means ± SEM, analysed by one way ANOVA with 
post hoc Tukey’s analysis. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 and Grb10m/+/Dlk1+/p n=5. 
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Figure 4.22 Representative SDS-PAGE gel with urine samples from wild type, Dlk1+/p, 
Grb10m/+ and Grb10m/+/Dlk1+/p mice. 
Visual inspection did not reveal any  apparent changes in protein content  in urine samples 
from 3 month old males of any of the analysed genotypes. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 
and Grb10m/+/Dlk1+/p n=5. 
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4.3 Discussion 
Different groups of imprinted genes might be controlled by various mechanisms in order 
to be able to play distinct roles in prenatal development and postnatal physiology. It is 
a challenging task to distinguish between the specific postnatal effects of imprinted genes and 
consequences of fetal programming, as early developmental changes can have a great 
influence on various aspects of postnatal life. In this chapter, we have provided a study of 
postnatal features of mice lacking the Grb10 and Dlk1 genes, both of which are known to 
function pre- and post-natally. We therefore believe that our investigation of the knockout 
phenotypes improves understanding of the potential link between these genes and provides 
more information on the postnatal effects of Grb10 and Dlk1 ablation, resulting either from 
fetal programming or directly from lack of Grb10 and/or Dlk1 expression in specific tissues. 
However, it can be difficult to firmly establish the underlying sources of observed phenotypic 
changes. 
Although both Grb10 and Dlk1 have been studied in a number of biochemical and in vitro 
experiments and have been implicated as members of several signalling pathways, their 
interactions and physiological impact in vivo need to be explored in more detail. Shortfalls of in 
vitro studies are exemplified by conflicting evidence regarding the Grb10 role in insulin 
signalling, which has been reported both to be negative (Langlais et al., 2004; Mori et al., 2005; 
Smith et al., 2007; Wang et al., 2007) as well as positive (O'Neill et al., 1996; Wang et al., 1999; 
Deng et al., 2003). As previously mentioned, employing in vivo models has allowed the 
identification of important roles for both Grb10 and Dlk1 in influencing embryonic growth but 
also in causing several postnatal phenotypic abnormalities. In both cases, the early 
developmental growth effects were persistent, but less prominent, following birth. The 
phenotypic variance and coefficient of variation for mouse body weight increase from birth to 
approximately 28 to 35 days of age, followed by a decrease and eventual stabilisation (Eisen, 
1976). The comparison of body weight alterations with age along with changes in body 
composition (specifically fat and lean tissue content) were previously assessed and compared 
between different mouse strains, and the results of comparison of 3 and 6 month old C57BL/6 
female and male mice showed variation of 19.8 ± 1.16 g in female and 25.8 ± 1.62 g in male 
3 month old animals against 23.8  ± 1.50 g and 29.9 ± 1.14 g in 6 month old female and male 
animals, respectively (Mouse Phenome Database; http://phenome.jax.org). For the purpose of 
our allometric analysis of adult mice we decided to pool together 3-6 and 7-9 month old mice, 
as we did not observe significant variations in weights between 3 and 6 and also between 
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7 and 9 month old animals. In order to perform more specific analysis, allometric examination 
of specifically 3, 6, 7 and 9 month old mice should be performed to discard any potential 
discrepancies in the total body and organ weights due to use of animals that were not strictly 
age-matched.  
 Allometric studies presented in this chapter confirm previously published findings, 
demonstrating significant overgrowth of Grb10m/+ knockout (Charalambous et al., 2003; Smith 
et al., 2007) and growth retardation of Dlk1 knockout (Moon et al., 2002) neonatal mice. Our 
primary interest, however, was to analyse the postnatal growth phenotype of Grb10m/+/Dlk1+/p 
double knockout mice. Grb10m/+/Dlk1+/p neonates displayed a growth phenotype that 
resembled that observed for Grb10m/+ single knockout mice, being significantly overgrown on 
the day of birth. The examination of mice at 1 week of age confirmed the persistent 
overgrowth in Grb10m/+ and Grb10m/+/Dlk1+/p animals, although the overgrowth was less 
prominent in Grb10m/+/Dlk1+/p double knockout mice. Analysis of total body weights of 3-6 and 
7-9 months old male and female mice revealed no obvious abnormalities with the exception of 
3-6 month female Grb10m/+ animals that were 21% heavier than wild type mice. Previous 
studies have also reported that the overgrowth phenotype of Grb10m/+ knockout mice 
diminished with time, but was persistent until at least 6 months of age when Grb10m/+ animals 
were still 13% larger than their wild type counterparts (Smith et al., 2007). Thus, in the present 
study there was either a more rapid or complete diminution of the increased mass of 
Grb10m/+/Dlk1+/p animals, as well as male and older female Grb10m/+ knockout mice, possibly 
due to the different genetic background that resulted from crossing Grb10m/+ with Dlk1+/p 
knockout animals.  
In addition to the examination of total body weights, organs from neonatal and adult 
animals were subject to allometric analysis. Assessment of neonatal organ weights revealed 
that in accordance with changes in total body size, there were proportional differences in 
weights of hearts and lungs in transgenic animals of each of the mutant genotypes, so these 
organs were enlarged in Grb10m/+ and Grb10m/+/Dlk1+/p and reduced in size in Dlk1+/p neonates. 
In contrast, sparing was noted in kidneys from Grb10m/+ and Grb10m/+/Dlk1+/p animals since 
their wet weights remained comparable to wild type and, consequently, relative kidney 
weights of Grb10m/+ and Grb10m/+/Dlk1+/p were significantly reduced whereas relative kidney 
weights of Dlk1+/p neonates were significantly elevated. In adulthood, no alterations were 
found in female kidney weights, however in the case of males the trend of significantly smaller 
wet kidney weights was noted in Grb10m/+ and Grb10m/+/Dlk1+/p along with decreased relative 
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kidney weights in Grb10m/+ and Grb10m/+/Dlk1+/p 7-9 months male mice (approximately 16% 
smaller for Grb10m/+ and 20% for Grb10m/+/Dlk1+/p). Interestingly, there has been some 
evidence provided for Grb10 expression in kidney tubules (Smith, 2004) and by looking at LacZ 
staining in kidneys of adult Grb10m/+ and Grb10m/+/Dlk1+/p mice we found that it was largely 
concentrated in proximal convoluted tubules. Control and regulation of arterial blood pressure 
is associated with the function of kidneys in maintaining water and salt homeostasis. More 
than 20 years ago it has been proposed that reduced nephron number could lead to higher risk 
of developing adult hypertension (Brenner et al., 1988), which has since been supported by 
experimental and clinical data. Examination of cases of intrauterine growth restriction in 
Aboriginal children showed that postnatal hypertension might be a consequence of abnormal 
fetal development (Spencer et al., 2001), most possibly as a result of a reduction in nephron 
number, and other human studies have also highlighted the association between the nephron 
number and hypertension (Keller et al., 2003; Douglas-Denton et al., 2006). Moreover, 
a decrease in nephron number as well as reduction in kidney size have been noted in mice 
overexpressing the Ret (REarranged during Transfection) kinase receptor (Yu et al., 2004), 
required for proliferation, migration and differentiation of neural crest cells and for kidney 
organogenesis in the developing urinary tract and kidney (Pachnis et al., 1993). The evidence 
of interaction between Ret and Grb10 (Pandey et al., 1995), together with the role of Grb10 in 
inhibiting receptor tyrosine kinase signalling, suggests that changes in this interaction may lead 
to the observed kidney phenotype that we found in Grb10m/+ and Grb10m/+/Dlk1+/p mice. 
Therefore, it would be interesting to investigate in the future Ret protein levels in these mice 
and look for any associated abnormalities.  
Fetal programming can potentially influence the postnatal phenotype, and it is largely 
possible that in the case of kidneys the fetal programming effect of neonatal under/over- 
growth of these organs in proportion to overall body size might lead to serious cardiovascular 
malfunctions in later life. To investigate the adult kidney morphology, we performed 
histological analysis along with an assessment of glomerulus numbers in 3 month old male 
kidneys. We did not find any histological differences in examined kidneys, and morphometric 
analysis provided evidence that there were no significant discrepancies in the overall 
glomerulus numbers between mice of all genotypes. Additionally, urine analysis aimed at 
investigating potential kidney malfunctions revealed no incidence of proteinurea in any of the 
genotypes, indicating that kidney function was normal in studied animals, regardless of their 
genotype. However, it would still be interesting to examine blood pressure in Dlk1+/p, Grb10m/+ 
and Grb10m/+/Dlk1+/p mice as a measure of another major aspect of kidney function and to 
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undertake an analysis of histology, morphometry and function of neonatal kidneys to 
investigate the possibility of kidney anomalies at the neonatal stage that might be resolved 
during the course of postnatal life.  
Studies of Silver-Russell syndrome patients demonstrate that cranial sparing is 
a frequent feature of this disorder (Price et al., 1999). Interestingly, a similar effect of cranial 
sparing in Grb10m/+ and Grb10m/+/Dlk1+/p neonates, along with relative brain overgrowth in 
Dlk1+/p neonates, was noted during allometric analysis of the brain. No modifications in wet 
and relative brain weights were identified in the adult animals, despite confirmed expression 
from the paternal Grb10 allele in the developing and postnatal brain (Garfield et al., 2011). 
Absence of maternal Grb10 expression in fetal CNS and a distinct pattern of paternal Grb10 
expression from fetal life into adulthood have been recently reported by our group (Garfield et 
al., 2011). Ablation of the paternal Grb10 copy has led to changes in some aspects of social 
behaviour, primarily increased social dominance. These observations have established Grb10 
as the first example of an imprinted gene whose monoallelic expression from each of the 
parental alleles in a tissue-specific manner is able to control distinct physiological and 
behavioural processes. Maternal Grb10 controls fetal growth along with postnatal metabolism 
(Charalambous et al., 2003; Smith et al., 2007; Garfield et al., 2011) and paternal Grb10 
controls aspects of social behaviour, highlighting complex mechanisms of action and roles for 
imprinted genes that go far beyond only affecting early development. 
One of the most interesting phenotypic features found during the study presented in 
this chapter was the growth of the livers, which was significantly different between genotypes 
and was also dependent on the stage of development. Neonatal Grb10m/+ liver overgrowth has 
already been reported (Charalambous et al., 2003), and liver overgrowth in Grb10m/+ and 
Grb10m/+/Dlk1+/p during fetal development has been shown in Section 3.2.1. Grb10m/+ and 
Grb10m/+/Dlk1+/p neonates displayed significantly increased wet and relative liver weights, 
whereas liver weights of Dlk1+/p mice were slightly (but not significantly) reduced, even in 
proportion to the reduced total body weights of these animals. At 1 week of age, both 
Grb10m/+ and Grb10m/+/Dlk1+/p wet liver weights were still significantly increased but this was 
not the case for relative liver weights. Interestingly, we found that at 3-6 months of age 
Grb10m/+ male mice had significantly smaller relative liver wet weights, whereas liver wet 
weights from Grb10m/+ 3-6 months old females were significantly higher, but this trend 
disappeared in relative liver weights. This suggests that liver weights in this case changed in 
proportion to total body weights which were also increased in Grb10m/+ and Grb10m/+/Dlk1+/p 
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3-6 month old female mice. Taken together, it seems that the liver enlargement in Grb10m/+ 
and Grb10m/+/Dlk1+/p mice that is prominent during later stages of fetal development persists 
until the day of birth and then diminishes with time during postnatal life, which appears to be 
in line with strong Grb10 expression during gestation that diminishes with time from the day of 
birth (Lui et al., 2008), so that lack of Grb10 in postnatal life leads to significant reduction in 
adult liver weight. The nature of changes in liver composition that could account for these 
variations in liver mass will be discussed further in the following chapter.  
The expression of Grb10 in adult pancreas is restricted to the endocrine part of this 
organ. Our lab has previously found that Grb10m/+ E14.5 pancreata were significantly 
overgrown (Smith, 2004). Here we report that relative pancreas weights of 3-6 month old 
Grb10m/+ and Grb10m/+/Dlk1+/p males were increased, becoming significantly larger for 
Grb10m/+/Dlk1+/p animals. In both 3-6 month and 7-9 month old females wet and relative 
weights of Grb10m/+ and Grb10m/+/Dlk1+/p pancreata were significantly enlarged. Postnatal 
pancreas overgrowth in Grb10m/+ 3 month old animals has been noted previously (Smith, 2004; 
Garfield, 2007), although this phenotypic feature did not persist until 6 months of age in these 
earlier studies. Former examination of pancreatic tissues from 3 weeks old Grb10m/+ mice 
revealed no endocrine hyperplasia or hypertrophy, thus it has been concluded that increased 
exocrine tissue is responsible for the apparent pancreatic overgrowth (Smith, 2004), which was 
a surprising finding due to the lack of Grb10 expression in this tissue. Further morphological 
and immunohistochemical investigation, and possibly investigation of pancreatic progenitor 
cell number during fetal development, are required to confirm the exact nature of the 
observed pancreatic overgrowth during pre- and post-natal life, along with an assessment of 
neonatal pancreatic weights and their morphology.  
It has been suggested that the pancreatic overgrowth could also occur as a consequence 
of the liver overgrowth even though liver overgrowth is not maintained in Grb10m/+ and 
Grb10m/+/Dlk1+/p animals between 3-9 months of age. The explanation for this could be based 
on simultaneous overgrowth of both of these organs during early development, which stops at 
the time of birth when Grb10 expression decreases and so does the liver size, whilst pancreas 
size does not. Reduction of liver size might also be influenced by other factors (such as changes 
within lipid and glucose storage), while pancreas remains overgrown. The possibility of liver 
and pancreas interacting with each other in some way during development could be 
investigated by culturing Grb10m/+ and Grb10m/+/Dlk1+/p pancreatic and liver buds separately in 
vitro and observing if without any signals from the other organ they both show enhanced 
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growth when compared to wild type controls. The results ought to show if the growth changes 
in these two organs result from two independent mechanisms or there are some common 
factors acting simultaneously in both liver and pancreas. It has also been argued, that, unlike 
liver, the size of pancreas correlates with the progenitor cell pool present during the 
development of the pancreatic bud (Stanger et al., 2007), suggesting that the organ size can be 
determined by the progenitor cell number rather than depend on the regulation by growth 
factors.  
Dlk1 is known to be expressed in multipotent mesenchymal stem cells (MSC) that are 
able to differentiate into a number of cell types, such as chondrocytes, adipocytes and 
osteoblasts. Even though there is a relatively large number of studies on the role of Dlk1 in 
adipogenesis (Smas et al., 1998; Mei et al., 2002; Moon et al., 2002; Lee et al., 2003), its role in 
chondrogenesis has not been analysed in such detail. A recent study has shown that Dlk1 along 
with secreted frizzled-related protein 1 (sFRP-1) are secreted in the bone marrow environment 
and control osteoblastogenesis and adipogenesis by mediating cross-talk between lineage 
committed cell populations along with governing differentiation choices of multipotent MSCs 
(Abdallah and Kassem, 2011).  
Sox9, a Dlk1 target, has been found to play a crucial role in skeletogenesis and in 
addition its downregulation proved to be necessary for adipocyte differentiation, as recent 
study suggested that Dlk1 is responsible for inhibition of adipocyte differentiation by 
upregulating Sox9 expression (Wang and Sul, 2009). It has also been shown that by induction 
of Sox9 Dlk1 is able to enhance chondrogenic induction of mesenchymal cells and 
simultaneously inhibit chondrocyte maturation and osteoblast differentiation (Wang and Sul, 
2009). Studies of Sox9 in chondrogenesis showed that the active form of Sox9 is vital for 
cartilage formation in mice (reviewed in de Crombrugghe et al., 2001), and mice with Sox9 
ablation and Sox9 overexpression exhibit similar skeletal phenotypes to the ones observed in 
Dlk1 knockout mice (Moon et al., 2002)and animals with Dlk1 overexpression (Lee et al., 2003), 
respectively. Dlk1 is able to inhibit osteoblast differentiation of human bone marrow stromal 
cells (Abdallah et al., 2004) and also to prevent the downregulation of Sox9, therefore 
inhibiting osteoblast differentiation as well as expression of the osteogenic transcription factor 
Runx2 (Wang and Sul, 2009). Co-expression of Sox9 and Runx2 has been detected in progenitor 
cells in early mesenchymal condensations. Runx2 has been identified as a osteogenesis 
promoter and enhancer of chondrocyte maturation (Takeda et al., 2001) and it seems to be 
able to fully function only in case of Sox9 downregulation in hypertrophic chondrocytes or in 
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osteoblasts. Additionally, recent in vitro study of Dlk1 overexpression in mouse cells identified 
Dlk1 as a novel factor able to control chondrogenesis through inhibiting PI3k/Akt pathways 
and subsequently inhibiting chondrogenesis (Chen et al., 2011). 
DLK1 contribution to normal human physiology is exemplified by the human syndrome 
with silent DLK1 (mUPD14), characterised by obesity, hypotonia, premature puberty, 
macrocephaly, short stature, and small hands (Berends et al., 1999; Kotzot, 1999). The 
contrasting syndrome of pUPD14 with DLK1 overexpression results in narrow thorax with 
abnormally-shaped ribs, facial dysmorphism and mild hypoplasia of the ilia (Berends et al., 
1999; Kotzot, 1999). These phenotypic abnormalities are largely associated with skeletal 
malformations and indicate a crucial role for DLK1 in normal osteo- and possibly also chondro-
genesis.  
Gsα, one of the protein products of another paternally imprinted locus Gnas, has also 
been found to be important in bone development and inhibition of ectopic ossification. The 
most dramatic phenotypic features of mice with local Cre-mediated inactivation of Gsα are 
skeletal malformations of the forelimbs due to shortened and fused extremity bones (Castrop 
et al., 2007). Loss-of-function mutations of Gsα in humans are linked to numerous 
developmental abnormalities, including phenotypes such as Albright’s hereditary 
osteodystrophy (AHO) and progressive osseous heteroplasia (POH), both associated with bone-
related symptoms.  
Bearing in mind the roles of imprinted genes in normal skeletal development, we 
decided to examine in detail the skeletons of one particular litter with individual mice of visible 
atypical postures (hunched and abnormally small versus large and elongated), although usually 
we saw no obvious signs of skeletal abnormalities in mice of any genotype. This analysis did 
not lead to the identification of previously reported malformations, such as rib fusion, fusion 
of vertebrae or asymmetrical rib fusion to the sternum (Moon et al., 2002). Rather, we 
concluded that Dlk1+/p animals were visibly smaller, and presented a ‘hunched’ posture, 
whereas, as expected, Grb10m/+ and Grb10m/+/Dlk1+/p mice were much larger than their wild 
type counterparts. It would be of interest to conduct bone/cartilage staining on larger cohorts 
of neonatal mice in order to look for any subtle skeletal abnormalities which might have been 
previously overlooked. In addition, analysis of the length of long bones in mice at the 
beginning of postnatal development would be informative if the growth differences are 
associated only with alterations in the weights of some organs or also with changes in body 
size due to elongated bones. Axial lengths of Grb10m/+ neonatal mice were previously 
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investigated in our lab (M. Cowley, data not published) and revealed significantly greater nose-
rump lengths of male and female animals in comparison to wild type littermates. Lengths of 
Grb10m/+ mice of both genders normalised to wild type littermates by around day 11-12. This 
finding is encouraging for further analysis of bone lengths in Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p mice, as our examination of 2 weeks skeletons suggests once again a similar 
growth phenotype of Grb10m/+ and Grb10m/+/Dlk1+/p mice and this could be further confirmed 
by detailed analyses of axial and bone length in mice of all four genotypes.  
The differential expression of Grb10 and Dlk1, among several other imprinted genes, has 
been reported in the growth plate of rat bones during postnatal growth (Andrade et al., 2009). 
The expression of growth promoting Dlk1 ceased towards adulthood whereas the expression 
of growth inhibiting Grb10 increased with time, in agreement with the possibility that the 
developmental processes related to differential expression patterns of growth promoting and 
growth inhibiting genes are responsible for the decrease in the growth of longitudinal bone 
over time. In order to investigate this ourselves, we have tracked LacZ expression in neonatal 
long bones of Grb10m/+ and Grb10m/+/Dlk1+/p animals and found that LacZ expression was 
restricted to the growth plate regions of the bones and, as expected, to associated skeletal 
muscle tissue. Further analysis, in particular of the expression in adult bones is under way. It 
will be informative of possible expression changes of Grb10 from neonatal to postnatal life, 
leading to the restriction of long bone growth. The comparison of long bone length and 
expression patterns in embryos at the later stages of gestation (for example at E17.5) could 
also be potentially useful in determining Grb10 and Dlk1 function in skeletal growth and 
development.  
Despite the general assumption of adipose tissue as a passive energy reservoir, it is in 
fact an active metabolic and endocrine organ with a dynamic role in energy metabolism. 
Adipose tissue is subject to signals from the CNS but at the same time it is responsible for 
secretion of adipokines, bioactive peptides involved in processes such as lipid metabolism, 
insulin sensitivity and energy homeostasis. In addition, brown adipose tissue (BAT), is able to 
accumulate triglycerides and acts as an effector organ for non-shivering thermogenesis. 
Therefore, it is not surprising that proliferation and differentiation of adipocytes are closely 
linked to the development of obesity. Several imprinted genes have so far been implicated in 
adipocyte metabolism, and these include Dlk1, Peg1 and Ndn (Necdin). Peg1 white adipose 
tissue (WAT) mRNA levels are increased in mice with high fat diet-induced, and genetically 
induced, obesity (Takahashi et al., 2005). Transgenic mice overexpressing Peg1 suffer from 
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obesity and associated adipose cell hypertrophy, and ectopic expression of Peg1 leads to 
elevated levels of adipocyte marker expression in vivo and in vitro (Takahashi et al., 2005). 
Additionally, it has been suggested that increased organ and body weight in mouse 
interspecies hybrids might be due to loss of imprinting of Peg1, causing biallelic expression of 
this gene (Shi et al., 2004). The importance of this gene in the regulation of fat metabolism has 
also been highlighted by study in which increased levels of Peg1 were found in adipose tissue 
of inbred mouse predisposed to diet-induced obesity (Koza et al., 2006).  
NDN, a transcriptional regulator of the melanoma-associated antigen (MAGE) protein 
family coded in the PWS region, has been demonstrated to act as a potent growth inhibitor 
regulating differentiation and survival of neurons (Taniura et al., 1998). NDN also has 
demonstrated expression in adipocytes and differential expression in white and brown 
preadipocytes (Gerard et al., 1999; Boeuf et al., 2001). Mice lacking Ndn gene did not exhibit 
features of obesity (Tsai et al., 1999), even though evidence has been provided of a role for 
Ndn in suppression of brown adipocyte differentiation through downregulation of Dlk1 and 
Wnt10a expression (Tseng et al., 2005), implying that Dlk1 is able to inhibit brown 
adipogenesis downstream of Necdin.  
Dlk1 is used as a preadipocytes marker as it reflects a level of adipocyte differentiation 
in vitro and in vivo (Shimomura et al., 1998; Fox et al., 2006; Wang et al., 2006; Rodeheffer et 
al., 2008; Wang et al., 2008). Various studies have shown that Dlk1 has an inhibitory role in 
adipocyte differentiation (Wolfrum et al., 2003; Wang et al., 2006) and that differentiation of 
3T3-L1 preadipocytes to adipocytes in vitro requires the downregulation of Dlk1 activity (Smas 
and Sul, 1993; Smas et al., 1999). Paternal transmission of the null allele of Dlk1 leads to 
moderate increase in fat pad weight on a normal diet and a significant 30% increase on a high-
fat diet, resulting from adipocyte hypertrophy (Moon et al., 2002). Overexpression of a soluble 
isoform of Dlk1 in white adipose tissue leads to reduction of adipocyte cell size along with 
reduced fat pad mass and decreased expression of adipocyte marker genes (Moon et al., 
2002). A wide range of metabolic changes, including hypertriglyceridemia, impaired glucose 
tolerance, and reduced insulin sensitivity, have been noted in transgenic mice exhibiting 
considerably reduced adipose tissue content (Lee et al., 2003). Dlk1 is downregulated in most 
tissues postnatally, but its overexpression during the prenatal period can still result in 
a postnatal decrease in adiposity (da Rocha et al., 2009), suggesting that the dosage of Dlk1 in 
prenatal life can influence postnatal white adipose tissue energy storage.  
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Overexpression of GRB10 protein in adipose cell lines results in inhibition of insulin 
stimulation of the mitogen-activated protein kinases pathway (Langlais et al., 2004). Increased 
lean mass and reduced adiposity postnatally are amongst the phenotypic consequences of 
Grb10 deficiency in mice (Smith et al., 2007). In light of unambiguous roles of Dlk1 and Grb10 
genes in maintenance of correct adipose and lean tissue content we have performed weight 
analysis of several types of fat pads and muscles in 3-6 and 7-9 month old mice of both sexes. 
We found that 3-6 month old Grb10m/+ female mice had significantly increased wet weights of 
gastrocnemius muscle, while analyses of fat pads revealed a significant increase in wet and 
relative renal fat content for Dlk1+/p animals as well as elevated gonadal fat content in Dlk1+/p 
mice when compared to Grb10m/+/Dlk1+/p. We also found significantly reduced wet weight of 
gonadal fat pads in 7-9 month old Grb10m/+ female mice, which was not identified during 
relative weight analysis. The fact that no alternations have been found in male mice along with 
differences between results obtained for both female age groups could be associated with the 
relatively large variance in weight within the analysed groups, evidenced by quite high error 
bars. To overcome this issue and more explicitly pinpoint any real trends, further analyses with 
expanded numbers of mice would be required. The observation that there was no obvious 
increase in adipose tissue mass of male Dlk1+/p animals could be explained by the fact that the 
authors who first reported a relationship between lack of Dlk1 and elevated adiposity (Moon 
et al., 2002) made their observations in high fat diet fed animals. Therefore, our data is 
consistent with increased adipose tissue content in Dlk1+/p mice being diet-dependent. Thus, it 
would be of interest to carry out similar adipose and muscle tissue weight analyses in 
Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p mice fed on high fat diet when the predispositions to 
obesity are expected to be elevated.  
Obvious indications of Grb10 and Dlk1 roles in the regulation of adipogenesis provided 
by in vitro studies as well as in vivo characterisation of phenotypic features in mouse models 
give clear indications for further investigation of these two genes in this particular tissue in 
Grb10m/+/Dlk1+/p animals. Examination of Grb10 and Dlk1 expression in different types of 
adipose tissue at various developmental stages with expanded mouse cohort numbers will 
help to delineate roles of these genes in adipose tissue. Investigation of any potential changes 
indicating on these two genes interacting in the same genetics pathway could tell us more 
about their mode of action in this particular tissue. More experiments that address Grb10 and 
Dlk1 influence on lipid metabolism will be discussed in Chapter 5.  
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A previously reported incidence of approximately 12% perinatal lethality amongst 
Grb10m/+ animals was linked to blood-filled alveoli and trachea (Charalambous et al., 2003), 
with abnormal lung development indicated as a cause of death by suffocation among these 
animals. Moreover, Dlk1 expression has been implicated to mark developing endothelium and 
sites of branching morphogenesis in the mouse embryo and placenta, and relatively high levels 
of Dlk1 expression have been demonstrated in developing lungs (Yevtodiyenko and Schmidt, 
2006). The Notch signalling pathway is necessary for branching morphogenesis and maturation 
of the lungs, and perinatal lethality due to lung hypotrophy can be a potential consequence of 
disrupting this pathway (reviewed in Collins et al., 2004). We therefore decided to undertake 
a histological and morphometric analysis of both neonatal and adult lungs of mice of all four 
genotypes. Histological examination of neonatal lungs revealed potentially thicker epithelial 
walls in Grb10m/+ and Grb10m/+/Dlk1+/p knockout mice when compared to wild type and 
surprisingly, Dlk1+/p animals in which Moon et al (2002) have previously reported pulmonary 
defects and pointed at them as one of the sources of observed increase in lethality. This result 
has been confirmed by morphometric assessment of neonatal lung epithelial wall thickness, 
which showed that indeed Grb10m/+ and Grb10m/+/Dlk1+/p neonates had significantly thicker 
epithelial walls. A similar examination was also undertaken in adult mice and at this stage no 
differences were found between the genotypes. These findings could indicate an important 
role of Grb10m/+ in normal lung development, as its absence leads to abnormalities during the 
perinatal period that possibly result in cases of lethality. However, it seems that in the majority 
of cases these lung malformations are overcome and most Grb10m/+ animals survive and go on 
to reach adulthood, when changes in lung morphology are no longer evident. This is consistent 
with the timing of Grb10 expression, which is high and widespread during embryonic 
development (Lui et al., 2008) and highly restricted in adulthood. Further study of neonatal 
along with late embryonic lungs should be undertaken to identify the first time point during 
development at which significantly thicker lung epithelium appears. Dlk1-specific antibodies 
could be used to determine differences in lung expression of Grb10m/+/Dlk1+/p double knockout 
mice and Grb10m/+ single knockout neonates and embryos.  
Aside from the obvious effects of imprinted genes in mother-offspring interface, there 
are potential secondary effects of imprinted genes seen in postnatal life. In light of established 
roles of Grb10 and Dlk1 genes in fetal growth and development along with the 
Grb10m/+/Dlk1+/p embryonic growth phenotype being similar to Grb10m/+ knockout, as 
described in the previous chapter, we undertook analyses of postnatal growth and 
characteristics of Grb10m/+/Dlk1+/p mice. We aimed to investigate potential influence of both 
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Dlk1 and Grb10 genes on proportionate growth and phenotypes of several organs following 
birth. Our study of neonatal and adult Grb10m/+/Dlk1+/p mice revealed similarities between 
them and Grb10m/+single knockout animals, which is in consistence with results obtained for 
prenatal growth and development discussed in Chapter 3. Whether identified postnatal 
consequences of Dlk1 and Grb10 ablation are direct effects of these imprinted genes on 
postnatal phenotype or whether they result from modified mother/offspring interactions in 
early development remains to be established. Even though further investigation is needed to 
gain more insight into the true nature of the identified phenotypic malformations, it seems 
plausible to suggest that our hypothesis of Grb10 and Dlk1 genes acting epistatically in the 
same genetic pathway is largely confirmed by studies of Grb10m/+/Dlk1+/p postnatal phenotype, 
as most of the identified postnatal differences were shared between Grb10m/+/Dlk1+/p and 
Grb10m/+animals. 
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double knockout mice 
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5.1 Introduction 
Increasing number of imprinted genes has been implicated in governing behaviour (Isles et 
al., 2006; Davies et al., 2007; Garfield et al., 2011) and postnatal metabolism (Da Costa et al., 
1994; Lee et al., 2003; Plagge et al., 2004; Chen et al., 2005; Smith et al., 2006; Smith et al., 
2007; Yamamoto et al., 2008), the latter suggesting crucial roles in maintaining correct overall 
metabolic status in both mice and humans. Many human disorders associated with 
impairment of glucose-related metabolic processes have been linked to changes in expression 
of imprinted genes (Table 5.1) (reviewed in Smith et al., 2006). It is likely that disrupted 
metabolic homeostasis can influence growth and, in a similar manner, altered growth can have 
an impact on metabolic homeostasis. Imprinted genes might provide a link between 
embryonic growth and metabolic functions, although it is difficult to distinguish between 
primary and secondary effects of imprinted genes in mice, the latter potentially being a result 
of disrupted early stage development. So far, expression of a single parental allele has not 
been specifically linked to metabolic effects, as both maternally and paternally imprinted 
genes can influence glucose-regulated and lipid metabolism with no consistent antagonism 
between the two parental genomes (Table 5.1). 
The role of imprinted genes in the regulation of adult metabolic status is complex and not 
well understood, as adult metabolic phenotypes could be the results of direct effects of gene 
expression in adult tissues or indirectly be consequences of disrupted embryonic development 
that may lead to altered metabolic health status in later life. Many epidemiological studies 
demonstrated that a restricted maternal diet during pregnancy causes a higher risk of 
developing various disorders in offspring’s postnatal life, such as metabolic syndrome, 
diabetes, hypertension, cardiovascular disease and obesity (reviewed in McMillen and 
Robinson, 2005), for example clinically growth restricted human babies were found to be more 
prone to adult hypertension and diabetes (Malamitsi-Puchner et al., 2006). A recent study 
suggested that maternal high fat diet during embryonic development initiates the 
misregulation of imprinted gene clusters crucial in regulation of various metabolic, cellular and 
physiological functions (Gallou-Kabani et al., 2010). The study investigated the influence of 
HFD during pregnancy on the expression of 20 imprinted genes, as well as the DNA 
methylation status of the whole genome and in DMRs of imprinted genes in embryos of both 
sexes. Dlk1 was among six genes that showed an altered expression pattern in E15.5 placentae 
when the mother was fed a HFD, and this effect was much more pronounced in female 
placentae (Gallou-Kabani et al., 2010), however the details of any role for Dlk1 in placenta 
remain unknown.  
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Gene 
Expressed  
allele 
Gene 
 manipulation 
Metabolic phenotype Reference 
Igf2 Paternal 
Overexpression reduced adiposity 
(Da Costa et al., 
1994) 
Knockout 
(brain) 
increased adiposity, occasional 
obesity and hypophagic 
(Jones et al., 2001) 
Gnas(E2) 
Maternal Knockout increased adiposity, hypometabolic, 
increased insulin sensitivity 
(Yu et al., 1998;  
Yu et al., 2000;  
Yu et al., 2001) 
Paternal Knockout reduced adiposity, hypermetabolic, 
increased insulin sensitivity 
Dlk1 Paternal 
Knockout increased adiposity, elevated lipid 
metabolite level, adult fatty livers 
(Moon et al., 2002) 
Overexpression reduced adiposity, hyperglycemia, 
hyperinsulinemia, insulin resistance 
(Lee et al., 2003) 
Rasgrf1 Paternal Knockout reduced adiposity, hypoinsulinemia, 
glucose intolerance 
(Font de Mora et 
al.,2003) 
Grb10 Maternal 
Knockout 
reduced adiposity, improved 
glucose clearance and insulin 
sensitivity 
(Smith et al., 2007;  
Wang et al., 2007) 
Overexpression 
hyperinsulinemia, increased 
adiposity, impaired glucose 
tolerance 
(Shiura et al., 
2005; Yamamoto 
et al., 2008) 
 
Gnas Paternal Knockout reduced adiposity, hypoglycemia, 
hypoinsulinemia 
(Plagge et al., 
2004) 
Zac1/Hy
ma1 
Paternal Overexpression hyperglycemia, impaired glucose 
tolerance 
(Ma et al., 2004) 
Table 5.1 Imprinted genes with roles in adiposity and glucose-regulated metabolism. 
The fetal programming hypothesis suggests that environmental factors acting during vital 
developmental periods can have permanent effects on normal development and function of 
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an organism (Drake and Walker, 2004). Numerous studies in both sexes in various human 
populations have provided evidence for a relationship between reduced growth during 
gestation and early postnatal development and subsequent adult consequences in the form of 
type 2 diabetes, hypertension, hyperlipidaemia, cardiovascular disease and insulin resistance. 
Proposed mechanisms of fetal programming include: the role of fetal undernutrition 
permanently decreasing number of cells and affecting growth and organ function, as well as 
altered DNA methylation and gene expression during embryogenesis leading to permanent 
changes within an organism (Drake and Walker, 2004). As epigenotype establishment during 
fetal development can be influenced by environmental factors, it has also been proposed that 
the epigenetic regulation of gene expression provides a link between fetal nutrition, gene 
expression and health status (Jirtle and Skinner, 2007). Nevertheless, the exact molecular 
mechanisms behind fetal programming remain to be established (McMillen et al., 2008).  
Several hypotheses attempt to explain the fact that the fetal nourishment results in 
permanent programming of metabolism and abnormal phenotype postnatally due to 
a mismatch between fetal and adult environmental conditions. One of the possible 
explanations is based on epigenetic alterations as causes for maternal diet having life-long 
effects on gene expression in progeny (Ozanne and Constancia, 2007). The main hypotheses 
trying to explain how adult metabolic disorders might originate from early development 
include the following: the ‘Thrifty Metabolic State’, a hypothesis which states that genes that 
help survival will be selected due to natural selection acting over long periods of irregular and 
poor nutrition (Neel, 1962); the ‘Predictive Adaptive Response’ hypothesis which states that 
‘Developmental induction’ or programming is not a sign of pathophysiological processes, but 
instead it is a result of an organisms ability to adapt to their phenotype during fetal and 
postnatal development to better adjust to a specific environment and thereby achieve 
maximal fitness (Gluckman and Hanson, 2006); and finally, the ‘Thrifty phenotype’ hypothesis 
which suggests that permanent changes in metabolic programming result from exposures in 
utero and that embryonic malnutrition leads to adopting a survival approach under poor 
postnatal nutrition conditions (Hales and Barker, 1992). This hypothesis has been proposed in 
order to account for the relationship between reduced fetal and early postnatal growth and 
subsequent higher risk of developing impaired glucose tolerance (Hales et al., 1991) along with 
metabolic syndrome (Barker et al., 1993) in adulthood. According to the thrifty phenotype 
hypothesis, altered postnatal metabolism is an adaptive response to poor fetal nutrition, which 
could be beneficial when poor nutrition is persistent into adult life but can have severe effects 
when there is an inconsistence between fetal and adult environments. Taking into account 
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insulin’s role as one of the most important fetal growth hormones, it is not surprising that poor 
fetal growth, although not very frequently, has been related to impaired insulin secretion 
resulting from genetic causes (Frayling and Hattersley, 2001). Frayling and Hattersley (2001) 
suggested the existence of ‘thrifty phenotype’ as a consequence of thrifty genotype, and that 
changes in fetal growth and type 2 diabetes might result as two different phenotypes of the 
same genotype.  
A strong association of birth weight and the occurrence of metabolic syndrome has been 
discovered, when men with smallest birth weights were eighteen times more likely to develop 
the metabolic syndrome than those with high birth weight (Barker et al., 1993). Metabolic 
syndrome, as recognised by the World Health Organisation is characterised by the following 
criteria: insulin resistance (type 2 diabetes, impaired fasting glucose or glucose tolerance) and 
any two of the following symptoms: high blood pressure, increased levels of plasma 
triglycerides, high density lipoprotein cholesterol, increased Body Mass Index and high urinary 
albumin.  
A variety of metabolic disorders have been associated with misregulation of imprinted 
genes (Table 5.1), for example the Gnas locus on mouse chromosome 2 is a cluster containing 
three imprinted, protein-coding genes (Gsα, Gnasxl and Nesp55) with crucial roles in 
maintenance of metabolic homeostasis (Plagge and Kelsey, 2006). Owing to distinct maternally 
and paternally expressed gene products of Gnas, maternal or paternal inheritance of an exon 
2 deletion leads to opposite physiological and metabolic phenotypes resulting from 
simultaneous loss of Gsα and Gnasxl transcripts (Yu et al., 1998). Mice with disruption of the 
maternal allele are obese and hypometabolic, while those with an ablated paternal allele are 
lean and hypermetabolic. Enhanced insulin sensitivity has been noted regardless of the 
parental origin of the mutation (Yu et al., 1998; Yu et al., 2000; Yu et al., 2001). Disruption of 
the Gnasxl transcript in mice caused decreased adiposity, hypoglycaemia, hypoinsulinemia, 
inactivity and mild postnatal growth retardation, a phenotype largely similar to that of mice 
with paternal Gnas exon 2 deletion (Plagge et al., 2004). On the other hand, Gsα knockout 
mice were obese and insulin resistant, resembling the phenotypic features previously noted in 
mice lacking maternal Gnas exon 2 (Chen et al., 2005). Gsα and Gnasxl seem to exert reciprocal 
effects on glucose-related and lipid metabolism. Pseudohypoparathyroidism type Ia (PHP-Ia) 
and Albright hereditary osteodystrophy (AHO), characterised by short stature and obesity, are 
human disorders associated with GNAS (Plagge and Kelsey, 2006). Maternal transmission of 
a mutated Gsα allele causes AHO and paternal transmission results in PHP1a, which is in 
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agreement with the phenotypes described previously resulting from either paternal and 
maternal loss, respectively, of mouse Gsα. 
Another extensively studied imprinted gene with known role in control of metabolism is 
paternally expressed Igf2. Mice with a knockout of the paternal copy of a maternally imprinted 
Igf2 gene show only 60% of normal growth on the day of birth, while those with an ablated 
maternal copy exhibit normal growth (DeChiara et al., 1990; DeChiara et al., 1991). Increased 
oxidation of fat in adipose tissue caused a lean phenotype in transgenic mice with elevated 
serum Igf2 levels (Da Costa et al., 1994; Rogler et al., 1994). Conversely, Jones et al. (2001) 
showed that lower Igf2 expression in the brain, caused by a deletion of a putative gene 
regulatory element located mid-way between Igf2 and H19, was associated with weight gain 
due to raised fat deposition, occasionally resulting in obesity. Obese animals were found to be 
hypophagic, which pointed at the increase in fat accumulation being a result of altered fat 
metabolism, rather than an increase in appetite or food intake (Jones et al., 2001). 
Maternally imprinted and postnatally expressed Rasgrf1 also affects normal growth and 
metabolic status, as its loss leads to growth retardation, reduced adiposity, hypoinsulinemia 
and glucose intolerance (Itier et al., 1998; Font de Mora et al., 2003). In contrast to that, 
disruption of Peg3, another imprinted, paternally expressed gene, resulted in increased 
adiposity and hypometabolism, which was associated with perturbed hypothalamic function 
(Curley et al., 2005). ZAC1 and HYMA1 are overlapping, paternally expressed genes situated 
within a region usually connected to transient neonatal diabetes mellitus (TNDM). The 
symptoms of this rare disease include intrauterine growth retardation and insulin dependence. 
Transgenic mice carrying human TNDM locus following paternal transmission exhibit 
hyperglycemia and disrupted impaired glucose tolerance (Ma et al., 2004).  
The significance of the imprinted Grb10 and Dlk1 genes not only in growth and 
development, but also in various aspects of maintaining correct metabolic status, has been 
highlighted by in vitro studies (reviewed in Holt and Siddle, 2005; Ceccarelli and Sicheri, 2009; 
Sul, 2009) but also by characterisation of transgenic animal models (Lee et al., 2003; Smith et 
al., 2007; Wang et al., 2007; Yamamoto et al., 2008), providing information about their 
functions in a physiological context. 
Grb10 has a somewhat controversial role in insulin signalling, with the majority of studies 
showing an inhibitory role but some indicating stimulatory effects (Wang et al., 1999; Deng et 
al., 2003). Interaction of the Grb10 adapter protein with a variety of receptor tyrosine kinases 
(RTKs) is possible through its BPS and SH2 domains (He et al., 1998; Hagan et al., 2009) and 
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Grb10 has the ability to bind IR and Igf1r (Dey et al., 1996; Hansen et al., 1996; Morrione et al., 
1996; O'Neill et al., 1996; He et al., 1998). Grb10 acts as a potential tumour suppressor that 
inhibits RTKs signalling upon phosphorylation by mTORC1 in a negative feedback loop (Hsu et 
al., 2011; Yu et al., 2011).  
Studies of mouse models provided evidence that Grb10 regulates postnatal glucose 
metabolism and related physiological processes. Transgenic mice with ectopic Grb10 
expression displayed growth retardation at 4 weeks after birth and 10-15% weight reduction at 
the age of 4 months (Shiura et al., 2005) along with insulin resistance and inability to clear 
a glucose load (Yamamoto et al., 2008), suggesting that Grb10 mutant animals share common 
characteristics with human type 2 diabetes. Grb10 transgenic mice also had significantly 
decreased levels of blood urea nitrogen, and conversely significantly higher levels of plasma 
triglyceride, insulin, adiponectin and resistin. In addition, significantly decreased body, visceral 
fat and liver weights along with 60% higher incidence of type 2 diabetes following high fat diet 
were observed in Grb10 mutants (Yamamoto et al., 2008). These results, however, should be 
interpreted with care, as possibly Grb10 transgenic mice did not in fact mirror the real 
expression profile of Grb10 gene during development due to the transgene coupled with 
heterogenous promoter causing ectopic Grb10 expression that might have produced 
artifactual effects.  
In order to overcome this limitation, another model expressing a double dose of Grb10 
transcripts in the correct organs and specific tissues has been generated by deletion of the 
imprinting control centre, Grb10- DMR (Shiura et al., 2009). The growth retardation phenotype 
in these mice resembled that observed in mice with maternal disomy Chromosome 11 
(MatDi(11)) and maternally duplicated proximal Chromosome 11 (MatDp(prox11)). By 
comparison of two strains of mice with Grb10-DMR deletion, ones with and without neomycin 
resistance genes in the deletion construct, the authors concluded that increased Grb10 
expression was a major factor that influenced fetal and neonatal growth in the examined mice 
(Shiura et al., 2009). They also implied that the double dosage of Grb10 was sufficient to cause 
pre- and postnatal growth retarded phenotypes in MatDi(11) and MatDp(prox11) mice.  
Knockout mice generated by the incorporation of a gene-trap cassette in the endogenous 
Grb10 locus displayed overgrowth of embryos and placenta and were 30% heavier than their 
wild type littermates on the day of birth (Charalambous et al., 2003). Due to the previously 
established ability of Grb10 to interact with both IR and Igf1r it would be most plausible to 
suggest that the overgrowth phenotype of Grb10 knockout mice is the result of an inhibitory 
interaction of Grb10 with the Igf1r, especially considering that the magnitude of the 
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overgrowth seen in Grb10 knockout animals is similar to the growth retardation of animals 
lacking genes in the IGF pathway (Efstratiadis, 1998). However, it has been proven genetically 
that Grb10 must be acting independent of this pathway (Charalambous et al., 2003). Grb10 
knockout mice displayed some key changes in normal metabolic characteristics, such as 
insulin-induced tyrosine phosphorylation of IRS-1, and associated IR hypophosphorylation, in 
muscle and white adipose tissue (Smith et al., 2007). Increased muscle mass and subsequent 
reduction in adiposity was found by Dual X-ray absorptiometry (DXA) analysis carried out on 
6 months old animals, which was confirmed by examination of wet weights of individual 
muscles and fat depots. In addition, Grb10 knockout mice showed improved whole-body 
glucose homeostasis and insulin sensitivity, most likely associated with a slightly improved 
insulin action in skeletal muscle and adipose tissue, along with a significantly enlarged skeletal 
muscle mass (Smith et al., 2007). In consistence with these results, a different strain of Grb10-
deficient mice exhibited skeletal muscle and adipose tissue-specific enhanced insulin-induced 
activation of Akt and Erk, as well as increased insulin sensitivity in skeletal muscle (Wang et al., 
2007). Another study of a compound Grb10/Grb14 mice showed double knockout animals 
having an increased lean mass comparable to Grb10 knockout mice, implying that this is an 
effect specific to Grb10 (Holt et al., 2009). This study did not identify any additive effects of 
Grb10 and Grb14 genes on insulin signalling and body composition in Grb10/Grb14 knockout 
mice, but showed that double knockout animals were immune to high fat diet-induced 
impaired glucose tolerance, a result not identified in single knockout animals.  
Dlk1 is known as a potent regulator of adipogenesis and has numerous metabolic-related 
functions (reviewed in Sul, 2009). Dlk1 expression is high in preadipocytes but diminishes 
during adipogenesis (Smas and Sul, 1993; Wang et al., 2006). Various studies utilising in vitro 
approaches have evidenced Dlk1 role in adipocyte differentiation, for example by 
demonstrating that Dlk1 responsible for inhibiting differentiation of 3T3-L1 preadipocytes into 
adipocytes (Smas and Sul, 1993; Smas and Sul, 1997; Smas et al., 1998). It has been reported 
that Dlk1 inhibits adipocyte differentiation by preventing downregulation of Sox9 that usually 
occurs during differentiation (Wang and Sul, 2009) and that bone morphogenetic protein 
7 (BMP7) could directly inhibit Dlk1 expression, allowing for adipogenesis initiation (Zhang et 
al., 2010).  
Mice with a disrupted Dlk1 gene not only showed reduction in weight at birth and at 
weaning, but also later on in life they exhibited diet-dependent increased adiposity together 
with elevated levels of serum lipid metabolites, such as triglycerides, cholesterol and free fatty 
acids (Moon et al., 2002). Histological analysis of fat depots from knockout animals suggested 
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adipocyte cell hypertrophy associated with an increase in both fat cell maturation and 
differentiation that contributed to elevated fat tissue mass in Dlk1 knockout mice. mRNA levels 
of FAS and SCD-1 (late adipocyte differentiation markers) were increased in fat pads and in 
enlarged fatty livers of Dlk1 knockout mice (Moon et al., 2002). Mice overexpressing a Dlk1 
transgene exhibited reduced adipose tissue mass with smaller adipocyte cells, 
hypertriglyceridemia, hyperinsulinemia and insulin resistance (Lee et al., 2003), again 
indicating an important role for Dlk1 in adipose tissue content and development of diabetes-
like syndromes. Consistent with mouse metabolic phenotype, the role of Dlk1 in human 
metabolic diseases has been highlighted by various studies, for example recently Dlk1 
expression has been associated adverse effects of severe obesity (O'Connell et al., 2011) and 
altered marrow adiposity and bone mineral density in women suffering from Anorexia Nervosa 
(Fazeli et al., 2009).  
Predisposition to type 2 diabetes and metabolic syndrome has been associated with 
adipogenic capacity, suggesting that altered expression of adipogenic genes might control 
susceptibility to diet-induced metabolic syndrome. As an adipogenesis inhibitor, the Dlk1 gene 
seems to be an appropriate candidate for this kind of function, as it has been shown to cause 
insulin resistance and simultaneously prevent diet-induced obesity and also had 6-fold higher 
expression in db/db mice resistant to obesity (Wang et al., 2008). These results raise 
a possibility of Dlk1 having a role in the regulation of adipogenic response to chronic 
overnutrition and susceptibility to metabolic syndrome. 
Both Grb10 and Dlk1 show pronounced expression in skeletal muscle during early 
development (see Table 1.3 in Section 1.4). Dlk1 overexpression has been indicated as the 
cause of callipyge (clpg) phenotype in sheep (Charlier et al., 2001; Fleming-Waddell et al., 
2009) associated with hypertrophic muscles, possibly resulting from an antiadipogenic function 
of Dlk1 gene. Conditional knockout and overexpression studies in mice suggested 
a fundamental role for Dlk1 in muscle development and regeneration (Waddell et al., 2010).  
As Grb10 has a confirmed role in insulin signalling and Dlk1 a role in antiadipogenic action, 
experiments presented in this chapter were aimed at addressing the roles of Grb10 and Dlk1 in 
the maintenance of both glucose and lipid homeostasis in vivo. To elucidate contributions of 
Grb10 and Dlk1 to correct metabolic status in mice, we have performed a range of metabolic 
analyses on animals with knockouts of either Grb10, Dlk1 or both of these genes. Analysis of 
feeding behaviour was undertaken along with an assessment of lean and fat tissue content by 
Dual X-ray absorptiometry. Mice have undergone glucose tolerance tests and, in addition, the 
levels of circulating blood glucose in fed and fasted mice were measured, together with levels 
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of triglycerides in blood serum. The histology of livers from mice of various ages was studied, 
together with white adipose tissue and potential changes in adipocyte cell size and/or number. 
Previous examinations of Grb10 (Charalambous et al., 2003; Smith et al., 2007) and Dlk1 
(Moon et al., 2002) knockout mice have shown that lack of either of these genes results in 
reciprocal metabolic phenotypes. Therefore, it was of interest to examine metabolic features 
of Grb10m/+/Dlk1+/p double knockout mice and investigate if their phenotype resembles either 
of the single knockouts. The aim of these studies was to determine whether Grb10 and Dlk1 
might influence metabolism by acting in a common pathway and, more generally, to provide 
additional information on how these imprinted genes influence metabolism in vivo.  
173 
 
5.2 Results 
5.2.1 Feeding behaviour of Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p mice 
Due to the previously described marked reduction in body fat of Grb10m/+ knockout 
animals (Smith et al., 2007) and diet-dependent predisposition to increased adiposity in Dlk1 
knockout mice (Moon et al., 2002) a study of feeding behaviour was undertaken in Grb10m/+, 
Dlk1+/p and Grb10m/+/Dlk1+/p mice. In order to investigate the influence of both Grb10 and Dlk1 
genes on feeding behaviour, the amount of food consumed and the fluctuations in body 
weights of individually caged animals were monitored over a period of 2 weeks. In addition, 
the food consumption rates for all genotypes were calculated using a ratio of 2/3 as a scaling 
component (White and Seymour, 2003) and compared to total body weights. Feeding 
behaviour was examined for animals of 2 different age groups (3-6 and 7-9 months) and both 
sexes, but as the results for both age groups showed similar trends (showed in Appendix 1) the 
data has been pooled together. 
The total amount of consumed food over the analysed period of time is presented in 
Figure 5.1 A and B. The statistical analysis revealed no significant differences between the 
amounts of consumed food by males and females of any genotype. Also the food consumption 
rates (Figure 5.1 C and D) proved to be similar between all the genotypes and for both sexes.  
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Figure 5.1 Analysis of feeding behaviour in wild type, Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p 
mice.  
Food intake was monitored over a period of two weeks. Food consumption rates have been 
calculated as food consumed per gram of animal body weight per day to the power of 2/3.  
A) Total amount of consumed food by males. B) Total amount of consumed food by females.  
C) Male consumption rates: total weight of food consumed by males per gram of body weight 
per day to the power of 2/3. D) Female consumption rates: total weight of food consumed by 
females per gram of body weight per day to the power of 2/3. There were no significant 
changes neither in the amounts of consumed food or in food consumption rates of transgenic 
mice when compared to wild type controls. E) Table summarising results of statistical analysis. 
All values represent means ± SEM and have been subject to one way ANOVA with post hoc 
Tukey’s analysis. Males: WT n=14, Dlk1+/p=12, Grb10m/+ n=12 and Grb10m/+/Dlk1+/p n=13; 
females: WT n=13, Dlk1+/p=12, Grb10m/+ n=12 and Grb10m/+/Dlk1+/p n=12. 
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5.2.2 Glucose tolerance tests of Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p 
mice 
Several imprinted genes have been implicated in maintenance of metabolic homeostasis 
(see Section 5.1). Glucose metabolism is of a vital importance in sustaining the correct 
metabolic body functions, therefore any abnormalities in glucose tolerance or clearance could 
have potentially detrimental effects on the overall fitness of an animal. Recently, some 
evidence has been provided for the role of Grb10 in glucose homeostasis (Smith et al., 2007; 
Wang et al., 2007; Yamamoto et al., 2008), supported by experiments showing Grb10 
interactions with the insulin receptor (O'Neill et al., 1996; He et al., 1998). Our lab has 
reported that Grb10m/+ mice clear glucose more rapidly when compared to wild type 
littermates (Smith et al., 2007). As a result we decided to use glucose tolerance tests (GTT) to 
establish whether Grb10m/+/Dlk1+/p mice might show the same trend. 
Male and female mice aged 3-9 months were subject to glucose tolerance tests as 
described in Section 2.5.4. Animals were pooled together as both age groups displayed similar 
trends (showed in Appendix 2). Consistent with insulin mediated glucose uptake, increased 
glucose levels were observed 15 min after glucose injection, with a subsequent gradual 
decrease in glucose concentration over time. The shapes of glucose curves differed slightly 
between sexes, but they were consistent with previously described results for Grb10m/+ mice 
(Smith et al., 2007). Our results showed that from 15 up to 90 minutes post injection both 
male and female Grb10m/+ and Grb10m/+/Dlk1+/p mice showed significantly improved abilities to 
clear a glucose load when compared to Dlk1+/p littermates (Figure 5.2 A and B), as assessed by 
analysis of the incremental areas under curves (Figure 5.2 C and D). In contrast, the trend of 
impaired ability to clear glucose load was noted in Dlk1+/p, however it did not become 
statistically significant. 
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Figure 5.2 Glucose tolerance in male and female wild type, Grb10m/+, Dlk1+/p and 
Grb10m/+/Dlk1+/p mice.  
Male and female 3-9 months old mice were examined for their ability to clear an 
intraperitoneal dose of glucose. A) and B) Results from glucose tolerance tests for male and 
female mice. C) and D) Histograms representing areas under glucose curves for male and 
female mice. Analysis of areas under glucose curves revealed that Grb10m/+ and 
Grb10m/+/Dlk1+/p mice of both sexes cleared glucose significantly faster than Dlk1+/p (**p<0.01) 
animals. E) Table summarising results of statistical analysis. All values represent means ± SEM 
and have been subject to one way ANOVA with post hoc Tukey’s analysis. Males: WT n=14, 
Dlk1+/p=12, Grb10m/+ n=12 and Grb10m/+/Dlk1+/p n=13; females: WT n=13, Dlk1+/p=12, Grb10m/+ 
n=12 and Grb10m/+/Dlk1+/p n=12. 
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5.2.3 Glucose levels in fed and fasted mice of Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p mice 
In order to examine levels of blood glucose in fasted (with food removed for 16 hours 
including the overnight period) and fed (fed regular diet available ad libitum) mice of all four 
genotypes, tail blood was collected as described in Section 2.5.5.  
The obtained results pointed towards slightly elevated glucose levels in both fed and 
fasted Dlk1+/p male mice (Figure 5.3 A and B), although they did not translate into significant 
differences. On the other hand, fed basal serum glucose levels in female mice indicated that 
Grb10m/+/Dlk1+/p and Grb10m/+ knockout female mice became significantly hypoglycaemic when 
compared to wild type control littermates (Figure 5.3 D). There was a slight, but non-
significant, trend in the same direction for Grb10m/+/Dlk1+/p and Grb10m/+ male mice  
(Figure 5.3 C). 
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Figure 5.3. Analysis of basal glucose levels in fed and fasted wild type, Grb10m/+, Dlk1+/p and 
Grb10m/+/Dlk1+/p mice.  
Concentration of serum glucose from tail blood was analysed using a glucometer in female and 
male mice. Fasted glucose readings were taken from animals without access to food for 
a period of 16 hours. Fed glucose readings were taken from animals receiving food ad libitum. 
A) and B) Male animals showed no deviation from WT glucose levels in either fed or fasted 
state. C) Female mutant mice showed no deviation from WT glucose levels in a fasted state. D) 
Female Grb10m/+ and Grb10m/+/Dlk1+/p animals were significantly hypoglycaemic in a fed state 
compared to WT controls (*p<0.05). E) Table summarising results of statistical analysis. All 
values represent means ± SEM and have been subject to one way ANOVA with post hoc 
Tukey’s analysis. Males: WT n=14, Dlk1+/p=12, Grb10m/+ n=12 and Grb10m/+/Dlk1+/p n=13; 
females: WT n=13, Dlk1+/p=12, Grb10m/+ n=12 and Grb10m/+/Dlk1+/p n=12. 
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5.2.4 Triglyceride levels in blood serum in Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p mice 
In addition to glucose, various other metabolic compounds are known to be crucial in 
maintenance of metabolic homeostasis. Triglyceride levels affect many basic body functions 
and Dlk1 knockout mice have been previously reported to show elevated levels of serum 
triglycerides (Moon et al., 2002). The concentration of triglycerides was measured and 
compared for all four genotypes (Figure 5.4). Dlk1+/p mice had significantly higher levels of 
triglycerides in their blood stream when compared to Grb10m/+ animals which were showing an 
opposite trend, however, neither increased triglyceride levels in Dlk1+/p mice nor lower 
triglyceride levels in Grb10m/+ were significantly different from those of wild type controls. In 
Grb10m/+/Dlk1+/p animals the triglyceride levels were also comparable to those of wild type 
animals. 
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Figure 5.4 Levels of triglycerides in mouse blood serum of wild type, Grb10m/+, Dlk1+/p and 
Grb10m/+/Dlk1+/p mice.  
A) Triglyceride levels in blood serum were measured in 3 month old male mice. Dlk1+/p mice 
were found to have significantly elevated (*p<0.05) levels of triglycerides in blood serum in 
comparison to Grb10m/+. B) Table summarising results of statistical analysis. All values 
represent means ± SEM and have been subject to one way ANOVA with post hoc Tukey’s 
analysis. WT n=6, Dlk1+/p=6, Grb10m/+ n=6 and Grb10m/+/Dlk1+/p n=6. 
182 
 
5.2.5 Dual energy X-ray absorptiometry analysis of Dlk1+/p, Grb10m/+ and 
Grb10m/+/Dlk1+/p mice 
Previous experiments showed that ablation of the Grb10 and Dlk1 genes had essentially 
opposite effects on adipose tissue content in corresponding knockout mice. Adult Grb10m/+ 
knockout mice displayed decreased levels of adipose tissue (Smith et al., 2007) while Dlk1 
knockout mice exhibited increased adiposity when fed a high fat diet (Moon et al., 2002). 
Therefore, it was of interest to investigate if Grb10m/+/Dlk1+/p knockout mice might resemble 
any of the previously identified phenotypes or follow the adiposity pattern of wild type control 
mice.  
To identify and compare physiological differences between mice of different genotypes 
we performed Dual energy X-ray absorptiometry (DXA) analysis of carcasses of animals 
previously used for study of food consumption and GTTs. Measured parameters included bone 
mineral density (BMD), bone mineral content (BMC) and lean and fat tissue content.  
No differences in bone mineral density and bone mineral content were identified in male 
mice (Figure 5.5 A and B), which suggested that there was no change in bone quantity and 
composition. We also did not find any alterations in bone mineral density in female mice 
(Figure 5.6 A), however Dlk1+/p female mice showed significantly decreased bone mineral 
content in comparison to wild types (Figure 5.6 B).  
Lean tissue content was significantly increased for Grb10m/+ male mice when compared to 
wild type and Dlk1+/p mice and it was also higher in Grb10m/+/Dlk1+/p mice when compared to 
Dlk1+/p (Figure 5.5 C). In addition, Grb10m/+ female mice had significantly higher content of lean 
tissue when compared to Dlk1+/p (Figure 5.6 C). Grb10m/+ mice also exhibited significantly 
increased percentage of lean mass compared to Dlk1+/p (for males Figure 5.5 E and for females 
Figure 5.6 E). No abnormalities were found in fat tissue content for any of the sexes (Figure 5.5 
D and Figure 5.6 D), although a significantly reduced percentage of fat mass was noted in 
Grb10m/+ compared to Dlk1+/p animals (for males, Figure 5.5 F and for females, Figure 5.6 F).  
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Figure 5.5 DXA analysis of adult wild type, Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p male mice.  
Carcasses of male animals were analysed by Dual X-ray absorptiometry to examine various 
parameters of body composition. A) and B) No differences were seen in bone mineral density 
(BMD) or bone mineral content (BMC). C) Total lean tissue mass was significantly elevated in 
Grb10m/+ animals when compared to wild type (*p<0.05) and Dlk1+/p mice (***p<0.001) and in 
Grb10m/+/Dlk1+/p animals when compared to Dlk1+/p (*p<0.05) D) No alterations were observed 
in total fat tissue content. E) Percentage of lean mass was significantly increased (**p<0.01) in 
Grb10m/+ mice in comparison to Dlk1+/p mice. F) Percentage of fat mass was significantly 
reduced (*p<0.05) in Grb10m/+ mice in comparison to Dlk1+/p mice. G) Table summarising 
results of statistical analysis. All values represent means ± SEM and have been subject to one 
way ANOVA with post hoc Tukey’s analysis. WT n=14, Dlk1+/p=12, Grb10m/+ n=12 and 
Grb10m/+/Dlk1+/p n=12. 
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Figure 5.6 DXA analysis of adult wild type, Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p female 
mice.  
Carcasses of female animals were analysed by Dual X-ray absorptiometry to examine various 
parameters of body composition. A) No differences were found in bone mineral density 
(BMD). B) Bone mineral content was significantly reduced in Dlk1+/p mice in comparison to wild 
type (*p<0.05). C) Total lean tissue mass was significantly elevated in Grb10m/+ animals 
(**p<0.001) when compared to Dlk1+/p. D) No changes were seen in total fat tissue content. E) 
Percentage of lean mass was significantly increased (*p<0.05) in Grb10m/+ mice in comparison 
to Dlk1+/p mice. F) Percentage of fat mass was significantly reduced (*p<0.05) in Grb10m/+ mice 
when compared to Dlk1+/p. G) Table summarising results of statistical analysis. All values 
represent means ± SEM and have been subject to one way ANOVA with post hoc Tukey’s 
analysis. WT n=13, Dlk1+/p=12, Grb10m/+ n=12 and Grb10m/+/Dlk1+/p n=12. 
185 
 
5.2.6 Liver lipid content in Dlk1+/p, Grb10m/+ and Grb10m/+/Dlk1+/p mice 
Lipid metabolism is strictly associated with maintenance of energy homeostasis and liver is 
known to play a key role in energy homeostasis of lipid metabolism. In vertebrate species liver 
is the typical site for fatty acid synthesis and lipid circulation through lipoprotein synthesis. Any 
discrepancies in lipid synthesis, storage or circulation might have significant effects on overall 
body health status and lead to serious diseases such as hepatic steatosis or fatty liver disease 
(Nguyen et al., 2008).  
In light of genotype-related liver weight discrepancies reported in previous chapters we 
performed histological analyses of livers from mice of various ages in order to investigate any 
potential morphological differences that might be associated with the identified growth 
phenotypes. No obvious differences were found in E14.5 embryonic livers stained with H&E 
(Figure 5.7), however, the presence of white, round spaces was noted in neonatal Grb10m/+ 
and Grb10m/+/Dlk1+/p livers (Figure 5.8). These spaces were also present in approximately half 
of examined Grb10m/+ and Grb10m/+/Dlk1+/p livers from 1 week old mice (Figure 5.9). in contrast 
to that Grb10m/+ and Grb10m/+/Dlk1+/p livers from 3 month old male mice looked comparable to 
wild type, but at this stage Dlk1+/p livers were found to have an abnormal accumulation of 
white, round spaces (Figure 5.10). To investigate the nature of the observed white structures, 
we carried out Periodic acid-Schiff (PAS) staining on neonatal old livers in order to learn if the 
abnormal appearance of these organs is the result of increased accumulation of glycogen. The 
result from PAS staining was negative, no differences were found between genotypes, 
suggesting that histological differences were not due to altered levels in glycogen content 
between genotypes (Figure 5.11). We then stained cryosections from neonatal livers with Oil 
Red O, an indicator of the presence of lipid droplets that stain red. Cryosections from Grb10m/+ 
and Grb10m/+/Dlk1+/p neonatal livers indeed showed increased accumulation of red lipid 
droplets (Figure 5.12). In keeping with results previously described for H&E staining, there was 
an increased red lipid droplet accumulation in Dlk1+/p but not in Grb10m/+ and Grb10m/+/Dlk1+/p 
adult livers (Figure 5.13).  
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Figure 5.7 H&E stained liver sections of wild type, Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p 
E14.5 embryos under 200x magnification.  
Livers were stained with H&E and representative sections are shown. No differences in liver 
histology were apparent among the analysed genotypes. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 and 
Grb10m/+/Dlk1+/p n=5. 
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Figure 5.8 H&E stained liver sections of neonatal wild type, Grb10m/+, Dlk1+/p and 
Grb10m/+/Dlk1+/p mice under 200x magnification.  
Livers from 1 day old mice were stained with H&E. Dlk1+/p sections were indistinguishable from 
wild type, but Grb10m/+ and Grb10m/+/Dlk1+/p livers showed the presence of large numbers of 
white, round spaces. Presented images show representative sections for each of the analysed 
genotypes. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 and Grb10m/+/Dlk1+/p n=5. 
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Figure 5.9 H&E stained liver sections of wild type, Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p 
1 week old mice under 200x magnification. 
Livers from 1 week old mice were stained with H&E. In wild type and Dlk1+/p no differences in 
histology were observed. This was also the case for some Grb10m/+ and Grb10m/+/Dlk1+/p 
(middle panel) livers but in other cases (bottom panel) the presence of white, round spaces 
was noted. Presented images show representative sections for each of the analysed 
genotypes. WT n=6, Dlk1+/p=6, Grb10m/+ n=6 and Grb10m/+/Dlk1+/p n=6. 
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Figure 5.10 H&E stained liver sections of wild type, Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p 
3 month old mice under 200x magnification.  
Livers from 3 month old male mice were stained with H&E. In wild type, Grb10m/+ and 
Grb10m/+/Dlk1+/p no differences in histology were observed, however the presence of abundant 
white, round spaces was noted in Dlk1+/p livers. Presented images show representative 
sections for each of the analysed genotypes. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 and 
Grb10m/+/Dlk1+/p n=5. 
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Figure 5.11 PAS stained liver sections of neonatal wild type, Grb10m/+, Dlk1+/p and 
Grb10m/+/Dlk1+/p neonatal old mice under 200x magnification. 
Livers from 1 day old mice were stained with PAS. No differences in liver histology were 
apparent among the analysed genotypes. Presented images show representative sections for 
each of the analysed genotypes. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 and Grb10m/+/Dlk1+/p n=5. 
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Figure 5.12 Oil Red O stained liver cryosections of neonatal wild type, Grb10m/+, Dlk1+/p and 
Grb10m/+/Dlk1+/p mice under 200x magnification. 
Livers from 1 day old mice were cryosectioned and stained with Oil Red O for the presence of 
lipid droplets. An increased number of lipid droplets was observed in both Grb10m/+ and 
Grb10m/+/Dlk1+/p livers. Presented images show representative sections for each of the 
analysed genotypes. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 and Grb10m/+/Dlk1+/p n=5. 
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Figure 5.13 Oil Red O stained liver cryosections of 3 month old wild type, Grb10m/+, Dlk1+/p 
and Grb10m/+/Dlk1+/p mice under 200x magnification. 
Livers from 3 months old male mice were cryosectioned and stained with Oil Red O for the 
presence of lipid droplets. An increased number of lipid droplets was observed in Dlk1+/p 
knockout mice. Presented images show representative sections for each of the analysed 
genotypes. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 and Grb10m/+/Dlk1+/p n=5. 
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5.2.7 Analysis of adipocyte cell size and number distribution in Dlk1+/p, 
Grb10m/+ and Grb10m/+/Dlk1+/p mice 
Previous phenotypic analysis of Dlk1 mice revealed high fat diet-related increased adipose 
tissue content (Moon et al., 2002). Consequently, Moon et al (2002) investigated if this was 
a result of adipocyte hypertrophy or hyperplasia. They found abnormalities in fat cell size 
distribution resulting in elevated cell size, indicating adipocyte hypertrophy in Dlk1 knockout 
animals as a potential cause of increased adiposity (Moon et al., 2002). Although DXA analysis 
described in the previous section showed only limited significant changes within fat tissue 
content in Grb10m/+ compared to Dlk1+/p animals, we decided to examine if the fat cell size 
distribution in mutant animals is in keeping with normal fat tissue.  
Abdominal fat pads from 3 month old male mice were sectioned and stained with H&E 
(Figure 5.14) and we did not note any obvious histological differences between the genotypes. 
Further morphometric analysis of adipocyte cells was performed as described in Section 2.4.8 
in order to investigate in detail any potential discrepancies in cell size or number distribution. 
Parameters including adipocyte mean and maximum width, adipocyte areas and numbers in 
field of view were recorded (Figure 5.15), but no significant differences were found between 
genotypes.  
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Figure 5.14 H&E stained white adipose tissue sections of wild type, Grb10m/+, Dlk1+/p and 
Grb10m/+/Dlk1+/p 3 months old adult old mice under 100x magnification. 
H&E stained sections of white adipose tissue. No obvious differences were noted between any 
of the analysed genotypes. Presented images show representative sections for each of the 
analysed genotypes. WT n=5, Dlk1+/p=5, Grb10m/+ n=5 and Grb10m/+/Dlk1+/p n=5. 
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Figure 5.15 Measurements of adipocyte numbers, mean and maximum width and areas in 
white adipose tissue of wild type, Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p mice.  
Morphometric analysis has been used to analyse the numbers (A), mean (B) and maximum 
areas (C), as well as widths (D) of adipocyte cells in sections of white adipose tissue. No 
significant differences were found for any of the analysed parameters in tissues from animals 
of all four genotypes. E) Table summarising results of statistical analysis. All values represent 
means ± SEM and have been subject to one way ANOVA with post hoc Tukey’s analysis. WT 
n=5, Dlk1+/p=5, Grb10m/+ n=5 and Grb10m/+/Dlk1+/p n=5.  
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5.3 Discussion 
Fetal growth and adult metabolism are closely linked and frequently the same genes or 
genetic pathways play parts in regulating both processes. Abnormalities during embryonic 
development have long been associated with postnatal disorders and epigenetic regulation of 
metabolic genes has been linked to nutritional influences during development (reviewed in 
Waterland and Jirtle, 2004), in a process known as fetal programming. Various imprinted genes 
are able to influence growth, metabolism and energy homeostasis, among them Grb10 and 
Dlk1 exerting roles in growth regulation and the maintenance of correct metabolic status 
(Moon et al., 2002; Lee et al., 2003; Smith et al., 2007; Wang et al., 2007). The mode of action 
for both genes might be based on direct control of metabolism or alternatively they could 
cause specific alterations during early development that influence the metabolic functions in 
postnatal life. Moreover, as various imprinted genes, including Grb10, have established roles in 
regulation of insulin signalling, any changes in their function might alter insulin signalling and 
have an effect on metabolism. Taking into account previous reports of Dlk1 and Grb10 
influence on adipocyte differentiation and insulin signalling, in this chapter we have studied 
consequences of Grb10 and Dlk1 ablation on glucose and lipid-related metabolism, as 
representative aspects of correct metabolic status.  
Grb10m/+ knockout mice have previously been reported to have a lean phenotype 
(Charalambous et al., 2003; Smith et al., 2007) and Dlk1 knockout mice to have increased 
adipose tissue mass when fed on high fat diet (Moon et al., 2002). One obvious explanation for 
any differences in body composition or overall body mass would be altered feeding behaviour, 
therefore we initially decided to check for hypophagia (reduced food consumption) or 
hyperphagia (increased food consumption), but statistical analysis revealed no differences in 
feeding behaviour in any of the analysed genotypes. Analysis of separate age groups (3-6 and 
7-9 month old male and female mice) revealed similar trends therefore the results pooled 
together for 3-9 month old male and female mice has been shown. These results indicate that 
any discrepancies in body composition of mice lacking Grb10, Dlk1 or both of these genes are 
not due to differences in feeding behaviour, but rather are results of metabolic changes. 
 Previous analysis of feeding behaviour in Grb10m/+ knockout mice, which still displayed 
increase in body weights, also did not show any alterations from normal (Garfield, 2007). Aside 
from that, Grb10m/+ serum leptin levels were reduced in proportion with decreased white 
adipose tissue mass (Smith et al., 2007). This was in agreement with the association between 
leptin concentration and mass of adipose tissue (Friedman and Halaas, 1998). Loss of 
correlation between plasma leptin and total body weight in Grb10m/+ suggested lean mass and 
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not adipose tissue mass as the main cause of body weight variability in these mice, similar to 
previous reports for other mouse models and for human patients with reduction in adiposity 
(Klaman et al., 2000; Bluher et al., 2002).  
In order for the brain to be able to control the energy homeostasis, it has to be able to 
receive signals about peripheral energy stores, specifically adipose tissue mass. Leptin is 
a widely studied peptide hormone secreted from adipocyte cells (mainly subcutaneous fat 
mass) acting as an indicator of the body’s adiposity status and its levels are correlated with the 
amount of body fat (Zhang et al., 1994). Insulin and leptin complement each other in 
regulating food consumption, uptake, and nutrient storage and several human studies indicate 
that leptin may play a part in insulin resistance in states of chronically elevated leptin levels 
(Segal et al., 1996; Boden et al., 1997; Ruige et al., 1999). Recent studies in a lean mouse 
model of type 2 diabetes have highlighted the role of leptin in improving insulin sensitivity in 
a manner independent of its effects on food intake (Li et al., 2011).  
Aside from that, evidence for a leptin-independent programming of adiposity and adult 
body weight in genetically obese strain of mice has also been provided. Leptin deficient mice 
with low birth weight managed to rapidly gain body mass during lactation and displayed 
increased weight in adulthood together with greater adiposity (Cottrell et al., 2011), suggesting 
that factors other than leptin are also important in energy homeostasis programming. 
Nevertheless, the level of leptin is still treated as one of the main indicators of body energy 
homeostasis, therefore it would be of interest to analyse its levels in Grb10m/+/Dlk1+/p double 
knockout mice and assess any potential changes in these animals resulting from lack of Grb10 
and Dlk1 genes. This type of analysis would be interesting especially in light of reduced 
expression of leptin in Dlk1 transgenic mice (Lee et al., 2003) and a recent report that leptin 
administration in mice reduced adiposity and decreased expression of adipogenesis-related 
genes, including Dlk1 (Ambati et al., 2009). In spite of the well-established role for Dlk1 in 
adipocyte differentiation, measurements of leptin levels in Dlk1+/p knockout mice have not 
been previously reported. 
An improved ability to clear a glucose load has previously been noted in Grb10m/+ 
knockout mice of both sexes, and was associated with an enhancement of insulin signalling 
efficacy in skeletal muscle and WAT rather than with an increase in circulating insulin levels 
(Smith et al., 2007). These results suggested that altered insulin signalling was the effect of 
a lack of Grb10 inhibitory action. In agreement with this, an opposite, glucose resistant 
phenotype was reported in transgenic mice ubiquitously overexpressing Grb10 under the 
control of a β-actin promoter (Shiura et al., 2005). More recent analysis of the same mouse 
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strain overexpressing Grb10 showed characteristics of a non-obese mouse model, including 
insulin resistance, glucose intolerance along with decreased body, visceral fat and liver weights 
and when fed on high fat diet. The Grb10 transgenic mice also showed increased plasma 
triglyceride and insulin levels and other characteristics similar to those seen in human type 
2 diabetes (Yamamoto et al., 2008). As mentioned previously, the limitation of this model is 
associated with an overexpression of Grb10 in all the tissues (including those that usually are 
not expressing Grb10), which is otherwise highly restricted postnatally, and may result in 
a non-physiological interactions of Grb10 with signalling components of postnatal growth axes, 
making it difficult to pinpoint the real Grb10 function.  
An increase in Irs1 phosphorylation and the failure to inhibit dephosphorylation of the Irs1 
binding site has been previously suggested as a mechanism through which Grb14 regulates 
insulin signalling (Cooney et al., 2004; Nouaille et al., 2006) and was therefore also considered 
a possible mechanism of action for Grb10. The cause for the observed glucose phenotype in 
Grb10m/+ knockout mice could be down to enhanced insulin signalling or, alternatively, 
increased muscle mass in Grb10m/+ knockout animals that could result in greater glucose 
uptake, causing an enhanced overall insulin response. Dlk1 can also influence glucose 
homeostasis, as mice with overexpression of soluble Dlk1 in adipose tissue showed 
hypertriglyceridemia, impaired glucose tolerance and decreased insulin sensitivity (Lee et al., 
2003).  
To investigate the ability to clear a glucose load by Grb10m/+/Dlk1+/p double knockout mice, 
3-9 month old animals of both sexes were subject to glucose tolerance tests (animals of 3-6 
and 7-9 months of age have been pooled together as both cohorts showed similar trends, as 
presented in Appendix 2). Similar to Grb10m/+, Grb10m/+/Dlk1+/p double knockout mice were 
also able to clear glucose significantly faster when compared to Dlk1+/p knockout mice which 
showed a trend towards slower glucose clearance. Even though adipose tissue is responsible 
for approximately 10% of whole body glucose uptake (Golay et al., 1988; Marin et al., 1992), 
insulin is highly important in promoting adipogenesis, inhibiting lipolysis and stimulating 
glucose uptake and liposynthesis (Rosen et al., 2000). Previous examination of Grb10m/+ 
knockout mice revealed that enhanced glucose clearance in these animals could not be 
associated with increased insulin levels and instead indicated there was improved insulin 
action, which was confirmed by insulin tolerance tests during which Grb10m/+ mice showed 
decreased serum glucose levels upon insulin injection (Smith et al., 2007). Consequently, to 
investigate the mechanism behind the improved glucose clearance ability in Grb10m/+/Dlk1+/p 
199 
 
double knockout mice, insulin tolerance tests (ITTs) and assessment of serum insulin levels 
could be performed in a similar manner.  
Control of glucose homeostasis is one of the major functions of the liver, which is highly 
regulated by insulin and other hormones. Liver insulin resistance and, more specifically, 
insulin’s inability to suppress glucose production have been associated with fasting 
hyperglycaemia in type 2 diabetes. Insulin degradation is also one of the liver functions, as 
insulin removal helps to control the cellular response to the hormone by decreasing 
availability. Generation of a Cre/Lox system under an albumin promoter to drive Cre 
expression only in the liver and tissue-specific inactivation of the IR gene in hepatocytes 
allowed for an examination of the consequences of the lack of direct insulin action in liver 
(Michael et al., 2000). Liver-specific insulin receptor knockout (LIRKO) mice displayed severe 
insulin resistance along with glucose intolerance and an inability of insulin to suppress hepatic 
glucose production and to regulate hepatic gene expression. Another metabolic feature 
confirmed in LIRKO mice is hyperinsulinemia due to a combination of reduced insulin clearance 
and enhanced insulin secretion. Over time LIRKO livers undergo changes in morphology (40% 
size reduction, areas of scattered focal dysplasia, decreased glycogen content, enlarged gall 
bladders, increased lipid content and enlarged mitochondria) and function (biliary tract 
dysfunction, hepatocellular damage), and the severity of the metabolic phenotype decreases 
(Michael et al., 2000). This model established the vital role of insulin receptors in the liver in 
glucose homeostasis regulation for normal insulin clearance as well as maintenance of 
a correct liver function, and also confirmed insulin’s role as an important metabolic regulator 
with both direct and indirect effects on majority of tissues.  
Only fed Grb10m/+ and Grb10m/+/Dlk1+/p female mice showed hypoglycaemia, a result 
difficult to explain, especially in light of the DXA analysis which showed that body composition 
in these mice was not significantly different to that of wild type animals. The handling of 
glucose was different between the sexes, as could be observed by comparing the shapes of 
glucose tolerance curves between males and females. In addition, the measurements of 
glucose levels in fed mice with constant access to food can be misleading because of lack of 
knowledge about the exact time at which the animals have eaten. Thus it is important to 
expand the numbers of analysed mice in order to confirm if the hypoglycaemia confirmed in 
Grb10m/+ and Grb10m/+/Dlk1+/p female mice is indeed a biologically meaningful result.  
Body composition, specifically lean/fat tissue content can exert dramatic effects on 
glucose homeostasis and potentially the development of diabetes-like syndromes, as 
exemplified by serious glucose tolerance defects in Dlk1 transgenic mice with a substantial 
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reduction in adipose tissue mass (Lee et al., 2003). Hence we have employed DXA analysis in 
order to establish the possible foundations of observed changes in glucose homeostasis. 
Consistent with previous studies, Grb10m/+ knockout mice of both sexes showed a trend 
towards reduced relative adipose tissue weight and elevated lean tissue mass when analysed 
using DXA (Smith et al., 2007). On the other hand, Dlk1+/p knockout mice did not display 
increased adiposity, which has been suggested previously (Moon et al., 2002), but in animals of 
different genetic background and fed on a high fat diet. The only significant difference found in 
Dlk1+/p mice was decreased lean tissue mass compared to Grb10m/+ mice. Grb10m/+/Dlk1+/p 
double knockout mice did not exhibit any lean/fat content alterations compared to wild type 
mice except for increased lean tissue mass in male mice. These results are in agreement with 
allometric muscle/fat depots analysis described in the previous chapter which did not reveal 
any substantial changes within lean/adipose tissue content in analysed mice.  
DXA also allowed us to investigate the possible changes within bone mineral density and 
bone mineral content, as we were very much interested in examining BMD and BMC in 
Grb10m/+/Dlk1+/p, especially in light of the role for Dlk1 in osteogenesis and normal skeletal 
development. A recent study has suggested Dlk1 exerts a negative influence on bone mass, as 
a negative correlation between serum Dlk1 and BMD has been identified in women suffering 
from Anorexia Nervosa (Fazeli et al., 2009). Examination of mice with osteoblast-specific Dlk1 
overexpression has shown Dlk1 as a regulator of bone mass that inhibits bone formation and 
stimulates bone resorption under estrogen deficiency (Abdallah et al., 2011b). This finding was 
supported by a report of elevated levels of serum Dlk1 in post-menopausal women that may 
be mediating the effects of estrogen deficiency on bone turnover (Abdallah et al., 2011a). The 
proposed molecular mechanism behind Dlk1 action in adipogenesis is that Dlk1 activates the 
MAPK/ERK pathway and blocks downregulation of Sox9, which in turn inhibits the 
differentiation of committed MSCs down the osteogenic and adipogenic lineages (reviewed in 
Sul, 2009). 
Previously, ablation of Grb14 in mice caused hypoinsulinemia and improved glucose 
tolerance indicative of enhanced insulin sensitivity, as upon in vivo insulin stimulation, livers 
and muscles of Grb14 knockout mice exhibited enhanced insulin signalling via IRS-1 and Akt 
and increased incorporation of glucose into glycogen and no changes in insulin action in 
adipose tissue were identified (Cooney et al., 2004). Improved glucose clearance and tissue-
specific changes in insulin-induced Insr and IRS1 tyrosine phosphorylation along with similar 
changes at the IGF1R and at the level of IRS1 tyrosine phosphorylation in response to IGF1 
were detected in Grb10m/+ mice and IGF1-induced signalling, at least to IRS1, was particularly 
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increased in muscles of adult Grb10-deficient animals (Smith et al., 2007). These results 
indicated on Grb10 and Grb14 being able to inhibit IR/IRS1 signalling in a similar manner but 
with distinct tissue specificity but Grb10 also showing an ability to modulate body composition, 
as the elevated muscles mass in Grb10m/+ animals on a whole-body basis could be associated 
with the improved glucose tolerance at least partly resulting from increased glucose clearance 
into muscle. The results of glucose tolerance tests and DXA analysis of body composition 
presented in this chapter showed that Grb10m/+ knockout animals, consistent with previous 
studies, had an increased lean tissue mass and improved glucose tolerance, whilst 
Grb10m/+/Dlk1+/p knockout animals had an essentially normal body composition but still 
exhibited improved glucose clearance, indicating on the improved glucose clearance in 
Grb10m/+ and Grb10m/+/Dlk1+/p mice most likely resulting from an enhanced insulin signalling 
due to  the lack of an inhibitory action of Grb10. Further work will be necessary to prove if the 
same changes in IR/IRS1 signalling are the basis for the improved glucose tolerant phenotype 
noted in Grb10m/+/Dlk1+/p mice.  
Moon et al (2002) have reported not only an increase in adipose tissue mass in Dlk1 
knockout mice fed on a high fat diet, but also elevated levels of serum lipid metabolites that 
included triglycerides, free fatty acids and cholesterol. All three types of metabolites were 
present at significantly increased levels, with elevated levels of triglycerides being the most 
pronounced (by 36% and 77% in Dlk1 knockout female and male mice, respectively). Both 
hypercholesterolemia and hyperlipidaemia indicated that in Dlk1 knockout mice lack of Dlk1 
antiadipogenic action results in disrupted lipid metabolism. To investigate if our Dlk1+/p mice 
also had altered serum triglyceride levels and if Grb10m/+/Dlk1+/p double knockout mice showed 
a similar trend we measured the levels of triglycerides in blood serum of fasted mice. In 
keeping with previous reports, Dlk1+/p mice indeed had raised triglyceride levels but only when 
compared to Grb10m/+ mice, indicating opposing effects of these to genes on triglyceride 
levels. It is possible that the elevated triglyceride levels in Dlk1+/p animals in our study signify 
the predisposition to accumulating fat, even though increased adiposity was not evident. It has 
to be taken into account that previous reports of significantly increased triglyceride levels by 
Moon et al (2002) were based on analysis in animals fed on high fat diet, in contrast to the 
animals used in our study, therefore any trends towards obesity would be more pronounced in 
HFD case. It would be of interest to employ a similar high fat diet in Grb10m/+, Dlk1+/p and 
Grb10m/+/Dlk1+/p knockout mice and again assess the levels of triglycerides together with other 
serum lipid metabolites, such as previously mentioned leptin, adiponectin, FAS (fatty acid 
synthase),and SCD (stearoyl-CoA desaturase1). These kinds of examination could tell us more 
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about the predisposition to obesity, or its lack, resulting from ablation of Grb10 and Dlk1 as 
well as providing more information about the metabolic state in the analysed mice. It would be 
interesting to check if Grb10m/+mice fed on HFD are protected from diet-induced obesity, as it 
has been previously shown in other mouse models with low adiposity (e.g. Klaman et al., 
2000). 
Increased adipose tissue mass might result from an increase in adipocyte cell size alone or 
together with a rise in adipocyte cell number due to disruption in differentiation from 
preadipocytes into adipocytes. Previously conducted morphometric analysis of adipocyte cell 
size, density and morphology in Dlk1 knockout mice revealed that lack of Dlk1 resulted in 
adipocyte hypertrophy in inguinal fat pads with no apparent changes in DNA content which 
suggested correct cell numbers (Moon et al., 2002). In agreement with that, overexpression of 
Dlk1 gene in mice led to a reduction in adipocyte size (Lee et al., 2003).  
The differentiation of cells into adipocytes is associated with altered expression of several 
genes, and the final outcome is a fat cell phenotype and adipocyte function specialised in 
triglyceride storage. Adipocyte cells secrete a variety of molecules, many of which are involved 
in energy homeostasis. In vitro studies have shown that dexamethasone-mediated repression 
of Dlk1 contributes to the mechanisms by which glucocorticoids promote adipogenesis (Smas 
et al., 1999), whilst constitutive expression of Dlk1 inhibits 3T3-L1 adipogenesis (Smas and Sul, 
1993) . Only the large soluble form of Dlk1 is able to inhibit 3T3-L 1 adipocyte differentiation in 
vitro (Mei et al., 2002) and the study of human serum levels of DLK1 revealed increased levels 
of this soluble protein with obesity and its possible negative influence on insulin sensitivity 
(Chacon et al., 2008). The mechanism by which Dlk1 inhibits adipocyte differentiation has been 
investigated by using soluble Dlk1 in mouse embryonic fibroblasts from Dlk1 knockout 
embryos. It has been reported that Dlk1 interacts with fibronectin via the Dlk1 juxtamembrane 
domain and fibronectin C-terminal domain (Wang et al., 2010), which is required for the 
inhibition of adipocyte differentiation through the activation of extracellular signal-regulated 
kinase/mitogen-activated protein kinase (MEK/ERK) (Kim et al., 2007) and the subsequent 
upregulation of Sox9 expression (Wang and Sul, 2009). Following that, Sox9 directly binds the 
promoter regions of C/EBPβ and C/EBPδ to suppress their transcription and in turn inhibits 
adipocyte differentiation (for details see Section 1.3.1).  
The role of Dlk1 in adipogenesis has also been investigated in vivo, by studying mice either 
overexpressing (Lee et al., 2003) or lacking (Moon et al., 2002) Dlk1. Mice overexpressing Dlk1 
exhibited a dramatic decrease in total fat pad weight and reduced expression of adipocyte 
markers and adipocyte-secreted factors (such as leptin and adiponectin). Animals with 
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considerable reduction in adiposity also displayed a slower glucose clearance rate together 
with hypertriglyceridemia and insulin insensitivity (Lee et al., 2003). In the same study, mice 
expressing a Dlk1 transgene solely in the liver under the control of an albumin promoter had 
a reduced amount of adipose tissue mass and adipocyte marker expression, suggesting that 
Dlk1 may act in an endocrine manner (Lee et al., 2003). Therefore, high expression of Dlk1 in 
preadipocytes, diminishing during differentiation, together with its role in correct adipocyte 
differentiation in vitro and in vivo have established Dlk1 as a potent negative regulator of 
adipogenesis.  
Bearing in mind the involvement of Dlk1 in adipogenesis, together with reports of Grb10 
ablation leading to postnatal overgrowth due to increased lean but not fat tissue mass, it was 
of interest to examine the consequences of lack of both of these genes on adipose tissue 
morphology, specifically on adipocyte size and numbers. Surprisingly, we found that, 
histologically and morphometrically, there were no evident changes in size of adipose cells in 
any of the analysed genotypes. As mentioned before, we did not see any significant 
modifications within the lean/fat tissue ratio in Dlk1+/p, but it was quite surprising that we also 
observed no alterations in adipocytes of Dlk1+/p knockout mice in our study, in contrast to 
a previous report of adipocyte hypertrophy (Moon et al., 2002). The clearly less pronounced 
metabolic phenotype in Dlk1+/p mice used in this study, in comparison to Dlk1 knockout 
animals characterised by Moon et al (2002), once again, highlights the possibility of the 
previously observed differences being diet-dependent. Future work should involve similar 
adipocyte cell analyses in Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p mice fed on a high fat diet to 
see if phenotype of Dlk1+/p mice is comparable to that of Dlk1 knockout mice observed by 
Moon and colleagues (2002), and to determine whether Grb10m/+/Dlk1+/p mice again resemble 
the Grb10m/+ mice, indicating a genetic interaction between Grb10 and Dlk1 genes to control 
normal lipid metabolism.  
In light of significant variations in the pre- and post-natal weights of livers reported in 
previous chapters and changes in liver histology of Grb10 and Dlk1 knockout mice described 
before (Moon et al., 2002; Charalambous et al., 2003), we have performed histological analysis 
of livers from mice at E14.5, 1 day, 1 week and at 3 months of age. Liver histology in E14.5 
embryos did not reveal any unusual features, however we noted presence of white, round 
spaces in liver sections from Grb10m/+ and Grb10m/+/Dlk1+/p neonatal animals. To investigate 
the nature of these further, we performed Periodic Acid- Schiff staining on neonatal livers to 
check for any alterations in glycogen content, as it has been previously suggested to be 
increased in Grb10m/+ animals (Charalambous et al., 2003), but we did not find any differences 
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between genotypes. In contrast, Oil Red O staining performed on cryosectioned neonatal livers 
revealed that Grb10m/+ and Grb10m/+/Dlk1+/p 1 day livers contained an elevated lipid droplet 
content in comparison to wild type and Dlk1+/p. This suggests that the overgrown liver 
phenotype identified in neonatal Grb10m/+ and Grb10m/+/Dlk1+/p mice (shown in Section 4.2.1) 
might result from an increased lipid content. To investigate if elevated lipid levels are present 
in Grb10m/+ and Grb10m/+/Dlk1+/p livers consistently during postnatal life we histologically 
examined livers from mice of 1 week and 3 months of age. Only half of the organs from 1 week 
old mice maintained the unusual accumulation of lipids. The diminishing presence of lipid 
droplets between birth and 1 week of age could be attributed to rapidly decreasing expression 
of Grb10 in the liver during this period (Lui et al., 2008). The majority of imprinted genes, 
including Grb10 and Dlk1, show the most pronounced expression during fetal development, 
with a substantial decline during postnatal life simultaneously in multiple organs, suggesting 
that the decrease of imprinted genes expression might match the decline in somatic growth. 
Developmental defects were previously reported in both Grb10 and Dlk1 knockout livers, as 
Grb10 ablation caused significant neonatal liver overgrowth (Charalambous et al., 2003) and 
lack of Dlk1 resulted in increased adult liver weight along with elevated total lipid content and 
enhanced expression of FAS and SCD-1, usually associated with increased hepatic lipogenesis 
and fat synthesis (Moon et al., 2002). In the previous chapter describing postnatal allometric 
organ analysis, we noticed a slight trend towards Dlk1+/p male liver overgrowth, which became 
significant during analysis of relative liver weights in 3-6 month old male mice when compared 
to Grb10m/+ and Grb10m/+/Dlk1+/p (Section 4.2.3). This interesting finding of fat livers is even 
more noteworthy due to the fact that it seems to be most pronounced at the time of birth, as 
analysis of E14.5 did not reveal significant changes in liver histology. It would be of interest to 
identify the specific time of liver lipid accumulation, especially that the analysis of E17.5 liver 
wet weights revealed that Grb10m/+ and Grb10m/+/Dlk1+/p livers were overgrown, possibly 
suggesting that at this gestational stage the lipid accumulation is already taking place. It would 
also be interesting to analyse the total lipid content in the livers (extracted by the method of 
Folch et al, 1957) and compare it between the genotypes and to identify the specific type of 
lipids accumulated in neonatal Grb10m/+ and Grb10m/+/Dlk1+/p livers and check for triglyceride, 
total cholesterol and phospholipid liver content.  
Variety of factors is thought to influence development of fatty liver, steatosis or hepatic 
lipidosis characterised by the abnormal accumulation of triglycerides within hepatocytes. In 
humans, fatty liver is frequently associated with chronic alcohol ingestion and is common in 
patients with maturity-onset diabetes mellitus, obesity and hyperlipidaemia. Various rodent 
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experimental models proved useful in uncovering the mechanisms of fatty liver development 
and the risk of fatty liver leading to more serious liver diseases, as fatty liver can be 
experimentally induced by nutritional treatments or by administering drugs such as carbon 
tetrachloride or ethionine (Farber, 1967; Recknagel, 1967). There are also some models 
genetically predisposed to develop fatty livers, for example fatty liver formation is frequently 
observed in mutant obese mouse strains such as ob/ob, db/db and fat/fat (Coleman and 
Hummel, 1967; Austin et al., 1984; Naggert et al., 1995), but there is a shortage of animals 
characterised by spontaneous fatty liver without developing obesity (Reue and Doolittle, 
1996), but recently an inbred strain named FLS (fatty liver Shionogi)  with spontaneous fatty 
liver without obesity has been established (Soga et al., 1999). Neonatal FLS mice had 
hepatocytes filled with fine lipid droplets which increased in size as the mice aged.  Prominent 
fatty liver is also a feature characteristic of fatty liver dystrophy (FLD) mice that carry a 
recessive mutation that arose spontaneously in an inbred mouse strain (Langner et al., 1989). 
The formation of fatty liver starts in FLD mice when the newborn animals start suckling milk 
and is also associated with increased levels of plasma triglycerides, but both abnormalities 
diminish by the time mutant mice are 2-3 weeks old, at which time they start to suffer from a 
peripheral neuropathy that persists throughout their lifetime (Langner et al., 1991). The jvs 
(juvenile visceral steatosis) mice also have fatty livers along with growth retardation, 
hypoglycaemia and hyperammonemia (Kuwajima et al., 1996).  
Hepatic lipid deposition can be associated with deficiency in lipoprotein metabolism, 
which could be accompanied by altered profiles of plasma lipids or lipoproteins. Therefore, it 
would be interesting to investigate the levels of blood serum triglyceride content in neonatal 
Grb10m/+ and Grb10m/+/Dlk1+/p mice and check if the increased liver adiposity is accompanied 
by elevated blood triglyceride levels resulting from an increased fatty acid mobilisation from 
adipocytes into the circulation.   
The contents of hepatic lipids at a particular developmental stage result from an 
equilibrium between a lipid synthesizing activity, the lipid-oxidizing capacity of the liver, lipid 
uptake by the liver and lipid secretion from the liver as lipoproteins. It is possible that lipid 
transfer across the placenta from the mother to the Grb10m/+ and Grb10m/+/Dlk1+/p fetuses is at 
least in part responsible for the observed increase in the contents of lipids in the fetal livers 
during late gestation that persists on the day of birth, therefore it would be crucial to examine 
the livers of E17.5-E18.5 embryos and check their lipid content. Additionally, it is possible that 
the transfer of dietary lipids through milk to suckling neonatal animals influences the liver lipid 
storage and also that Grb10m/+ and Grb10m/+/Dlk1+/p exhibit decreased lipid export from the 
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liver. Further experiments are needed to explain the mechanisms of fat accumulation in 
Grb10m/+ and Grb10m/+/Dlk1+/p neonatal mice. 
It is interesting to note that, once again, Grb10m/+ and Grb10m/+/Dlk1+/p share a phenotypic 
feature contrasting with the one observed in Dlk1+/p mice. During histological analysis we 
found that adult Grb10m/+ and Grb10m/+/Dlk1+/p livers were indistinguishable from wild types, 
whilst Dlk1+/p knockout livers had increased lipid droplet content, as confirmed by Oil Red O 
staining. Liver, an organ of crucial importance in maintenance of correct metabolic state, is a 
site of a Grb10 and Dlk1 embryonic expression which declines upon birth (Lui et al., 2008), but 
here we report that lack of the Dlk1 gene affects the postnatal liver phenotype, which is 
consistent with previous reports (Moon et al., 2002). It would therefore be interesting to 
conduct a more thorough histological analysis of embryonic and neonatal livers to pinpoint the 
exact time of unusual lipid accumulation in Grb10m/+ and Grb10m/+/Dlk1+/p livers. Significantly 
overgrown Grb10m/+ and Grb10m/+/Dlk1+/p neonatal livers could be a result of increased lipid 
accumulation and/or changes in hepatocyte size/numbers, however previous examination 
demonstrated that hepatocyte size was not affected following Grb10 ablation (Charalambous 
et al., 2003). We could also use Western Blot analysis of embryonic livers to more directly 
investigate the possible molecular interaction between Grb10 and Dlk1 genes in this organ, as 
it is a site of prominent expression for both genes.  
Work in this chapter demonstrates the importance of imprinted genes, Grb10 and Dlk1, in 
the maintenance of metabolic homeostasis. We hypothesised that reciprocal metabolic 
phenotypes of Grb10 (increased lean mass, reduced adiposity, improved glucose tolerance) 
and Dlk1 (elevated adipose tissue mass, slight obesity, raised blood serum triglyceride levels) 
knockout mice would allow us to dissect if these two genes are potentially interacting with 
each other in the same genetic pathway in regulating postnatal metabolism. By characterising 
the phenotype of Grb10m/+/Dlk1+/p double knockout animals we aimed to elucidate if these 
animals share metabolic characteristics with any of the single knockouts, which could indicate 
that Grb10 and Dlk1 are acting antagonistically in the same pathway in order to control 
metabolic homeostasis. The findings are summarised in Table 5.2. Although our metabolic 
analysis did not show that Grb10m/+/Dlk1+/p double knockout mice and Grb10m/+ knockout mice 
are metabolically similar in every aspect, we found some important similarities supporting the 
possibility of a Grb10-Dlk1 interaction within a common pathway. The most striking finding 
was that these two genes might potentially be acting together in order to regulate glucose 
clearance. Despite having essentially a normal lean tissue content Grb10m/+/Dlk1+/p double 
knockout animals still exhibited faster glucose clearance, supporting the idea that the reason 
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for improved glucose tolerance in Grb10m/+and Grb10m/+/Dlk1+/p animals is mostly due to 
increased insulin signalling, rather than increased lean tissue mass. Importantly, 
Grb10m/+/Dlk1+/p did not share any abnormal characteristics found in Dlk1+/p mice, for example 
associated with age-related liver lipid deposition. Further analysis of other metabolic 
parameters, including insulin tolerance tests or the analysis of adiposity in mice exposed to 
a high fat diet, will be necessary to fully establish the role of these two genes in specific 
aspects of metabolism. Given the established functions of Dlk1 in adiposity and Grb10 in 
insulin signalling, gaining more detailed insights into their roles in metabolism could prove 
useful for future development of for treatments for obesity, diabetes or various other 
metabolic disorders in humans.  
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Table 5.2 Summary of analyses in wild type, Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p mice of glucose-regulated metabolism and insulin-responsive tissues.  
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CHAPTER 6 
6 Final discussion 
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         The advantage of diploidy over haploidy is evident, as diploid organisms are less prone to 
deleterious effects of mutations due the presence of two active chromosomal copies. 
Therefore, it remains one of the most intriguing issues why did complex organisms, such as 
seed plants and mammals, evolve to contain a subset of genes with monoallelic expression. 
There is no doubt over the crucial roles of these so-called imprinted genes, clearly evidenced 
by lethality as well as fetal and placental growth malformations in androgenetic and 
parthenogenetic mouse embryos (Barton et al., 1984; Mann and Lovell-Badge, 1984; McGrath 
and Solter, 1984; Surani et al., 1984; Barton et al., 1985). Various hypotheses have been 
proposed to explain the driving forces behind the evolution of genomic imprinting, these 
include a host-defence mechanism to protect the mammalian genome against the integration 
of foreign DNA (Barlow et al., 1991), prevention of parthenogenesis and aneuploidy (Thomas, 
1995) and also protection of the female against invasive trophoblastic tumours (Varmuza and 
Mann, 1994), although arguments against each of these hypothesis have been provided. Haig 
and Westoby (1989) proposed the most widely accepted theory explaining the genomic 
imprinting phenomenon, termed the parental conflict hypothesis. According to this 
hypothesis, imprinting evolved as a result of the parental conflict over the allocation of 
maternal resources. Many aspects of imprinted gene actions might be explained by this 
hypothesis, especially in the case of growth and metabolic effects. For example, the Grb10 
gene, predominantly expressed from the maternal allele, acts as a growth suppressor and is 
primarily involved in maintaining not only the optimal fitness of offspring, but also of the 
mother. Maternally expressed imprinted genes are therefore thought to prevent excessive 
fetal growth that could disrupt delivery and have detrimental consequences for the mother 
(Henriksen, 2008). The reciprocally expressed Dlk1 promotes the growth of offspring, 
apparently regardless of potential deleterious effects on the mother’s fitness.  
So far none of the proposed hypotheses for imprinting evolution can explain all aspects of 
the imprinting phenomenon. The remaining questions about the reasons for imprinting genes 
evolution and their regulation are handled by an abundance of studies of specific imprinted 
clusters, the relationships between specific imprinted genes and by analysing their function 
(notably in knockout mice and human disorders associated with mutations, or epimutations, at 
imprinted loci). Three primary characteristics of imprinted genes include: monoallelic 
expression from a specific parental allele, clustering in evolutionarily conserved imprinted 
domains, and parental-allele-specific methylation. Epigenetic modifications, among them 
histone modifications and DNA methylation have been indicated as the bases for the different 
epigenetic state on the two parental alleles (Ferguson-Smith, 2011).  
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Imprinted genes are capable of affecting growth and differentiation along with mediating 
postnatal metabolism and behaviour (reviewed in Charalambous et al., 2007; Wilkinson et al., 
2007). Studies in mice and humans revealed that all these functions are affected following 
disruption of either Grb10 or the Dlk1-Dio3 locus, which both show complex modes of 
regulation. Therefore, better understanding of regulation and function of Grb10 and Dlk1 and 
their domains, especially in light of their established roles as tumour suppressors and growth 
regulators, has important implications for human disorders and cancer. Thus, the study of 
these and other imprinted genes holds not only fundamental scientific interest, but also 
medical interest.  
Epistasis is the masking of one mutant phenotype by the phenotype of a mutation at 
a different locus, and as such it can be useful in identification of a functional order of action of 
two genes. Even though epistatic analysis can be used irrespective of the direction, or order, of 
the interaction between the two genes, it is most instructive in the case of two genes 
regulating a common process as it can confirm the findings from phenotypic analysis or 
suggest a sequence of events. A typical regulatory gene pathway involves genes that can be 
switched on or off, so that their different states result in different outcomes of the pathway. 
The crucial requirement is that genes involved in this pathway result in reciprocal phenotypes 
and also are able to bypass the requirement for upstream genes. Therefore, the generation of 
double mutants is informative in determining the relationship between two genes, as the 
epistatic mutation is the one resulting in the phenotype of a double mutant which resembles 
one of the single mutant phenotypes.  
It was surprising that in spite of the known biochemical interaction between Grb10 and 
IGF1R, through the generation of double knockout mutants our lab has demonstrated a non-
epistatic relationship of Grb10 and Igf2 (Charalambous et al., 2003), implying that IGF 
signalling is not the axis through which Grb10 is able to mediate embryonic and placental 
growth. This was further supported by generation of Grb10/Igf1r double mutant mice and the 
discovery of a lack of an epistatic association between Grb10 and Igf1r. Furthermore, studies 
of Grb10 interaction with IR in vivo have indicated Grb10 as an inhibitor of IR in the liver but 
not generally in controlling fetal or placental growth (Smith, 2004). Failure to identify the 
Grb10 genetic pathway up until now has encouraged further investigation of possible Grb10 
interacting partners involved in the growth regulatory function of Grb10.  
Ablation of Grb10 or Dlk1 leads to reciprocal phenotypic outcomes in mice (Moon et al., 
2002; Charalambous et al., 2003). We proposed a hypothesis that these two genes may act 
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antagonistically in a common genetic pathway. Availability of mouse models lacking each of 
the genes of interest permitted the generation and characterisation of Grb10m/+/Dlk1+/p double 
knockout animals in order to address the possible epistatic relationship between the Grb10 
and Dlk1 genes. Here we report the results of prenatal, postnatal and metabolic 
characterisation of Grb10m/+/Dlk1+/p double knockout mice and suggest that Grb10 might 
indeed be acting epistatically to Dlk1 in the same genetic pathway in order to regulate some 
aspects of growth and metabolism (Figure 6.1).  
 
Figure 6.1 The possible genetic pathway for Dlk1 and Grb10 action as concluded from results 
presented in this study.  
The proposed epistatic pathway shows Dlk1 acting as a Grb10 inhibitor, whilst simultaneously 
Grb10 is exerting inhibitory effects on growth and other phenotypic aspects, such as glucose 
homeostasis. Whether the interaction between Dlk1 and Grb10 is direct or indirect remains to 
be elucidated. 
In light of previous reports of Grb10 and Dlk1 opposite effects on prenatal growth and 
development, along with several sites of imprinted co-expression and similar time of action, 
we have characterised Grb10m/+/Dlk1+/p double knockout conceptuses to analyse the 
consequences of Grb10 and Dlk1 ablation on embryogenesis. Grb10m/+/Dlk1+/p embryos 
showed significant overgrowth similar to Grb10m/+ embryos from E12.5 onwards and placental 
overgrowth from E14.5. Our results for E17.5 which also showed Grb10m/+/Dlk1+/p and Grb10m/+ 
embryonic and placental overgrowth along with increased placental efficiency, should 
however be further supported by extending the size of the analysed cohort. It was exciting to 
see that Grb10m/+/Dlk1+/p shared the phenotype of Grb10m/+ embryos, possibly suggesting an 
epistatic relationship between Grb10 and Dlk1 to control embryonic development. However, 
the important issue to consider before interpreting results obtained during this study involves 
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the maternal genotype (Grb10m/+) possibly influencing development and growth of the 
offspring of all four genotypes, therefore in the future use of Grb10m/p dams should be 
considered as the main point of our study was to compare the phenotype of Grb10m/+/Dlk1+/p 
animals to the phenotypes of Grb10m/+ and Dlk1+/p single knockout animals. 
The co-localisation analysis of reciprocally imprinted genes during embryonic 
development has been used as a useful approach in identifying different mechanisms 
underlying imprinting mechanisms in different imprinted clusters, as exemplified by analyses 
of Igf2/H19 (Ohlsson et al., 1994), Nespas within the Gnas locus (Ball et al., 2001), as well as 
Dlk1 and Gtl2 (da Rocha et al., 2007). It would therefore be informative to carry out similar 
analysis of Grb10 and Dlk1 co-expression during embryogenesis as both genes show their most 
pronounced expression during this time of development.  
Extensive Grb10 expression from the maternal allele has been reported in several organs 
of Grb10m/+ E14.5 embryos, including various muscle tissues, lung bronchioles, liver, adrenal 
gland and pancreatic bud as well as developing tubules and the mesenchyme of the kidneys 
(Charalambous et al., 2003). Furthermore, expression has been noted in cartilage primordia 
including those of the atlas, ribs and long bones. On the other hand, paternal Grb10 expression 
has been noted in the developing CNS and, in parallel with maternal expression, in cartilage 
tissue (Charalambous et al., 2003). One of the most prominent sites of Dlk1 expression in the 
brain is the developing pituitary gland, along with the dermomyotome, myotome and 
sclerotome of the somites at E10, and afterwards skeletal muscle along with the primordial 
cartilage of different types of bones (da Rocha et al., 2007). Prominent Dlk1 expression has 
also been noted in the preadipocytes, cortex of the adrenal gland and pancreas, and the 
expression in both of these organs persisted until adulthood. Dlk1 is also expressed in the 
cytoplasm of some fetal hepatic cells, ducts of salivary glands and segmental bronchi of the 
lungs, where it is suspected to play a role in branching morphogenesis (Yevtodiyenko and 
Schmidt, 2006). Therefore, there are several sites of Grb10-Dlk1 co-expression, notably in the 
liver, lung, adrenal gland, skeletal muscle and cartilage.  
Embryonic growth is largely influenced by correct function of the placenta, an organ that 
evolved in eutherian mammals to provide nutrients for the developing embryo. Various 
imprinted genes have been postulated to mediate a network of supply and demand factors in 
utero, for example the Igf2 gene (Coan et al., 2008), which, however has been shown to not 
interact with Grb10 in the same genetic pathway (Charalambous et al., 2003) 
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Extraembryonic Dlk1 expression has been demonstrated in all three layers of the placenta: 
(labyrinth zone, junctional zone and decidua basalis), chorionic plate and yolk sac 
(Yevtodiyenko and Schmidt, 2006; da Rocha et al., 2007). The Dlk1 expression within the 
labyrinth zone decreases with time and it is confined to the membrane of the fetal capillary 
endothelium, whereas in the junctional zone and decidua basalis it is found within the 
glycogen cells (Yevtodiyenko and Schmidt, 2006; da Rocha et al., 2007). Furthermore, 
predominantly maternal Grb10 expression has also been reported in the labyrinth 
compartment of the placenta, more specifically in the fetal endothelium and in at least one of 
the three trophoblast layers of the labyrinth (Charalambous et al., 2010). The labyrinth zone of 
the placenta is a site of the nutrient exchange between mother and offspring, which occurs by 
passive diffusion and active transport (Sibley et al., 1997). Grb10 has been reported as the 
unique imprinted gene not only able to influence the size (Charalambous et al., 2003) but also 
the efficiency of the placenta (Charalambous et al., 2010), although previous reports of 
changes within placental efficiency (Constancia et al., 2002) or size (Frank et al., 2002) affected 
by imprinted genes exist. Co-localised expression of Grb10 and Dlk1 in the placental labyrinth 
zone suggests each could function in mediating maternal-nutrient exchange, which could 
influence fetal growth, as exemplified by genetic studies (Moon et al., 2002; Charalambous et 
al., 2003; Charalambous et al., 2010). Therefore it was of interest to analyse the effects of 
Grb10 and Dlk1 ablation on growth of Grb10m/+/Dlk1+/p placentae. Our results showing similar 
overgrowth in Grb10m/+and Grb10m/+/Dlk1+/p E14.5 placentae could possibly support the 
hypothesis of Grb10-Dlk1 interaction in extraembryonic tissues that influences the embryonic 
growth, and results obtained for E17.5 show a similar trend but they need to be further 
confirmed using larger sample size. It also needs to be taken into account that alternative 
explanation for the observed overgrowth in Grb10m/+/Dlk1+/p embryos may be provided by the 
highly increased efficiency of nutrient supply by the Grb10m/+/Dlk1+/p placentae. Therefore, 
more detailed stereological measurements, including percentage volume fractions of 
junctional and labyrinth zones, the surface areas within the labyrinth zone (fetal capillaries and 
maternal blood spaces), and the interhemal membrane thickness will be applied in order to 
analyse the morphology and function of Grb10m/+/Dlk1+/p placenta in comparison with Grb10m/+ 
and Dlk1+/p placentae. It will also be interesting to study the details of nutrient transfer in 
Grb10m/+, Grb10m/+/Dlk1+/p and Dlk1+/p placentae check if, especially in light of shortage of 
information on Dlk1+/p placentae characteristics. These kinds of studies are important as 
deregulation of supply and demand affects fetal growth and can have detrimental 
consequences on health in the neonatal period and, as a result of fetal programming, in 
adulthood. 
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We have used in vitro analysis to investigate the cellular basis for the enhanced growth in 
Grb10m/+/Dlk1+/p conceptuses, as we studied the proliferation rates in pMEFs derived from 
E14.5 embryos and discovered that Grb10m/+/Dlk1+/p and Grb10m/+ cells proliferated 
significantly faster than wild type and Dlk1+/p cells, findings in agreement with significant 
embryonic overgrowth in mice of the former genotypes. Again, the identified similarity in 
phenotype between Grb10m/+/Dlk1+/p and Grb10m/+ cells further supports the possible epistatic 
action of Grb10 to Dlk1. This is the first report of the growth rates of Dlk1+/p pMEFs, which 
proliferated at a lower rate than Grb10m/+/Dlk1+/p and Grb10m/+ pMEFs, but not significantly 
slower than wild type cells. This is consistent with results from allometric analyses which 
showed Dlk1+/p embryos being smaller than those of other the other analysed genotypes, but 
the differences did not become significant until birth.  
To further examine the nature of Grb10m/+/Dlk1+/p and Grb10m/+ embryonic overgrowth, 
we used FACS analysis to determine cell size and cycle kinetics in cells derived from E11.5 
embryos and in E14.5 pMEFs. No apparent hypertrophy has been observed in Grb10m/+/Dlk1+/p 
and Grb10m/+ cells, however results from this experiment need to be interpreted with great 
care due to the unspecific gating of the singlet and dublet cells that might have influenced and 
covered the real results. Therefore, the analysis of the results from this experiment should be 
repeated and gating carried out in the same manner as performed during cell cycle analysis. 
The examination of cell cycle phases revealed a shortened S-phase and elongated G2-phase 
with in these cells, which is in agreement with previous reports of the hyperproliferative 
nature of Grb10m/+ cells that was not associated with changes in intrinsic apoptosis or with 
altered cell size (Garfield, 2007). This suggests that Grb10 acts as a repressor of cell cycle 
progression (most possibly during S and G2 phases) and that its lack causes cell 
hyperproliferation resulting in somatic overgrowth. Some features observed in mice with 
ablation of Grb10 resemble characteristics of patients suffering from Silver-Russell syndrome, 
although there is a shortage of firm evidence for its role in this disease. Whilst several clinical 
studies have implicated Grb10 in SRS cases (Joyce et al., 1999; Hannula et al., 2001), others 
have argued against its role in this disorder (McCann et al., 2001). Nonetheless, it is still 
possible that Grb10 plays a role in the aetiology of other disorders associated with growth, 
such as mUPD7. Taken together, these results indicate that Dlk1 and Grb10 possibly interact 
with each other to provide an optimal size of the developing embryo at birth, at least in part, 
by regulating cell proliferation rates during embryogenesis.  
The effects of Grb10 on placental and embryonic growth are potentially consistent with 
both parental conflict and coadaptation theories of imprinted gene evolution. The recent 
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discovery by our lab that the Grb10 gene is most likely involved in a coadaptive strategy to 
influence the maintenance of optimal offspring fitness (Cowley et al., submitted) has led us to 
reconsider the driving forces that have resulted in evolution of imprinting at this locus.  
Allometric analysis revealed that significant overgrowth of Grb10m/+/Dlk1+/p and Grb10m/+ 
mice during embryogenesis persisted until birth, but was not evident in the adulthood, in 
contrast to the previously described Grb10m/+ overgrowth that persisted until the age of 
6 months (Smith et al., 2007). The explanation for the diminished increase of total body 
weights in Grb10m/+ mice could be provided by the different genetic background that resulted 
from crossing Grb10m/+ with Dlk1+/p knockout animals, as Dlk1+/p animals were of C57BL/6 
background whereas Grb10m/+mice were maintained on a mixed C57BL/6/CBA background, 
which also needs to be taken into consideration when comparing the growth of these animals. 
Similarly, the use of animals that were not strictly age-matched (3-6 and 7-9 month old) could 
potentially influence the results of allometric analyses of total body and organ weights in 
studied animals, therefore future examination should be based on the use of mouse cohorts of 
more similar ages.   
We observed that neonatal Grb10m/+/Dlk1+/p and Grb10m/+ mice displayed significantly 
elevated relative liver weights and cranial and kidney sparing. The cranial sparing, previously 
observed in Grb10m/+ neonates (Charalambous et al., 2003; Garfield, 2007), could be explained 
by limited maternal Grb10 expression within the developing CNS. Although neonatal lung 
weights changed proportionally to changes of total body weights, their histological analysis 
revealed abnormalities in Grb10m/+/Dlk1+/p and Grb10m/+ mice. Previous reports of pulmonary 
defects in Dlk1 knockout mice as well as incidence of Grb10 knockout perinatal lethality due to 
blood-filled lung alveoli encouraged us to investigate in more detail the lung morphology in 
Grb10m/+/Dlk1+/p knockout mice. In neonatal, but not adult, Grb10m/+/Dlk1+/p and Grb10m/+ 
mice, we identified thickened lung epithelial walls and reduced airway spaces, which could 
reduce the oxygen exchange area and consequently lead to impaired breathing efficiency. It 
was interesting and somewhat surprising that we did not find any abnormalities within Dlk1+/p 
lungs, especially in light of a demonstrated strong Dlk1 expression in segmental bronchi of the 
lungs (Yevtodiyenko and Schmidt, 2006; da Rocha et al., 2007), where it might influence the 
process of lung branching morphogenesis. In addition, altered lung morphology in 
Grb10m/+/Dlk1+/p and Grb10m/+ neonates did not persist until adulthood, suggesting that 
possible perinatal lung dysfunctions have been overcome postnatally.  
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Recent studies have demonstrated that Grb10 has a capacity to inhibit RTKs, including 
insulin receptor, through acting in a negative feedback loop upon phosphorylation by mTORC1 
(Figure 6.2; Hsu et al., 2011; Yu et al., 2011). Mammalian target of rapamycin (mTOR) is known 
as an important effector of cell growth, protein synthesis and proliferation. It functions by 
integrating various signals expected to change during late gestation, the birth process, and the 
neonatal period, including amino acid and energy availability, hormonal levels and changes in 
pO2 (reviewed in Martin and Hall, 2005). A recent study has aimed to investigate mTOR 
signalling in translational regulation in the developing rat lung and at birth (Otulakowski et al., 
2009). Otulakowski et al (2009) provided evidence that mTOR functions in perinatal lung 
physiology, as mTOR signalling was found to control protein synthesis in perinatal rat lung, 
causing a substantial increase in protein synthesis following birth. Disruption of a downstream 
effector of mTOR, S6K1, causes growth reduction in mice, whereas double knockout of S6K1 
and its homolog S6K2 leads to a high incidence of perinatal lethality, indicating the importance 
of these genes in normal fetal growth and particularly the transition from fetal to postnatal life 
(Pende et al., 2004). This raises a possibility that as another identified mTOR downstream 
target Grb10 could have similar function and influence adaptation from fetal to postnatal life 
by influencing the lung physiology.  
Dlk1 expression has been reported in hepatoblasts and immature hepatocytes (Tanimizu 
et al., 2003), where it has been confined to cytoplasm of the majority of hepatic cells in mouse 
embryos (da Rocha et al., 2007). Grb10 expression in developing liver has also been noted 
(Charalambous et al., 2003), although liver expression of both Grb10 and Dlk1 genes 
significantly declines after birth (Lui et al., 2008). Here we used histological analyses to look for 
abnormalities that could account for differences in liver weights postnatally. Abnormally high 
accumulation of lipids was noted in all neonatal and half of 1 week old Grb10m/+/Dlk1+/p and 
Grb10m/+ livers, along with similar lipid accumulation in overgrown adult Dlk1+/p livers, and at 
the same time we have observed the increased growth of these livers during allometric 
analysis. It was interesting to note that at the stage of E14.5 Grb10m/+/Dlk1+/p and Grb10m/+ 
livers did not show any discrepancies from wild type histology, indicating at the later 
gestational stages or day of birth that could possibly mark the start of the abnormal lipid 
accumulation. Thus it would be of interest to histologically examine livers of Grb10m/+/Dlk1+/p 
and Grb10m/+ embryos during late fetal development. Similarly, investigation of the types of 
lipids accumulated in Grb10m/+/Dlk1+/p and Grb10m/+ livers along with total liver lipid content 
and examination of blood lipid levels in neonatal mice should clarify the nature of the 
observed Grb10m/+/Dlk1+/p and Grb10m/+ fatty livers. The significant neonatal liver overgrowth 
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would require further investigation through morphometric analysis of hepatocyte numbers to 
check if high adiposity could solely account for the observed overgrowth phenotype or there 
are also other factors that play part in it, as previous analysis has shown that hepatocyte size 
was not altered in   Grb10m/+ neonatal livers (Charalambous et al., 2003).  
Neonatal hepatic steatosis is a fatal condition associated with a rapid microvesicular fat 
infiltration and enhanced growth of the liver, and subsequent early postnatal mortality (Satran 
et al., 1969). Impaired mitochondrial function related to hepatic steatosis has been previously 
associated with genetic defects in the oxidation of fatty acids (Boles et al., 1998), with 
inhibition of oxidation by drugs (Fromenty et al., 1997; Fromenty and Pessayre, 1997), with 
defective carnitine-dependent transport of fatty acids (Brivet et al., 1999),  with an impaired 
production of ATP (Krahenbuhl, 1993) and with a deficit in adenosine-dependent metabolism 
(Boison et al., 2002). Mice carrying disrupted Adenosine Kinase (Adk) gene displayed normal 
embryonic development but within 4 days after birth they showed microvesicular hepatic 
steatosis and lethality within 2 weeks after birth, at which stage they also had fatty livers 
(Boison et al., 2002). Histological analysis of the livers from Adk mutant mice and wild type 
littermates performed at different perinatal time points (E17.5, P0.5, P2, P4, P6 and P14) did 
not reveal any morphological abnormalities in the livers of Adk mice at E17.5, but 12 h after 
birth (P0.5) the first morphological differences were observed in the form of microvesicular 
steatosis. The development of macrovesicular steatosis started at P2 as the entire cytoplasm 
was often occupied by lipids and the nucleus was frequently moved to the cell periphery. 
Eventually, a homogenous mixture of micro- and macrovesicular steatosis without any lobular 
predominance was observed at day P4 in the Adk mutant livers (Boison et al., 2002). Adk 
homozygous livers were similar size to wild type despite overall 20% growth reduction in Adk 
mutants, and their livers did not show any alterations in glycogen content as confirmed by PAS 
staining. Therefore, impaired adenosine metabolism has been implied as a potential source of 
neonatal hepatic steatosis, as it provided a model for the development of postnatal fatty liver 
leading to early mortality. There are similarities between the Adk and Grb10m/+ or 
Grb10m/+/Dlk1+/p neonatal fatty livers, as in both cases they develop during perinatal period 
and are not associated with altered liver glycogen content, however further examination of 
Grb10m/+ or Grb10m/+/Dlk1+/p late embryonic livers will help to specify if Grb10m/+ or 
Grb10m/+/Dlk1+/p mice develop fatty livers specifically upon birth or the liver lipid accumulation 
begins during late embryogenesis. In addition, unlike in the case of Adk mutant mice, neonatal 
fatty livers of Grb10m/+ or Grb10m/+/Dlk1+/p did not lead to lethality within first two weeks of 
life, probably due to the fact that in contrast to progressing hepatic steatosis in Adk livers, lipid 
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content of Grb10m/+ or Grb10m/+/Dlk1+/p livers appeared to diminish with time, as confirmed by 
decreased adiposity in Grb10m/+ or Grb10m/+/Dlk1+/p 1 week old livers compared to neonatal 
ones. Therefore, it is possible that two different mechanisms are underlying the development 
of Grb10m/+ or Grb10m/+/Dlk1+/p and also Adk fatty livers, but it still would be of interest to 
assess the possible contribution of adenosine metabolism to the liver pathology of Grb10m/+ or 
Grb10m/+/Dlk1+/p mice.  
In contrast to Adk mutant mice, fatty liver dystrophy (fld) mice are characterised by 
hypertriglyceridemia and fatty liver during neonatal development that spontaneously resolves 
between the age of 14–18 days (Rehnmark et al., 1998). It would be of interest to check at 
specifically what age the fatty livers are not detectable in Grb10m/+ or Grb10m/+/Dlk1+/p mice 
and if their increased liver adiposity also resolves at around 2 weeks after birth. Triglyceride 
accumulation in the fld fatty liver has been associated with disrupted expression of proteins 
involved in fatty acid oxidation as 60% reduction in hepatic fatty acid oxidation has been noted 
in fld neonates but was normal in adult fld mice that do not have fatty livers (Rehnmark et al., 
1998). Therefore, to investigate the biochemical basis for the increased lipid accumulation in 
Grb10m/+ or Grb10m/+/Dlk1+/p neonatal livers, their protein expression patterns could be 
compared to those of wild type littermates and quantification of rates of fatty acid oxidation 
could also be performed. An exciting discovery of specifically-neonatal hepatic steatosis in 
Grb10m/+ or Grb10m/+/Dlk1+/p livers and identification of the underlying causes could add to our 
understanding of genes and biochemical mechanisms contributing to fatty liver formation as it 
becomes clear that steatosis can lead to the development of more advanced liver pathology.  
The observation of liver lipid accumulation in adult Dlk1+/p mice could be explained by lack 
of Dlk1 affecting normal adipocyte differentiation and, subsequently, resulting in abnormal 
lipid storage, which is further supported by the elevated levels of triglycerides in blood serum 
of Dlk1+/p mice. Both liver lipid accumulation and elevated blood serum triglyceride levels were 
reported previously (Moon et al., 2002) and associated with lack of normal anti-adipogenic 
Dlk1 action. The occurrence and nature of the adult pancreatic overgrowth and its association 
with liver overgrowth is currently being investigated.  
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Figure 6.2 mTOR signalling and processes controlled by mTOR. Figure adapted from (Yea and 
Fruman, 2011). 
mTOR functions in two separate protein complexes (mTORC1 and mTORC2), which both act to 
control the majority of AGC (cAMP-dependent, cGMP-dependent and protein kinase C) protein 
superfamily members, including Akt and S6K1. mTORC1, which is activated downstream of 
insulin or IGFs, directly phosphorylates Grb10 and enhances its ability to inhibit signals from 
insulin and IGF receptors. This negative feedback loop is complementary to another feedback 
pathway with S6K1 phosphorylating IRS and targeting it for degradation.  
Allometric analysis did not show the previously demonstrated reduction of adiposity in 
Grb10m/+ or Grb10m/+/Dlk1+/p mice, and incidence of higher fat tissue content was found only in 
Dlk1+/p 3-6 month female mice. DXA analysis of body composition showed opposite trends in 
lean tissue content of Grb10m/+ and Dlk1+/p mice, with Grb10m/+ animals having a significantly 
elevated lean tissue mass. It would be interesting to investigate Grb10 function as a promoter 
of proliferation or differentiation of adipocytes by feeding Grb10m/+ and Grb10m/+/Dlk1+/p mice 
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on high fat diet, especially in light of previous studies showing opposite results of HFD on the 
fat tissue content in Dlk1+/p and Grb10m/+ mice, as the former showed significant increase in 
adipose depots (Moon et al., 2002) whereas the latter displayed significantly smaller fat depots 
when compared to control animals (Holt et al., 2009). As we did not see any changes in 
adipose/lean tissue composition of Grb10m/+/Dlk1+/p mice, it would be of interest to study 
changes within their body composition following high fat diet. Correlation between Grb10, 
Dlk1 and adipogenesis make them exciting targets in studying obesity.  
Grb10m/+ adult mice exhibit enhanced glucose metabolism, which has been partly 
associated with an increased lean/fat ratio (Smith et al., 2007; Wang et al., 2007). Recent study 
by our lab provided evidence that normal lean/fat ratio requires correct Grb10 function in both 
dam and pup, as by controlling supply and demand after birth, Grb10 regulates body 
composition (Cowley et al., submitted). This finding further supports a role for Grb10 in 
coadaptation between maternal and offspring genomes in order to optimise offspring fitness 
by influencing correct body proportions. It also indicates a role for Grb10 in early development 
programming of adult health status and suggests that adult lean/fat ratio in Grb10m/+ mice 
does not represent a postnatal-specific phenotype.  
Enhanced insulin signalling has been implicated as a cause of improved whole-body 
glucose homeostasis in Grb10 (Smith et al., 2007) and Grb14 deficient mice (Cooney et al., 
2004), but only mice with Grb10 ablation also exhibited reduced adipose tissue mass. 
Furthermore, the ablation of Grb7 likewise resulted in increased glucose tolerance and slightly 
reduced adiposity, suggesting overlapping roles in glucose-related metabolism for all members 
of the Grb7 protein family. Largely similar effects of Grb10 and Grb14 ablation in mice have 
encouraged the generation of compound knockout mice (Holt et al., 2009), but surprisingly 
double knockout animals did not show further increased insulin signalling but rather displayed 
an increase in lean mass, indicating that this is a function specific to the Grb10 gene. In spite of 
that, Grb10/Grb14 knockout mice were protected from adverse changes in glucose tolerance 
following feeding on a HFD, a result not observed in animals with the single gene ablations. 
This suggests Grb10 and Grb14 might not only regulate glucose homeostasis by exerting 
effects on Irs-1/Akt signalling, but employ some other mechanisms, and implies that genes 
within the Grb7 family might indeed prove to be excellent therapeutic targets for treatment or 
prevention of type 2 diabetes and obesity.  
Although the imprinting status of Grb10 and Dlk1 has been identified more than a decade 
ago (Miyoshi et al., 1998; Schmidt et al., 2000), the details of their regulation and modes of 
222 
 
action are yet to be determined, and with every new finding they continue to be even more 
exciting to work on. With time and more intricate studies of the Grb10 imprinting more 
interesting features are discovered in this unique gene, which makes it a great model for 
investigation of imprinted gene function and regulation. Grb10 is unusual among other 
imprinted genes, with its reciprocal, parent-of-origin- expression conserved in mice and human 
(Blagitko et al., 2000; Arnaud et al., 2003; Monk et al., 2009) that regulates entirely distinct 
physiological processes in a tissue-specific manner (Garfield et al, 2011). Preliminary results 
showing the function of the two zebrafish Grb10 orthologs suggest that the growth regulatory 
function of Grb10 might be mammal-specific, which is in agreement with the evolution of 
genomic imprinting in mammals but not fish (Lee, Kelsh and Ward, unpublished data). 
Although a recent study has proposed a novel mechanism by which tissue-specific imprinting 
of Grb10 is controlled (Sanz et al., 2008), the reasons underlying this kind of allele-specific 
expression remains unknown. Generation of mice with Grb10 ablation transmitted separately 
through each of the parental alleles allowed this issue to be addressed by characterising the 
role of each of the parental Grb10 alleles in a physiological context. Maternally expressed 
Grb10 regulates embryonic growth (Charalambous et al., 2003) and litter size (Charalambous 
et al., 2010) along with body composition and glucose-regulated metabolism (Smith et al., 
2007). Moreover, our lab has recently found that Grb10 maternal expression in mammary 
gland during pregnancy influences postnatal nutrient supply and demand, regulating the size 
of the offspring and that maternal and offspring Grb10 have distinct consequences on the 
body composition of the progeny (Cowley et al., submitted). On the other hand, the pattern 
and role of maternally imprinted Grb10 is somewhat different, as paternal Grb10 is mostly 
expressed in the CNS where it functions to control behaviour, specifically social dominance 
(Garfield et al., 2011). This is the first example of opposite imprinting within one gene that has 
evolved according to different, tissue-specific functions, and this situation is likely to be 
conserved in humans (Blagitko et al., 2000). The ability of Grb10 to control growth, metabolism 
and behaviour adds to the complexity and importance of imprinted genes in normal organism 
function and makes it a unique, exciting gene to study.  
Much attention has also been put into investigation of the establishment, function and 
regulation of the imprinted Dlk1/Dio3 locus (da Rocha et al., 2008; Edwards et al., 2008; Sato 
et al., 2011), as its developmental importance has been exemplified by dramatic phenotypes 
associated with altered dosage of genes within this locus in mice and humans. Impaired 
expression of genes within the Dlk1-Dio3 cluster results in a range of phenotypic alterations 
including growth abnormalities and developmental defects in the embryo and placenta as well 
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as disrupted adult metabolism and brain function. The Dlk1-Dio3 imprinted domain has 
emerged as a useful model for analysing the regulation, function, genomic organisation and 
evolution of imprinted clusters in mammalian species (reviewed in da Rocha et al., 2008; 
Edwards et al., 2008).  
Dlk1, situated within Dlk1-Dio3 cluster, is another very exciting gene to study, with its 
unusual structure and obviously crucial role in normal growth, development and metabolism. 
Dlk1 codes for a transmembrane glycoprotein with six EGF-like motifs in the extracellular 
domain, showing a similar structure to Delta-Notch-Serrate protein family, although it does not 
possess the DSL domain crucial for interacting with and activating the Notch receptor. Indeed, 
some studies have reported that Dlk1 can act as a Notch antagonist (Baladron et al., 2005; 
Nueda et al., 2007; Bray et al., 2008).  
Accumulated evidence suggests Dlk1 roles in a wide range of differentiation processes, 
including hematopoiesis (Bauer et al., 1998; Kaneta et al., 2000; Sakajiri et al., 2005), 
chondrogenesis (Chen et al., 2011), osteogenesis (Abdallah et al., 2004; Abdallah and Kassem, 
2011) and neuroendocrine (Floridon et al., 2000) and hepatocyte differentiation (Tanimizu et 
al., 2003). It has also been shown to regulate cell growth and cancer (Laborda et al., 1993; Yin 
et al., 2004; Kawakami et al., 2006). However, the most widely studied process regulated by 
Dlk1 is adipogenesis, as Dlk1 has been established as a potent inhibitor of adipocyte 
differentiation in vitro (Smas and Sul, 1993; Smas et al., 1998; Garces et al., 1999). Mouse 
models with Dlk1 gain and loss of function have unequivocally confirmed a crucial role for Dlk1 
in adipogenesis. Dlk1 was found to influence adipose tissue content, glucose homeostasis, and 
circulating levels of triglycerides as well as impaired expression of adipocyte markers and 
adipocyte-secreted factors (Moon et al., 2002; Lee et al., 2003; Villena et al., 2008). All these 
findings strongly support Dlk1 as a potent inhibitor of adipogenesis and indicate its possible 
roles in obesity (especially due to obesity observed in patients with mUPD14) and 
lipodystrophy, commonly associated with pathologies including diabetes and cardiovascular 
diseases.  
Aside from developmental roles, correct imprinting status is also crucial in postnatal 
health, as disrupted imprinted gene expression has been implicated in various diseases 
pronounced in adulthood, including cancers and neurological disorders such as Angelman and 
Prader-Willi syndromes (discussed in more detail in Section 1.1.4). Here we have 
demonstrated that Grb10 and Dlk1 ablation leads to number of postnatal phenotypic 
abnormalities in mice, although it is difficult to firmly state if they are direct consequences of 
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lack of Grb10 and Dlk1 postnatal expression or rather they result from fetal programming of 
adult growth. As expression of Grb10 and Dlk1 upon birth is largely restricted, it could be 
argued that fetal programming effects could be a more plausible explanation for the observed 
phenotypes.  
It was interesting to find that the embryonic growth similarities between Grb10m/+/Dlk1+/p 
and Grb10m/+ mice discussed in Chapter 3 had similar foundations for both genotypes, as we 
demonstrated that hyperproliferation is the most probable cause of the observed embryonic 
overgrowth phenotype. Interestingly, growth effects seen during embryogenesis were largely 
persistent until day of birth, as we revealed significant overgrowth in Grb10m/+/Dlk1+/p and 
Grb10m/+ neonates among other changes within neonatal organ weights, including liver 
overgrowth and cranial sparing discussed in Chapter 4. Aside from that, we also found that 
Grb10m/+/Dlk1+/p and Grb10m/+ handled a glucose load in a similar manner, displaying the 
capacity to clear the glucose significantly faster than control animals (Chapter 5), which 
indicated that this ability is associated with enhanced insulin signalling rather than increased 
lean tissue mass, as has previously been suggested for Grb10m/+ mice. An epistatic interaction 
between two genes is observed if the combined effects of mutations in both genes are 
different from the sum of each mutation’s individual effects. Better understanding of epistatic 
genetic interactions is needed to uncover the genotype-phenotype relationships. The 
generation of Grb10m/+/Dlk1+/p double knockout mice proved to be of a great benefit in 
investigating the possible epistatic interaction between Grb10 and Dlk1 genes, although it was 
expected that not all aspects of Grb10m/+andDlk1+/p knockout mice phenotypes will be 
mirrored by Grb10m/+/Dlk1+/p and explained by their interaction. Here we demonstrate that 
Grb10 and Dlk1 genes can potentially interact with each other in order to regulate embryonic 
and placental growth, postnatal size and morphology of several organs and some aspects of 
adult metabolism (summarised in Table 6.1). Further investigation, specifically of the details of 
biochemical basis of Dlk1-Grb10 interaction is under way, as Western Blot analysis of embryos 
and mid-gestational livers should provide some further evidence for possible Grb10 and Dlk1 
interaction.  
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Prenatal analysis Postnatal analysis Metabolic analysis 
E12.5, E14.5 and E17.5 
embryonic overgrowth 
Neonatal body and live 
overgrowth, cranial and 
kidney sparing, thicker 
epithelial walls in neonatal 
lungs 
Significantly improved 
ability to clear glucose 
load 
E14.5 placental overgrowth 
3-6 month old males: 
increased wet and relative 
pancreas weights, decreased 
wet weights of the kidneys 
and relative liver weights 
Lower glucose levels in fed 
female mice 
Higher proliferation rate of 
E14.5 pMEFs 
7-9 month old males: smaller 
wet and relative kidney 
weights 
Increased liver lipid 
accumulation in neonatal 
and 1 week old mice 
Shortened S-phase and 
elongated G2-phase of the 
cell cycle 
3-6 month old females: 
higher relative pancreas 
weights decreased renal fat 
pad weights 
 
Table 6.1 Summary of the phenotypic features shared between Grb10m/+/Dlk1+/p and 
Grb10m/+ mice that were significantly different to those of wild type mice.  
To summarise, the studies described here have not only confirmed and widened our 
knowledge on the crucial roles of Grb10 and Dlk1 genes in correct embryonic and postnatal 
growth and development and adult metabolism, but most importantly provided evidence for 
a possible interaction between these two genes within the same genetic pathway (Figure 6.1). 
The majority of studies presented here have substantiated the hypothesis that Grb10 and Dlk1 
form part of an epistatic pathway, in which Dlk1 inhibits Grb10 which in turn acts to supress 
growth and exert other effects on the correct heath status of an organism. Whether this 
interaction is direct or indirect remains to be determined. The results presented here provide 
a foundation for future investigations of a novel imprinted gene pathway consisting of genes 
that are able to influence the crucial sites of imprinted gene action: growth, metabolism and 
behaviour.  
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Appendix 1 
 
Analysis of feeding behaviour in 3-6 month old wild type, Grb10m/+, Dlk1+/p and 
Grb10m/+/Dlk1+/p mice.  
Food intake was monitored over a period of two weeks. Food consumption rates have been 
calculated as food consumed per gram of animal body weight per day to the power of 2/3.  
A) Total amount of consumed food by males. B) Total amount of consumed food by females.  
C) Male consumption rates: total weight of food consumed by males per gram of body weight 
per day to the power of 2/3. D) Female consumption rates: total weight of food consumed by 
females per gram of body weight per day to the power of 2/3. There were no significant 
changes neither in the amounts of consumed food or in food consumption rates of transgenic 
mice when compared to wild type controls. E) Table summarising results of statistical analysis. 
All values represent means ± SEM and have been subject to one way ANOVA with post hoc 
Tukey’s analysis. Males: WT n=7, Dlk1+/p=7, Grb10m/+ n=6 and Grb10m/+/Dlk1+/p n=7; females: 
WT n=9, Dlk1+/p=6, Grb10m/+ n=6 and Grb10m/+/Dlk1+/p n=7. 
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Analysis of feeding behaviour in 7-9 month old wild type, Grb10m/+, Dlk1+/p and 
Grb10m/+/Dlk1+/p mice.  
Food intake was monitored over a period of two weeks. Food consumption rates have been 
calculated as food consumed per gram of animal body weight per day to the power of 2/3.  
A) Total amount of consumed food by males. B) Total amount of consumed food by females.  
C) Male consumption rates: total weight of food consumed by males per gram of body weight 
per day to the power of 2/3. D) Female consumption rates: total weight of food consumed by 
females per gram of body weight per day to the power of 2/3. There were no significant 
changes neither in the amounts of consumed food or in food consumption rates of transgenic 
mice when compared to wild type controls. E) Table summarising results of statistical analysis. 
All values represent means ± SEM and have been subject to one way ANOVA with post hoc 
Tukey’s analysis. Males: WT n=7, Dlk1+/p=6, Grb10m/+ n=6 and Grb10m/+/Dlk1+/p n=6; females: 
WT n=6, Dlk1+/p=6, Grb10m/+ n=6 and Grb10m/+/Dlk1+/p n=5. 
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Appendix 2 
 
Glucose tolerance in male and female wild type, Grb10m/+, Dlk1+/p and Grb10m/+/Dlk1+/p mice.  
Male and female 3-9 months old mice were examined for their ability to clear an 
intraperitoneal dose of glucose. A) and B) Results from glucose tolerance tests for male and 
female mice. C) and D) Histograms representing areas under glucose curves for male and 
female mice. Analysis of areas under glucose curves revealed that Grb10m/+ and 
Grb10m/+/Dlk1+/p mice of both sexes cleared glucose significantly faster than Dlk1+/p (**p<0.01) 
animals. E) Table summarising results of statistical analysis. All values represent means ± SEM 
and have been subject to one way ANOVA with post hoc Tukey’s analysis. Males: WT n=14, 
Dlk1+/p=12, Grb10m/+ n=12 and Grb10m/+/Dlk1+/p n=13; females: WT n=13, Dlk1+/p=12, Grb10m/+ 
n=12 and Grb10m/+/Dlk1+/p n=12. 
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